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DNA methylation at carbon 5 of cytosine (5-methylcytosine, 5-meC) is a stable but 
reversible epigenetic mark associated to gene silencing, and plays essential roles in 
development and genome defense against transposons. DNA methylation patterns are 
the dynamic outcome of methylation and demethylation processes, but the latter are not 
yet well understood in animal cells. In plants, however, there is genetic and 
biochemical evidence that a family of DNA glycosylases excise 5-meC and initiate 
active DNA demethylation through a base excision repair (BER) pathway. Arabidopsis 
thaliana ROS1 is a representative enzyme of such family, whose members are uniquely 
characterized by a discontinuous catalytic domain, a conserved carboxy-terminal 
domain of unknown function, and a basic amino-terminal domain mediating 
nonspecific binding to DNA. A first aim of this thesis has been to investigate how 
ROS1 and its homologs recognize and excise its target base. Results obtained show that 
ROS1 uses three predicted helix-invading residues (Q607, M905 and R903) to actively 
interrogate DNA in search for 5-meC and to destabilize 5-meC:G base pairs. During 
this process, Q607 restrains ROS1 sliding on DNA. 
ROS1 removes 5-meC at several hundred loci across the genome in vegetative tissues, 
apparently to counteract excessive methylation. However, it is still unknown how 
ROS1 activity is directed to specific genomic regions. In chromatin, DNA is intimately 
associated to core histones (H2A, H2B, H3 and H4), whose N-terminal tails undergo 
different post-translational modifications. A second major aim of this thesis has been to 
determine whether ROS1 interacts with histones and the possible functional relevance 
of such interaction. It has been found that the C-terminal domain of ROS1 binds the N-
tails of histones H2A, H3 and H4. Importantly, interaction with H3 is specifically 
abrogated by phosphorylation of Ser28, which suggests a possible mechanism to 
restrict ROS1 activity to defined chromatin locations. 
Targeted demethylation is a major objective of Epigenetic Editing, which aims to 
modulate gene expression by overwriting of epigenetic marks at specific genome 
regions. A third major aim of this thesis has been to transform ROS1 in an epigenetic 
editing tool by fusing its catalytic domain to a specific DNA binding domain, in order 
to direct its activity to desired target sequences. Recombinant ROS1 fused to either the 
natural GAL4 DNA Binding Domain (GBD-ROS1) or an engineered zinc finger 
protein (ZFP-ROS1) displays preferential DNA binding and enzymatic activity on 
specific sequences in vitro. Transient expression of GBD-ROS1 in human cells elicited 
targeted demethylation and reactivation of a methylation-silenced reporter gene. 
Additional studies are needed to achieve similar results with ZFP-ROS1 or with an 
RNA-guided CRISPR-based system (dCas9-ROS1). 
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Altogether, the results obtained in this thesis shed light onto the mechanisms of active 
DNA demethylation in plants and support the feasibility of using plant 5-meC DNA 
glycosylases as epigenetic editing tools. 
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La metilación del DNA en el carbono 5 de la citosina (5-metilcitosina, 5-meC) es una 
marca epigenética estable, pero reversible, que promueve el silenciamiento génico y 
que desempeña un papel importante en el desarrollo y en la defensa del genoma frente a 
elementos transponibles. Los patrones de metilación del DNA son el resultado 
dinámico de procesos de metilación y desmetilación, pero estos últimos todavía no se 
conocen con detalle en células animales. Sin embargo, en plantas hay convincentes 
pruebas genéticas y bioquímicas de que proteínas de una familia de DNA glicosilasas 
escinden 5-metilcitosina e inician una ruta de desmetilación activa del DNA a través de 
una ruta de reparación por escisión de bases (Base Excision Repair, BER). La proteína 
ROS1 de Arabidopsis thaliana es una enzima representativa de esta familia, cuyos 
miembros se caracterizan por presentar un dominio catalítico discontinuo, un dominio 
carboxilo-terminal muy conservado entre ellas pero de función desconocida, y un 
dominio amino-terminal básico implicado en la unión inespecífica a DNA. Un primer 
objetivo de esta tesis ha sido investigar cómo ROS1 y sus homólogos reconocen y 
escinden su base diana. Los resultados obtenidos muestran que ROS1 intercala tres 
aminoácidos (Q607, R903 y M905) en la doble hélice para interrogar activamente el 
DNA en busca de 5-meC y para desestabilizar pares de bases 5-meC:G. Durante este 
proceso, Q607 frena el deslizamiento de ROS1 a lo largo del DNA. 
ROS1 elimina 5-meC de varios cientos de genes en tejidos vegetativos, aparentemente 
para contrarrestar una metilación excesiva. Sin embargo, aún no se conoce cómo se 
dirige la actividad de ROS1 a regiones concretas del genoma. En la cromatina, el DNA 
está íntimamente asociado a histonas (H2A, H2B, H3 y H4), cuyas colas amino-
terminales sufren diferentes modificaciones post-traduccionales. Un segundo objetivo 
de esta tesis ha sido determinar si ROS1 interacciona con histonas y la posible 
relevancia funcional de dicha interacción. Se ha encontrado que el dominio carboxilo-
terminal de ROS1 se une a las colas amino-terminales de las histonas H2A, H3 y H4. 
Además, la fosforilación de la Ser28 inhibe de forma específica la interacción con H3, 
lo que sugiere un posible mecanismo para restringir la actividad de ROS1 a posiciones 
concretas de la cromatina. 
La desmetilación dirigida a secuencias concretas es un objetivo importante de la 
Edición Epigenética, cuyo propósito es modular la expresión génica a través de la 
sobreescritura de marcas epigenéticas en regiones específicas del genoma. Un tercer 
objetivo de esta tesis ha sido transformar ROS1 es una herramienta para la edición 
epigenética mediante la fusión de su dominio catalítico a dominios de unión a DNA 
específicos, con el fin de dirigir su actividad a secuencias diana deseadas. Proteínas 
recombinantes que contienen el dominio catalítico de ROS1 fusionado al dominio 
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natural de unión a DNA de GAL4 (GBD-ROS1) o a proteínas artificiales de dedos de 
zinc (ZFP-ROS1) muestran una unión a DNA y una actividad enzimática preferencial 
sobre secuencias específicas in vitro. Además, la expresión transitoria de GBD-ROS1 
en células animales promueve in vivo la desmetilación dirigida y la consiguiente 
reactivación de un gen reportero silenciado por metilación. Se requieren estudios 
adicionales para conseguir resultados similares con ZFP-ROS1 o con un sistema 
dirigido por RNA basado en CRISPR (dCas9-ROS1). 
En definitiva, los resultados obtenidos en esta tesis han contribuido a aclarar algunos 
aspectos del mecanismo de desmetilación activa del DNA en plantas y respaldan la 
posibilidad de utilizar 5-meC DNA glicosilasas como herramientas para la edición 
epigenética. 
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1. Chromatin and Epigenetics 
Eukaryotic genomes are composed of linear molecules of DNA packaged inside the cell 
nucleus by binding to proteins in a complex and dynamic association called chromatin. 
These proteins comprise mainly histones, which are intimately associated to DNA 
(Hayes and Hansen, 2001), but also include polymerases, topoisomerases, and 
regulatory factors. Changes in chromatin structure control gene expression and other 
fundamental cellular processes, and can be inherited independently of the DNA 
sequence itself (Felsenfeld and Groudine, 2003). Such regulatory role of chromatin as 
an organizing principle for genomes has become the major focus of a rapidly advancing 
field known as Epigenetics.  
Epigenetics is classically defined as “the study of mitotically and/or meiotically 
heritable changes in gene function that cannot be explained by changes in DNA 
sequence” (Russo, 1996). The use of the term “heritable” has been abandoned in recent 
usage, allowing the term epigenetic to mean the information carried by chromatin, not 
coded in DNA. However, it is important to retain the classic term, that includes 
heritability, as it defines a non-genetic memory of gene function that is transmitted 
from generation to generation (Kouzarides, 2007). There are several types of important 
biological phenomena that fit both the classic and modern definitions of the term 
epigenetic. Some examples are X chromosome inactivation in female mammalian cells 
for dosage compensation, genomic imprinting causing parent-of-origin dependent gene 
expression, or even cell differentiation, where different patterns of gene expression are 
generated from an unique genome which its DNA sequence is invariable during 
organismal development (Goldberg et al., 2007).  
Progress in Epigenetics has favored the use of the concept epigenome as responsible for 
genome regulation (Beck et al., 1999). The epigenome includes a set of epigenetic 
marks that provide an additional layer of information superimposed on the DNA 
sequence. Unlike the genome, which is identical in all cell types throughout life, the 
epigenome is dynamic and changes in each cell type and in every moment of the life 
cycle. To date, two types of epigenetic marks have been identified: DNA methylation 
and covalent modifications of histones (Holliday, 2005; Tamaru and Selker, 2001).  
1.1. Chromatin structure 
DNA, comprising a double helix with a diameter of 2 nm, binds to histones proteins to 
create nucleosomes with a diameter of 11 nm, the fundamental repetitive subunit of 
chromatin. Each nucleosome consists of ∼150 base pairs (bp) of DNA wound around a 
Doctoral Thesis  Jara Teresa Parrilla Doblas 
12 
central octamer containing two molecules of each core histone: H2A, H2B, H3 and H4. 
Nucleosomes are interconnected by ∼50-70 bp DNA linker segments, and fold into a 
compact fiber with a diameter of ∼30 nm by the action of a fifth histone called histone 
H1. This structure further compacts through interactions with non-histone proteins until 
reaching the maximal level of packaging in metaphasic chromosomes, which are visible 
in dividing cells (Figure 1). In non-dividing cells, chromatin is distributed throughout 
the nucleus into highly condensed regions (heterochromatin) and more open regions 
(euchromatin) (Felsenfeld and Groudine, 2003). The structure and packaging states of 
chromatin are related with transcriptional activity: while heterochromatin is 
transcriptionally inactive, euchromatin is transcriptionally active (Bender, 2004a). 
Specific euchromatic regions can be silenced by packaging in a heterochromatic form 
known as facultative heterochromatin, which is silenced only at specific moments and 
is different in each cell type. Heterochromatin that is permanently silenced and is 
identical in all cell types is known as constitutive heterochromatin (Richards and Elgin, 
2002).  
Figure 1. Packaging chromatin levels. The nucleosome, which is composed by two turns of 
DNA wound around a histone octamer, is the lowest level of organization. Nucleosomes are 
connected to one another by short stretches of linker DNA and fold into a fiber with a diameter 
of ∼30 nm by the action of the linker histone H1. These fibers are then further folded into 
higher-order structures until reaching the maximal packaging level in metaphasic chromosomes.  
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1.2. Chromatin modifications 
Chromatin is dynamic and alterations in its structure change its accessibility to different 
enzymes that participate in processes that require DNA as template, such as replication, 
transcription, recombination, and repair.  
Chromatin structure can be modulated by several mechanisms that are not mutually 
exclusive but cooperate to regulate chromatin structure and DNA accessibility (Hsieh 
and Fischer, 2005). First, DNA methylation at carbon 5 of cytosine (5-methylcytosine) 
modulate chromatin structure by recruiting protein complexes that bind to methylated 
DNA and promote gene silencing (Hsieh and Fischer, 2005). Second, posttranslational 
modifications of histones (such as acetylation, methylation, or phosphorylation) 
directly or indirectly influence chromatin structure, since they act as signal marks that 
can be read by different effector/reader proteins and chromatin-remodeling enzymes, 
influencing in particular cellular processes. Third, canonical histones can be replaced 
with histone variants, which possess different properties and create localized specific 
domains within the chromatin fiber. Finally, ATP-dependent remodeling complexes 
can modify the positioning of nucleosomes on DNA to temporarily open or close 
chromatin conformation for specific enzymatic reactions (Kouzarides, 2007). 
 
2. DNA methylation 
DNA methylation is present in prokaryotic and eukaryotic genomes. In prokaryotes 
methylation can occur in adenine and cytosine bases, and is associated with restriction 
modification systems (Wilson and Murray, 1991). Only adenine methylation serves as 
an epigenetic modification in bacteria, controlling DNA-protein interactions 
(Casadesus and Low, 2006). In eukaryotes, DNA methylation is only present at 
cytosine residues and functions as an epigenetic mark that inhibits gene expression 
(Bender, 2004b; Bird, 2002), regulating many critical biological processes such as gene 
imprinting, silencing of transposable elements, and X-chromosome inactivation (Zhang 
and Zhu, 2012). Cytosine methylation inhibits gene expression either directly by 
blocking transcription factor from binding their target sites (Figure 2A), or indirectly by 
proteins that specifically recognize methylated DNA through methyl binding domains 
(MBD), and in turn recruit repressor factors that modify chromatin structure and silence 
transcription (Figure 2B) (Klose and Bird, 2006). 
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Figure 2. Mechanisms for DNA methylation-induced transcriptional repression. (A) The 
transcription factor (TF) cannot bind DNA since it does not recognize its target sequence when 
DNA is methylated. (B) Proteins that specifically bind methylated DNA (Methyl Binding 
Proteins, MBP) recruit co-repressors, which modify the chromatin state and promote 
transcriptional silencing. Modified from (Klose and Bird, 2006). 
2.1. Genomic distribution of DNA methylation 
DNA methylation levels are different between species. While 3-8% of mammalian 
cytosines are methylated (Jeltsch, 2002), this percentage varies from 6% to 30% in 
plants (Chen and Li, 2004). At the low extreme, only 0.001% of cytosines are 
methylated in Drosophila melanogaster, whereas methylation levels in yeast and 
nematodes genomes are undetectable (Doerfler, 1983). Furthermore, the genomic 
distribution of DNA methylation varies between mammals and plants.  
In mammals, DNA methylation is mainly restricted to symmetrical CG sequences, also 
designated as CpG sites (Ehrlich et al., 1982). About 70-80% of all CG dinucleotides 
are methylated along the mammalian genome (Bird, 2002), including coding regions 
and non-coding DNA such as introns, repetitive elements and transposons (Jones and 
Takai, 2001). In mammalian genomes, CG sequences are less frequent than expected 
according to the G+C content, and many are clustered in regions of relatively high CG 
density known as CpG islands. CpG islands are usually unmethylated, and are 
frequently associated with gene promoters (Figure 3A) (Jones and Takai, 2001; Weber 
and Schubeler, 2007). Mammalian DNA can also be methylated in non-CG contexts, as 
has been observed in embryonic stem cells (Lister et al., 2009; Ramsahoye et al., 2000). 
In plants, although DNA methylation predominantly occurs in the CG context, 
significant levels are also found in both symmetrical CHG and asymmetrical CHH 
sequences (where H represents either C, A or T) (Henderson and Jacobsen, 2007). Plant 
DNA methylation is located mainly in heterochromatic regions rich in repetitive 
sequences (centromeres, telomeres and transposons), but a significant proportion is 
located in the coding sequences of active genes (Zhang et al., 2006; Zilberman et al., 
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2007), where it may silence cryptic promoters and/or avoid that abnormal transcripts 
interfere with normal gene expression (Figure 3B). 
Figure 3. Genomic distribution of DNA methylation. (A) In mammals. (B) In plants. For 
details, see text. Modified from (Weber and Schubeler, 2007). 
2.2. Mechanisms of DNA methylation 
DNA methylation is catalyzed by DNA methyltransferases that transfer a methyl group 
from S-adenosil-L-methionine (Adomet) to carbon 5 of cytosine, generating 5-
methylcytosine (5-meC) (Figure 4) (Grace Goll and Bestor, 2005).  
Figure 4. Chemical structure of cytosine and 5-methylcytosine. 
DNA methylation patterns are established by de novo DNA methyltransferases at non-
methylated specific sequences early in development. Methylation patterns are preserved 
during cell division by maintenance methyltransferases, which preferentially recognize 
hemimethylated symmetrical sequences (CG and CHG) produced by semiconservative 
DNA replication and methylate the symmetrical cytosines in the new strand (Figure 5). 
Maintenance of methylation patterns of asymmetrical sequences (CHH) is not yet well 
understood, but likely involves de novo methylation after each replication cycle (Bird, 
2002; Grace Goll and Bestor, 2005). 
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Figure 5. Establishment and maintenance of DNA methylation patterns. For details, see 
text. 
A large number of eukaryotic DNA methyltransferase homologues have been identified 
by sequence similarity. Although the fungal enzymes show greater divergence, most 
DNA methyltransferases can be grouped into four distinct families based on sequence 
homology within their C-terminal catalytic domains: DNMT1, DNMT2, DNMT3 A/B 
and DMNT3L in mammals, and MET1 (DNA METHYLTRANSFERASE 1), DNMT2, 
DRM1/2 (DOMAINS REARRANGED METHYLTRANSFERASE 1/2) and CMT3 
(CHROMOMETHYLASE 3) in plants (Figure 6). Some eukaryotes, notably 
Caenorhabditis elegans and Saccharomyces cerevisiae, lack detectable cytosine 
methylation in their genomes and have no sign of any DNA methyltransferase coding 
sequence (Grace Goll and Bestor, 2005). 
In mammals, DNMT3A and DNMT3B catalyze de novo methylation during early 
embryogenesis (Sasaki and Matsui, 2008), and DNMT3L, which lacks DNA 
methyltransferase activity, functions as a regulatory factor (Grace Goll and Bestor, 
2005). DNMT1 shows preference for hemimethylated DNA and catalyzes maintenance 
DNA methylation together with a cofactor called UHRF1 (ubiquitin-like containing 
PHD and RING finger domains 1). An altered pattern of DNA methylation is central to 
many common human diseases (Robertson and Wolffe, 2000), including cancer. The 
genome of cancer cells is usually hypomethylathed, whereas tumor-suppressor genes 
are transcriptionally silenced by CpG-island-promoter hypermethylation (Esteller, 
2007). 
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Figure 6. Domain organization and sequence comparison of DNA methyltransferases 
from different species. Families of DNA methyltransferases and their homologs in M. 
musculus, A. thaliana and N. crassa. In addition to the catalytic domain, other conserved 
domains that participate in protein-protein and DNA-protein interactions are indicated. Modified 
from (Goll and Bestor, 2005). 
In plants, the domains rearranged methyltransferase (DRM) family is responsible for 
the initial establishment of methylation in all sequence contexts by a process called 
RNA-directed DNA methylation (RdDM), which actively targets the methyltransferase 
to DNA through 24-nt small interfering RNAs (siRNAs) (Cao et al., 2000). MET1 
(together with the cofactor VIM, VARIATION IN METHYLATION), and CMT3 
(which recognizes H3K9 methylated by the histone methyltransferase KYP, 
KRYPTONITE), maintain methylation of CG and CHG sequences, respectively (Grace 
Goll and Bestor, 2005; Saze et al., 2012). DNA methylation of CHH sequences is 
maintained by constant de novo DNA methylation carried out by DRM2 (Matzke and 
Birchler, 2005), although it is additionally controlled by CMT3 and DRM2 in some loci 
(Cao et al., 2003). Inactivation of different genes coding for DNA methyltransferases in 
mammals and plants helped to understand DNA methylation functions during 
development and its fundamental role in transposons silencing and other cellular 
processes (Holliday and Pugh, 1975; Yoder et al., 1997). 
Interestingly, DNMT2 displays weak DNA methyltransferase activity and actually 
functions as an RNA methyltransferase. DNMT2 has the same function in mammals, 
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flowering plants, and dipteran insects: it specifically methylates cytosine-38 in the 
anticodon loop of aspartic acid transfer RNA that protects tRNAs from cleavage under 
stress conditions (Goll et al., 2006; Schaefer et al., 2010). 
 
3. DNA demethylation 
Although methylation patterns are stable during successive cell divisions, DNA 
methylation is a reversible process. Therefore, methylation patterns are subject to 
dynamic regulation involving both methylation and demethylation processes in 
response to developmental and environmental cues (Roldán-Arjona and Ariza 2009). 
DNA demethylation can be either passive or active. Passive demethylation involves 
dilution of 5-meC after DNA replication cycles in the absence of maintenance 
methylation. Active demethylation occurs independently of replication and involves 
one or more enzymes (Kress et al., 2001).  
Evidence for active demethylation in animals derives from genome-wide 
reprogramming events during development. In mammalian embryos, for example, the 
paternal genome is rapidly demethylated immediately after fertilization in the absence 
of replication, whereas the maternal genome is subsequently demethylated by a passive 
mechanism. Both genomes are remethylated after implantation. Methylation levels of 
imprinted genes and some methylated repeat sequences are not altered. A second 
demethylation wave involves erasure of genome-wide DNA methylation patterns in 
primordial germ cells (PGCs) after implantation (Reik and Dean, 2001). 
In plants, modifications of methylation patterns during normal development and stress 
response are well documented (Messeguer et al., 1991; Steward et al., 2002). The most 
conclusive evidence of alteration of methylation patterns during plant development 
concerns genomic imprinting (Feng et al., 2010), which refers to parent-of-origin 
dependent gene expression and occurs in both animal and plants (Feil and Berger, 
2007). In plants, this process requires an active demethylation of the maternal genome 
that affects gene expression in the seed endosperm (Hsieh et al., 2009), a food reserve 
tissue similar to mammalian placenta. In Arabidopsis endosperm, paternal alleles of 
MEA, FIS2 and FWA genes are hypermethylated, whereas maternal alleles of these 
genes are hypomethylated (Jullien et al., 2006; Kinoshita et al., 2004). 
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In addition to genome-wide regulation during early development, active DNA 
demethylation also functions extensively in locus-specific gene expression in plants and 
animals (Zhang and Zhu, 2012). 
3.1. Mechanisms of active DNA demethylation 
Three different biochemical mechanisms of active DNA demethylation, which differ in 
the first step involved, have been proposed (Kress et al., 2001; Wu and Zhang, 2014): 
1) direct removal of the methyl group, 2) excision of the methylated nucleotide together 
with one or more surrounding nucleotides through a Nucleotide Excision Repair (NER) 
pathway, and 3) excision of the methylated base or its derivatives by a Base Excision 
Repair (BER) mechanism (Figure 7). To date, none of these mechanisms has been 
generally accepted in animals. However, in plants there is biochemical and genetic 
evidence of direct removal of 5-meC through a BER mechanism. 
1) Direct removal of the methyl group 
Although this is a thermodynamically unfavorable reaction, one study proposed that 
methyl-CpG-binding domain protein 2 (MBD2) has DNA demethylase activity in vitro, 
replacing the methyl group by a hydrogen atom in a reaction that releases methanol 
(Bhattacharya et al., 1999). However, other laboratories could not reproduce this 
finding (Ng et al., 1999; Wade et al., 1999) and active 5-meC elimination occurs 
normally in fertilized oocytes lacking MBD2 (Wu and Zhang, 2010). 
Figure 7. Mechanisms of active DNA demethylation. See text for details. Modified from 
(Kress et al., 2001). 
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2) Excision of the methylated nucleotide by Nucleotide Excision Repair 
Nucleotide Excision Repair (NER) repairs bulky DNA lesions formed by exposure to 
radiation or chemicals, and is a potential mechanism to indirectly eliminate 5-meC 
through excision of short genomic regions (usually 24–32 nucleotides) that contain 
methylated cytosine nucleotides (Weiss et al., 1996). The GADD45a (Growth Arrest 
and DNA Damage-inducible protein 45) protein was reported to stimulate active DNA 
demethylation in mammals together with XPG (Xeroderma Pigmentosum 
Complementation group G), a nuclease that repairs DNA through NER (Barreto et al., 
2007). However, Gadd45a null mice have no global alteration in DNA methylation 
levels (Engel et al., 2009).  
3) Excision of the methylated base or its derivatives by Bases Excision 
Repair 
In plants, active DNA demethylation is initiated by a family of DNA glycosylases 
(DML family, DEMETER-LIKE) that specifically excise 5-meC and trigger its 
replacement with unmethylated C in a Base Excision Repair (BER) process (Figure 8) 
(Roldán-Arjona and Ariza 2009; Wu and Zhang, 2010; Zhu, 2009) (see Section 6 
Introduction).  
Animal cells apparently lack 5-meC DNA glycosylases. Although TDG and/or MBD4 
(Methyl-Binding Domain protein 4) have been reported to excise 5-meC, they do so 
with an extremely low efficiency, compared to their activity on T:G or U:G mispairs, 
and its relevance in vivo remains uncertain (Hardeland et al., 2007; Zhu et al., 2000). 
Furthermore, no sequences encoding structural DML homologs have been identified in 
metazoan genomes. However, there is some evidence that animals may use BER of 
oxidized and/or deaminated derivatives of 5-meC to perform active demethylation 
(Bhutani et al., 2011; Gong and Zhu, 2011) (Figure 8). 
Active demethylation via oxidation involves the Ten-Eleven Translocation (TET) 
family, which includes TET1, TET2, and TET3 enzymes. TET enzymes are Fe(II) and 
α-oxoglutarate-dependent dioxygenases that can hydroxylate 5-meC to form 5-
hydroxymethylcytosine (5-hmeC) in vitro and in vivo (Branco et al., 2012; Ito et al., 
2010), and can further oxidize 5-hmeC to 5-formylcytosine (5-fC) and 5-
carboxylcytosine (5-caC) (Ito et al., 2011). The oxidation derivatives 5-fC and 5-caC 
can be actively removed by a specific DNA glycosylase, such as TDG, thus initiating a 
BER demethylation pathway. They might also be substrates of a putative deformylase 
and decarboxylase, respectively, which have not been identified yet (Raiber et al., 
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2012) (Figure 8). By other hand, it has been reported that DNMT1, the maintenance 
DNA methyltransferase, is much less efficient on hemi-hydroxymethylated substrates 
than on hemimethylated ones (Hashimoto et al., 2012). Therefore, the presence of 5-
meC oxidative derivatives could also facilitate passive DNA demethylation. 
Active demethylation in animal cells might also occur via a deamination pathway 
mediated by Activation-Induced Deaminase (AID)/Apolipoprotein B mRNA-Editing 
Enzyme Complex (APOBEC) family members, which can deaminate 5-meC or 5-
hmeC to form thymidine (T) or 5-hydroxymethyluracil (5-hmeU), respectively (Guo et 
al., 2011). These deaminated intermediates may be replaced by unmethylated C through 
BER initiated by DNA glycosylases such as TDG, MBD4, or Single-Strand Specific 
Monofunctional Uracil-DNA Glycosylase (SMUG1) (Shen et al., 2014) (Figure 8). 
Figure 8. Passive and active DNA demethylation pathways. See text for details. 
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4. DNA glycosylases 
4.1. Catalytic mechanism and Base Excision Repair (BER) 
pathway 
DNA glycosylases are monomeric enzymes that recognize lesions (oxidation, 
alkylation and deamination of the nucleobases) caused by endogenous or exogenous 
genotoxic agents or replication errors. These enzymes catalyze the cleavage of the N-
glycosidic bond between the target base and the sugar-phosphate backbone, initiating 
the Base Excision repair (BER) pathway (Figure 9) (Scharer and Jiricny, 2001). 
Figure 9. Base excision repair (BER) pathway. For details, see text. UA = unsaturated 
aldehyde; P = phosphate group; dRP = deoxyribose-phosphate. Modified from (Baute and 
Depicker, 2008).  
There are different types of DNA glycosylases, each specialized for a particular type of 
chemical damage or a range of structurally related lesions. There is emerging evidence 
that most DNA glycosylases search for the target base through facilitated diffusion, in a 
process that may combine a one-dimensional (1D) diffusion of the protein along the 
contour length of DNA, called sliding, and short- or long-range three-dimensional (3D) 
intramolecular excursions named hopping or jumping, respectively (Loverdo et al., 
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2009). During hopping and sliding, the DNA glycosylase acquires a conformation 
known as search complex (SC), followed by the formation of a transient interrogation 
complex (IC), where the enzyme extra-helically inspects both normal and damaged 
bases. The IC rapidly collapses back to the SC in case of a normal base, while a 
catalytically competent excision complex (EC) is formed in case of a damaged base 
(Friedman and Stivers, 2010) (Figure 10).  
Figure 10. Proposed mechanism used by DNA glycosylases for searching and recognition 
of damaged bases. The search complex is the conformation acquired by the DNA glycosylase 
during hopping and sliding along DNA. A transient interrogation complex serves for extra-
helical interrogation of both normal and damaged bases. An excision complex is specifically 
formed in case of a damaged base. Modified from (Friedman and Stivers, 2010). 
Most DNA glycosylases studied to date remove the target base through a base flipping 
mechanism, that is, by DNA bending and distortion that facilitate the extrusion of the 
damaged base. Then, the damaged base is inserted into a hydrophobic pocket so that the 
enzyme can access to the N-glycosidic bond, and an amino acid (called the base flipper 
residue) fills in the vacant space left behind in the double helix by the flipped base. In 
some cases, the intercalated residue and/or other enzyme residues interact with and 
detect the opposite base in the complementary strand (Dalhus et al., 2009; Huffman et 
al., 2005).  
DNA glycosylases can be monofunctional, when they only cleave the N-glycosidic 
bond and excise the target base (DNA glycosylase activity), or bifunctional, when 
excision is followed by an additional cleavage of the sugar phosphate backbone (AP 
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lyase activity) (Friedberg et al., 1995) (Figure 11). Monofunctional DNA glycosylases 
cleave the glycosidic bond between N and C1′ by using an activated water molecule as 
nucleophile to attack C1′ of the target nucleotide (Figure 11). The resulting abasic site 
is usually processed by an apurinic/apyrimidinic (AP) endonuclease (APE1 in human 
cells), which cleaves the DNA backbone 5′ to the abasic site, generating a 3′ hydroxyl 
(OH) and a 5′ deoxyribose-5-phosphate (5′-dRP). To allow further repair, the 5′-dRP is 
restored to a 5’ P through a deoxyribose-phosphatase diesterase (dRPase) activity 
(associated to Pol β in human cells) (Figure 9). Bifunctional DNA glycosylases cleave 
the glycosidic bond between N and C1′ by using as nucleophile the amine moiety of a 
residue from the active site, thereby forming a Schiff base intermediate. Then, a β-
elimination reaction cleaves the sugar-phosphate backbone and generates a 5′ P and a 3′ 
α,β-unsaturated aldehyde (3´ UA) (Figure 11). In some cases, a subsequent δ-
elimination reaction converts the 3´ UA in a 3′ P terminus. The unconventional 3´-UA 
or 3′-P termini have to be restored to 3′ OH to allow further repair, through the 
diesterase activity of AP endonuclease or the phoshatase activity of polynucleotide 
kinase phosphatase (PNKP), respectively (Figure 9) (Baute and Depicker, 2008; 
Dodson et al., 1994). 
Once 5’ P and 3’ OH termini are generated, gap filling may continue through either a 
short-patch or a long-patch sub-pathway, by insertion of either only one or 2–13 
nucleotides, respectively (Figure 9). In the mammalian short-patch pathway, 
nucleotides are incorporated into the DNA by Polβ, which also has dRP lyase activity 
(Singhal et al., 1995), and the resulting nick is ligated by a complex of XRCC1 and 
LigIIIα (Nash et al., 1997). During long-patch repair in mammals, Polβ probably also 
incorporates the first nucleotide (Podlutsky et al., 2001) but when the 5′ end cannot be 
processed, the additional elongation and strand displacement are carried out by the Polδ 
or Polε replicative polymerases (Fortini et al., 1998; Stucki et al., 1998). The resulting 
structure is then removed by the endonuclease FEN1 via a single-stranded break (SSB) 
and, subsequently, the nick is sealed by LIG1 (Levin et al., 1997). 
In contrast to the rapid progress made for mammalian and microbial cells, studies on 
BER in plants have been scarce. Recent studies have demonstrated that plants possess a 
BER mechanism similar to that found in mammals that may be completed by short-
patch or long-patch pathways (Córdoba-Cañero et al., 2009). Up to date, some enzymes 
that participate in BER have been identified in Arabidopsis. For example, the AtNTH1 
is a DNA glycosylase that recognizes oxidized pyrimidines (Roldán-Arjona et al., 
2000), AtOGG1 processes 8-oxoG (García-Ortiz et al., 2001) and AtUNG initiates 
uracil repair (Córdoba-Cañero et al., 2010). Furthermore, the repair intermediates 
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arising during plant BER are processed both by AP lyases and AP endonucleases 
(Córdoba-Cañero et al., 2009), being ARP the major AP endonuclease activity in 
Arabidopsis cell extracts (Córdoba-Cañero et al., 2011). Finally, there is evidence that 
DNA ligase I (LIG1) is responsible for the ligation step during both short-patch and 
long-patch BER in Arabidopsis (Córdoba-Cañero et al., 2011). The Arabidopsis 
genome does not encode an orthologue of Polβ, but contains a gene for a putative 
homologue of mammalian Polλ (Garcia-Diaz et al., 2000), which also possesses dRP 
lyase activity (Garcia-Diaz et al., 2001) and contributes to BER (Braithwaite et al., 
2010). Recombinant Oryza sativa Polλ has been shown to possess dRP lyase activity 
(Uchiyama et al., 2004). However, its possible role in short-patch BER in Arabidopsis, 
if any, remains unknown.  
Figure 11. Reaction mechanisms of monofunctional and bifunctional DNA glycosylases. 
Monofunctional DNA glycosylases cleave the N-glycosidic bond between N and C1′ (DNA 
glycosylase activity) by using an activated water molecule as nucleophile to attack C1′ of the 
target nucleotide. Bifunctional DNA glycosylases cleave the glycosidic bond between N and C1′ 
by using as nucleophile the amine moiety of a residue from the active site, thereby forming a 
Schiff base intermediate. Then, a β-elimination reaction (and in some cases a subsequent δ-
elimination reaction), cleaves the sugar-phosphate backbone (AP lyase activity). Modified from 
(Baute and Depicker, 2008). 
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4.2. DNA glycosylases superfamilies 
DNA glycosylases are classified in five structural superfamilies: uracil DNA 
glycosylase (UDG), helix–hairpin–helix (HhH-GPD), helix–two-turn–helix (H2TH), 
alkyladenine DNA glycosylase (AAG) and HEAT-like repeat (HLR) (Dalhus et al., 
2009) (Figure 12). Despite their divergent architectures, these proteins, with the 
exception of the HLR family (Mullins et al., 2015), have evolved the base-flipping 
strategy to correctly identify and orient their substrates for catalysis. 
Figure 12. Crystal structure of different enzymes belonging to the five superfamiles of 
DNA glycosylases. Modified from (Dalhus et al., 2009). 
 
UDG superfamily 
The members of the UDG superfamily are compact single-domain enzymes that 
contain a core of a four-stranded parallel twisted β-sheet flanked by α-helices (Mol et 
al., 1995). UDGs are the major repair enzymes that recognize and repair uracil resulting 
from either misincorporation of dUTP or cytosine deamination in DNA (Huffman et al., 
2005). This superfamily has been divided into a number of subfamilies. Family 1, 
represented by Escherichia coli UNG, contains highly conserved DNA glycosylases 
present in most species examined. Family 2 enzymes, represented by the bacterial 
MUG (mismatch-specific uracil-DNA glycosylase) and the human thymine-DNA 
glycosylase (TDG), initiate BER of T/U:G mismatches. Family 3, represented by the 
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single-strand-selective monofunctional uracil DNA-glycosylase (SMUG1) recognizes 
several oxidized pyrimidines as well as uracil. Families 4 and 5 were discovered in 
thermophilic bacteria and archaea (Huffman et al., 2005). In addition, a sixth family of 
uracil-recognizing DNA glycosylases has been found with more structural homology to 
the helix-hairpin-helix superfamily (Chung et al., 2003). 
H2HT superfamily  
The H2TH superfamily enzymes are compact proteins comprising two characteristic 
domains with the active site at the junction. They contain an N-terminal domain with an 
α-helix carrying a proline catalytic residue that is used as nucleophile and a two-layered 
β-sandwich structure. The C-terminal domain is built from α-helices in addition to two 
β-strands forming a zinc finger (Sugahara et al., 2000). Archetypal member of this 
family are E. coli MutM (also known as Fpg), mammalian Nei-like proteins (NEIL1, 
NEIL2, and NEIL3) and bacterial EndoVIII (Endonuclease VIII or Nei), all of them 
involved in repair of oxidative damage (Fromme and Verdine, 2002, 2003; Huffman et 
al., 2005). 
AAG superfamily 
The members of the AAG superfamily are compact single-domain enzymes that have 
an antiparallel β-sheet surrounded by α-helices similar to the methionyl-tRNAMetf 
formyltransferase C-terminal domain (Lau et al., 1998). These enzymes remove 
alkylated bases in DNA. 
HLR superfamily 
The enzymes within the HRL superfamily contain an alpha-alpha superhelix fold 
comprising six HEAT-like repeats (Dalhus et al., 2007). Three subfamilies have been 
identified: AlkC, AlkD and AlkF/AlkG. AlkC and AlkD were shown to display specific 
activities towards N3- and N7-alkylpurines (Alseth et al., 2006), whereas neither AlkF 
nor AlkG display any DNA glycosylase activity (Backe et al., 2013). Recent studies 
demonstrated that AlkD protein repairs bulky lesions in the absence of base flipping 
(Mullins et al., 2015). 
HhH-GPD superfamily 
The HhH-GPD superfamily is the most diverse, with divergent substrate specificities. 
Its characteristic HhH motif is a DNA-binding domain that is present in a number of 
proteins that bind DNA in a sequence-independent manner (Doherty et al., 1996; 
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Thayer et al., 1995). Some members of this superfamily are EndoIII (Endonuclease III 
or Nth, thymine glycol DNA glycosylase/AP lyase), AlkA (3-methyladenine DNA 
glycosylase II), Ogg1 (8-oxoguanine glycosylase), MutY (adenine DNA glycosylase), 
MBD4 (methyl-CpG binding domain protein 4), MIG (thymine DNA glycosylase), and 
their homologues in different organisms (Huffman et al., 2005). These enzymes remove 
a broad spectrum of lesions, including those generated by oxidative, alkylation and 
hydrolytic damage. As in the H2TH family, these enzymes are compact proteins 
comprising two characteristic domains with the active site located at their junction. The 
core fold consists of four N-terminal and six to seven C-terminal α-helices, linked by a 
type-II β-hairpin (Doherty et al., 1996). The HhH motif is followed by a loop (GPD 
motif) containing glycine (G), proline (P) and an invariable aspartic acid (D) residue 
(Huffman et al., 2005) (Figure 13). The conserved aspartic acid activates the 
nucleophile (a molecule of water or a lysine residue in monofunctional or bifunctional 
DNA glycosylases, respectively) for attack of the glycosidic bond (Huffman et al., 
2005). In various DNA glycosylases of this superfamily, additional functional domains 
serve specialized biological roles: an [4Fe-4S] iron sulfur cluster in EndoIII, MutY, and 
MIG, involved in DNA binding (Fromme and Verdine, 2003), a β-sheet in AlkA and 
hOGG1 (Hollis et al., 2000), a MutT-like domain in MutY (Bruner et al., 2000; Kwon 
et al., 2003), a zinc-binding domain in TAG (Kwon et al., 2003), and a methyl-CpG-
binding domain in MBD4 (Hendrich et al., 1999). 
Figure 13. The Helix-hairpin-Helix and Glycine/Proline-Aspartic acid (HhH-GPD) motif. 
Partial alignment of the amino acid sequence of Endo III, Mig, MutY, MBD4, Ogg1 and AlkA 
DNA glycosylases. Asterisks indicate the conserved aspartic acid (D) residue that is invariant in 
all HhH-GPD family members, and the lysine (K) residue only present in those that are 
bifunctional DNA glycosylases. Glycine (G) and Proline (P) residues are shown in orange. 
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5. DML proteins: a family of 5-meC DNA glycosylases 
5.1. Identification 
In 2002, a subfamily of plant-specific DNA glycosylases belonging to the HhH-GPD 
superfamily was identified. This group of atypical glycosylases, designated as DML 
(DEMETER-LIKE) or ROS1/DME family, is represented by the Arabidopsis proteins 
DME (DEMETER) and ROS1 (REPRESSOR OF SILENCING 1) (Choi et al., 2002; 
Gong et al., 2002). DME, ROS1 and their homologs have 5-meC DNA glycosylase 
activity and are involved in active DNA demethylation through a BER process. They 
appear to be unique to plants, with putative orthologs present in mosses (Phycomitrella 
patens) and unicellular green algae (Ostreococcus, for example), suggesting that active 
demethylation through excision of 5-meC may have appeared early during plant 
evolution (Roldán-Arjona and Ariza 2009). 
DME was identified in a search for mutations causing parent-of-origin effects on seed 
viability (Choi et al., 2002). Loss of function of this protein causes endosperm damage, 
alterations in embryonic development and, therefore, abortive seeds (Choi et al., 2002). 
DME is expressed primarily in the central cell of the female gametophyte, where it is 
required for the expression of the maternal alleles of the imprinted genes MEA, FWA 
and FIS2 and perhaps other unidentified imprinted loci in female gametes before 
fertilization (Choi et al., 2002; Jullien et al., 2006; Kinoshita et al., 2004). ROS1 was 
identified in a screen for mutants with deregulated expression of the repetitive RD29A-
LUC transgene (Gong et al., 2002). Whereas in wild plants the transgene and the 
homologous endogenous gene are expressed, ros1 mutants display transcriptional 
silencing and hypermethylation of both loci (Gong et al., 2002). ros1 mutant plants 
show vegetative and reproductive developmental abnormalities, with retarded growth 
and low silique production, and high abortive seeds proportion (Gong et al., 2002). In 
addition to ROS1 and DME, the genome of Arabidopsis encodes two additional 
paralogs: DEMETER-LIKE proteins DML2 and DML3 (Ortega-Galisteo et al., 2008; 
Penterman et al., 2007). dml2 and dml3 mutants did not show any phenotypic alteration 
under normal growth conditions (Ortega-Galisteo et al., 2008). 
Plant 5-meC DNA glycosylases belong to the HhH-GPD superfamily (Gong et al., 
2002; Morales-Ruiz et al., 2006). The HhH-GPD motif, with the invariant aspartic acid 
residue and the conserved lysine residue (characteristic of bifunctional DNA 
glycosylases), and a [4Fe-4S] cluster are both clearly identified. However, they are 
unusually large (1100–2000 amino acids compared to 200–400 amino acids of the rest 
of the superfamily proteins) and, unlike other DNA glycosylases, are distinctively 
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characterized by a bipartite catalytic domain divided by a large insert predicted to have 
an unstructured conformation (Ponferrada-Marín et al., 2011). They also contain a 
carboxy-terminal domain of unknown function that is not related with any known 
protein (Choi et al., 2002; Gong et al., 2002; Morales-Ruiz et al., 2006), and a short 
amino-terminal domain significantly rich in lysine (Ponferrada-Marín et al., 2010) 
(Figure 14).  
Figure 14. Schematic alignment of some representative members of DML family. Colored 
boxes represent conserved regions among DML family proteins: a non-conserved N-terminal 
lysine-rich region (green), a non-contiguous DNA glycosylase domain distributed over two 
segments (blue and red) separated by a non-structured linker region, and a highly conserved C-
terminal domain (yellow) that is not found in any other protein family. 
5.2. In vivo functions 
The precise in vivo roles of plant 5-meC DNA glycosylases are not fully understood, 
but they seem to contribute to the stability and flexibility of the plant epigenome. DME 
contributes to genome-wide demethylation during endosperm development and is 
required for imprinting, since such demethylation activates the maternal allele of 
several imprinted genes in the endosperm (Gehring et al., 2009; Hsieh et al., 2009). 
However, its basal function appears to be the reactivation of transposons in companion 
cells to generate short interfering RNAs (siRNAs) that would reinforce transposon 
silencing in male and female gametes (Calarco et al., 2012; Ibarra et al., 2012). ROS1, 
DML2 and DML3 may also contribute to such reactivation in male gametes (Calarco et 
al., 2012). 
ROS1 prevents transcriptional gene silencing and hypermethylation of a repetitive 
transgene (Gong et al., 2002) but also regulates endogenous loci that show reduced 
expression and hypermethylation in ros1 plants (Zhu et al., 2007). Furthermore, 
genome-wide analyses of DNA methylation patterns have identified hundreds of 
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regions that become hypermethylated in a ros1 dml2 dml3 triple mutant (Lister et al., 
2008; Penterman et al., 2007). Taken together, these results suggest that an important in 
vivo function of ROS1, DML2 and DML3 is to protect the genome from excess 
methylation, counteracting hypermethylation at several hundreds of discrete regions 
across the plant genome in vegetative tissues (Ortega-Galisteo et al., 2008; Penterman 
et al., 2007; Zhu et al., 2007). On the other hand, there is some evidence to suggest that 
these proteins may be needed not only to counteract deleterious methylation, but also to 
maintain high methylation levels at properly targeted sites (Lister et al., 2008; Ortega-
Galisteo et al., 2008). 
It is unclear how these 5-meC DNA glycosylases are targeted to specific genomic 
regions, but there is evidence indicating that demethylation by ROS1 may be guided by 
small RNAs bound to ROS3 (Zheng et al., 2008). Furthermore, a recent study 
discovered a histone acetyltransferase (IDM1) that controls the DNA methylation levels 
of a subset of loci targeted by ROS1 and its homologs in Arabidopsis. IDM1 binds 
methylated DNA at chromatin sites with unmethylated H3K4 and acetylates H3K18 
and H3K23 to create a chromatin environment that allows 5-meC DNA glycosylases to 
function (Qian et al., 2012). 
5.3. Catalytic activity of 5-meC DNA glycosylases and the 
DNA demethylation pathway in Arabidopsis 
ROS1 and DME are the best in vitro-characterized members of this family of atypical 
DNA glycosylases (Agius et al., 2006; Gehring et al., 2006; Morales-Ruiz et al., 2006). 
Both enzymes remove 5-meC as a free base from DNA using a glycosylase/lyase 
mechanism (Morales-Ruiz et al., 2006) and cleave the phosphodiester backbone at the 
5-meC removal site by β- or β, δ-elimination, generating single nucleotide gaps with 
either 3´-PUA (3-phosphor-α, β-unsaturated aldehyde) or 3´-P (3´-phosphate) ends, 
respectively (Agius et al., 2006; Gehring et al., 2006; Morales-Ruiz et al., 2006; 
Penterman et al., 2007). The DNA 3′-phosphatase zinc finger DNA 3′-phosphoesterase 
(ZDP) functions downstream of ROS1 by catalyzing the conversion of the blocking 3′-
phosphate group to a 3′-hydroxyl (3′-OH) (Martínez-Macías et al., 2012) and the repair 
protein XRCC1 stimulates 5-meC excision and facilitates 3′-end cleaning and DNA 
ligation (Martínez-Macías et al., 2013). The β-elimination product (3′-PUA) also must 
be converted to a 3′-OH to allow completion of the demethylation process through 
single-nucleotide insertion or long patch DNA synthesis by DNA polymerase and 
ligase (Córdoba-Cañero et al., 2009). The apurinic/apyrimidinic endonuclease APE1L 
functions downstream of ROS1 and DME in Arabidopsis by processing 3′-PUA termini 
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to generate 3′-OH ends and it also displays a weak activity in converting 3′-phosphate 
termini to 3′-OH ends (Li et al., 2015) (Figure 15). 
Figure 15. A model for the active DNA demethylation pathway in Arabidopsis. ROS1 (or 
its homologs of the DML family) is a bifunctional DNA glycosylase that excises 5-
methylcytosine and then cleaves the sugar-phosphate backbone at the abasic site using β- or β, 
δ-elimination, resulting in a gap with PUA or phosphate at the 3′ terminus, which needs to be 
removed by APE1L or ZDP. Then, an as yet unknown DNA polymerase will fill the gap with an 
unmethylated cytosine base and DNA ligase I (Lig 1) will seal the processed strand. Along the 
demethylation process, the scaffold protein XRCC1 stimulates gap-tailoring and ligation. 
Excision of 5-meC in vitro is more efficient in sequences that are more likely to be 
methylated in vivo. Thus, ROS1 and DME erase 5-meC at CG, CHG and CHH 
sequences, with a preference for CG sites (Gehring et al., 2006; Morales-Ruiz et al., 
2006), which matches the pattern of DNA methylation in plants. Furthermore, both 
proteins remove 5-meC more efficiently from a CAG context than when located in the 
outer position of a CCG context (Morales-Ruiz et al., 2006), consistent with the fact 
that CCG is the sequence with the lowest methylation level among CHG sites (Cokus et 
al., 2008).  
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DML2 and DML3 are also 5-meC DNA glycosylases/lyases (Ortega-Galisteo et al., 
2008; Penterman et al., 2007). While DML2 activity is very weak, at least in vitro, 
DML3 has an enzymatic activity and substrate specificity comparable to those of DME 
and ROS1 (Ortega-Galisteo et al., 2008; Penterman et al., 2007). 
In addition to 5-meC, DME, ROS1 and DML3 also remove T mismatched to guanine 
(Gehring et al., 2006; Morales-Ruiz et al., 2006; Ortega-Galisteo et al., 2008), thus 
suggesting an additional role in neutralizing the mutagenic consequences of the 
spontaneous deamination of 5-meC to T (Roldán-Arjona and Ariza 2009). They can 
also process 5-hydroxymethylcytosine (5-hmeC) as well as 5-hydroxymethyluracil (5-
hmeU), the deamination product of 5-hmeC (Brooks et al., 2014; Jang et al., 2014; 
Ponferrada-Marín et al., 2010). 
5.4. Arabidopsis thaliana ROS1 
Arabidopsis thaliana ROS1 is a prototypical member of this group of atypical DNA 
glycosylases, and it is being successfully used to study how active DNA demethylation 
is initiated in plants. As described above, ROS1 is a multi-domain bifunctional DNA 
glycosylase that directly removes 5-meC, generating an apyrimidinic (AP) site that is 
subsequently incised by its own AP lyase activity (Agius et al., 2006; Morales-Ruiz et 
al., 2006; Ponferrada-Marín et al., 2009). Its substrate specificity arises by a 
combination of selective recognition at the active site and thermodynamic stability of 
the target base (Ponferrada-Marín et al., 2009). Furthermore, ROS1 is a low-turnover 
catalyst because it binds tightly to the abasic site left after 5-meC removal, which leads 
to a highly distributive behaviour of the enzyme on DNA substrates containing multiple 
5-meC residues, and may help to avoid generation of double-strand breaks during 
processing of bimethylated CG dinucleotides (Ponferrada-Marín et al., 2009).  
Interestingly, ROS1 binds with similar affinity to both methylated and non-methylated 
DNA. In such non-specific binding plays an essential role its basic, amino-terminal 
domain. This domain is not necessary for catalysis, but facilitates 5-meC excision on 
long DNA substrates, modulates ROS1 substrate preference (Ponferrada-Marín et al., 
2010) and endows the protein with the capacity to perform facilitated diffusion through 
random 1D sliding along DNA (Ponferrada-Marín et al., 2012).  
Sequence alignment and available structural data of HhH-GPD enzymes allowed 
generating a tridimensional model of the discontinuous catalytic domain of ROS1 
(Ponferrada-Marín et al., 2011) (Figure 16). Together with biochemical analysis, this 
model has been used for identifying residues important for ROS1 function (Ponferrada-
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Marín et al., 2011). Two amino acids predicted to be positioned between the base stack 
and the recognition pocket (T606 and D611) were found to be essential for catalysis, 
whereas mutational changes in two aromatic residues presumably located in the 
substrate-binding pocket (F589 and Y1028) altered the base specificity of the enzyme. 
This study also proposed Q607, which is essential for both catalytic activity and stable 
DNA binding, as a strong candidate for the plug residue that replaces the flipped 5-meC 
in the base stack (Ponferrada-Marín et al., 2011) during the base flipping mechanism.  
It remains to be established the role of the C-terminal domain. A recent study showed 
that the isolated glycosylase domain of ROS1 is inactive for 5-meC excision but retains 
partial AP lyase activity (Hong et al., 2014). Base excision was restored and AP lyase 
activity was increased after the addition of the C-terminal domain, suggesting that this 
region is indispensable for the 5-meC DNA glycosylase activity of ROS1 (Hong et al., 
2014). However, although the ROS1 C-terminal domain is highly conserved among 
DML family proteins, it is not related with any other known protein. 
In general, available data suggest that ROS1 and its DML family homologs are 
complex 5-meC DNA glycosylases that perform the remarkable task of excising a non-
damaged, correctly paired base, among a vast excess of non-target bases. 
Figure 16. Structural model for the discontinuous DNA glycosylase domain of ROS1 and 
the crystallographic Bst EndoIII structure used as template. The duplex DNA containing an 
abasic site is shown in orange. Modified from (Ponferrada-Marín et al., 2011). 
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6. Histone modifications and associated functions  
Histones are small basic proteins, highly conserved through evolution. They consist of 
a globular domain and a more flexible and charged NH2-terminus (called histone tail) 
that protrudes outward from the nucleosomes (Jenuwein and Allis, 2001). The histone 
tails are subject to numerous posttranslational, covalent modifications, including 
acetylation, methylation, phosphorylation, ubiquitination, ribosylation, glycosylation, 
and sumoylation, that modulate chromatin structure (for example, they established 
silent heterochromatin and active euchromatin), and influence many biological tasks, 
such as gene activity, DNA repair, DNA replication or chromosome condensation 
(Hsieh and Fischer, 2005; Jenuwein and Allis, 2001; Kouzarides, 2007; Rothbart and 
Strahl, 2014). A number of posttranslational modifications occurring in the histone fold 
or globular domains also regulate histone–histone and histone–DNA interactions 
(Cosgrove and Wolberger, 2005). It has been proposed that distinct histone 
modifications may act sequentially or in combination to form a “histone code” that is 
read by other proteins for specific tasks (Jenuwein and Allis, 2001; Strahl and Allis, 
2000). 
There are two mayor mechanisms that explain the effects of histone modifications on 
chromatin packaging. One is a direct mechanism, by which specific modifications 
facilitate or disrupt contacts between DNA and histones, thus resulting in chromatin 
folding or unfolding. The second one is an indirect mechanism by which specific 
modifications, either singly or in combination, recruit non-histone proteins equipped 
with effector modules that in turn modify chromatin properties (Kouzarides, 2007). 
These proteins are recruited to histone modifications via specific domains known as 
readers (Figure 17 and Table 1). Readers typically provide an accessible surface (such 
as a cavity or surface groove) to accommodate a modified histone residue. They also 
interact with the flanking sequence of the modified amino acid to distinguish sequence 
context (Yun et al., 2011). 
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Figure 17. Readers of histone modifications. Domains used for the recognition of methylated 
lysines or arginines, acetylated lysines, or phosphorylated serines or threonines. Modified from 
(Kouzarides, 2007). 
6.1. Histone acetylation 
Acetylation was the first type of histone modification to be discovered (Phillips, 1963). 
Histone acetylation neutralizes the positive charge of lysine residues and weakens the 
histone-DNA and histone-histone interactions between one or more nucleosomes, thus 
increasing the accessibility of DNA to the transcription machinery, to replication 
factors and to repair factors (Bannister and Kouzarides, 2011; Zentner and Henikoff, 
2013). At present, acetylation has been found to occur on several lysine residues in all 
four core histones H3, H4, H2A and H2B (Musselman et al., 2012).  
Acetylation of lysines is highly dynamic and regulated by the opposing action of 
histone acetyltransferases (HATs) and histone deacetylases (HDACs). HATs utilize 
acetyl CoA as cofactor and catalyze the transfer of an acetyl group to the ε-amino group 
of lysine side chains, neutralizing their basic charge, whereas HDACs remove the 
acetyl group from lysine residues, restoring their positive charge (Figure 18). 
Acetylation of lysine residues is almost invariably associated with activation of 
transcription, since it allows access of the transcription machinery to DNA, while 
deacetylation correlates with transcriptional repression. Furthermore, acetylation also 
functions in other cellular processes that require DNA access, such as DNA replication 
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or DNA repair (Kouzarides, 2007; Zentner and Henikoff, 2013). For example, histone 
acetylation is associated with productive origin activation during S phase 
(Unnikrishnan et al., 2010), and also occurs at DNA double-strand breaks to increase 
DNA access for repair factors (Xu and Price, 2011). 
Table 1. Histone readers and their target marks. (Musselman et al., 2012; Patel and Wang, 
2013). 
Recognition of Reader Histone mark 
Acetylated lysine 
Bromodomain Kac of all core histones 
DPF H3K14ac 
PH H3K56ac 
Methylated lysine 
Chromodomain* H3K9me2/3, H3K27me2/3 
Chromo-barrel* H3K4me1, H3K36me2/3, H3K20me1 
MBT* H3Kme1/2, H4Kme1/2 
PWWP* H3K36me3, H3K79me3, H4K20me1/3 
Tudor* H3K36me3 
TTD* H3K4me2/ 3, H3K9me3, H4K20me2 
ADD H3K9me3 
Ankyrin H3K9me1/2 
BAH H3K9me2, H4K20me2 
DCD H3K4me1/2/3 
PHD H3K4me2/3, H3K9me3 
WD40 H3K9me3, H3K27me3, H4K20me3, H1K26me3 
Zf-CW H3K4me3 
Methylated 
arginine 
Tudor H3Rme2, H4Rme2 
WD40 H3R2me2 
ADD H3R3me2s 
Phosphorylated 
serine 
14-3-3 H3S10P, H3S28P 
Tandem BRCT H2A.XS139P 
Phosphorylated 
threonine 
BIR H3T3P 
Unmodified 
histones 
ADD H3K4 
PHD H3R2, H3K4 
WD40 H3R2 
*The Royal Superfamily. 
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Figure 18. Effect of acetylation/deacetylation on histone tails. Histone acetylation 
neutralizes the basic charge of lysine residues and weakens the histone-DNA interaction, 
increasing the accessibility of DNA to different factors, whereas histone deacteylation restores 
the positive charge of lysine residues.  
There are two major classes of HATs: type-A and type-B. Based on amino acid 
sequence homology and conformational structure, type-A HATs can be subdivided into 
at least three families: GNAT, MYST and CBP/p300 (Hodawadekar and Marmorstein, 
2007). Type-A HATs are often found associated in large multiprotein complexes which 
include other histone-modifying enzymes (Yang and Seto, 2007). Type-B HATs, which 
are less diverse that type-A and are highly conserved, are predominantly cytoplasmic 
(Parthun, 2007). 
There are four classes of HDACs (Yang and Seto, 2007). Classes I and II contain 
enzymes that are most closely related to yeast scRPD3 and scHDA1, respectively. 
Class III (sirtuins) are homologous to yeast scSir2 and require the cofactor NAD+ for its 
activity, while class IV comprises HDAC11 as the only member. In general, HDACs 
have a relatively low substrate specificity since a single enzyme is able to deacetylate 
multiple sites. Furthermore, they are involved in multiple signaling pathways and are 
present in numerous repressive chromatin complexes, often with other HDAC family 
members, which makes difficult to determine which activity is responsible for a 
specific effect (Bannister and Kouzarides, 2011; Yang and Seto, 2007).  
Readers of histone acetylation  
Histone acetylation is specifically recognized by the bromodomain (BRD) (Figure 17 
and Table 1). All BRDs fold into a highly conserved four-helix bundle structure 
(helices αA, αB, αC and αZ). The inter-helical ZA and BC loops create a pocket that 
recognizes the acetyl-lysine modification. The acetylated lysine makes several contacts 
with hydrophobic residues, including two frequently conserved tyrosines, and is 
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stabilized by a hydrogen bond with a highly conserved asparagine (Sanchez et al., 
2014). In general, isolated bromodomains bind to acetylated histones weakly and 
specificity arises from interaction with surrounding residues. Simultaneous recognition 
of multiple acetylated sequences, either by a single bromodomain or by covalently 
linked bromodomains, can substantially enhance binding, as seen in TAF1 and BRDT 
(Moriniere et al., 2009). 
Two others histone readers that recognize acetylated lysines have been identified: the 
tandem PHD (plant homeodomain) finger (DPF) of DPF3B, which binds to H3K14ac 
(Zeng et al., 2010), and the tandem plextrin homology (PH) domain of the histone 
chaperone RTT106, which binds to each of the two H3K56ac sites in the H3-H4 
tetramer, contributing to gene silencing and to the DNA damage response (Figure 17 
and Table 1) (Su et al., 2012).  
Others lysine acylations 
In addition to acetylation, a variety of less well understood acylations of histone lysine 
residues have been described: crotonylation, formylation, succinylation, malonylation, 
propionylation and butyrylation (Olsen, 2012; Tan et al., 2011). Their function is 
similar to acetylation, neutralizing the basic charge of lysine and weakening histone-
DNA interactions, which may facilitate DNA access for several processes such as 
transcription, replication and repair. 
6.2. Histone methylation 
This histone modification mainly occurs on the side chains of lysine and arginine 
residues. Lysines may be mono-, di- or tri-methylated, whereas arginines may be 
mono-, or symmetrically or asymmetrically di-methylated (Bannister and Kouzarides, 
2011). Histone methylation is associated with activation or repression of transcription, 
but in a less direct manner than acetylation, since methylation does not change the 
positive charge of the modified residues, although it does alter their hydrophobic 
character and size.  
6.2.1. Lysine methylation 
To date, lysine methylation has been found in histones H3, H4 and H1 (Musselman et 
al., 2012), and is carried out by histone lysine methyltransferases (HKMTs), which 
catalyze the transfer of a methyl group from S-adenosylmethionine (SAM) to a lysine's 
ε-amino group. Most of HKMTs methylate lysines within the N-terminal tails, and a 
SET domain is the responsible for their enzymatic activity. However, DOT1 (disruptor 
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of telomeric silencing) enzyme methylates H3K79 within the histone globular core and 
does not contain a SET domain (Bannister and Kouzarides, 2011).  
In general, some lysine methylations (for example H3K4, H3K36, or H3K79) are 
consistently implicated in activation of transcription, whereas others (H3K9, H3K27, or 
H4K20) are usually associated to transcriptional repression (Kouzarides, 2007). 
However, some methylations have the potential to activate or repress under different 
conditions. Thus, methylation at H3K36 or H3K9 has a positive effect when it is found 
on coding regions and a negative effect when is present in promoters (Vakoc et al., 
2005). H3K4me3, which is established by the Trithorax complex, antagonizes 
Polycomb silencing by inhibiting trimethylation of H3K27 (Schwartz and Pirrotta, 
2007), whereas H3K36me3, which is established co-transcriptionally by SET2, is 
involved in suppressing cryptic transcription within the coding region by enhancing 
nucleosome stability through histone deacetylation and chromatin remodeling 
(Carrozza et al., 2005).  
H3K9me3 and H3K27me3, which are associated with heterochromatin formation and 
Polycomb silencing, respectively, enhance the affinity of certain protein domains for 
methylated lysines of the histone tails (Taverna et al., 2007). H4K20 methylation has a 
role in the formation of heterochromatin and in DNA repair. For example, mono- or di-
methylated H4K20 is recognized by the cell-cycle checkpoint protein CRB2 in fission 
yeast (p53BP1, the homolog of CRB2, in human cells), which signals a G2/M arrest in 
order for the DNA to be repaired (Sanders et al., 2004). CRB2 is previously recruited to 
the specific DNA-damage site through recognition of phosphorylated H2A.X (Du et al., 
2006).  
The function of some histone marks, for example all methylated states of H3K4 and 
H3K36, which are restricted to euchromatin, are apparently common to animals and 
plants. However, others are lineage-specific, such as H3K9me3, H3K27me3, 
H4K20me2 and H4K20me3, which are typical marks for euchromatin in Arabidopsis, 
but located at heterochromatin in animals (Fuchs et al., 2006). 
Histone lysine methylation is reversed by lysine demethylases, which possess a high 
level of substrate specificity with respect to their target lysine and they are also 
sensitive to the degree of lysine methylation. There are two types of demethylase 
domain that uses different catalytic mechanisms: the lysine-specific demethylase 1 
(LSD1) domain (Shi et al., 2004) and the catalytic jumonji (JMJC) domain (Tsukada et 
al., 2006). LSD1 uses FAD as co-factor and, since the demethylation reaction requires a 
protonated nitrogen, only demethylates mono- and di-methylated, but not tri-
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methylated, lysines. Furthermore, LSD1 only demethylates in a nucleosomal context 
when is associated with complex members, which in turn determine which lysine is to 
be demethylated by LSD1. For example, when LSD1 is complexed with the Co-REST 
repressor complex, it demethylates H3K4me1/2, but when LSD1 is complexed with the 
androgen receptor, it demethylates H3K9 (Klose and Zhang, 2007). By contrast, certain 
enzymes in JMJC class are capable of demethylating up to tri-methylated lysines and 
use Fe(II) and α-ketoglutarate as co-factors, and a radical attack mechanism (Tsukada 
et al., 2006).  
Readers of histone lysine methylation  
Lysine methylation is recognized by several histone readers: the Royal superfamily 
[chromodomain, chromo-barrel, malignant brain tumor (MBT), PWWP (Pro-Trp-Trp-
Pro), Tudor and tandem Tudor domain (TTD) modules], ADD (ATRX-DNMT3-
DNMT3L), ankyrin, bromo-adjacent homology (BAH), double chromodomain (DCD), 
PHD (plant homeodomain), WD40 and the zinc finger CW (zf-CW) (Figure 17 and 
Table 1) (Musselman et al., 2012). All of them bind the methylated lysine through an 
aromatic cage, typically formed by two to four aromatic residues. The mono-, di- or 
trimethylated state of lysine is selected for by the size and exact composition of the 
pocket. Thus, a small size exclude interaction with a higher methylation state, and 
mono- or dimethylated lysine is preferred over trimethylated lysine if an aspartate or 
glutamate residue replaces one of the walls of the pocket. Specificity for a particular 
methylated lysine is given by interaction with surrounding residues and varies between 
histone readers (Musselman et al., 2012). 
6.2.2. Arginine methylation 
Histone methylation of arginines is carried out by protein arginine methyltransferases 
(PRMTs), which transfer a methyl group from SAM to the ω-guanidine group of 
arginine within a variety of substrates. The omega nitrogen atoms of arginine can be 
monomethylated or dimethylated symmetrically (Rme2s) or asymmetrically (Rme2a). 
To date, arginine methylation of histones H3, H4 and H2A has been described 
(Musselman et al., 2012).  
Information on writing and erasing of arginine methylation is rather limited, as 
compared to lysine methylation. There are two classes of PRMT: type-I enzymes, 
which generate Rme1 and Rme2as (asymmetric), and type-II enzymes, which generate 
Rme1 and Rme2s (symmetric) (Bedford and Clarke, 2009; Wolf, 2009). Arginine 
methylation can be either activator or repressive for transcription, and PRMTs are 
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recruited to promoters by transcription factors (Lee et al., 2005). Arginine methylation 
is reversed either indirectly by the conversion of arginine to citrulline via a deimination 
reaction (Cuthbert et al., 2004) (see Section 7.4. Introduction), or directly by the JMJD6 
protein, which demethylates H3R2 and H4R3 (Chang et al., 2007). However, these 
findings have yet to be reproduced by other independent studies. 
Readers of histone arginine methylation  
Information on recognition of methylated arginine is also scarce. However, several 
arginine methylation readers have been identified: Tudor domain, WD40 and ADD 
finger (Figure 17 and Table 1). 
6.3. Histone phosphorylation 
Histone phosphorylation takes place on serine, threonine and tyrosine residues, 
predominantly in the N-terminal histone tails, but also within the histone-fold and 
globular regions. Phosphorylation has been detected in all four core histones, histone 
variant H2A.X, and the linker histone H1 (Musselman et al., 2012; Rossetto et al., 
2012). Phosphorylation levels are dynamically controlled by the opposite action of 
kinases, which transfer a phosphate group from ATP to the hydroxyl group of the target 
amino acid side chain, and phosphatases, which remove the modification (Bannister 
and Kouzarides, 2011). 
Multiple studies have shown that histone phosphorylation plays crucial roles in 
chromatin remodeling within a diverse range of signal transduction pathways linked to 
several nuclear processes, such as DNA repair, transcription and chromatin compaction 
during cell division and apoptosis (Rossetto et al., 2012). The deposition or elimination 
of this mark at specific residues is controlled by specific kinases or phosphatases, 
respectively, depending on the initial stimuli and the process involved.  
In mammalian cells, phosphorylation at S139 of the H2A.X variant by ATM and ATR 
protein kinases (commonly referred to as γH2A.X), occurs in all phases of the cell 
cycle and is involved in diverse DNA-damage response pathways including non-
homologous end joining (NHEJ), homologous recombination (HR) and replication-
coupled DNA repair (Celeste et al., 2003; Downs et al., 2000). Phosphorylation of 
linker histone H1 is also regulated in a cell cycle-dependent manner and is proposed to 
disrupt HP1 binding to H1, resulting in chromatin destabilization and efficient cell-
cycle progression (Rossetto et al., 2012; Roth and Allis, 1992).  
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Histone H3 phosphorylation has been related with chromosome 
condensation/segregation during mitosis and meiosis, but it has also been involved in 
chromatin relaxation and transcriptional activation of specific genes during interphase 
in both animals and plants (Cerutti and Casas-Mollano, 2009; Houben et al., 2007; 
Rossetto et al., 2012; Sawicka and Seiser, 2012). In animals, phosphorylation of H3S10 
and H3S28 starts in late G2 in pericentromeric regions and then spreads throughout the 
chromosome arms until late anaphase, and it has been proposed to participate in 
chromosome condensation (Cerutti and Casas-Mollano, 2009). H3T3 phosphorylation 
has been related to regulation of chromosome separation. Mitotic H3T11P is also found 
to preferentially associate with the centromere (Preuss et al., 2003). In plants, 
phosphorylation of H3S10 and H3S28 remains limited to pericentromeric regions, and 
it might play a role in sister centromere cohesion. By other hand, phosphorylation of 
H3T3 and H3T11 is correlated with chromosome condensation (Cerutti and Casas-
Mollano, 2009).  
H3S10P and H3S28P are highly enriched during mitosis, and they have been associated 
with chromatin compaction. However, both modifications are also found in interphasic 
cells in a small fraction of histone H3 molecules, and restricted to gene regulatory 
elements to activate transcription (Healy et al., 2012; Sawicka and Seiser, 2012). In 
mammalian cells, after stimulation with epidermal growth factor (EGF), both marks 
directly localize at the promoter region of immediate-early genes, such as c-fos, c-jun 
and c-myc, suggesting that they play a role in the regulation of transcription activation 
(Healy et al., 2012; Strelkov and Davie, 2002). In addition, targeting H3S28 
phosphorylation to c-fos and α-globin promoters controlled their activation (Lau and 
Cheunga, 2011). Furthermore, phosphorylation of H3S10 and H3S28 has been clearly 
associated with H3 acetylation, strongly implicating these modifications in transcription 
activation. For example, phosphorylation of H3S10 promotes acetylation of H3K14 by 
the GCN5 acetyltransferase in vitro and allows GCN5-regulated gene transcription in 
vivo (Lo et al., 2000). In plants, H3 phosphorylation has also a role in the 
transcriptional activation of genes after cold, salt or hormone stress stimulation 
(Houben et al., 2007).  
The positive or negative role of H3S10 or H3S28 phosphorylation in chromatin 
condensation is better understood in combination with other histone marks within a 
particular chromatin context (Cerutti and Casas-Mollano, 2009). For example, since 
many methylated lysine residues of histone H3 are adjacent to residues suitable to be 
phosphorylated, a “phospho-methyl switch” mechanism may control the association of 
proteins with chromatin in various biological processes. In mammals, the amino-
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terminal chromodomain of heterochromatin protein 1 (HP1) interacts with tri-
methylated H3K9 during interphase, mediating heterochromatin formation. 
Phosphorylation of the adjacent H3S10 during mitosis abrogates the binding of HP1 to 
methylated Lys9 (Fischle et al., 2005), and its dephosphorylation at the end of mitosis 
re-establishes the association of HP1 with chromatin. Thus, it has been suggested that 
this binary “phospho-methyl switch” permits dynamic control of the HP1–H3K9me 
interaction (Fischle et al., 2003a). A similar binary switch involves H3K27 and H3S28. 
Polycomb Repressive Complex 2 (PRC2) di- and tri-methylates H3K27, and binds this 
mark in order to represses Polycomb group (PcG) target genes (Cao et al., 2002). 
Phosphorylation of the adjacent H3S28 by MSK1/2 kinases in response to mitogen, 
stress or differentiation signals displaces PcG proteins, leading to gene activation 
(Gehani et al., 2010) (Figure 19).  
Figure 19. Phospho-methyl and phospho-acetyl switch mechanisms in the activation of 
polycomb-repressed genes. PcG proteins bind H3K27me3 and repress expression of their 
target genes. Phosphorylation of the adjacent H3S28 creates a phospho-methyl switch 
(H3K27me3S28P) that displaces PcG proteins, leading to transient expression of these genes in 
response to environmental cues. When H3K27me3S28P is further demethylated and 
subsequently acetylated, this phospho-acetyl switch (H3K27acS28P) leads to continued 
activation of PcG target genes in response to differentiation or developmental signals. Modified 
from (Lau and Cheung, 2011b). 
Masking of H3K27me3 by phosphorylating Ser28 and the subsequent displacement of 
PRC components could be an efficient way to allow transient activation of PcG target 
genes in response to environmental cues. However, it has been proposed that an 
additional “phospho-acetyl switch” allows continued activation of polycomb-repressed 
genes (Lau and Cheung, 2011b; Lau and Cheunga, 2011) (Figure 19). In this case, tri-
methylation from Lys27 is removed to subsequently acetylate it, creating a phospho-
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acetyl mark that would achieve full activation and sustained expression of key 
developmental regulators during differentiation or development in response to 
differentiation or developmental signals (Lau and Cheung, 2011b) (Figure 19). 
Readers of histone phosphorylation 
Several histone readers recognize phosphorylation at serine or threonine residues: 14-3-
3 proteins, Tandem BRCT domains and BIR domains (Figure 17 and Table 1). 
a) 14-3-3 proteins 
14–3–3 proteins form a large family of phosphoserine/phosphothreonine binding 
modules that homo- and heterodimerize to associate with other factors, including many 
transcriptional regulators and chromatin-modifying proteins (Sawicka and Seiser, 
2014). The 14-3-3ζ  isoform recognizes H3S10P and H3S28P (Macdonald et al., 2005). 
Furthermore, 14-3-3 proteins are excluded from mitotic chromosomes and function as a 
docking site for factors involved in transcriptional regulation during interphase (Winter 
et al., 2008). For example, upon MAP kinase signaling, 14-3-3 recruits BRG1, the 
ATPase subunit of SWI/SNF remodeling complex, to H3 phosphorylated nucleosomes 
at the target promoters, followed by RNA polymerase II recruitment and subsequent 
transcriptional activation.  
b) Tandem BRCT domains 
Tandem breast cancer susceptibility (BRCT) domains recognize phosphorylation marks 
in response to DNA double-strand breaks. For example, the BRCT domain of MDC1 
specifically recognizes phosphorylated S139 of H2A.X (γH2A.X) (Stucki et al., 2005).  
c) BIR domains 
The baculovirus IAP repeat (BIR) domain of Survivin, an inhibitor of apoptosis family 
proteins implicated in mitosis and apoptosis, recognizes the H3T3P mark. Survivin is a 
component of the chromosomal passenger complex, a key player during mitosis since 
its H3T3P recognition allows proper Aurora B activity at inner centromeres 
(Jeyaprakash et al., 2011), and it also recognizes the Smac/DIABLO protein, that plays 
a role in apoptosis (Du et al., 2012).  
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6.4. Other histone modifications 
Deimination 
Deimination involves the conversion of arginine to citrulline, and antagonizes the 
activator effect of arginine methylation, neutralizing the positive charge of the arginine. 
(Cuthbert et al., 2004; Wang et al., 2004). In mammalian cells, histone deimination is 
catalyzed by the peptidyl deiminase PADI4. Deimination may be restricted by pre-
existing modifications. Thus, in vivo data demonstrate that mono- (but not di-) 
methylated arginines can be deiminated (Wang et al., 2004). 
Ubiquitylation 
Ubiquitin, a 76-amino acid polypeptide, may be attached to histone lysines via the 
sequential action of three enzymes (E1-activating, E2-conjugating and E3-ligating 
enzymes), which determine which lysine is targeted as well as the degree of 
ubiquitylation (either mono- or poly-ubiquitylated) (Hershko and Ciechanover, 1998). 
In human cells, ubiquitylation of H2AK119 is associated with transcriptional repression 
(Wang et al., 2006), whereas when affecting H2BK120 (H2BK123 in yeast), plays an 
important role in transcriptional initiation and elongation (Zhu et al., 2005). Ubiquitin 
is removed by isopeptidases called de-ubiquitin enzymes (Ubp8 and Ubp10 in budding 
yeast, that antagonize ubiquitylation of H2BK123), which are important for both 
activation of transcription and gene silencing at heterochromatic sites, respectively 
(Emre et al., 2005). 
Sumoylation 
SUMO (small ubiquitin-related modifier) is a reversible protein modifier of ∼10 kDa 
that resemble the three-dimensional structure of ubiquitin (Geiss-Friedlander and 
Melchior, 2007). Sumoylation is similar to ubiquitylation and occurs in all four core 
histones. Sumoylation seems to antagonize acetylation and ubiquitylation that occur on 
the same lysine side chain, so it has mainly been associated with repressive functions 
(Shiio and Eisenman, 2003). 
ADP ribosylation 
All four core histones, as well as linker histone H1, can be mono- and poly-ADP 
ribosylated on glutamate and arginine residues. The enzymes responsible are mono-
ADP-ribosyltransferases (MARTs) or poly-ADP-ribose polymerases (PARPs) (Hassa 
et al., 2006). The poly-ADP-ribose-glycohydrolase family of enzymes reverses this 
modification. However, relatively little is known about the function of ADP-
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ribosylation. The levels of poly-ADP ribosylated histones have been correlated with a 
relatively relaxed chromatin state, probably due to the negative charge that the 
modification confers to the histone (Hassa et al., 2006), but also by elevating the levels 
of core histone acetylation (Cohen-Armon et al., 2007). Histone ADP-ribosylation is 
also detected upon induction of DNA damage (Messner and Hottiger, 2011), enhancing 
the access of repair proteins to DNA. 
Glycosylation  
It has been reported that β-N-acetylglucosamine (OGlcNAc) may occur on several 
threonine and serine residues of histones H2A, H2B and H4. Such modification might 
be involved in transcriptional repression (Sakabe et al., 2010), although O-
GlcNAcylation of H2BS112 has been linked to H2BK120ub1 and active transcription 
(Fujiki et al., 2011).  
6.5. Histone modification crosstalk 
The presence of a large number of histone modifications involves an extra level of 
complexity: the crosstalk between modifications, which presumably helps to refine the 
overall control of chromatin structure and may occur via multiple mechanisms 
(Bannister and Kouzarides, 2011; Kouzarides, 2007).  
Crosstalk interactions can occur in cis, where effectors bind modifications within the 
same histone tail, or in trans, where effectors bind modifications that are in different 
histone tails or in histones and DNA, either within the same nucleosome or on adjacent 
nucleosomes that are directly linked by DNA or are otherwise in close spatial proximity 
(Figure 20).  
The same target site may suffer different types of modifications that are mutually 
exclusive, such as lysines residues that can be acetylated, methylated or ubiquitylated, 
resulting in a competitive antagonism between modifications. The neighboring histone 
modifications can enhance or impede a protein interaction with its target modification, 
since many readers associate with an important stretch of the histone tail, allowing for 
the detection of multiple marks. A good example is the phosphorylation of H3S10, 
which disrupt the binding of HP1 chromodomain to the adjacent K9me3 during mitosis 
(see Section 7.3. Introduction). An enzyme may recognize its substrate more effectively 
when a second modification is present, as occurs with GCN5 acetyltransferase, which 
recognizes H3 more effectively when H3S10 is phosphorylated. Another example is the 
ubiquitinilation of H2B (H2BK123ub1), which is required for methylation of 
H3K4me3 and H3K79me3 (Briggs et al., 2002). 
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Figure 20. Single and combinatorial readout of epigenetics marks. Black circles represent 
DNA modifications, whereas histone marks are indicated as blue circles and red triangles. 
Interactions in cis occur within the same histone, whereas interactions in trans occur on adjacent 
histones or spanning histones and DNA, either within the same nucleosome or on neighboring 
nucleosomes. Modified from (Rothbart and Strahl, 2014). 
A number of proteins contain more than one histone reader, either as several copies of 
the same type or as a combination of various readers that are often specific for distinct 
modifications (Musselman et al., 2012; Rothbart and Strahl, 2014). For example, 
UHRF1 plays an essential role in maintenance of DNA methylation and synergistically 
recognizes unmodified H3 and K9me3 of the H3K9me3 peptide via its PHD finger and 
TTD (Arita et al., 2012). Another example is the BPTF subunit of the NURF 
chromatin-remodeling complex, which contains a PHD finger and a bromodomain 
connected by a rigid α-helical linker, thus interacting with H3K4me3 and H4K16ac, 
respectively, on the surface of a single nucleosome (Ruthenburg et al., 2007). 
Chromatin complexes that contain histone readers in multiple subunits generate a high 
level of histone modifications crosstalk, which provides a high degree of specificity. 
For example, the SAGA complex, which has a major role in transcription regulation, 
contains bromodomains, chromodomains and TTDs that bridge the complex to 
acetyllysine- and H3K4me3-enriched chromatin (Bian et al., 2011). Histone 
modification crosstalk can also trigger cascades of serial writing, erasing and reading 
processes through specific chromatin anchoring. For example, the PIM1 kinase 
phosphorylates S10 of H3K9ac, so that 14-3-3 can recognize H3K9acS10P and recruit 
the acetyltransferase MOF, which in turn acetylates H4K16. Finally, the bromodomain 
of BRD4 binds H4K16ac, which subsequently recruits P-TEFb necessary for 
transcription elongation (Zippo et al., 2009). 
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6.5.1. Histone modifications and DNA methylation crosstalk 
Both histone and DNA epigenetic marks cooperate to regulate chromatin organization 
and facilitate the recruitment of effector proteins and their macromolecular complexes 
to specific locations throughout the genome. For example, CpG methylation enhances 
UHRF1 binding to nucleosomes marked with H3K9me3, since it contains a SRA (SET 
and RING-associated) domain, a PHD finger, and a TTD histone binding domain 
(Rothbart and Strahl, 2014). In contrast, CpG methylation disrupts binding of the 
histone lysine demethylase KDM2A to H3K9me3-containing nucleosomes, since it has 
a CxxC domain that reads unmethylated CpG dinucleotides. Furthermore, the Jumonji 
C (JMJC) domain of KDM2A catalyzes the removal of H3K36me2, providing a likely 
explanation for why CpG island promoters lack H3K36me2 (Blackledge et al., 2010).  
The establishment, maintenance, and removal of DNA methylation has recently been 
linked to the recognition of histone modifications. The de novo DNA 
methyltransferases DNMT3A and DNMT3B (with the associated, but non-catalytic 
DNMT3L) share a cysteine-rich ADD motif that binds the unmodified N-terminus of 
histone H3. Such binding may have a role in DNMT3A/DNMT3L recruitment, since in 
vitro catalysis of DNA methylation by DNMT3A/DNMT3L on linker DNA of semi-
synthetic nucleosomal arrays was disrupted when nucleosomes harbored H3K4me2 or 
H3K4me3. By other hand, DNMT3A and DNMT3B also harbor PWWP domains that 
read H3K36me3 and are essential for chromatin targeting in cells (Rothbart and Strahl, 
2014). In plants, several histone marks and chromatin modifiers can influence DNA 
methylation. For example, methylation of H3K9 is recognized by the DNA 
methyltransferase CMT3, and demethylation of H3K4 by distinct classes of histone 
demethylases is required for maintenance of DNA methylation (Saze et al., 2012). 
 
7. Histone variants 
Canonical histones are expressed during the S phase of the cell cycle, contributing to 
the packaging of the newly synthesized DNA strand and to chromatin remodeling 
through their covalent modifications (Henikoff and Ahmad, 2005). However, they may 
be replaced by histone variants that confer new structural and functional properties to 
nucleosomes. Histone variants are expressed during all phases of the cell cycle and can 
be assembled into nucleosomes in differentiated cells, thus representing another 
mechanism for chromatin remodeling and regulation in many cellular processes (Malik 
and Henikoff, 2003). There are histone variants of all four core histones and the linker 
Doctoral Thesis  Jara Teresa Parrilla Doblas 
50 
histone. To date H2A and H3 variants are the best studied. Some variants involve only 
a few amino acid changes, whereas others contain changes that affect larger portions of 
the histone molecule (Ausio, 2006).  
The major H2A histone variants are H2A.Bbd (Barr-body deficient), H2A.Z, H2A.X 
and macroH2A (mH2A). Variant H2A.Z is indispensable for survival (Clarkson et al., 
1999) and plays an essential role in transcription and development in plants and 
animals (March-Díaz and Reyes, 2009). Furthermore, an antagonist relation between 
H2A.Z and DNA methylation has been found (Zilberman et al., 2008). H2A.X is one of 
the most studied variants, due to its specific phosphorylation in response to DNA 
double-strand break (DSB) (Foster and Downs, 2005) and its connection with genome 
integrity (Li et al., 2005) (see Section 7.3. Introduction). Histone H2A.X has also been 
involved in other processes such as apoptosis, V(D)J recombination, meiosis and 
replication (Ausio, 2006).  
The number of histone H3 variants is different between species, but at least two of them 
are universal. All eukaryotes have a centromere-specific H3 variant (CenH3, or CENP-
A in mammals) that is indispensable for survival, since it is essential for kinetochore 
assembly and correct chromosome segregation during mitosis (Ahmad and Henikoff, 
2002; Santisteban et al., 2000; Smith, 2002). CenH3 variants differ from canonical H3 
(designated H3.1) by a long extension of the N-terminal tail that is poorly conserved 
among eukaryotes (Malik and Henikoff, 2003). There are also differences in the 
histone-fold domain, which in CENP-A displays only 62% identity with H3.1 (Sullivan 
et al., 1994). Another universal histone H3 variant is H3.3 (Talbert and Henikoff, 
2010). In animals, only four invariant amino acids differentiate canonical H3.1 (A31, 
S87, V89 and M90) from variant H3.3 (S31, A87, I89 and G90). In plants, substitutions 
distinguishing H3.1 from H3.3 comprise positions 31, 41, 87, and 90 (Okada et al., 
2010). These amino acids are crucial for the distinct deposition properties of H3.1 and 
H3.3, which play different roles when incorporated into chromatin (Ingouff and Berger, 
2010). H3.3 is enriched in actively transcribed regions of the genome (Mito et al., 
2005), where it replaces H3.1 during transcriptional elongation (Schwartz and Ahmad, 
2005). In Drosophila and mammals, H3.3 is enriched in posttranslational modifications 
associated with transcriptional activity (McKittrick et al., 2004). Two distinct histone 
chaperone complexes are involved in the replication-coupled deposition of H3.1/H4 
and replication-independent deposition of H3.3/H4: the chromatin assembly factor-1 
(CAF-1) complex and the HIR histone cell cycle regulation defective homolog A 
(HIRA) complex, respectively (Nakatani et al., 2004). 
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8. ATP-dependent remodeling complexes 
Nucleosomes can be repositioned along the DNA molecule through the action of ATP-
dependent remodeling complexes that catalyze DNA translocation around 
nucleosomes, leading to changes in chromatin condensation (Hsieh and Fischer, 2005). 
These complexes use the energy of ATP hydrolysis to locally disrupt or alter the 
association of histones with DNA. Most of them belong to the SWI/SNF family, whose 
members have similar helicase-motif subunits, and are subdivided into several classes 
(SWI2/SNF2, ISWI, and CHD) based on the presence of other protein motifs (Langst 
and Becker, 2004; Lusser and Kadonaga, 2003). Each subfamily differs in the 
mechanism used for disrupting nucleosome structure, as well as in their association 
with additional co-factors for selective interaction with regulatory proteins that bind to 
specific DNA sequences (Felsenfeld and Groudine, 2003). 
 
9. Epigenome editing 
In recent years there has been an enormous progress in characterizing the different 
types epigenetic marks (histone modifications and DNA methylation) and the enzymes 
responsible for writing, reading and erasing them. As described above, these epigenetic 
modifications organize the DNA in the nucleus of eukaryotic cells and are essential for 
the spatio-temporal regulation of gene expression. However, in many cases it remains 
unclear whether they are heritable and have epigenetic roles, or have transient functions 
(Kungulovski and Jeltsch, 2016).  
Progress in epigenetics has led to the emergence of epigenome editing as a novel and 
powerful approach with many applications in gene functions studies, chromatin 
biology, cell reprogramming, and even molecular medicine (Figure 21) (Kungulovski 
and Jeltsch, 2016). Epigenome editing allows the directed writing, erasing or alteration 
of epigenetic marks at particular genomic regions by fusing a specific DNA binding 
domain (DBD) with the catalytic domain (effector domain, ED) of a chromatin-
modifying enzyme. Thus, the DBD specifically binds to a unique DNA sequence and 
targets the ED to desired regions in the genome, where it can alter the chromatin 
modification state, leading to modulation of gene expression or other biological 
processes without altering the underlying DNA sequence (Figure 21) (de Groote et al., 
2012; Kungulovski and Jeltsch, 2016).  
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Epigenome editing is a promising field in Biomedicine, since epigenetic alterations 
(often called epimutations) are associated with different diseases, including cancer 
(Falahi et al., 2015). Until recently, reversal of epimutations required the use of 
mutational approaches or pharmacological inhibitors, but both methods alter epigenetic 
marks globally and nonspecifically. In contrast, epigenome editing reduces genome-
wide off-targets and represents a powerful tool to create precise and long-lasting 
epigenetic modifications without the need to keep or maintain the system after the 
initial event (de Groote et al., 2012; Jurkowski et al., 2015). 
Figure 21. Epigenome editing technology and its applications in basic research and 
molecular medicine. Epigenome editing uses a DNA binding domain (DBD), which 
specifically binds to a unique DNA sequence, fused to the catalytic domain (effector domain, 
ED) of a chromatin-modifying enzyme, and thus targets the ED activity to desired regions. 
Epigenome editing has multiple applications in gene functions studies, chromatin biology, cell 
reprogramming, and even molecular medicine. Modified from (Kungulovski and Jeltsch, 2016). 
9.1. DNA Binding Domains (DBDs) 
To date, various DBDs have been used to direct activating or repressing epigenetic 
modifiers to desired loci (de Groote et al., 2012; Jurkowski et al., 2015). Some of them 
include non-mammalian DBDs and/or multiple repeats of their specific recognition 
sequences, such as the yeast Gal4 DNA Binding Domain (GBD), which binds to the 
Upstream Activation Sequence (UAS) (Giniger et al., 1985), or the prokaryotic Tet 
Repressor (TetR)-Tet Operator (TetO) (Wray et al., 1981). Furthermore, mammalian 
DBDs have been used to target enzymes to native endogenous chromatin sites, like the 
Methyl Binding Domain (MBD) of MeCP2 to target enzymes to genomic sites 
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consisting of hypermethylated DNA (Fukushige et al., 2008), and the DBD of NFκB to 
affect NFκB targets (Gregory et al., 2012).  
However, all of these systems have some disadvantages, such as the need to introduce 
foreign DBD recognition sites in the host cells, or the non-specific targeting to one 
unique site in the genome (de Groote et al., 2012). To solve this problem, various 
classes of DBDs can be engineered, such as Zinc Finger proteins (ZFPs), comprising 
several ZF modules binding three base pairs each (Figure 22A), transcription activator-
like effector (TALE) proteins, in which each TALE repeat recognizes one base pair 
(Figure 22B) (Moscou and Bogdanove, 2009; Mussolino and Cathomen, 2012), or the 
clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 
(CRISPR/Cas) system, in which a guide RNA directs a catalytically inactive Cas9 
nuclease (dead or deactivated Cas9, dCas9) fused to the ED (Figure 22C) (Cong et al., 
2013; Jinek et al., 2012; Mali et al., 2013b; Mali et al., 2013; Qi et al., 2013). These 
three methodologies are discussed below. 
Figure 22. Three major strategies for (epi)genome editing, according to the type of 
engineered DNA binding domain (DBD) fused to the effector domain (ED). (A) Zinc fingers 
(ZFs), in which each ZF module binds three base pairs, (B) TALEs, in which each TALE repeat 
recognizes one base pair, and C) the CRISPR/dCas9 system, in which a guide RNA binds a 20-
nt target DNA sequence and guides dCas9 fused to the ED. 
9.1.1. Zinc finger (ZF) domains  
Zinc finger (ZF) domains were discovered in 1985 in TFIIIA of Xenopus laevis (Miller 
et al., 1985) and are one of the most common DNA-binding motifs in eukaryotes, 
although they are also present in prokaryotes (Papworth et al., 2005). They are called 
ZF motifs because of the folding of a short stretch of amino acid residues (∼30 aa) 
around a zinc atom in the shape of a finger. Although most of them recognize DNA, 
some ZFs bind RNA (Lu et al., 2003) or proteins (Mackay and Crossley, 1998).  
Based on their structure and the way of coordinating zinc, there are at least three classes 
of ZFPs (Papworth et al., 2005). One of them contains the Cys6-zinc cluster motif (also 
known as Cys6-binuclear cluster), which is present in metabolic regulators of Fungi, 
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such as the yeast GAL4. Another class (Cys2Cys2 or Cys4) contains the consensus Cys–
n2–Cys–n13–Cys–n2–Cys sequence, which is found in nuclear steroid or hormone 
receptors such as the glucocorticoid receptor. Finally, a third class contains the classical 
ZF domain Cys2His2, which is present in a large number of regulatory proteins and is 
the most widely used for designing proteins with new DNA-binding specificities.  
Each Cys2His2 ZF comprises around 30 aa with the conserved sequence of (Tyr/Phe)–
n–Cys–n(2–5)–Cys–n3–(Tyr/Phe)–n5–Leu–n2–His–n(3–5)–His (Figure 23) (Miller et 
al., 1985), and is built as a ββα fold stabilized by a zinc atom (Lee et al., 1989). Two 
conserved cysteine residues within the two β-sheets (at the N-terminal part of the 
finger) and two histidine residues within the α-helix (at the C-terminal part of the 
finger) interact with the zinc atom (Figure 24). Three hydrophobic amino acids form a 
hydrophobic core that helps the module to maintain its shape (Figure 23).  
Figure 23. Conserved structure of Cys2His2 Zinc Fingers. The upper diagram shows 
important amino acids for zinc coordination (two cysteines and two histidines) and folding 
(three hydrophobic residues that help stabilize the arrangement). Several ZF modules can be 
joined through linkers to recognize longer sequences. The multiple alignment shown below 
illustrates the conservation of these residues in several ZF domains in the protein TFIIIA. 
Modified from (Rhodes and Klug, 1993). 
Each ZF interacts with the major groove of DNA through base contacts with side 
chains of specific amino acids (at positions -1, 3 and 6, numbered from the start of the 
α-helix), and specifically recognizes three contiguous base pairs of a DNA sequence 
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(Pavletich and Pabo, 1991) (Figure 25). Furthermore, the amino acid residue at position 
2 within the α-helix contacts a fourth base in the opposite strand, which is 
complementary to the base recognized by the amino acid at position 6 of a preceding 
ZF, causing cross-strand interaction and target site overlap (Figure 25). Thus, a single 
ZF domain recognizes 3–4 bp but several ZFs can be linked together in a modular array 
for efficient recognition of an extended sequence. For example, arrays with six ZFs 
motifs can recognize 18-19 bp, a sequence long enough to be unique within the human 
genome or any other genome (Liu et al., 1997).  
Figure 24. Positions of important residues for DNA recognition in a Cys2-His2 zinc finger. 
Modified from (Gommans et al., 2005). 
Figure 25. Important protein-DNA contacts in two adjacent ZF modules. For details, see 
the text. Modified from (Pabo et al., 2001). 
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The simple “one-to-one” mode of DNA recognition by the Cys2His2 ZF motifs and 
their relatively conserved backbone make feasible to use them as scaffolds for 
designing and customizing proteins with novel sequence specificities by changing the 
amino acid residues present at the DNA recognition positions, without altering the 
shape of the ZF motif itself (Gommans et al., 2005; Papworth et al., 2005). Thus, 
specific ZF arrays can be designed using a code that relates residues at the key 
positions of the ZF structure with the readout of individual nucleotides in the target 
DNA (Pabo et al., 2001). 
Many ZF domains that target different sequences have been engineered by rational 
design or high-throughput selection (Jurkowski et al., 2015; Papworth et al., 2005), and 
online tools for designing of ZF arrays are available (http://zifit.partners.org/ZiFiT/) 
(Sander et al., 2010; Sander et al., 2007). 
Using ZFPs as DBDs has several advantages, but also some limitations (Falahi et al., 
2015; Jurkowski et al., 2015). Their modular architecture and small size simplifies their 
production and potentially their delivery into the cells. Furthermore, since ZFPs are 
engineered from natural mammalian proteins, they might be less susceptible to adverse 
immune responses when used in the clinic. However, new proteins must be generated 
for each DNA target, which is complex and time-consuming, and not every nucleotide 
triplet has a corresponding zinc finger. 
9.1.2. Transcription activator-like effectors (TALEs) 
More recently, a new class of customizable and modular DBDs has been found. The 
transcription activator-like effectors (TALEs) were initially isolated from the bacterial 
plant pathogen Xanthomonas (Deng et al., 2014) and act as transcription factors that 
bind to and activate the promoters of disease resistance-related genes in plants, causing 
infection in plant hosts. TALEs consist of a series of tandem repeats of 33–35 (typically 
34) highly conserved amino acids, in which each repeat specifically recognizes a single 
bp of DNA, as opposed to the triplet combinations of a ZFPs recognition sequence. 
Two hypervariable amino acids located at positions 12 and 13 of each repeat (known as 
the repeat variable di-residues, RVD) are the responsible for the recognition specificity 
of TALEs (Scholze and Boch, 2010).  
Although TALEs represent a significant improvement in specificity and other 
advantages, such as the simplicity of the recognition code and the lack of influence by 
sequence and chromatin surrounding the target site (Boch et al., 2009; Moscou and 
Bogdanove, 2009), they have several limitations (Falahi et al., 2015; Jurkowski et al., 
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2015). For example, their repetitive nature implies susceptibility to DNA 
rearrangements. Also, their big size limits their delivery into the cells and target tissues 
(Gaj et al., 2013). Furthermore, some TALEs are sensitive to DNA methylation of the 
targeted region (Maeder et al., 2013a), although this can be overcome by re-engineering 
the RVD (Valton et al., 2012). Finally, in the same way as ZFs, TALEs need to be 
redesigned for each particular DNA sequence, which is time and resource consuming, 
and sometimes an unpredictable task. 
9.1.3. The CRISPR/Cas9 system 
In 2013, CRISPR/Cas technology emerged as a new genome-engineering tool. The 
clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 
(CRISPR/Cas) system is an adaptive immune system found in bacteria an archaea that 
acts as a RNA-guided defense mechanism against invasion by foreign DNA elements, 
such as viral genome or plasmids (Barrangou et al., 2007; Garneau et al., 2010; Mojica 
et al., 2005). The CRISPR/Cas system is currently divided into two major classes and 
five types (Makarova et al., 2015), being type II the simplest one and, therefore, the 
most widely used for genome-engineering applications.  
In the naturally occurring system, bacteria and archaea integrate short fragments of 
foreign nucleic acids (known as protospacers) primarily at one end of the Cas genomic 
locus (Figure 26). This first phase minimally requires two nucleases, Cas1 and Cas2, 
and generates a CRISPR array that functions as molecular memory of previous 
invaders. This array is transcribed by RNA polymerase III into a precursor CRISPR 
RNA (pre-crRNA) that contains nuclease guide sequences (spacers) interspaced by 
identical direct repeats. The pre-crRNA is next processed into small CRISPR RNAs 
(crRNAs, also known as guided RNAs, gRNAs) by specific endoribonucleases. Thus, 
each crRNA contains sequence complementarity to a prior nucleic acid invader. In the 
type II system, a transactivating crRNA (tracrRNA) is involved in the processing of 
pre-crRNA into crRNA through the formation of a duplex with the CRISPR repeat 
sequence (Deltcheva et al., 2011). A mature crRNA associates with the tracrRNA and 
the Cas9 endonuclease, and through complementary base pairing, guides the Cas9 
complex to the foreign DNA sequence to induce a double strand break, conferring 
immunity to the host (Bhaya et al., 2011).  
In essence, the CRISPR/Cas9 system can be targeted to DNA using RNA, enabling the 
edition of any region of the genome in a variety of organisms, such as bacteria, human 
cells, mice, rats, zebrafish, fruit flies, yeast and nematodes (Cong et al., 2013; Hsu et 
al., 2014; Jinek et al., 2012; Mali et al., 2013b; Pennisi, 2013). The system has been 
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further simplified by using an engineered single guide RNA (sgRNA), containing a 
designed hairpin that mimics the tracrRNA-crRNA complex, and a Cas9 protein 
isolated from the Streptococcus pyogenes (Jinek et al., 2012), which crystal structure in 
complex with guide RNA and target DNA has been recently obtained (Nishimasu et al., 
2014). 
A short DNA sequence (protospacer adjacent motif, PAM) at the 3’ end of the DNA 
target site is required for efficient binding and cleavage by the Cas9/RNA complex 
(Sternberg et al., 2014). DNA strand separation and the RNA–DNA heteroduplex are 
initiated at the PAM site. The PAM sequence is a component of the invading DNA, but 
not of the genomic CRISPR locus (and therefore it is not part of the 20 nt guide 
sequence within the gRNA), allowing the system to discern between self- and non-self 
DNA (Mali et al., 2013b). Cas9 proteins isolated from different organisms have 
different PAM requirements. The PAM sequence required by Streptococcus pyogenes 
Cas9, which is the most commonly used Cas9 protein, is 5’-NGG-3’, where N is any 
nucleotide (Jinek et al., 2012). 
Figure 26. The CRISPR/Cas9 adaptive immune system of bacteria and archaea. For 
details, see text. Modified from (Bhaya et al., 2011). 
The CRISPR/Cas9 methodology has been successfully used for genome editing through 
targeted mutation by Cas9-induced strand breaks (Cong et al., 2013; Mali et al., 2013b; 
Mali et al., 2013; Ran et al., 2013). However, it can be also used for targeted 
modulation of gene expression. To this end, the endonuclease domains (RuvC1 and 
HNH) of the Cas9 protein can be inactivated by point mutations (D10A and H840A in 
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SpCas9), resulting in a nuclease dead or deactivated Cas9 (dCas9) molecule that cannot 
cleave but retains the ability to bind the target DNA based on the sgRNA targeting 
sequence (Qi et al., 2013). By fusing dCas9 to transcriptional activators or repressors, 
or to epigenetic modifying domains, these dCas9 fusion proteins are targeted to the 
promoter region by a sgRNA, resulting in modulation of downstream target genes 
(Figure 27).  
 
Figure 27. Use of the CRISPR/dCas9 system in the modulation of gene expression. A) 
Transcriptional up-regulation of a specific gene. (B) Transcriptional down-regulation of a 
specific gene. A deactivated Cas9 protein (dCas9) is fused to a transcritptional activator or 
repressor or to an epigenetic modifier. A 20-nt guide RNA directs the fusion protein to a target 
sequence that is immediately followed by the protospacer adjacent motif (PAM sequence). 
The CRISPR/Cas9 system offers substantial advantages over ZFs and TALEs. For 
example, it is much easier, cheaper and quicker to use than ZFPs or TALEs, since Cas9 
can be easily retargeted to new DNA sequences by simply designing and exchanging 
oligonucleotides encoding the 20 nt gRNA sequence. Furthermore, the CRISPR/Cas9 
technology offers the possibility of targeting multiple loci at the same time in a host 
genome (multiplexing) (Cong et al., 2013) and, because DNA sequence recognition of 
CRISPR/Cas9 relies on the Watson-Crick base pairing of the RNA guide, it is not 
affected by DNA methylation (Hsu et al., 2013). However, this system is unnatural for 
mammals, which can trigger potentially adverse immunogenicity when used in the 
clinic. Furthermore, the requirement for the PAM motif adjacent to the target site limits 
the genomic sequences that can be targeted, although this can be partially overcome by 
using Cas9 orthologs with alternative PAM sequences. Use of smaller orthologs of 
SpCas9 could also facilitate its packaging with a sgRNA cassette into a single adeno-
associated virus (AAV) vector for in vivo delivery. One of such orthologs is Cas9 from 
Staphylococcus aureus, which is 25% shorter (> 1 kb) but has similar editing 
capabilities to SpCas9 (Ran et al., 2015). Another limitation is that not all the positions 
of the recognized sequence are read with equal stringency, so that relaxed target 
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specificity leads to frequent off-target binding (Fu et al., 2013). Nevertheless, the 
number of off-targets of the CRISPR/Cas9 system is relatively small: between 10 and 
<1000 in the human genome depending on the sgRNA used (Kuscu et al., 2014). In 
general, Cas9 can tolerate up to 3 mismatches within the target site (Ran et al., 2013). 
Interestingly, extending the 5’ end of the sgRNA with one or two guanine nucleotides 
(Cho et al., 2014) or reducing the length of gRNAs to 17–18 nucleotides increased the 
specificity and the efficacy of gRNAs (Fu et al., 2014). Off-target cleavage is highly 
sensitive to relative ratios of Cas9 and sgRNA; high concentrations of Cas9 lead to 
higher off-target activity (Hsu et al., 2013). Finally, on rare occasions, certain sgRNAs 
may not work for reasons yet unknown; therefore, at least two or more sgRNAs for 
each locus need to be designed and examined in the intended cell type to determine the 
most effective DNA targets. Nevertheless, despite its limitations, the CRISPR/Cas9 
system is the most promising genome targeting approach available so far. 
9.2. Effector domains and examples of epigenetic editing 
All three types of DBDs mentioned above (ZFs, TALEs and/or the CRISPR/dCas9 
system) have been already fused to different effector domains (EDs) in order to 
regulate the expression of specific genes (endogenous or genome integrated targets, 
reporter plasmids or viral DNA) without altering the DNA sequence (Jurkowski et al., 
2015). In this context, it is perhaps useful to distinguish between the terms genome 
reprogramming and epigenetic editing. Genome reprogramming employs 
transcriptional activators and repressors as EDs, whereas in epigenome editing the EDs 
are chromatin-modifying enzymes (usually their catalytic domains) such as DNA 
methylases or demethylases, and different histone modifiers (histone acetyltransferases 
or deacetylases, and histone lysine methyltransferases or demethylases) (Kungulovski 
and Jeltsch, 2016). Although genome reprogramming is naturally transient, it may also 
lead to stable changes in gene expression if the targeted activating or repressing domain 
induces secondary epigenetic changes. Therefore, transcriptional activators or 
repressors might be able to trigger epigenome editing (Kungulovski and Jeltsch, 2016). 
Engineered DBD-ED proteins have potential applications for the study of gene 
expression and function in normal and disease processes, as well as for gene therapy for 
the treatment of cancer and genetic disorders. For example, epigenome editing could be 
used to reactivate tumor suppressors genes, which are usually silenced in cancer cells, 
or to repress oncogenes, which should be silenced in normal cells and are activated in 
cancer cells. Thus, epigenome editing could potentially be applied to tumor 
microenvironment cells to decrease tumor growth or metastatic potential, minimizing 
cancer cell selection (Kungulovski and Jeltsch, 2016). 
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9.2.1. Transcriptional activators 
The most widely used transcriptional activator is VP64, which consist of four tandem 
copies of amino acids 437–447 [DALDDFDLDML] of the Herpes Simplex Viral 
Protein 16 (VP16) connected by glycine-serine linkers (Beerli et al., 1998). VP16 is a 
transcriptional activator (Sadowski et al., 1988) that interacts with multiple 
transcriptional components, such as TATA-binding protein (TBP), TFIIB, and the 
SAGA histone acetylase complex in vivo (Hall and Struhl, 2002). It has been recently 
reported that VP64 recruits p300, which in turn acetylates H3K27 at the targeted locus, 
leading to robust transcriptional activation (Gao et al., 2014). VP64 has been fused to 
several DBDs. For example, when fused to a specific ZFP (CD54-Opt31), VP64 
increases the targeted expression of the endogenous tumor suppressor gene ICAM-1 
(intercellular adhesion molecule 1) in ovarian cancer cells (de Groote et al., 2014). 
Another study used five different engineered ZFPs fused to VP64 to target and re-
express the C13ORF18 tumor suppressor gene in cervical carcinoma cell lines 
(Huisman et al., 2013).  
Likewise, VP64 has been linked to TALEs or the CRISPR/dCas9 system to specifically 
up-regulate both reporter and endogenous genes (Hu et al., 2014; Maeder et al., 2013b; 
Maeder et al., 2013c; Perez-Pinera et al., 2013a; Perez-Pinera et al., 2013b). For 
example, TALE-VP64 fusion proteins targeted to the promoter regions of IL1RN, 
KLK3, CEACAM5 or ERBB2 induced substantial gene activation, and it was higher 
when using combinations of several TALEs-VP64 targeted to a particular promoter, 
instead of a single TALE-VP64 (Perez-Pinera et al., 2013b). Interestingly, when using 
dCas9 fused to VP64, the activation level of the target gene was significantly higher 
when using multiple sgRNAs combinations instead of a single one. Something similar 
was also observed when using three tandem copies of VP16 (VP48) fused to a dCas9 
system directed to a reporter system (Nanog promoter controlling the enhanced green 
fluorescent protein, eGFP, reporter gene) in mouse zygotes (Cheng et al., 2013), as 
well as when using ten tandem copies of VP16 (VP160) fused to dCas9 system directed 
to interleukin 1 receptor antagonist (IL1RN), octamer-binding 4 (OCT4) and SRY-box 
2 (SOX2) endogenous genes in human cell lines (Cheng et al., 2013). 
Another transcriptional activator used as ED is the transcription activation domain of 
the 65 kDa polypeptide of the nuclear form of the NFκB transcription factor: the p65 
activation domain (p65AD). For example, a study showed that dCas9-p65AD directed 
to UAS (upstream activation sequence, the binding site of the yeast Gal4) in a HEK293 
reporter cell line expressing a UAS-GFP reporter, can effectively activate the reporter 
gene expression (Gilbert et al., 2013). Another study used individual or combinations 
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of TALEs fused to either VP64 or p65AD transcriptional activators directed to different 
sites of several human genes promoters (such as VEGFA or NTF3), and achieved robust 
increase expression of these endogenous human genes, although activation was lower 
when using TALEs-p65 (Maeder et al., 2013c). 
Several studies have optimized the CRISPR/dCas9 system to enhance transcription 
activation, by engineering either dCas9 (Chavez et al., 2015; Tanenbaum et al., 2014) 
or sgRNA (Konermann et al., 2015). One approach fused dCas9 to a carboxy-terminal 
SunTag array containing 10 copies of a small peptide epitope (dCas9-SunTag). The 
peptides are recognized by a cognate single-chain variable fragment (scFV) fused to a 
superfolder GFP (sfGFP) for improving protein folding and to VP64 (scFV-sfGFP-
VP64). This method allows recruiting multiple copies of VP64 to a single dCas9 
(Tanenbaum et al., 2014). Significant activation of CXCR4 was achieved using dCas9-
SunTag and a single sgRNA. Another tactic fused dCas9 to a tripartite activator domain 
that contains VP64, p65AD and the Epstein–Barr virus R transactivator Rta (VPR). The 
resulting fusion protein (dCas9-VPR) improved activation of endogenous coding and 
non-coding genes using multiple sgRNAs, when compared with dCas9-VP64 (Chavez 
et al., 2015). A third improved strategy is the synergistic activation mediator (SAM) 
method, which uses dCas9 with a sgRNA encoding MS2 RNA aptamers. This aptamer 
portion of the sgRNA recruits MS2 coat protein (MCP) fused to the activators p65AD 
and heat shock factor 1 (HSF1). The SAM technology, together with dCas9-VP64, 
further increased endogenous gene activation compared with dCas9-VP64 alone and 
was shown to activate 10 genes simultaneously (Konermann et al., 2015). 
9.2.2. Transcriptional repressors 
The human Krüppel-associated box (KRAB) domain of the KOX-1 protein is a 
commonly used repressor domain (Margolin et al., 1994). Interestingly, the KRAB 
repressor domain recruits histone modifying enzymes and results in a decrease of 
activating H3K4me3 and increase of repressive H3K9me3 and H3K27me2, but does 
not alter DNA methylation (Ma et al., 2014). The KRAB repressor domain comprises 
two regions known as A and B boxes and is highly conserved between eukaryotes. 
Only 45 amino acids in the KRAB-A box are sufficient for the repression of 
transcription, but both the complete KRAB and the KRAB-A domains have been 
successfully used as effector domains for targeted gene repression. For example, 
different ZFPs fused to the KRAB-A repressor domain were able to down-regulate the 
activity of the endogenous epithelial glycoprotein-2 (EGP-2) promoter as well as the 
EGP-2 controlling a luciferase reporter vector in different human cancer cells 
Introduction 
 63 
(Gommans et al., 2007). Furthermore, a study showed that KRAB fused to a dCas9 
system directed to UAS (upstream activation sequence, the binding site of the yeast 
Gal4) in a HEK293 reporter cell line expressing a UAS-GFP reporter, can efficiently 
silence GFP expression (Gilbert et al., 2013). 
Another transcriptional repressor that has been used as effector domain fused to 
different DBDs systems is the mSin3 interaction domain (SID) (Ayer et al., 1996; 
Beerli et al., 1998; Cong et al., 2012). 
9.2.3. DNA methyltransferases 
ZFPs have been successfully fused to bacterial or mammalian DNA methyltransferases 
for targeting DNA methylation and gene repression (Jurkowski et al., 2015; Laufer and 
Singh, 2015). For example, expression of an engineered M.HpaII enzyme fused to a 
ZFP with four ZFs results in specific de novo methylation of a target locus in HeLa 
cells (Smith and Ford, 2007). In another study, the catalytic domain of mouse 
DNMT3A DNA methyltransferase was fused with engineered ZFPs containing three or 
six ZFs, which specifically recognized a target sequence in the promoter of HSV-1 
gene IE175k, cloned upstream the luciferase reporter gene in a reporter vector (Li et al., 
2007d). These targeted methyltransferases specifically methylated the target promoter, 
causing significant repression of the luciferase reporter gene in different human cell 
lines (Li et al., 2007d). Finally, another study obtained a single chain fusion protein 
containing the catalytic domain of the de novo methyltransferase DNMT3A and the C-
terminal domain of DNMT3L, which stimulates DNMT3A’s activity (Siddique et al., 
2013). The DNMT3A-DNMT3L single-chain construct, fused to an artificial ZFP that 
binds the vascular endothelial cell growth factor A (VEGF-A) gene, caused stronger 
methylation in the gene promoter than the targeted DNMT3A catalytic domain itself, 
leading to strong silencing of the VEGF-A gene in SKOV3 cells (a cancer cell line with 
unmethylated VEGF-A promoter and active VEGF-A expression) (Siddique et al., 
2013). 
Likewise, TALEs fused to eukaryotic DNA methyltransferases (TALE-DNMTS) have 
shown to specifically direct DNA methylation to the CDKN2A locus, which encodes 
the cyclin-dependent kinase inhibitor p16, leading to decreased CDKN2A expression 
and increased replication of primary human fibroblasts (Bernstein et al., 2015). 
A recent study has developed a CRISPR/dCas9 system fused to DNMT3A DNA 
methyltransferase targeted to endogenous genes in HEK293 cells and has shown an 
increase in DNA methylation levels at the target sites that was heritable across mitotic 
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divisions and that was accompanied by a decrease in gene expression (Vojta et al., 
2016). 
9.2.4. DNA demethylases 
Several enzymes implicated in active DNA demethylation in mammalian cells have 
been fused to artificial ZFPs to direct demethylation and reactivate specific genes. For 
example, targeting multiple ZF-TDG (thymidine DNA glycosylase) constructs to the 
promoter of the inducible nitric oxide synthase (NOS2) gene (methylated and silenced 
in 3T3 fibroblasts) showed a cumulative effect and led to significant DNA 
demethylation in the promoter and CpG island of NOS2 (Gregory et al., 2013). 
Furthermore, stimulation by LPS and IFNγ (classical inducers of NOS2 in cell types 
where the gene is not silenced) enhanced transcriptional responsiveness, leading to ~3- 
to 4-fold increases in mRNA expression and to elevated production of NO (Gregory et 
al., 2013). Another study fused the catalytic domain of mouse TET2 (Ten-Eleven 
Translocation 2 dioxygenase) to an engineered ZFP (CD54) that specifically binds to 
endogenous ICAM-1 gene promoter, which is hypermethylated in A2780 ovarian 
cancer cells, and showed targeted DNA demethylation at specific CpG sites and 2-fold 
re-activation of expression of the target gene in A2780 cells (Chen et al., 2013a). 
One study generated 11 TALE-TET1 proteins targeted to sites that are in close 
proximity to different CpGs in the RHOXF2/2B homeobox gene (RHOXF2) promoter, 
which is expressed primarily in male germ cells but is strongly repressed by DNA 
methylation in non-germ cells (Maeder et al., 2013a). Some of the constructs induced 
significant demethylation, and two of them also induced high levels of mRNA 
expression of RHOXF2 in HEK293 and HeLa cell lines, indicating that demethylation 
of critical methylated promoter CpG positions can lead to significant increases in the 
expression of endogenous human genes. Similar results were obtained with several 
TALE-TET1 fusion proteins targeted to he human beta-globin (HBB) gene promoter in 
K562 cells (Maeder et al., 2013a). 
A recent study has achieved targeted DNA demethylation and up-regulation of specific 
genomic loci (RANKL or MAGEB2) in HEK293-FT cells by fusing TET1 catalytic 
domain both to MS2 RNA element-containing sgRNA2.0 system-guided dCas9 and 
MS2 bacteriophage coat protein (Xu et al., 2016). 
It should be remembared that TET proteins mediate DNA demethylation indirectly 
through oxidation of 5-meC to 5-hmC, and further oxidation of 5-hmeC to 5-fC and 5-
caC (Figure 12). Furthermore, it has to be considered that the studies mentioned above 
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targeting TET proteins used bisulfite sequencing to measure 5-meC levels and this 
technique is not able to distinguish between C, 5-fC and 5-caC, since 5-fC and 5-caC 
are not resistant to deamination by sodium bisulfite. Therefore, these studies did not 
strictly demonstrate DNA demethylation (Pastor et al., 2013). 
9.2.5. Histone modifiers 
There are several examples of different histone modifiers fused to different DBDs to 
achieve targeted histone methylation or demethylation, as well as targeted histone 
acetylation or deacetylation of specific histone residues, with the subsequent repression 
or activation of target gene expression (Jurkowski et al., 2015; Laufer and Singh, 
2015). For example, a study fused the catalytic activity of both SUV39H1 and G9a 
histone methyltransferases to an engineered ZFP that specifically recognizes the 
endogenous VEGF-A locus, and showed specific methylation of H3K9 within 
nucleosomes proximal to the ZFP binding site in HEK293 cells and demonstrated that 
it was the cause of the target gene repression (Snowden et al., 2002). Then, ZFs have 
been designed with histone methyltransferases to repress oncogenes (Falahi et al., 
2013). 
When fusing the SET domain of EHMT2 (Epithelial-Mesenchymal Transition) to a 
TALE, the TALE-SET fusion protein increased H3K9me2 mark in the promoter region 
of E-cadherin, leading to repression of E-cadherin expression and increasing the cell 
migration/invasion (Cho et al., 2015). TALEs fused to the LSD1 histone demethylase 
were capable of demethylating enhancer-associated chromatin modifications from 
target loci (Mendenhall et al., 2013). 
LSD1 has been also fused to a CRISPR/dCas9 system targeted to the distal enhancer 
region of the endogenous transcription factor gene OCT4, and it caused repression of 
OCT4 and loss of pluripotency in mouse embryonic stem cells (ES cells) (Yeom et al., 
1996). Finally, a CRISPR/Cas9-based acetyltransferase consisting of dCas9 fused to the 
catalytic core of the human acetyltransferase p300 was shown to acetylate H3K27 
specifically at its target sites and to robustly activate transcription of different target 
genes, including IL1RN, MYOD and OCT4, in human cells (Hilton et al., 2015). 
Interestingly, dCas9-p300 targeted to the mammalian β-globin locus control region 
(LCR) induced gene expression of downstream hemoglobin genes, but such induction 
could not be achieved with a dCas9-VP64 fusion protein (Hilton et al., 2015).  
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Active DNA demethylation is a crucial process poorly understood in mammalian cells. 
In plants, DNA demethylation is initiated by DNA glycosylases that excise 5-
methylcytosine (5-meC). The hypothesis of this thesis is that plant 5-meC DNA 
glycosylases are complex enzymes containing key residues for 5-meC excision and for 
histone interaction, and identifying such residues will help to use these proteins as 
epigenetic editing tools to revert the methylation status of specific target sequences in 
human cells. To test this hypothesis, Arabidopsis thaliana ROS1 protein has been used 
as a model plant DNA demethylase and the following specific aims have been 
established: 
1. To identify through mutational analysis key ROS1 amino acids involved in 5-
meC recognition and excision. 
2. To determine whether ROS1 interacts with histones and their specific post-
translational modifications, and identify which ROS1 region(s) is (are) 
involved in such interaction. 
3. To transform ROS1 in an epigenetic editing tool by fusing its catalytic domain 
to different DNA binding domains, in order to direct its activity to desired 
target sequences. 
 

  
!
RESULTS !

Results 
 73 
CHAPTER 1 
Identification and mutational analysis of 
ROS1 residues important for 5-mec 
recognition and excision 
 
Active DNA demethylation is crucial for epigenetic control, but the underlying 
enzymatic mechanisms are still incompletely understood. In plants, active DNA 
demethylation is initiated by a family of bifunctional DNA glycosylases, typified by 
Arabidopsis thaliana REPRESSOR OF SILENCING 1 (ROS1), that specifically excise 
5-meC and initiate its replacement with unmethylated C in a base excision repair (BER) 
process (Agius et al., 2006; Morales-Ruiz et al., 2006). These enzymes belong to the 
HhH-GPD superfamily, but they are uniquely characterized by a bipartite catalytic 
domain divided by a large insert predicted to have an unstructured conformation 
(Ponferrada-Marín et al., 2011). They also contain a carboxy-terminal domain of 
unknown function, and a short amino-terminal domain significantly rich in lysine. In 
ROS1, this basic domain is the major responsible for nonspecifically binding to DNA 
and endows the protein with the capacity to slides along the substrate in search of 5-
meC (Ponferrada-Marín et al., 2010; Ponferrada-Marín et al., 2012). A central question 
that remains to be answered is how ROS1 recognizes and excises its target base. Most 
DNA glycosylases use a common base-flipping mechanism to extrude the target lesion 
from the base stack into a substrate-recognition pocket (Brooks et al., 2013; Dalhus et 
al., 2009; Huffman et al., 2005). The resulting distortion of the DNA is stabilized by 
insertion of a bulky intercalating side chain that plugs the vacant space left by the 
flipped-out nucleotide and a second side chain that wedges between the bases on the 
opposite strand (Brooks et al., 2013). The first objective of this thesis has been to gain 
insight into the mechanism of target recognition and excision by ROS1. Towards this 
aim, functional residues that participate in detection and excision of the modified base 
were predicted by combining sequence alignment and homology-based modeling, and 
tested by site-directed mutagenesis.  
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1. Identification of putative helix-invading residues in 
ROS1 
A multiple sequence alignment that included Arabidopsis thaliana ROS1 and DME, 
Nicotiana tabacum ROS1, and several HhH-GPD proteins was performed in a previous 
study (Ponferrada-Marín et al., 2011) and has been used in this thesis to gain insight 
into residues that participate in location and recognition of 5-meC (Figure 28). The 
alignment revealed that sequence similarity to HhH-GPD enzymes in DML proteins is 
distributed over two non-contiguous segments separated by a long, non-structured 
linker region (Ponferrada-Marín et al., 2011). The Q607 amino acid of ROS1 protein, 
which is essential for both catalytic activity and stable DNA binding, was previously 
proposed as a strong candidate for the plug residue that replaces the flipped 5-meC in 
the base stack (Ponferrada-Marín et al., 2011) and locates in the first segment of the 
discontinuous DNA glycosylase domain of the enzyme (Figure 28B). In E. coli 
Endonuclease III, the side chain of L82 serves as the wedge that intercalates into the 
DNA duplex and stacks with the G opposite the lesion (estranged G), which donates a 
hydrogen bond to the backbone carbonyl of I80 (Fromme and Verdine, 2003). The 
homologous residues of L82 and I80 in ROS1 are M905 and R903, respectively, and 
both are located in the second segment of ROS1 DNA glycosylase domain (Figure 
28B). The residues R903 and Q607 are conserved within the ROS1/DME family of 
DNA demethylases, whereas Q instead of M is observed at the homologous position of 
M905 in some members of the family (Figure 29).  
In a prior study, the crystal structure of Bacillus stearothermophilus Endonuclease III 
[Protein Data Bank accession code: 1P59, (Fromme and Verdine, 2003)] was used as a 
template to generate a tridimensional model structure of the discontinuous DNA 
glycosylase catalytic domain of ROS1 (amino acids 567–625 and 883–1062) 
(Ponferrada-Marín et al., 2011). The model predicts that R903 and M905 are positioned 
close to the G opposite 5-meC on the complementary strand (Figure 28C). In the same 
way, the model suggests that Q607 residue fills the vacant space left behind by the 
flipped 5-meC (Figure 28C). To test the prediction that R903 and M905 have a role in 
ROS1 enzymatic activity, these residues were mutated to Ala (R903A) and Gly 
(M905G), respectively. The mutant version Q607A, which lacks the putative plug 
residue (Ponferrada-Marín et al., 2011), was also used in these experiments. 
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Figure 28. Identification of putative helix-invading residues in ROS1. (A) Schematic 
diagram showing conserved regions among members of the ROS1/DME family: a N-terminal 
lysine-rich region (green), a non-contiguous DNA glycosylase domain distributed over two 
segments (blue and red) separated by a non-structured linker region and a highly conserved C-
terminal domain (yellow) that is not found in any other protein family. (B) Multiple sequence 
alignment of part of the DNA glycosylase domain of ROS1/DME proteins and several HhH-
GPD superfamily members. ROS1 amino acids analyzed in this work are indicated by inverted 
triangles and highlighted in orange (Q607), green (R903) or pink (M905). Names of organisms 
are abbreviated as follows: Ath, Arabidopsis thaliana; Nta, Nicotiana tabacum; Bst, Bacillus 
stearothermophilus; Eco, Escherichia coli; Mth, Methanobacterium thermoautotrophicum; 
Mmu, Mus musculus; Hsa, Homo sapiens. Genbank accession numbers are as follows: Ath 
ROS1: AAP37178; Ath DME: ABC61677; Nta ROS1: BAF52855; Bst EndoIII: 1P59; Eco 
EndoIII: P20625; Mth Mig: NP_039762; Eco MutY: NP_417436; Mmu MBD4: 1NGN; Hsa 
OGG1: O15527; Eco AlkA: P04395. (C) Structural model for the DNA glycosylase domain of 
ROS1 bound to a DNA containing an abasic site. The position of Q607, R903 and M905 
residues (colored as in panel B) in relation to the estranged guanine (blue) are shown. The model 
was generated as described in (Ponferrada-Marín et al., 2011) and the figure was prepared with 
PyMOL (http://www.pymol.org). (D) Schematic sequence diagram indicating the predicted 
interactions between mutated amino acids and the orphan guanine (blue) opposite 5-meC (M, in 
red). 
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Figure 29. Conservation of Q607, R903 and M905 residues among members of the 
ROS1/DME family. (A) The upper schematic diagram shows the conserved regions among 
members of the ROS1/DME family: a N-terminal lysine-rich region (green), a non-contiguous 
DNA glycosylase domain distributed over two segments (blue and red) separated by a non-
structured linker region, and a highly conserved C-terminal domain (yellow) that is not found in 
any other protein family. (B) Multiple sequence alignment of part of the DNA glycosylase 
domain of members of the ROS1/DME family. ROS1 amino acids analyzed in this work are 
indicated by inverted triangles and highlighted in orange (Q607), green (R903) or pink (M905). 
Names of organisms are abbreviated as follows: Ath, Arabidopsis thaliana; Nta, Nicotiana 
tabacum; Osa, Oryza sativa; Sbi, Sorghum bicolor; Ppa, Physcomitrella patens. Genbank 
accession numbers are: Ath ROS1 AAP37178; Ath DME ABC61677; Ath DML2 Q9SR66; Ath 
DML3 O49498; Nta ROS1 BAF52855; Nta ROS2 BAF52856; Osa DMLA BAD23025; Osa 
DMLB BAF04322; Osa DMLC EEE63898; Sbi DML  XP_002441186; Ppa DML  DS545358. 
 
2. Q607, R903 and M905 are specifically required for 
processing of 5-meC:G base pairs 
The ability of WT and mutant proteins M905G, R903A and Q607A to process a 51-mer 
duplex oligo substrate containing a single 5-meC opposite G, A, T or C was firstly 
examined by kinetic analysis (Figure 30). A representative example of 5-meC DNA 
glycosylase assay and kinetic analysis is shown in Figure 31 (for details, see Materials 
and Methods, Section 5). Consistent with previously reported observations (Ponferrada-
Marín et al., 2009), WT ROS1 processed 5-meC with higher efficiency when mispaired 
with either C, T or A than when paired with G. Mutants M905G and R903A had no 
detectable base excision activity on a 5-meC:G pair, whereas the Q607A mutant 
displayed a strongly reduced activity on the same substrate (Figure 30). Interestingly, 
however, all three mutant proteins retained a significant activity on DNA substrates 
containing a mismatched 5-meC. In contrast, two catalytically disabled mutants 
(D611V and T606L) did not show detectable base excision activity on either paired or 
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mispaired 5-meC (data not shown). Therefore, Q607, R903 and M905 are specifically 
required for efficient excision of 5-meC opposite G.  
Figure 30. Enzymatic activity of WT ROS1 and mutant variants on DNA substrates 
containing 5-meC opposite different bases. Purified proteins (20 nM) were incubated at 30°C 
with 51-mer double-stranded oligonucleotide substrates (20 nM) containing 5-meC opposite G, 
A, T or C, as indicated. Relative processing efficiencies were determined in kinetic assays as 
described in ‘Materials and Methods’ section. Values are mean ± SE (error bars) from three 
independent experiments. 
 
Figure 31. Representative example of 5-meC DNA glycosylase assay and kinetic analysis. 
The time-dependent generation of incision products was measured by incubating purified WT 
ROS1 (20 nM) at 30°C with a fluorescein-labeled duplex substrate containing a single 5-meC:G 
pair (20 nM). Reactions were stopped at the indicated times, products were separated in a 12% 
denaturing polyacrylamide gel and quantified by fluorescence scanning. The graph shows the 
generation of incision products versus time. Values are means ± S.E. (error bars) from three 
independent experiments. Data were fitted to the equation [Product] = Pmax[1-exp(-kt)] using non-
linear regression analysis. Blue and red curves indicate 95% confidence and prediction intervals, 
respectively. 
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These results strongly suggest significant differences in recognition and processing of 
5-meC:G pairs and 5-meC mismatches. To explore further such possibility, the 
temperature dependence of WT ROS1 activity on both types of substrates was 
examined (Figure 32). The catalytic activity on all four DNA substrates increases with 
temperature from 5 to 30ºC, but the temperature dependence is significantly lower for 
the DNA substrate containing a 5-meC:G pair. These results suggest that the inherent 
instability of 5-meC mismatches facilitates their processing by both WT and mutant 
proteins, in comparison with 5–meC:G pairs. 
Figure 32. Temperature dependence of ROS1 activity on 5-meC opposite G, A, T or C. 
Generation of incision products was measured by incubating for 4 h at the indicated 
temperatures purified WT ROS1 or mutant proteins (20 nM) with double-stranded 
oligonucleotide substrates (20 nM) containing 5-meC opposite G (red circles), A (yellow 
circles), T (green triangles) or C (blue triangles) on the complementary strand. Products were 
separated in a 12% denaturing polyacrylamide gel, and the amount of incised oligonucleotide 
was quantified by fluorescence scanning. Values are mean ± SE (error bars) from three 
independent experiments. 
ROS1 is a bifunctional DNA glycosylase/lyase that catalyzes both the release of 5-meC 
and the cleavage of DNA at the resulting abasic site (Morales-Ruiz et al., 2006). 
Therefore, the incapacity of the three mutant proteins to process 5-meC:G pairs was 
further analyzed to determine if it is due to a deficiency in DNA glycosylase activity, 
lyase activity or both (Figure 33). To detect DNA glycosylase activity, the reaction 
products generated by different ROS1 variants were analyzed after an additional 
alkaline treatment with NaOH, which cleaves all abasic sites generated by the enzyme 
and reflects 5-meC excision. Both R903A and M905G mutant enzymes did not show 
detectable excision, whereas the Q607A variant showed a significantly decreased 
activity (Figure 33B). Analogous results were obtained when performing reactions in 
the presence of human APE1 AP endonuclease, instead of NaOH treatment (data not 
shown). To determine whether the three variants retained AP lyase activity, the proteins 
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were incubated with a 51-mer duplex oligo substrate containing an AP site opposite G. 
All three mutant variants cleaved the abasic site as efficiently as WT ROS1 (Figure 
33C). These results indicate that R903A, M905G and Q607A exhibit a specific defect 
in catalysis of glycosylic bond cleavage. Because such defect is greatly alleviated when 
the target base is mispaired, it can be concluded that Q607, R903 and M905 are critical 
for destabilization of 5-meC:G base pairs and are likely to perform a key role in 
extrusion of the target base from DNA. However, they are not required for the 
subsequent cleavage of the sugar-phosphate backbone. 
Figure 33. Q607A, M905G and R903A mutant proteins lack DNA glycosylase activity on 
5-meC:G pairs but retain AP lyase activity. (A) Schematic diagram of ROS1 DNA 
glycosylase/AP lyase activity on 5-meC. ROS1 excises 5-meC as a free base and then cleaves 
the phosphodiester backbone at the 5-meC removal site by successive β,δ-elimination. (B) DNA 
glycosylase assay. The generation of incision products was measured by incubating purified WT 
ROS1 or mutant variants (20 nM) at 30°C for 4 h with a double-stranded oligonucleotide 
substrate (20 nM) containing a single 5-meC:G pair. After incubation, NaOH (100 nM) was 
added and samples were immediately transferred to 90°C for 10 min. Products were separated in 
a 12% denaturing polyacrylamide gel and the amounts of incised oligonucleotide were 
quantified by fluorescent scanning. (C) AP lyase assay. A double- stranded oligonucleotide 
substrate containing an AP site opposite G (20 nM) was incubated at 30°C for 2 h in the 
presence of purified WT ROS1 or mutant variants (20 nM). Samples were treated with NaBH4 
(300 mM) at 0°C for 30 min to stabilize non-processed AP sites and neutralized with 100 mM 
Tris–HCl, pH 7.4. Products were separated in a 12% denaturing polyacrylamide gel and the 
amount of incised oligonucleotide was quantified by fluorescent scanning. Values are mean ± 
SE (error bars) from three independent experiments. 
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3. R903 and M905 are dispensable for DNA binding 
A previous study reported that the Q607A mutant exhibits a drastically reduced DNA 
binding capacity (Ponferrada-Marín et al., 2011). In order to determine if R903 and 
M905 also play a role in substrate binding, the DNA binding capacity of the 
corresponding mutant proteins was examined by electrophoretic mobility shift assay 
(EMSA). Increasing concentrations of WT ROS1, R903A, M905G or Q607A proteins 
were incubated with a labeled DNA substrate containing a 5-meC:G pair (Figure 34). 
No protein–DNA complexes were detected in binding reactions containing the mutant 
protein Q607A. In the case of WT ROS1, R903A and M905G proteins, a major band 
with retarded mobility was observed at high protein concentrations and a minor diffuse 
band was detectable at low protein concentrations. Analogous results were obtained 
with nonmethylated DNA (data not shown). These results suggest the formation of 
protein–DNA complexes containing more than one ROS1 molecule. A similar 
observation has been previously reported for a mammalian homolog of the DNA 
glycosylase MutY (Pope and David, 2005). Quantitation of the total amount of protein–
DNA complexes (Figure 34, left) indicates that there are not significant differences in 
DNA binding capacity between WT ROS1 and either R903A or M905G proteins. 
Furthermore, DNA binding measurements at different time points showed that WT 
ROS1, R903A and M905G proteins rapidly formed a detectable complex with the 
methylated substrate that is stable over time (Figure 35C and D). 
Next, the binding affinity of WT ROS1, R903A and M905G was examined in detail 
through competition experiments with unlabeled oligonucleotides (Figure 36). In 
agreement with its methylation-independent DNA binding capacity (Ponferrada-Marín 
et al., 2010), WT ROS1 binding to a methylated DNA probe was reduced with 
equivalent intensity when incubated with increasing amounts of either nonmethylated 
or methylated unlabeled competitor DNA (Figure 36, upper panel). The two mutant 
proteins exhibited dissociation rates not significantly different from those of the WT 
protein, and both bound methylated and nonmethylated DNA with similar affinity 
(Figure 36, middle and lower panels). Furthermore, the two mutant versions do not 
show any enhanced affinity for DNA substrates containing mismatched 5-meC, or for a 
single nucleotide gap opposite A, T or C (Figure 37). Altogether, these results indicate 
that R903 and M905 are dispensable for DNA binding. 
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Figure 34. DNA binding capacity of R903A, M905G and Q607A mutant proteins. 
Increasing concentrations of purified WT ROS1 or mutant variants were incubated at 25°C for 1 
h with 10 nM of fluorescein-labeled 5-meC:G duplex. After non-denaturing gel electrophoresis, 
gels were scanned to detect fluorescein-labeled DNA. Protein–DNA complexes were identified 
by their retarded mobility compared with that of free DNA. A representative gel is shown for 
each protein. Graphs on the left show the percentage of protein–DNA complex versus protein 
concentration. All bands with slower mobility were used in quantitation of bound protein. 
Values are mean ± SE (error bars) from three independent experiments. 
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Figure 35. Analysis of DNA binding of M905G and R903A mutant proteins to methylated 
DNA over time. (A-B) Purified WT or mutant variants of ROS1 (132 nM) were incubated at 
25°C with 100 nM of fluorescein-labeled 5-meC:G duplex and the reactions were monitored for 
0 min (lanes 1, 6 and 11), 15 min (lanes 2, 7 and 12), 30 min (lanes 3, 8 and 13), 45 min (lanes 
4, 9 and 14) and 60 min (lanes 5, 10 and 15). After non-denaturing gel electrophoresis (B), the 
gel was scanned to detect fluorescein-labeled DNA and quantify the percentage of protein–DNA 
complexes (A). Protein-DNA complexes were identified by their retarded mobility compared 
with that of free DNA, as indicated. Values are means ± SE (error bars) from two independent 
experiments. 
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Figure 36. Binding of R903A and M905G mutant proteins to methylated and non-
methylated DNA. WT ROS1 (upper panel), R903A (center panel) or M905G (lower panel) 
proteins (130nM) were incubated at 25°C for 1 h with 100 nM labeled methylated DNA 
containing a single 5-meC:G pair, in the presence of increasing amounts (0, 0.1, 0.25, 0.5 and 
1.0 mM) of either methylated (lanes 2–6) or non-methylated (lanes 2 and 7–10) unlabeled 
competitor DNA. After non-denaturing gel electrophoresis, the gel was scanned to detect 
fluorescein-labeled DNA. Protein–DNA complexes were identified by their retarded mobility 
compared with that of free DNA, as indicated. Graphs on the left show the percentage of 
remaining complex versus competitor molar excess ratios. Values are mean ± SE (error bars) 
from three independent experiments. M indicates 5-meC. 
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Figure 37. R903A and M905G mutant proteins bind with similar affinity to both 
substrate and product, independently of whether the opposite base is G, A, T or C. DNA-
binding reactions were performed incubating at 25°C for 60 min purified WT ROS1 or mutant 
variants (130 nM) with 100 nM of fluorescein-labeled substrates containing either 5-meC (upper 
panel) or a 1-nt gap flanked with 3´-P and 5´-P termini (lower panel) opposite G, A, T or C. 
After non-denaturing gel electrophoresis, the gel was scanned to detect fluorescein-labeled 
DNA. Protein-DNA complexes were identified by their retarded mobility compared with that of 
free DNA, as indicated. The asterisk depicts 5'-end labelling of the upper strand. 
 
4. Q607 inhibits ROS1 sliding along DNA 
The model shown in Figure 28C suggests that Q607 is the plug residue used by ROS1 
to flip out 5-meC and compensate its extrusion by filling in the vacant space in the 
DNA base stack. By other hand, the results discussed above indicate that all three 
residues Q607, R903 and M905 are required for excision of 5-meC opposite G, but 
only Q607 is critical for stable DNA binding to both methylated and unmethylated 
DNA (Figure 34) (Ponferrada-Marín et al., 2011). Altogether, these observations raise 
the possibility that ROS1 performs extrahelical interrogation of unmethylated base 
pairs by insertion of Q607 into the DNA helix.  
ROS1 performs sliding on DNA while searching for its target base (Ponferrada-Marín 
et al., 2012). Therefore, if Q607 plays any role in DNA interrogation, the absence of 
this residue in the mutant protein should have an effect on DNA sliding. To examine 
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this possibility, the diffusive behavior of Q607A on a substrate containing tetraloop 
obstacles along the DNA surface were compared to that of WT ROS1 (Figure 38). WT 
ROS1 or Q607A were preincubated with labeled substrates S or SL1-2 and then 
increasing concentrations of unlabeled S competitor were added to promote 
dissociation. Consistent with previously reported observations (Ponferrada-Marín et al., 
2012), WT ROS1 dissociates from substrate S when chased by the competitor, but 
remains bound to substrate SL1-2 even at high competitor concentrations. As expected, 
Q607A was unable to bind substrate S. However, the mutant protein was able to form a 
stable complex with substrate SL1-2, resisting competition with increasing 
concentrations of unlabeled S (Figure 38). By performing DNA binding measurements 
at different time points in the absence of competitor, stable complexes of WT ROS1 
with both S and SL1-2 were detected, whereas Q607A only bound stably to SL1-2 
(Figure 39). Furthermore, when unblocking one of the substrate ends, the capacity of 
Q607A to form a stable complex with DNA was greatly reduced (Figure 40). Therefore 
it can be concluded that the Q607A variant is unable to form a stable complex with a 
DNA substrate containing free ends, but remains bound to a molecule whose ends are 
obstructed with tetraloop blocks. Importantly, the stable binding of Q607A to substrate 
SL1-2 did not have any positive effect on the reduced catalytic activity of the mutant 
protein (Figure 41), thus corroborating the essential role of Q607 for base excision. 
Altogether, these results indicate that Q607 has an inhibitory effect on ROS1 sliding 
along DNA, and suggest that the enzyme extrudes unmethylated bases for interrogation 
by inserting this residue into the base stack. 
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Figure 38. The Q607A variant remains bound to a DNA substrate with blocked ends. (A) 
Schematic diagram showing the experimental setup used to assay for linear diffusion. Proteins 
were pre-incubated for 5 min with fluorescein-labeled substrates S or SL1-2, both containing a 
single 5-meC:G pair, and then chased by addition of unlabeled S competitor. If linear diffusion 
occurs, dissociation will be faster from labeled substrate S. (B) Gel shift assay showing 
dissociation of WT ROS1 (upper panel, 130 nM) and the Q607A mutant (lower panel, 130 nM) 
from fluorescein-labeled substrates S (lanes 2–6, 100 nM) and SL1-2 (lanes 7–11, 100 nM) on 
addition of increasing amounts (0, 0.1, 0.25, 0.5 and 1.0 mM) of methylated unlabeled 
competitor S. After non-denaturing gel electrophoresis, the gel was scanned to detect 
fluorescein-labeled DNA. Protein–DNA complexes were identified by their retarded mobility 
compared with that of free DNA, as indicated. Graphs on the left show the percentage of 
remaining complex versus competitor molar excess ratios. Values are mean ± SE (error bars) 
from three independent experiments. 
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Figure 39. Binding of Q607A variant to a DNA substrate with blocked ends is stable over 
time. Purified WT ROS1 (upper panel, 130 nM) or Q607A mutant variant (lower panel, 130 
nM) were incubated at 25°C with 100 nM of fluorescein-labeled substrates S (lanes 2–6) or 
SL1-2 (lanes 7–11), both containing a single 5-meC:G pair, and the reactions were monitored 
for 60 min. After non-denaturing gel electrophoresis, the gel was scanned to detect fluorescein-
labeled DNA. Protein–DNA complexes were identified by their retarded mobility compared 
with that of free DNA, as indicated. Graphs on the left show the percentage of protein–DNA 
complexes at different incubation times. Values are mean ± SE (error bars) from three 
independent experiments. 
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Figure 40. Unblocking one substrate end reduces stable DNA binding of Q607A mutant 
protein. Purified WT ROS1 (upper panel, 130 nM) or Q607A mutant variant (lower panel, 130 
nM) were incubated at 25°C with 100 nM of fluorescein-labeled substrates S, SL1 or SL1-2, 
containing a single 5-meC:G pair. Samples were analyzed by non-denaturing gel electrophoresis 
either immediately (0 min) or after 60 min incubation. Protein-DNA complexes were identified 
by their retarded mobility compared with that of free DNA, as indicated. The asterisk depicts 5'-
end labelling of the upper strand. 
 
Figure 41. The Q607 residue is required for ROS1 5-meC excision activity on both 
blocked and unblocked substrates. Purified WT ROS1 and Q607A mutant proteins (20 nM) 
were incubated at 30°C for 7 h with fluorescein-labeled substrates S and SL1-2 (20 nM) 
containing a single 5-meC:G pair. Reaction products were separated in a 12% denaturing 
polyacrylamide gel and quantified by fluorescence scanning. Values are mean ± SE from three 
independent experiments. 
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CHAPTER 2 
Study of ROS1 interaction with histones 
and their specific post-translational 
modifications 
 
ROS1 removes 5-meC at several hundred loci across the genome in vegetative tissues, 
apparently to counteract excessive methylation (Penterman et al., 2007; Zhu et al., 
2007). However, it is still unknown how ROS1 activity is directed to these specific 
genomic regions. In order to elucidate this question it is useful to remember that ROS1 
is a large and complex enzyme working not on naked DNA, but in a chromatin 
environment. In chromatin, DNA is closely associated to core histones proteins (H2A, 
H2B, H3 and H4) (Hayes and Hansen, 2001), whose N-terminal tails undergo different 
post-translational modifications. These modifications act as signal marks that can be 
read by different effector/reader proteins and chromatin-remodeling enzymes, thus 
influencing particular cellular processes (Kouzarides, 2007). As indicated above (see 
Introduction, section 9), ROS1 is an atypical DNA glycosylase containing a carboxy-
terminal domain of unknown function that is highly conserved between DML family 
proteins (Morales-Ruiz et al., 2006). Based on these premises, it can be hypothesized 
that ROS1 contains at its C-terminus a yet non-described effector module that is able to 
bind one or more histones modifications, and that such interaction may direct the 
enzyme activity to specific chromatin regions. Therefore, a second major objective of 
this thesis has been to determine if ROS1 is able to bind histones containing different 
post-translational modifications and, if that is the case, to identify which domain is 
responsible for the interaction. 
 
1. ROS1 binds all four core histones but specific 
modifications abrogate the interaction 
As a starting approach to determine if ROS1 is able to interact with histones and 
specific histone marks, a massive scrutiny using a histone peptide array was performed. 
The array (Active Motif) comprises 384 peptide spots from different regions of the N-
terminal tails of core histones (H3 1–19, 7–26, 16–35 and 26–45, H4 1–19 and 11–30, 
H2A 1–19 and H2B 1–19). It features 59 post-translational modifications in many 
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different combinations and each 19-mer peptide may contain up to four distinct 
modifications. For quality control, all peptides included in the array are spotted in 
duplicate.  
The array was incubated with purified His-tagged ROS1, and after several washes the 
bound protein was detected with an anti-His antibody. The results (Figure 42A) showed 
that ROS1 remained bound to most peptides, as well as to two control spots (P23 and 
P24) containing a mixture of modifications that are present in the array. However, no 
signal was detectable in three negative control spots (P20-P22) containing a biotin 
control peptide, a c-myc tag or a no histone peptide, thus ruling out non-specific 
interactions.  
Although ROS1 bound most histone peptides, it was consistently observed, both among 
duplicates in the same array and in independent experiments with different arrays, that 
no signal was detectable at specific spots. The most relevant observation was that 
ROS1 binding to H3 was disrupted when Ser28 was phosphorylated, independently of 
whether other modification marks were present or not in the same peptide (Figure 42A 
and B). In contrast, phosphorylation at Ser10 did not affect ROS1 binding to H3, even 
though Ser28 and Ser10 are located at almost identical ARKS sequence motifs (Figure 
42C). The inhibition of ROS1 binding by specific modifications was also observed for 
other histones. For example, binding to H2B was inhibited when Ser14 was 
phosphorylated in combination with acetylation at Lys15, whereas binding to H4 was 
not detectable when acetylation at both Lys12 and Lys16, and di-methylation at Lys20 
were combined in the same peptide (Figure 42). Altogether, these results suggest that 
ROS1 interacts with the N-tails of all four core histones, but such interaction may be 
abolished by specific modifications. 
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Figure 42. Massive scrutiny of ROS1 interaction with different histone peptides. (A) 
Binding of ROS1 to a Histone peptide array (ActiveMotif) containing 384 different modification 
combinations. The array was incubated with purified His6-tagged ROS1 (10 nM) for 1 hour at 
25°C with gentle agitation, and washed three times. ROS1 binding was detected by incubating 
the array with an anti-His6-tag antibody, followed by cheluminescence detection. Coloured 
boxes indicate selected spots described in panel B. (B) Description of selected spots of the 
histone array. The position, sequence, name, and type of modifications are shown. Colouring 
scheme is as in panel A. For a detailed annotation of all spots, see Appendix 1. (C) Schematic 
diagram of the N-terminal tail of histone H3. Boxes indicate the two ARKS motifs. 
Phosphorylation at Ser10 (blue) and Ser28 (red) amino acids is shown. 
 
2. Phosphorylation of H3S28, but not H3S10, 
specifically abrogates ROS1 interaction with histone 
H3 
To validate the array results, ROS1 interaction with specific histone marks was 
assessed by pull-down assays using different biotinylated peptides bound to 
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streptavidin magnetic beads (Dynabeads). To specifically study the differences in 
ROS1 binding to H3S28P and H3S10P marks, pull-down assays were carried out by 
incubating a purified His-tagged protein with 4 different biotinylated H3 peptides 
corresponding to two different H3 regions (1-21 or 21-44 amino acids), either 
unmodified or phosphorylated at Ser10 or Ser28, respectively. After several washes, the 
amount of ROS1 protein bound to each peptide was detected by immunoblotting with 
anti-His antibody (Figure 43B). Consistent with the array results, ROS1 interacted with 
both regions (amino acids 1-21 and 21-44) of unmodified histone H3. The interaction 
was also detectable when Ser10 was phosphorylated, but was abolished when 
phosphorylation was present at Ser28 (Figure 43B). As mentioned above, both serine 
residues are part of the same ARKS sequence motif (Figure 43A). Therefore, these 
results indicate that the absence of ROS1 interaction with phosphorylated histone H3 at 
Ser28 is sequence-specific and most likely involves residues preceding and/or 
following the ARKS motif.  
Figure 43. Analysis of ROS1 interaction with H3 peptides containing either unmodified or 
phosphorylated versions of Ser10 and Ser28. (A) Schematic diagram of the N-terminal tail of 
histone H3. Boxes indicate the two ARKS motifs. Phosphorylation at Ser10 (blue) and Ser28 
(red) amino acids is shown. (B) Pull-down assays performed with different ROS1 variants 
(schematized in panel C) and biotinylated H3 histone peptides (1-21 or 21-44 amino acids) 
phosphorylated or not at Ser10 or Ser28, respectively. Peptides were fixed to streptavidin 
dynabeads (Invitrogen) and incubated with His6-tagged proteins. After washes, proteins 
associated to beads were separated by SDS-PAGE, transferred to a nitrocellulose membrane and 
detected with an anti-His6-tag antibody. Beads with no peptide were used to control for non-
specific binding. (C) Schematic diagrams showing the domains deleted in the different ROS1 
variants. Discontinuous lines indicate deleted regions. 
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3. The C-terminal domain of ROS1 is responsible for 
binding to histone H3  
Once the interaction of ROS1 with histone H3 was confirmed by pull-down assays, the 
next step was to identify the domain(s) involved in such interaction. As indicated above 
(see Section 6 Introduction), ROS1 is a large and complex protein composed of three 
major domains: a lysine-rich N-terminal domain, a discontinuous DNA glycosylase 
catalytic domain, and a C-terminal domain that is highly conserved among DML family 
proteins. Different His-tagged truncated versions of ROS1 lacking one or more 
domains (Figure 43C) were purified and compared to the WT protein in their ability to 
bind H3 peptides containing either unmodified or phosphorylated versions of Ser10 or 
Ser28 (Figure 43B).  
A ROS1 variant lacking the N-terminal domain (NΔ294) behaved like the WT protein, 
since it bound to the H3 peptides, unless Ser28 was phosphorylated (Figure 43B). 
Conversely, no interaction with any H3 peptide was detected when incubated with a 
ROS1 version containing only the N-terminal domain (NΔ88CΔ1075) (Figure 43B). 
These results indicate that the N-terminal domain of ROS1 is not involved in the 
interaction with histone H3.  
A truncated ROS1 version containing only the discontinuous DNA glycosylase domain 
(NΔ519CΔ313) showed a reduced capacity to bind the unmodified H3 peptide 
containing amino acids 1-21 and the interaction with the H3S10P peptide was barely 
detectable (Figure 43B). Also in contrast to the WT protein, it displayed a very weak 
interaction with the 21-44 peptide containing phosphorylated Ser28, and the binding to 
the unmodified version was almost completely abolished (Figure 43B).  
Finally, a ROS1 variant containing only the C-terminal domain (NΔ1080) displayed a 
binding behavior identical to the full-length protein. It bound the two unmodified H3 
peptides and the one phosphorylated at Ser10, but was unable to bind the peptide 
containing the phosphorylation mark at Ser28 (Figure 43B).  
Altogether, these results suggest that the main region responsible for ROS1 interaction 
with histone H3 is located at the C-terminal domain of the enzyme. Although it cannot 
be ruled out that amino acids located on the DNA glycosylase domain modulate such 
interaction, particularly with the 1-21 region the histone, these experiments support the 
idea that the main residues involved in the specific interaction of ROS1 with H3 are 
located in the C-terminal domain of the enzyme. 
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4. Identification of ROS1 C-terminal residues important 
for interaction with histone H3 
To look for candidate residues involved in the interaction of ROS1 with H3, a multiple 
sequence alignment of the C-terminal domain of several DML family proteins was 
performed (Figure 44). The alignment confirmed that the C-terminus is highly 
conserved among members of this family of atypical DNA glycosylases. Two major 
conserved regions are observed, separated by a section containing 4 Cys residues that 
may be a permuted version of a single unit of a ZF-CXXC domain (Long et al., 2013). 
However, the two highly conserved regions separated by such domain are not related to 
any known protein. Sequence conservation is particularly high in the second region 
(residues 1279-1317 in Arabidopsis ROS1), suggesting that this area contains amino 
acids important for ROS1 function. Therefore three different ROS1 mutant versions at 
this region of the C-terminus were generated by site-directed mutagenesis: one 
containing a single mutation (E1305Q), and two double-mutants (CR1286AA and 
YF1300AA). The mutated residues are indicated by inverted triangles in Figure 44.  
The three His-tagged mutant versions of ROS1 were purified and compared to the WT 
protein for their ability to bind biotinylated H3 peptides containing either unmodified or 
phosphorylated versions of Ser10 or Ser28 (Figure 45). In contrast to the WT protein, 
all three mutant versions almost entirely lacked the capacity to interact with the 
unmodified 21-44 region of H3. As expected, none bound the phosphorylated version. 
However, they retained at different degrees the capacity to interact with both the 
unmodified and phosphorylated versions of the 1-21 region of the histone. These results 
suggest that the five mutated residues (C1286, R1287, Y1300, F1301 and E1305) are 
specifically involved in the phosphorylation-sensitive recognition of the region 
surrounding S28, but are only marginally implicated in the phosphorylation-
independent interaction with the region surrounding S10. 
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Figure 44. Multiple sequence alignment of the C-terminal domain of several DML family 
proteins. The upper schematic diagram shows the conserved regions among members of the 
DML family: a N-terminal lysine-rich region (green), a non-contiguous DNA glycosylase 
domain distributed over two segments (blue and red) separated by a non-structured linker region 
(striped), and a highly conserved C-terminal domain (yellow) that is not found in any other 
protein family. The C-terminal domain contains two conserved sub-regions separated by 4 
invariant Cys residues (highlighted in red). Inverted grey triangles indicate mutated amino acids. 
Names of organisms are abbreviated as follows: Ath, Arabidopsis thaliana; Nta, Nicotiana 
tabacum; Osa, Oryza sativa; Vvi, Vitis vinifera. Genbank accession numbers are as follows: Ath 
ROS1: AAP37178; Ath DME: ABC61677; Nta ROS1: BAF52855; Osa DMLB: BAF04322; 
Osa DMLC: EEE63898; Osa DMLA: BAD23025; Vvi DMLA: CAO46558. 
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Figure 45. Analysis of the interaction of ROS1 C-terminal mutants proteins with H3 
peptides containing either unmodified or phosphorylated versions of Ser10 and Ser28. (A) 
Schematic diagram of the N-terminal tail of histone H3. Boxes indicate the two ARKS motifs. 
Phosphorylation at Ser10 (blue) and Ser28 (red) amino acids is shown. (B) Pull-down assays 
performed with different ROS1 variants (schematized in panel C) and biotinylated H3 histone 
peptides (1-21 or 21-44 amino acids) phosphorylated or not at Ser10 or Ser28, respectively. 
Peptides were fixed to streptavidin dynabeads (Invitrogen) and incubated with His6-tagged 
proteins. After washes, proteins associated to beads were separated by SDS-PAGE, transferred 
to a nitrocellulose membrane and detected with an anti-His6-tag antibody. Beads with no peptide 
were used to control for non-specific binding. (C) Schematic diagrams showing ROS1 protein 
domains. Grey asterisks indicate mutated amino acids in the C-terminal domain. (D) Partial 
multiple sequence alignment of the C-terminal domain of several DML family proteins. Inverted 
grey triangles indicate mutated amino acids. Names of organisms are abbreviated as follows: 
Ath, Arabidopsis thaliana; Nta, Nicotiana tabacum; Osa, Oryza sativa; Vvi, Vitis vinifera. 
Genbank accession numbers are as follows: Ath ROS1: AAP37178; Ath DME: ABC61677; Nta 
ROS1: BAF52855; Osa DMLB: BAF04322; Osa DMLC: EEE63898; Osa DMLA: BAD23025; 
Vvi DMLA: CAO46558.  
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5. The methylation status of Lys27 on histone H3 does 
not affect ROS1 binding to histone H3 
Adjacent to S28, there is a lysine residue at position 27 of histone H3 that can be 
methylated to different states (mono-, di- or tri-methylated). Since methylation at 
H3K27 is an important histone mark that is related to transcriptional repression (Cao et 
al., 2002), it was assayed whether the methylation status of H3K27 affects ROS1 
binding to H3. To this end, the C-terminal domain of ROS1 (NΔ1080) was incubated 
with four different versions of an H3 peptide (21-44 amino acids) containing 
unmodified, mono-, di- or tri-methylated H3K27. After several washes, the amount of 
NΔ1080 protein bound to each peptide was detected by immunoblotting with anti-His 
antibody (Figure 46). The results show that the C-terminal domain of ROS1 binds 
histone H3 regardless of whether Lys27 is either unmodified or mono-, di- or tri-
methylated (Figure 46B). These findings agree with those observed in the peptide array 
experiments (Figure 42A), where peptides containing mono-, di- or tri-methylated 
H3K27 (spots K20, K21 and K22, see Appendix 1) and the peptide containing 
unmodified H3K27 (spot K19, see Appendix 1) retained ROS1 with similar affinity. 
Altogether these results indicate that the methylation status of Lys27 does not affect 
ROS1 binding to H3. 
Figure 46. Analysis of ROS1 C-terminal domain interaction with H3 peptides containing 
different methylation states of Lys27. (A) Schematic diagram of the N-terminal tail of histone 
H3. Boxes indicate the two ARKS motifs. Methylation at Lys27 amino acid is shown. (B) Pull-
down assay of ROS1NΔ1080 with biotinylated H3 histone peptides (21-44 amino acids) 
unmodified, mono-, di- or tri-methylated at Lys27. Peptides were fixed to streptavidin 
dynabeads (Invitrogen) and incubated with His6-tagged ROS1NΔ1080. After washes, proteins 
associated to beads were separated by SDS-PAGE, transferred to a nitrocellulose membrane and 
detected with an anti-His6-tag antibody. Beads with no peptide were used to control for non-
specific binding. 
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6. Study of ROS1 interaction with other core histones 
The histone peptide array experiments showed that, in addition to binding different 
histone H3 peptides, ROS1 also bound peptides from the remaining core histones 
(H2A, H2B and H4) (Figure 42A, spots A1, J4, J20, L7, L12, M18, O12 and P4; see 
Appendix 1). To confirm this observation, pull-down assays were performed using 
unmodified peptides corresponding to all four core histones (H3 1-21, H4 8-30, H2A 1-
20, and H2B 1-21), and different ROS1 versions. Consistent with the array results, 
purified WT ROS1 protein interacted with H3 1-21, H4 and H2A peptides. However, 
no interaction was detected with the H2B peptide (Figure 47A).  
The C-terminal domain displayed the same binding pattern as the full-length WT 
protein (Figure 47), thus indicating that this domain is responsible not only for binding 
to H3 but also to H4 and H2A. The results with the three C-terminal mutants confirmed 
that they retain the capacity to bind the H3 1-21 region (compare with Figure 45B), as 
well as H4 and H2A. However, and unlike the WT protein, they displayed detectable 
binding to H2B, although in the case of CR12866AA the affinity was lower than for the 
other core histones. Altogether these results indicate that the C-terminal domain confers 
ROS1 the ability to interact with H3, H4 and H2A, and that residues at this region may 
be involved in precluding interaction with H2B. 
Figure 47. Analysis of ROS1 interaction with H3, H4, H2A and H2B peptides. (A) Pull-
down assays performed with different ROS1 variants (schematized in panel B) and biotinylated 
H3 (1-21 amino acids), H4 (8-30 amino acids), H2A (1-20 amino acids) or H2B (1-21 amino 
acids) peptides with no modifications. Peptides were fixed to streptavidin dynabeads 
(Invitrogen) and incubated with His6-tagged proteins. After washes, proteins associated to beads 
were separated by SDS-PAGE, transferred to a nitrocellulose membrane and detected with an 
anti-His6-tag antibody. Beads with no peptide were used to control for non-specific binding. (B) 
Schematic diagrams showing the domains deleted and/or mutated in the different ROS1 
variants. Discontinuous lines indicate deleted regions. Grey asterisks indicate mutated amino 
acids in the C-terminal domain.  
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7. Molecular characterization of ROS1 C-terminal 
mutant variants 
7.1. The C-terminal mutant proteins E1305Q, CR1286AA and 
YF1300AA are deficient in catalytic activity 
Previously published studies suggest that the C-terminal domain of DML family 
proteins is necessary for 5-meC excision (Hong et al., 2014; Mok et al., 2010). 
Therefore, the catalytic activity of the C-terminal mutant proteins E1305Q, CR1286AA 
and YF1300AA was examined to study whether they play a role in ROS1 enzymatic 
activity (Figure 48A). Whereas the WT protein displayed a significant level of activity 
on a 51-mer duplex oligo substrate containing a single 5-meC opposite G, the amount 
of incisions products generated by CR1286A was significantly reduced, and mutants 
E1305Q and YF1300AA had almost no detectable base excision activity on that 
substrate. Therefore, the mutated residues are required for efficient excision of 5-meC.  
Since ROS1 is a bifunctional DNA glycosylase/lyase that catalyzes both the release of 
5-meC and the cleavage of DNA at the resulting abasic site (Morales-Ruiz et al., 2006) 
(Figure 48B), the reduced capacity of the three mutant proteins to process 5-meC:G 
pairs was further analyzed to determine if it is due to a deficiency in DNA glycosylase 
activity, lyase activity or both (Figure 48C and D). To detect DNA glycosylase activity, 
the reaction products generated by different ROS1 variants were analyzed after an 
additional alkaline treatment with NaOH, which cleaves all abasic sites generated by 
the enzyme and reflects 5-meC excision. All three mutant variants showed a 
significantly decreased DNA glycosylase activity (Figure 48C). To determine whether 
the three variants retained AP lyase activity, the proteins were incubated with a 51-mer 
duplex oligo substrate containing an AP site opposite G. The CR1286AA mutant 
variant cleaved the abasic site less efficiently than WT ROS1 (Figure 48D), whereas 
E1305Q and YF1300AA mutant proteins lack significant AP lyase activity, since they 
showed incision levels similar to those detected in a reaction with no enzyme (Figure 
48D). These results indicate that the at least three out of the five mutated residues 
(C1286, R1287, Y1300, F1301 and E1305) are essential for efficient 5-meC excision 
and the subsequent sugar-phosphate cleavage, although C1286 or R1287 are not critical 
for AP lyase activity. 
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Figure 48. Analysis of the catalytic activity of ROS1 C-terminal mutant proteins. (A) 
Combined DNA glycosylase/AP lyase activity of WT ROS1 and C-terminal mutant variants on 
a DNA substrate containing a 5-meC:G pair. Purified proteins (20 nM) were incubated at 30°C 
for 24 h with a double-stranded oligonucleotide substrate (20 nM) containing 5-meC opposite G. 
(B) Schematic diagram of ROS1 DNA glycosylase/AP lyase activity on 5-meC. ROS1 excises 
5-meC as a free base and then cleaves the phosphodiester backbone at the 5-meC removal site 
by successive β,δ-elimination. (C) DNA glycosylase assay. The generation of incision products 
was measured by incubating purified WT ROS1 or mutant variants (20 nM) at 30°C for 24 h 
with a double-stranded oligonucleotide substrate (20 nM) containing a single 5-meC:G pair. 
After incubation, NaOH (100 nM) was added and samples were immediately transferred to 90°C 
for 10 min. (D) AP lyase assay. A double-stranded oligonucleotide substrate containing an AP 
site opposite G (20 nM) was incubated at 30°C for 2 h in the presence of purified WT ROS1 or 
mutant variants (20 nM). Samples were treated with NaBH4 (300 mM) at 0°C for 30 min to 
stabilize non-processed AP sites and neutralized with 100 mM Tris–HCl, pH 7.4. Products were 
separated in a 12% denaturing polyacrylamide gel and the amount of incised oligonucleotide 
was quantified by fluorescent scanning. Values are mean ± SE (error bars) from two 
independent experiments. 
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7.2. Residue E1305 is required for DNA binding 
Since the catalytic activity of C-terminal mutant proteins was null or drastically 
reduced, their DNA binding capacity was examined to determine whether the mutated 
residues are also important for binding to methylated DNA. Two different 
concentrations of WT ROS1, E1305Q, CR1286AA or YF1300AA proteins were 
incubated with a labeled DNA substrate containing a 5-meC:G pair in a gel-shift assay 
(Figure 49). In the case of WT ROS1, a major band with retarded mobility was 
observed at the highest protein concentration and a minor diffuse band was detectable 
at the lowest protein concentration, suggesting the formation of protein–DNA 
complexes containing more than one ROS1 molecule, as previously indicated (see 
Chapter 1, page 81). In contrast, no protein–DNA complexes were detected in binding 
reactions containing the mutant protein E1305Q; only a barely detectable, diffuse band 
was observed at the highest protein concentration. Finally, both CR1286AA and 
YF1300AA proteins bound DNA less efficiently than WT ROS1, since an intermediate 
and a major band with retarded mobility was observed at the highest concentration, 
whereas a minor diffuse band was detectable at the lowest protein concentration. The 
intermediate band suggests the formation of protein–DNA complexes containing a 
smaller number of ROS1 molecules than the major band. Altogether, these results 
suggest that E1305 is essential for DNA binding, whereas at least two of the other 
mutated residues (C1286, R1287, Y1300 or F1301) contribute to stabilize DNA-protein 
complexes. 
Figure 49. DNA binding capacity of ROS1 C-terminal mutant proteins. WT ROS1 or C-
terminal mutant variants proteins (40 and 100 nM) were incubated at 25°C for 5 min with a 
double-stranded oligonucleotide substrate (100 nM) containing a single 5-meC:G pair. After 
non-denaturing gel electrophoresis, the gel was scanned to detect fluorescein-labeled DNA. 
Protein–DNA complexes were identified by their retarded mobility compared with that of free 
DNA, as indicated. 
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8. Effect of histone peptides on ROS1 catalytic activity 
Since the results described above indicate that specific residues at the C-terminus are 
important for both histone binding and efficient catalytic activity, the next question to 
be explored was whether histone binding influences the enzymatic activity of ROS1. 
Therefore, the catalytic activity of WT ROS1 was analyzed in the absence or presence 
of different histone peptides. This type of experiment proved to be technically 
challenging, requiring previous optimization in order to detect both DNA incision 
activity and peptide binding under the same experimental conditions (data not shown). 
Once optimal conditions were found, purified ROS1 was pre-incubated or not with 
different biotinylated peptides (H3 1-21, H3S10P, H3 21-44, H3S28P and H2B), and 
the amount of incision products generated on DNA substrate containing a single 5-meC 
was quantified (Figure 50). Compared to the amount of incision products obtained in 
the absence of any peptide, no significant differences were observed when pre-
incubating with either unmodified or phosphorylated versions of histone H3 peptides, 
or in the presence of H2B peptides (Figure 50). These results suggest that ROS1 
interaction with histone peptides does not alter its catalytic activity to process 5-meC. 
Figure 50. Effect of histone peptides on ROS1 enzymatic activity. Purified WT ROS1 
protein (20 nM) was pre-incubated at 4°C for 2 h with unmodified H3 (1-21 or 21-44 amino 
acids), H3S10P, H3S28P or unmodified H2B (1-21 amino acids) peptides (200 nM). After pre-
incubation, a 51-mer double-stranded oligonucleotide substrate (20 nM) containing a 5-meC:G 
pair was added and samples were incubated at 30°C for 8 h. Products were separated in a 12% 
denaturing polyacrylamide gel and the amount of incised oligonucleotide was quantified by 
fluorescent scanning. Values are mean ± SE (error bars) from at least two independent 
experiments. 
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CHAPTER 3 
Development of a targeted DNA 
demethylase directed to specific 
sequences 
 
Over the past few years, Epigenetic Editing has emerged as a new discipline aimed to 
develop molecular tools to modulate gene expression. One of its most promising 
approaches is to overwrite epigenetic marks at specific genome regions by targeting 
epigenetic effector domains (EDs) fused to a DNA binding domain (DBD) that 
specifically recognizes a particular DNA sequence (de Groote et al., 2012). These 
chimeric proteins can be very useful in basic research and might also have important 
therapeutic applications (Klug, 2005; Kungulovski and Jeltsch, 2016).  
Among the DBDs successfully used for targeting of epigenetic enzymes or other 
effector proteins are the Gal4 DNA Binding Domain (GBD), which binds to the 
Upstream Activator Sequence (UAS) (Giniger et al., 1985), the Methyl Binding 
Domain (MBD) of MeCP2 (Fukushige et al., 2008), the Rel-homology domain (RHD) 
of NFkB (Gregory et al., 2012), or Zinc Finger (ZF) domains, which are one of the 
most common and well-characterized DNA binding proteins in eukaryotes (Gommans 
et al., 2005; Rhodes and Klug, 1993). Recently, other technologies including 
transcription activator-like effector (TALE) proteins (Cong et al., 2012) or the clustered 
regularly interspaced short palindromic repeats/CRISPR-associated protein 
(CRISPR/Cas) system (Cong et al., 2013; Mali et al., 2013b; Mali et al., 2013) have 
been developed, thus extending the range of methods available for epigenetic editing. 
DNA methyltransferases or histone modifiers, as well as some enzymes indirectly 
involved in active DNA demethylation in animal cells are found among the effector 
domains (EDs) fused to DBDs to specifically modify the epigenome in order to 
modulate gene expression (Chen et al., 2013a; Cho et al., 2015; Gregory et al., 2012; 
Hilton et al., 2015; Li et al., 2007d; Maeder et al., 2013a; Mendenhall et al., 2013; 
Siddique et al., 2013; Vojta et al., 2016).  
Targeted demethylation is a major objective of Epigenetic Editing. Animals apparently 
lack 5-meC DNA glycosylases or, at least, they have not been identified yet. Up to 
date, 5-meC excision in animal cells seems to occur indirectly, requiring prior 
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deamination or oxidation of 5-meC, followed by the recognition and excision of the 
modified base (thymine, 5-hydroximethylcytosine, etc.) by a DNA glycosylase 
(Morgan et al., 2004; Tahiliani et al., 2009). However, in plants biochemical and 
genetic studies have convincingly demonstrated the existence of atypical DNA 
glycosylases that directly excise 5-meC from DNA (Agius et al., 2006; Gong et al., 
2002; Morales-Ruiz et al., 2006). Up to date, no efforts have been reported on 
expressing or targeting plant demethylases in mammalian cells. However, there are 
some indications that they may be successfully used to modify mammalian 
methylomes. Thus, preliminary data show that expression of DME (a ROS1 paralogue) 
in human cancer cells partially reverts their hypermethylation phenotype (Morales-Ruiz 
et al., data not published). By other hand, the structural and functional properties of 
ROS1 are well-characterized. Previous studies has defined its catalytic domain 
(Ponferrada-Marín et al., 2011) and has demonstrated that its N-terminal domain 
facilitates non-specific binding to DNA, but is not required for catalysis (Ponferrada-
Marín et al., 2010). These results suggest that it would be possible to use a specific 
DBD replacing the ROS1 N-terminal domain without changing ROS1 catalytic 
efficiency, in order to minimize non-specific binding and direct its activity to desired 
sequences.  
In this context, the third objective of this thesis has been to explore the possibility of 
using Arabidopsis thaliana ROS1 as an epigenetic editing tool, in order to demethylate 
specific target sequences in human cells. Towards this aim, two different well-
characterized DBDs were fused to the catalytic domain of ROS1 (ROS1_CD): the 
GAL4 DNA Binding Domain (GBD) and different engineered ZF proteins (ZFPs). 
These targeted ROS1_CD versions were first analyzed in vitro and then expressed in 
human cell lines to study their effect in the methylation levels of the analyzed target 
genes. Furthermore, an RNA-guided CRISPR system based on dCas9 fused to 
ROS1_CD was also tested. 
 
1. Targeting ROS1 activity by fusing its catalytic 
domain to Gal4 DNA Binding Domain (GBD) 
1.1. In vitro characterization of GBD-ROS1_CD recombinant 
fusion protein 
As a first step, the biochemical properties of a recombinant fusion protein containing 
the Gal4 DNA Binding Domain (GDB) fused to a ROS1 truncated version lacking its 
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lysine-rich N-terminal domain (ROS1_CD, also designated as ROS1NΔ294) were 
analyzed in vitro. A construct expressing GBD-ROS1_CD (Figure 51A) was generated, 
and the recombinant fusion protein, with an expected molecular weight of 147 kDa, 
was overexpressed in E. coli and purified as a N-terminal His-tagged protein as 
described in Material and Methods (Section 2).  
1.1.1. GBD-ROS1 binds preferentially to a DNA substrate containing the 
GBD target sequence 
The DNA binding specificity of GBD-ROS1_CD was analyzed by electrophoretic 
mobility shift assay (EMSA) (Figure 51). Increasing concentrations of GBD-ROS1_CD 
were incubated with either a GBD-targeted substrate or a non-targeted substrate (Figure 
51B). Both substrates contain two 5-meC:G pairs separated by 9 bp and located in the 
same sequence context. The targeted substrate (UAS) contains an Upstream Activator 
Sequence (5’-CGGAGGACAGTACTCCG-3’) specifically recognized by GBD and 
located 17 bp upstream the first methylated position. The non-targeted substrate (no-
UAS) lacks the GBD target site.  
With both types of substrate, a major band with retarded mobility and a minor diffuse 
band were observed at high protein concentrations, whereas a higher mobility complex 
was detectable at low protein concentrations (Figure 51C, left panel). These results 
suggest the formation of protein–DNA complexes containing more than one ROS1 
molecule, as previously reported with WT ROS1 protein (Figure 34 Chapter 1). 
Quantitation of the total amount of protein–DNA complexes (Figure 51C, right panel) 
showed that, at protein concentrations higher than 60 nM, almost every substrate was 
bound to the fusion protein (>80%) and no significant differences in DNA binding 
capacity to both UAS and no-UAS substrates were observed (Figure 51C, right panel). 
However, at protein concentrations lower than 60 nM, a significantly higher percentage 
of DNA-protein complexes were detected with the UAS substrate than with the no-
UAS DNA (Figure 51C). These results indicate that GBD-ROS1_CD fusion protein 
binds with higher affinity the targeted substrate than the non-targeted DNA. 
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Figure 51. Analysis of the DNA binding capacity of GBD-ROS1_CD. (A) Schematic 
diagram of the GBD-ROS1_CD recombinant fusion protein. The fusion protein is composed of 
a His6-tag (purple) at the N-terminus, followed by the Gal4 DNA Binding domain (GBD, grey), 
a c-myc tag (pink), a nuclear localization signal (NLS, black) and the ROS1 catalytic domain 
(ROS1_CD) at the C-terminus. ROS1_CD (also designated as ROS1NΔ294) comprises residues 
295-1393 of ROS1, and contains a non-contiguous DNA glycosylase domain distributed over 
two segments (blue and red) separated by a non-structured linker region (striped), and a C-
terminal domain (yellow). (B) Schematic diagram showing the design of DNA substrates. Two 
different 60-mer duplexes containing two 5-meC:G pairs at positions 39 and 49, and labeled 
with fluorescein at the 5’-end, were used. The targeted substrate contains a GBD target site 
(UAS). (C) Binding of GBD-ROS1_CD to both targeted (UAS) and non-targeted (no-UAS) 
DNA substrates. Increasing concentrations of purified GBD-ROS1_CD were incubated at 25°C 
for 30 min with 10 nM of fluorescein-labeled duplex (UAS or no-UAS). After non-denaturing 
gel electrophoresis, gels were scanned to detect fluorescein-labeled DNA. Protein–DNA 
complexes were identified by their retarded mobility compared with that of free DNA. A 
representative gel for each substrate is shown. The graph on the right shows the percentage of 
protein–DNA complexes versus protein concentration. All bands with slower mobility were 
used in quantitation of bound protein. Values are mean ± SE (error bars) from two independent 
experiments. 
 
Results 
 107 
1.1.2. Analysis of the enzymatic activity of GBD-ROS1_CD 
Next, the catalytic activity of GBD-ROS1_CD protein on UAS and no-UAS substrates 
was examined (Figure 52). It has been previously reported that ROS1 is a low-turnover 
catalyst because it binds tightly to the abasic site left after 5-meC removal. This binding 
leads to a highly distributive behavior of the enzyme on DNA substrates containing 
multiple 5-meC residues, revealed as the accumulation of partially processed reaction 
intermediates (Ponferrada-Marín et al., 2009). 
Therefore, up to two incision products of different sizes can be generated on each of the 
two DNA substrates, depending on which one of the two 5-meC residues of the duplex 
is excised: a 48-nt intermediate product (P2), if the protein only cleaves the 5-meC at 
position 49, and a 38-nt product (P1), if the protein excises the 5-meC at position 39 
(Figure 52A). 
In order to minimize the non-specific binding observed above, a low concentration of 
the fusion protein and two different salt concentrations (50 and 100 mM NaCl) were 
tested (Figure 52B). Incision at the first 5-meC residue (P1) was higher with the UAS 
substrate, both at 100 mM and 50 mM NaCl. In contrast, incision at the second 5-meC 
residue (P2) at both salt concentrations was not significantly different between the UAS 
and no-UAS substrates. A kinetic analysis under 100 mM NaCl (Figure 52C) 
confirmed that incision at the first 5-meC residue (P1) was more efficient with the UAS 
substrate, whereas no differences were observed for the second (P2). Altogether, these 
results suggest that in vitro the GBD-ROS1_CD protein is more efficiently targeted to 
methylated sites that are close to the DNA sequence recognized by the DBD. 
 
Doctoral Thesis  Jara Teresa Parrilla Doblas 
108 
Figure 52. Study of the catalytic activity of GBD-ROS1_CD. (A) Schematic diagram 
showing the expected reaction products in the DNA glycosylase/lyase assay. Substrates are 
described in Figure 1. A 48 nt product (P2) is generated when the protein only excises the 5-
meC at position 49, while a 38 nt product (P1) is observed when the protein excises the 5-meC 
at position 39. (B) GBD-ROS1_CD enzymatic activity on UAS and no-UAS substrates in the 
presence of two different salt concentrations. The generation of incision products was measured 
by incubating purified GBD-ROS1_CD (20 nM) at 30°C for 4 h with either UAS or no-UAS 
substrate (10 nM) in the presence of either 50 or 100 mM NaCl. Products were separated in a 
12% denaturing polyacrylamide gel and the amounts of incised oligonucleotide were quantified 
by fluorescent scanning. Values are means ± SE (error bars) from at least two independent 
experiments. (C) Kinetic analysis of GBD-ROS1_CD activity on UAS and no-UAS substrates. 
Purified GBD-ROS1_CD (20 nM) was incubated at 30°C for 0, 0.5, 2 and 4 h with either UAS 
or no-UAS substrate (10 nM) in the presence of 100 mM NaCl. Reactions were stopped at the 
indicated times, products were separated in a 12% denaturing polyacrylamide gel and the 
amount of incised oligonucleotide was quantified by fluorescent scanning. Values are means ± 
SE (error bars) from two independent experiments. 
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1.2. Targeted DNA demethylation activity of GBD-ROS1_CD 
on a reporter gene in human cells 
Next, the possibility to direct the enzymatic activity of GBD-ROS1_CD to a UAS 
sequence in human cells was explored using a dual-luciferase reporter system.  
1.2.1. GBD-ROS1_CD and its mutant variants are efficiently expressed 
after transient transfection in HEK293 cells 
The plasmids constructed for expression of GBD-ROS1_CD-or its catalytically inactive 
(ROS1_CD D971A) or binding deficient (GBD L32PC38P) mutant variants in human 
cells are shown in Figure 53A. All three fusion proteins contained a Flag-tag at the N-
terminus, and a c-myc tag and a nuclear localization signal (NLS) between GBD and 
ROS1_CD (Figure 53A). Each expression construct was co-transfected in HEK293 
cells with a targeted reporter plasmid expressing the firefly luciferase gene under the 
control of a TK promoter with five added binding sequences for GBD (5xUAS). A non-
targeted reporter plasmid containing a TK promoter with no UAS region was used as a 
control (Figure 53B). The firefly reporter vectors were previously methylated in vitro 
with M.SssI as described in Material and Methods (Section 10). A second reporter 
plasmid expressing Renilla luciferase gene (RLL) under the control of a CMV promoter 
(pRL-CMV, Promega) was used for normalization of transfection yield and cell number 
in all co-transfection experiments.  
The co-transfection efficiency with different combinations of constructs ranged 
between 70-75 %, as measured by flow cytometry 48 h after co-transfection with a 
GFP-expressing reporter plasmid (Figure 54). Transient expression of all GBD-
ROS1_CD versions in HEK293 cells, 48 h after co-transfection with either the targeted 
or the non-targeted reporter vector, was confirmed by western-blot analysis with an 
anti-Flag antibody (Figure 55). 
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Figure 53. Schematic diagrams of constructs used for co-transfection of HEK293 cells 
with GBD-ROS1-CD and a reporter luciferase gene. (A) Constructs for expression of 
targeted GBD-ROS1_CD fusion proteins. The fusion proteins are composed of a Flag-tag 
(purple) at the N-terminus, followed by the Gal4 DNA Binding domain (GBD, grey), a c-myc 
tag (pink), a nuclear localization signal (NLS, black) and the ROS1 catalytic domain 
(ROS1_CD) at the C-terminus. Control constructs encode a catalytically inactive ROS1_CD 
D971A mutant version (GBD-ROS1_CDmut) and a GBD with two mutations that abolish 
binding to target UAS (GBDmut-ROS1_CD). (B) Reporter constructs contain the TK promoter 
fused to the firefly luciferase gene. The targeted version includes five copies of GBD binding 
sites (5xUAS) upstream the TK promoter. 
Figure 54. Analysis of co-transfection efficiency of HEK293 cells. Co-transfections were 
performed with GBD-ROS1_CD or GBD-ROS1_CDmut expression constructs (250 ng) 
together with the methylated reporter plasmid 5xUAS-TK-Luc (250 ng) and pACGFP-C1 
plasmid (250 ng). Co-transfection efficiencies were monitored 48 h after co-transfection by 
green fluorescent protein (GFP) signal count by flow cytometry. Non-transfected cells were 
used as control. 
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Figure 55. Transient expression of GBD-ROS1_CD fusion proteins in HEK293 cells. 
Western blot analysis with an anti-Flag antibody was performed in cell extracts (80 µg) prepared 
48 h after co-transfection of different expression constructs with either the targeted (upper 
panel) or the non-targeted (lower panels) methylated reporter plasmid. Actin was used as an 
input control. 
1.2.2. Analysis of luciferase activity after transient expression of GBD-
ROS1_CD in HEK293 cells 
As expected, the luciferase activity of both targeted (5xUAS-TK-Luc) and non-targeted 
(TK-Luc) reporter plasmids in HEK293 cells was strongly reduced after in vitro 
methylation by M.SssI (Figure 56). These results confirm that the TK promoter is 
highly sensitive to DNA methylation, as previously reported (Li et al., 2007d). The 
effect exerted by the transient expression of different GBD-ROS1_CD versions on this 
silenced luciferase activity was determined 48 h after co-transfection with a targeted or 
a non-targeted methylated reporter plasmid (Figure 56). Co-transfection with GBD-
ROS1_CD significantly increased the luciferase activity of the methylated 5xUAS-TK-
Luc reporter gene by 2.6-fold (P<0.001) (Figure 56A). In contrast, no significant 
increase was detected in the methylated TK-Luc gene (Figure 56B).  
To investigate whether the increase in luciferase activity observed for the targeted gene 
actually depends on ROS1_CD catalytic function, a conserved aspartic acid residue in 
the glycosylase domain of ROS1 (D971) was changed to alanine, a mutation that 
completely abolishes ROS1 catalytic activity (Morales-Ruiz et al., 2006). On the other 
hand, to examine whether the reactivation of 5xUAS-TK-Luc is due to the specific 
DNA binding of GBD to its target site, a double mutation (L32P and C38G) was 
introduced into GBD that eliminates its DNA binding capacity (Johnston and Dover, 
1987). When GBD-ROS1_CDmut or GBDmut-ROS1_CD variants were transiently 
expressed luciferase activity did not increase compared to that observed with the empty 
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expression vector, either with the targeted (5xUAS-TK-Luc) or the non-targeted (TK-
Luc) gene (Figure 56).  
Figure 56. Analysis of luciferase reporter activity in HEK293 cells after transient co-
transfection with constructs expressing GBD-ROS1_CD or its mutant versions. Cells were 
co-transfected with 250 ng of in vitro-methylated reporter plasmid [5xUAS-TK-Luc (A) or TK-
Luc (B)] and different GBD-ROS1_CD expression constructs (250 ng). Luciferase activity, 
determined 48 h after co-transfection, is shown relative to that detected after co-transfection 
with unmethylated reporter and empty vector. Values are means ± SE (error bars) from eight 
independent experiments. The asterisk indicates that silenced luciferase activity in HEK293 was 
significantly increased (P"<"0.001) when co-transfected with GBD-ROS1_CD construct in 
comparison with empty vector. The respective P-values were calculated using a Student’s 
unpaired t-test. 
Altogether, these results suggest that both ROS1_CD catalytic activity and specific 
binding by GBD are required for targeted gene activation by the fusion protein GBD-
ROS1_CD.  
1.2.3. Analysis of firefly luciferase gene transcription after transient 
expression of GBD-ROS1_CD in HEK293 cells 
To study whether changes in luciferase activity correlate with mRNA levels of the 
luciferase reporter gene, total RNA was isolated 48 h after co-transfection of targeted or 
non-targeted reporter plasmid with constructs expressing different GBD-ROS1_CD 
versions, and levels of firefly luciferase transcript were analyzed by quantitative real-
time PCR (qRT-PCR). As expected, transcript levels of both the targeted (5xUAS-TK-
Luc) and the non-targeted (TK-Luc) genes strongly decreased after in vitro methylation 
of the reporter plasmids by M.SssI (Figure 57). Co-transfection with GBD-ROS1_CD 
slightly increased mRNA levels of the targeted gene, although not to statistically 
Results 
 113 
significant levels (Figure 57A). In contrast, the effects of GBD-ROS1_CD on mRNA 
levels of the non-targeted gene were not noticeable (Figure 57B). Altogether, these 
results indicate that changes in luciferase activity induced by GBD-ROS1_CD partially 
correlate with mRNA levels of the targeted gene. 
Figure 57. Analysis of luciferase reporter gene transcription in HEK293 cells after 
transient co-transfection with constructs expressing GBD-ROS1_CD or its mutant 
versions. Cells were co-transfected with 250 ng of in vitro-methylated reporter plasmid 
[5xUAS-TK-Luc (A) or TK-Luc (B)] and different GBD-ROS1_CD expression constructs (250 
ng). Levels of firefly luciferase transcript, assessed 48 h after transfection by qRT-PCR and 
normalized to GAPDH, are shown relative to those detected after co-transfection with 
unmethylated reporter and empty vector. Values are means ± SE (error bars) from two 
independent experiments. 
1.2.4. The histone deacetylase inhibitor TSA enhances luciferase activity 
after transient expression of GBD-ROS1_CD in HEK293 cells 
Several studies have shown that transient transfected plasmids in mammalian cells can 
associate in the nucleus with histone proteins, acquiring a nucleosome structure 
(Burkhart et al., 2005; Reeves et al., 1985; Smith and Hager, 1997). In that case, GBD-
ROS1_CD access to the target sequence could be hindered if N-tails of associated 
histones are deacetylated. Trichostatin A (TSA) is an inhibitor of histone deacetylases 
(HDACs) that induce chromatin relaxation and can trigger increase in gene expression. 
In fact, several studies have demonstrated that TSA activates transcription by inhibiting 
HDACs and facilitates demethylation of ectopically methylated reporter genes after 
transient co-transfection in human cells (Cervoni and Szyf, 2001; Detich et al., 2003; 
Detich et al., 2002).  
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To examine the effect of TSA on the targeted activation of 5xUAS-TK-Luc, HEK293 
cells were treated or not with TSA at a final concentration of 0.3 µM 24 h after co-
transfection. Cells that transiently expressed GBD-ROS1_CD protein and treated with 
TSA showed an increase in luciferase activity of 2.4-fold compared with non-treated 
cells (Figure 58). Interestingly, TSA-treated cells that transiently expressed the 
catalytically inactive mutant version GBD-ROS1_CDmut showed a small increase in 
luciferase activity compared to the control cells, but these luciferase activity levels 
were much lower than those observed in non-treated cells expressing WT GDB-
ROS1_CD. These results suggest that TSA facilitates targeting of GBD-ROS1_CD 
protein and enhances luciferase activity. 
Figure 58. Effect of Trichostatin A (TSA) on luciferase reporter activity in HEK293 cells 
after transient co-transfection with constructs expressing GBD-ROS1_CD or GBD-
ROS1_CDmut. Co-transfection was performed with 250 ng of in vitro-methylated reporter 
plasmid 5xUAS-TK-Luc and different GBD-ROS1_CD expression constructs (250 ng). Cells 
were either treated or not with TSA (0.3 µM) 24 h after co-transfection. Luciferase activity, 
determined 48 h after TSA treatment, is shown relative to that detected after co-transfection with 
unmethylated reporter and empty vector. Values are means ± SE (error bars) from two 
independent experiments. 
1.2.5. Analysis of the methylation status of 5xUAS-TK region after 
transient expression of GBD-ROS1_CD in HEK293 cells 
To determine if the increased luciferase activity of the methylated reporter after 
expression of GBD-ROS1_CD is due to ROS1_CD DNA demethylase function, 
methylation levels at the 5xUAS-TK promoter were analyzed by bisulfite 
pyrosequencing. A total of 18 CpG sites distributed over a 179-bp region, were 
analyzed (Figure 59A). A reduction in methylation levels of at least four CpG sites (-
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35, -32, -28 and -20, located 338, 289, 251 and 177 bp upstream the start codon (ATG), 
respectively) was found in cells transiently expressing GBD-ROS1_CD compared to 
cells expressing GBD-ROS1_mut variant (Figure 59B). These methylation differences 
were not affected by TSA treatment (Figure 59B).  
Figure 59. DNA methylation analysis of the 5xUAS-TK promoter region of the luciferase 
reporter construct. (A) Schematic diagram of the targeted reporter construct containing five 
copies of GBD binding sites (5xUAS) upstream the TK promoter fused to the firefly luciferase 
gene. CpG sites analyzed by bisulfite pyrosequencing, numbered relative to the start codon 
(ATG), are shown in red. (B) Quantitative methylation analysis of the 5xUAS-TK region. Co-
transfection was performed with methylated reporter plasmid (250 ng) and different expression 
constructs (250 ng). Cells were either treated or not with TSA (0.3 µM) 24 h after co-
transfection. Plasmid DNA was isolated 48 h after TSA treatment, bisulfite-treated, PCR-
amplified, and pyrosequenced. The graph shows the percentage of methylated CpGs (vertical 
axis) at different positions (horizontal upper axis, CpGs – 36 to –19 from the ATG) along the 
5xUAS-TK region (horizontal lower axis, -340 bp to -163 bp from ATG). Values are means ± 
SE (error bars) from two independent experiments. C+ = methylated TK-Luc. 
Altogether, these results suggest that targeted DNA demethylation by GBD-ROS1_CD 
protein at certain CpG sites of the 5xUAS-TK promoter leads to reactivation of 
luciferase gene expression. Such reactivation is further enhanced by inhibition of 
HDACs, thus facilitating demethylation-independent changes in the putative 
nucleosome structure acquired by the reporter plasmid. 
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2. Targeting ROS1 activity by fusing its catalytic 
domain to different Zinc Fingers Proteins (ZFPs) 
As an alternative approach for targeted demethylation, ROS1_CD was fused to a more 
universal, well-characterized type of DBD: a classical Cys2His2 ZF domain (henceforth 
ZF domain). A ZF domain recognizes 3 bp. Up to six ZF modules can be engineered 
and joined though flexible linkers to specifically recognize up to 18 bp of DNA, a 
sequence long enough to be unique within large genomes (Liu et al., 1997). In this 
sense, a ZF protein (ZFP) can be used to potentially target any given DNA sequence 
(Papworth et al., 2005). The DNA binding capacity and the catalytic activity of a ZFP-
ROS1_CD recombinant fusion protein were firstly tested in vitro, and its targeted-
demethylation activity was assessed in vivo in human cells using a luciferase reporter 
system. 
2.1. In vitro characterization of 6F6-ROS1_CD recombinant 
fusion protein 
As a proof of concept, a previously characterized ZFP designated 6F6 (Papworth et al., 
2003) was fused to ROS1_CD. The 6F6 ZFP consists of 6 ZF modules that together 
bind specifically within a 19 bp target sequence in the HSV-1 immediate early gene 
IE175k promoter (Papworth et al., 2003). A construct expressing 6F6-ROS1_CD 
(Figure 60A) was generated, and the recombinant fusion protein, with an expected 
molecular weight of 150.5 kDa, was overexpressed in E. coli and purified as a N-
terminal His-tagged protein as described in Material and Methods (Section 2).  
2.1.1. The 6F6-ROS1_CD fusion protein specifically binds a substrate 
containing the ZFP target site 
The DNA binding specificity of 6F6-ROS1_CD fusion protein was firstly analyzed by 
electrophoretic mobility shift assay (EMSA) using three different methylated substrates 
(Figure 60). All three substrates were 60-mer duplexes containing two 5-meC:G pairs 
separated by 9 bp, and labeled with fluorescein at the 5’ end of the methylated strand. 
In two substrates the 6F6 target site is located either at 4 bp or 14 bp from the first 5-
meC residue, and were designated as “Target site substrate 1” (T1) and “Target site 
substrate 2” (T2), respectively (Figure 60B). The other substrate, called “Mutated 
Target site substrate 1” (T1mut), contains a mutated 6F6 target site located at 4 bp from 
the first 5-meC residue. When the purified 6F6-ROS1_CD was incubated with any of 
the two targeted substrates (T1 or T2), a protein-DNA complex migrating slower than 
free DNA was observed (Figure 60C). However, no complex was detected with the 
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non-targeted substrate (T1mut) (Figure 60C). These results indicate that 6F6-
ROS1_CD fusion protein binds specifically to a DNA containing the ZF target site, and 
that such binding is completely abolished when the target site is mutated. In additional 
EMSAs, increasing concentrations of 6F6-ROS1_CD were incubated with T1 substrate 
and total amount of protein–DNA complexes was quantified (Figure 60D). The results 
indicate that 6F6-ROS1_CD fusion protein has a strong affinity for a substrate 
containing the ZF binding site, since a complex formation could be detected at very low 
protein concentrations (20 nM).  
2.1.2. Analysis of the enzymatic activity of 6F6-ROS1_CD fusion protein 
The catalytic activity of 6F6-ROS1_CD was analyzed using T1, T2 and T1mut 
substrates (Figure 61). Up to two incision products of different size may be generated, 
depending on which one of the two 5-meC residues of the duplex is excised: a 48 nt 
intermediate product (P2), if the protein only cleaves the 5-meC at position 49, and a 38 
nt product (P1), if the protein excises the 5-meC at position 39 (Figure 61A). Reactions 
were performed with equimolar amounts of enzyme and substrate, and two different 
salt concentrations (Figure 61B).  
At 100 mM NaCl, the 5-meC excision activity was lower and no significant differences 
were found between all three substrates (T1, T2 and T1mut). By contrast, in general at 
50 mM NaCl the enzymatic activity was higher, showing a significantly greater 
excision of the 5-meC at position 39 (P1), but only on the T2 substrate, in which the ZF 
binding site is further away from the target base. Altogether, these results suggest that 
replacing the N-terminal domain of Arabidopsis thaliana ROS1 protein by a ZF motif 
does not abolish its enzymatic activity, and that in vitro the fusion protein shows 
targeted demethylase activity, but it is modulated by the salt concentration and the 
distance between the 5-meC residue and the ZF binding site. 
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Figure 60. Analysis of the DNA binding capacity of 6F6-ROS1_CD. (A) Schematic diagram 
of the 6F6-ROS1_CD recombinant fusion protein. The fusion protein is composed of a His6-tag 
(purple) at the N-terminus, followed by the 6F6 zinc finger protein (containing six zinc fingers), 
a nuclear localization signal (NLS, black) and the ROS1 catalytic domain (ROS1_CD) at the C-
terminus. ROS1_CD (also designated as ROS1NΔ294) comprises residues 295-1393 of ROS1, 
and contains a non-contiguous DNA glycosylase domain distributed over two segments (blue 
and red) separated by a non-structured linker region (striped), and a C-terminal domain (yellow). 
(B) Schematic diagram showing the design of DNA substrates. Three different 60-mer duplexes 
containing two 5-meC:G pairs at positions 39 and 49, and labeled with fluorescein at the 5’-end, 
were used. The targeted substrates 1 and 2 (T1 and T2) contain a 6F6 target site located at 4 bp 
and 14bp from the first 5-meC, respectively. The T1 mut substrate contains a mutated 6F6 target 
site. (C) Comparison of the binding capacity of 6F6-ROS1_CD to T1, T2 and T1mut substrates. 
Purified 6F6-ROS1_CD protein (100 nM) was incubated at 25°C for 30 min with 25 nM of 
fluorescein-labeled duplex (T1, T2 or T1mut). After non-denaturing gel electrophoresis, gels 
were scanned to detect fluorescein-labeled DNA. Protein–DNA complexes were identified by 
their retarded mobility compared with that of free DNA. (D) Binding of 6F6-ROS1_CD to the 
T1 substrate. Increasing concentrations of purified 6F6-ROS1_CD were incubated at 25°C for 
30 min with 10 nM of fluorescein-labeled duplex (T1). After non-denaturing gel electrophoresis, 
gels were scanned to detect fluorescein-labeled DNA. Protein–DNA complexes were identified 
by their retarded mobility compared with that of free DNA. A representative gel for each 
substrate is shown. The graph on the right shows the percentage of protein–DNA complexes 
versus protein concentration. All bands with slower mobility were used in quantitation of bound 
protein. Values are mean ± SE (error bars) from two independent experiments. 
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Figure 61. Study of the catalytic activity of 6F6-ROS1_CD. (A) Schematic diagram showing 
the expected reaction products in the DNA/glycosylase assay. Substrates are described in Figure 
11. A 48 nt product (P2) is generated when the protein only excises the 5-meC at position 49, 
while a 38 nt product (P1) is observed when the protein excises the 5-meC at position 39. (B) 
6F6-ROS1_CD enzymatic activity on T1, T2 and T1mut substrates in the presence of two 
different salt concentrations. The generation of incision products was measured by incubating 
purified 6F6-ROS1_CD (20 nM) at 30°C for 4 h with either T1, T2 or T1mut substrate (20 nM) 
in the presence of 50 or 100 mM NaCl. Products were separated in a 12% denaturing 
polyacrylamide gel and the amounts of incised oligonucleotide were quantified by fluorescent 
scanning. Values are means ± SE (error bars) from at least two independent experiments.  
2.2. Study of targeted DNA demethylation activity by ZFP-
ROS1 fusion proteins on specific sequences in reporter 
plasmids in human cells 
The results obtained in vitro suggest that it could be possible to direct 6F6-ROS1_CD 
activity to a substrate containing the ZF binding sequence, at least under specific 
conditions. To explore the feasibility of targeting ROS1 demethylase activity with ZF 
DBDs in vivo, several constructs were generated for expression of different ZFP-ROS1 
fusion proteins in human cells co-transfected with a luciferase reporter gene (Figure 
62). 
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Figure 62. Schematic diagrams of constructs used for co-transfection of HEK293 cells 
with different versions of ZFP-ROS1 and a reporter luciferase gene. (A) Constructs for 
expression of targeted ZFP-ROS1 fusion proteins. The fusion proteins are composed of a Flag-
tag (purple) at the N-terminus, a six- or three-zinc fingers protein module (6F6 or B1, 
respectively), a nuclear localization signal (NLS, black) and either the ROS1 catalytic domain 
(ROS1_CD) or the ROS1 catalytic core domain (ROS1_CCD) at the C-terminus. ROS1_CCD is 
a more compact version of the catalytic domain with shorter linker regions. Control constructs 
(6F6-ROS1_CDmut or ZFP-ROS1_CCDmut) encode catalytically inactive D971A mutant 
versions. (B) The reporter construct contains the HSV-1 IE175k promoter fused to the firefly 
luciferase gene. The target site for the ZFP is shown in pink. 
2.2.1. ZFP-ROS1 fusion proteins and its mutant variants are efficiently 
expressed after transient transfection in HEK293 cells 
Two different ZFP were used: 6F6 (a 6-ZF module), and B1 (a 3-ZF module) 
(Papworth et al., 2003) (Figure 62A). Since B1 is one of the two 3-ZF modules that 
comprise 6F6, both B1 and 6F6 bind specifically to the same target sequence in the 
HSV-1 IE175k promoter. However, 6F6 binds to the target site with higher affinity 
than B1 (Papworth et al., 2003).  
The 6F6 ZFP was fused to the ROS1 Catalytic Domain (ROS1_CD), whereas the B1 
ZFP was fused to ROS1_CD and also to a shorter version (Catalytic Core Domain, 
ROS1_CCD). ROS1_CCD is active in vitro (Villaécija-Aguilar and Córdoba-Cañero, 
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data not published) and contains shorter linker regions flanking the first segment of the 
discontinuous ROS1 catalytic domain (Figure 13A). 
For all three fusion proteins, matched catalytically-inactive mutant versions (D971A) 
were used as controls (Figure 62A). All six fusion proteins contain a Flag-tag at the N-
terminus and a NLS between the ZF and ROS1 sequences (Figure 62A).  
Targeted demethylation by ZP-ROS1 proteins was explored using a dual-luciferase 
reporter system. The firefly luciferase reporter gene was cloned under the control of the 
IE175k promoter, which contains the specific binding site of 6F6 and B1 ZFPs (Figure 
62B). The reporter vector (IE175k–Luc) was methylated in vitro with M.SssI as 
described in Material and Methods (Section 10). A second reporter plasmid with the 
Renilla luciferase gene (RLL) under the control of a CMV promoter (pRL-CMV, 
Promega), was used for normalization of transfection yield and cell number in all co-
transfection experiments.  
Transient expression of all ZFP-ROS1 versions in HEK293 cells was confirmed by 
western-blot analysis using an anti-Flag antibody 48 h after co-transfection with the 
targeted reporter vector (Figure 63). 
Figure 63. Transient expression of ZFP-ROS1 fusion proteins in HEK293 cells. Western 
blot analysis with an anti-Flag antibody was performed in cell extracts (80 µg) prepared 48 h 
after co-transfection of different expression constructs with the targeted methylated reporter 
plasmid IE175k-Luc. Actin was used as an input control. 
2.2.2. Analysis of firefly luciferase activity after transient expression of 
different ZFP-ROS1 proteins in HEK293 cells 
The effect of transient expression of different ZFP-ROS1 fusion proteins on luciferase 
activity in HEK293 cells was examined 48 h after co-transfection with IE175k-Luc 
(Figure 64). As expected, luciferase activity was strongly reduced after in vitro 
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methylation of the reporter IE175k-Luc plasmid, decreasing to about 0.12% activity of 
the un-methylated control. These results confirm that the IE175k promoter is highly 
sensitive to DNA methylation, as previously reported (Li et al., 2007d).  
When cells were co-transfected with constructs expressing different ZFP-ROS1 
versions, luciferase activity levels decreased even further in all cases (Figure 64). 
Furthermore, no differences were observed between 6F6-ROS1_CD and B1-ROS1_CD 
proteins, which presumably bind with different affinities to the target promoter. Similar 
results were obtained when using IE175k-Luc : ZFP-ROS1 ratios other than 1:1 (data 
not shown). These results indicate that the methylation-induced silencing of the IE175k 
promoter is not reversed by expression of ZFP-ROS1 proteins. 
Figure 64. Analysis of luciferase reporter activity in HEK293 cells after transient co-
transfection with constructs expressing different ZFP-ROS1 variants. Cells were co-
transfected with 250 ng of in vitro-methylated reporter plasmid IE175k-Luc and different ZFP-
ROS1 expression constructs (250 ng). Luciferase activity, determined 48 h after co-transfection, 
is shown relative to that detected after co-transfection with unmethylated reporter and empty 
vector. Values are means ± SE (error bars) from two independent experiments. 
2.3. Study of targeted DNA demethylation activity by ZFP-
ROS1_CCD fusion proteins on endogenous genes in 
human cells 
In addition to the exogenous reporter system described above, the activity of 
engineered ZFP-ROS1 proteins was tested on endogenous genes in human cells. To this 
end, ROS1_CCD was fused either to CD54 (Magnenat et al., 2004) or to ZF2 
(customized in the laboratory of Dr. Marianne G. Rots). These ZFP are designed to 
specifically bind an 18-bp sequence in the promoter downstream the transcription start 
site (TSS) of the InterCellular Adhesion Molecule-1 gene (ICAM-1) or in the promoter 
Results 
 123 
around the TSS of the Ras-association domain family 1 gene, isoform A (RASSF1A), 
respectively. Retroviral transduction experiments were carried out to express these two 
ZF-ROS1_CCD versions in two human cells lines in which those target genes are 
hypermethylated (the human ovarian cancer A2780 cells and the human breast cancer 
MCF7 cells, respectively), and their effect in DNA methylation levels were analyzed. 
All these experiments were performed in Marianne G. Rots’s Laboratory at the 
University Medical Center Groningen (UMCG, The Netherlands). 
2.3.1. Analysis of ICAM-1 targeted DNA demethylation by CD54-
ROS1_CCD protein in A2780 cancer cells 
To explore the possibility of inducing targeted demethylation by ROS1 demethylase in 
endogenous genes in human cells, an ICAM-1-targeting ZF (CD54) was fused to the 
ROS1_CCD. A fusion of CD54 to the VP64 transcription activator and the empty 
vector were used as positive and negative controls, respectively (Figure 65A).  
A total of 5 CpG sites surrounding the ZF binding region (CpG sites 10–14 downstream 
the TSS) were selected for quantitative analysis of methylation levels by 
pyrosequencing after expression of CD54-ROS1_CCD and several controls (Figure 
65B). The ZF binding region contains CpG sites 10 and 11. As expected, non-
transduced A2780 cells showed high methylation levels: 79.5%, 86.3%, 57.5%, 75% 
and 63.5% at CpG sites 10, 11, 12, 13 and 14, respectively (Figure 65C). Only 
methylation levels at CpG site 13 in cells transduced with empty vector were higher 
(87.5%) compared with non-transduced cells. Methylation levels in A2780 cells 
expressing CD54-VP64 or CD54-ROS1_CCD were no significantly different from 
those observed in non-transduced cells and in cells transduced with the empty vector 
(Figure 65C). These results indicate that ZF-mediated targeting of VP64 or ROS1_CD 
has no effect on the methylation status of ICAM-1, at least at the analyzed CpG sites. 
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Figure 65. DNA methylation analysis of the endogenous ICAM-1 promoter in A2780 
cancer cells after expression of different CD54 fusion proteins. (A) Schematic diagram of the 
CD54 fusion proteins used. Expression constructs consist of a six-zinc finger protein module 
(CD54, which binds a specific sequence at the ICAM-1 gene promoter), fused to either the VP64 
transcription activator or ROS1_CCD. A construct with no effector domain (CD54-NED) was 
used as a negative control. (B) ICAM-1 target region and CpG sites (red) analyzed by bisulfite 
pyrosequencing. The CD54 binding site is shown in pink. (C) Quantitative methylation analysis 
of the ICAM-1 targeted region after transduction of A2780 cells with different CD54 constructs. 
Genomic DNA was isolated 48 h after the last infection, bisulfite-treated, PCR-amplified, and 
pyrosequenced. The graph shows the percentage of methylated CpGs (vertical axis) at different 
positions along the ICAM-1 region (horizontal axis), numbered relative to transcription start site 
(TSS). Values are means ± SE (error bars) from at least two independent experiments. 
2.3.2. Analysis of RASFF1A targeted DNA demethylation by CD54-
ROS1_CCD protein in MCF7 cancer cells 
As an alternative to the ICAM-1-targeting ZF (CD54), a RASSF1A-targeting ZF (ZF2) 
was fused to the ROS1_CCD. A fusion of ZF2 to the VP64 transcription activator was 
used as positive control (Figure 66A), whereas the empty vector and a fusion of ZF2 to 
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the catalytically inactive mutant version of ROS1_CCD (ZF2-ROS1_CCDmut) were 
used as negative controls (Figure 66A).  
Figure 66. DNA methylation analysis of the endogenous RASSF1A promoter in MCF7 
cancer cells after expression of different ZF2 fusion proteins. (A) Schematic diagram of the 
ZF2 fusion proteins used. Expression constructs consist of a six-zinc finger protein module 
(ZF2, which binds a specific sequence at the RASSF1A gene promoter), fused to either the VP64 
transcription activator or ROS1_CCD. A construct with no effector domain (CD54-NED) and a 
catalytically-inactive mutant ROS1_CCD were used as negative controls. (B) RASSF1A target 
region and CpG sites (red) analyzed by bisulfite pyrosequencing. The ZF2 binding site is shown 
in pink. CpG sites 3 and 4 from the transcription start site (TSS) located within the zinc finger 
binding region. (C) Quantitative methylation analysis of the RASSF1A targeted region after 
transduction of MCF7 cells with different ZF2 expressing constructs. Genomic DNA was 
isolated 48 h after the last infection, bisulfite-treated, PCR-amplified, and pyrosequenced. The 
graph shows the percentage of methylated CpGs (vertical axis) at different positions along the 
RASFF1A region (horizontal axis), numbered relative to transcription start site (TSS). Values 
are means ± SE (error bars) from two independent experiments. 
Doctoral Thesis  Jara Teresa Parrilla Doblas 
126 
A total of 9 CpG sites surrounding the ZF binding region (CpG sites -1 to 8 from the 
TSS) were selected for quantitative analysis of methylation levels by pyrosequencing 
after expression of ZF2-ROS1_CCD and several controls (Figure 66B). The ZF binding 
region contains the CpG sites 3 and 4. As expected, non-transduced MCF7 cells 
showed high methylation levels: 42% and 55.5% at CpG sites -1 and 2, and >80% at 
the remaining CpG sites (Figure 66C). These values were very similar in all cells 
transduced with the different constructs, except for CpG sites 5 and 6, where 
transduced cells expressing ZF2-ROS1_CCD or ZF2-VP64 showed a reduction in 
methylation levels (around 75%); however, these levels were not significantly different 
from those observed in cells transduced with the empty vector or ZF2-ROS1_CCDmut 
(negative controls) (Figure 66C). These results indicate that the DNA demethylation 
observed at CpG sites 5 and 6 in cells expressing ZF2-VP64 or ZF2-ROS1_CCD could 
not be attributed to VP64 action or ROS1_CCD catalytic activity, respectively. 
 
3. Targeting ROS1 activity by fusion to an RNA-guided 
dCas9 protein 
The two previous sections have described results obtained after fusing two different 
specific DNA Binding Domains (GBD or ZFPs) to the catalytic domain of ROS1, in 
order to direct its demethylase activity to specific sequences in human cells. Although 
ZFPs can be engineered to target almost any specific sequence in large genomes, its use 
has some limitations: it depends on generating new proteins for each DNA target, 
which is complex and time-consuming, and not every nucleotide triplet has a 
corresponding zinc finger.  
CRISPR (clustered regularly interspaced palindromic repeats) is a recently developed 
technology for genetic editing that overcomes some of these limitations. The CRISPR 
methodology derives from a bacterial adaptive immune defense system against viruses 
(Mojica et al., 2005) that uses an RNA-guided nuclease to target and destroy invading 
DNA (Bhaya et al., 2011; Cong et al., 2013; Jinek et al., 2012; Mali et al., 2013b; 
Pennisi, 2013). Several CRISPR systems have been identified, but the most simple is 
the type II CRISPR/Cas system. It comprises a ribonucleoprotein complex formed by a 
single CRISPR-associated protein (Cas9), a mature CRISPR RNA (crRNA) and a 
trans-acting crRNA (tracrRNA) that can carry out efficient crRNA-directed recognition 
and site-specific cleavage of foreign DNA (Jinek et al., 2012).  
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This natural CRISPR system has been further simplified in two elements: 1) an 
engineered single guide RNA (sgRNA), containing a designed hairpin that mimics the 
tracrRNA-crRNA complex, and 2) a Cas9 protein from Streptococcus pyogenes 
(SpCas9) (Jinek et al., 2012). Binding specificity is determined by both sgRNA-target 
DNA base pairing (20 nt) and a short DNA motif [protospacer adjacent motif (PAM) 
sequence: NGG, for SpCas9] at 3’ to the DNA complementary region. The 
CRISPR/Cas9 technology offers several potential advantages over other methods, 
including the ease of customization. Unlike ZFPs, CRISPR/Cas9 does not require 
protein design and engineering for every gene being targeted. Cas9 can be easily re-
targeted to new DNA sequences by simply purchasing a pair of oligos encoding the 20-
nt guide sequence (Sander and Joung, 2014). 
The CRISPR/Cas9 methodology has been successfully used for genome editing through 
targeted mutation by Cas9-induced strand breaks (Cong et al., 2013; Mali et al., 2013b; 
Mali et al., 2013; Ran et al., 2013). However, it can be also used for targeted 
modulation of gene expression. To this end, the endonuclease domains (RuvC1 and 
HNH) of the Cas9 protein are inactivated by point mutations (D10A and H840A in 
SpCas9), resulting in a nuclease dead Cas9 (dCas9) molecule that cannot cleave but 
retains the ability to bind to target DNA based on the sgRNA targeting sequence (Qi et 
al., 2013). Transcriptional repressors or activators fused to dCas9 can be efficiently 
directed by specific sgRNAs to appropriate promoter regions, resulting in 
transcriptional repression or activation of downstream target genes, respectively (Figure 
26 Introduction). 
In this thesis, the CRISPR/dCas9 system has been used to target ROS1 demethylase 
activity to specific sequences in reporter plasmids in human cells. Two different 
strategies have been followed: (1) a dual construct expressing both dCas9-ROS1 fusion 
proteins and sgRNA from different promoters (Section 3.1), and (2) different constructs 
for separate expression of dCas9-ROS1 fusion proteins and sgRNAs (Section 3.2). 
3.1. Targeting dCas9 fusion proteins guided by one sgRNA 
expressed from the same plasmid 
3.1.1. Transient expression of dCas9-ROS1_CD fusion protein and its 
mutant variant in HEK293 cells 
To validate the feasibility of targeting ROS1 demethylase activity using the 
CRISPR/dCas9 system, dCas9 from Streptococcus pyogenes was fused to ROS1_CD 
(Figure 67A). A catalytically inactive mutant version of ROS1_CD (D971A) was also 
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fused to dCas9 and used as a negative control. An HA-tag located at N-terminus of the 
fusion protein and two nuclear localization signals (NLS) flanked dCas9 to ensure 
nuclear compartmentalization in mammalian cells. Two NLSs have been reported to be 
more efficient at targeting SpCas9 to the nucleus than only one (Cong et al., 2013). A 
sequence coding for 2A peptide followed by enhanced Green Fluorescent Protein (2A-
eGFP) was cloned in frame downstream ROS1_CD (Figure 67A). The 2A sequence, 
which encodes a 18 amino acids “self-cleaving” small peptide (Kim et al., 2011; Ryan 
et al., 1991), allows the simultaneous expression of both proteins from the same open 
reading frame. Thus, expression of dCas9-ROS1_CD may be inferred from eGFP 
expression (see below). 
A dual plasmid with separate promoters for expression of both the fusion protein and its 
corresponding sgRNA was used. For each fusion protein, expressed from a CBh 
promoter, the corresponding sgRNA was cloned under the control of a U6 promoter 
(Figure 67A). Since certain sgRNAs may not work for reasons yet unknown, at least 
two sgRNAs for each region should be designed and tested (Ran et al., 2013). Two 
sgRNAs were designed targeting different 20-nt DNA sequences on the sense strand in 
the TK promoter (sgRNAs TK 1 and TK 2) (Figure 67B and Table 7). These sgRNAs 
were cloned by annealing 25-nt oligo pairs (containing the 20-nt target sequence, an 
additional G/C nt for efficient U6-dependent transcription and 5’-overhangs for BbsI 
restriction site) followed by insertion between two BbsI sites, located upstream the 
sgRNA scaffold (Figure 67A). A negative control without sgRNA (no sgRNA) was 
also constructed. Therefore, three different sgRNA combinations (sgRNA TK 1, 
sgRNA TK 2 and no sgRNA) were generated for each fusion protein (dCas9-
ROS1_CD and dCas9-ROS1_CDmut). 
Targeted demethylation by dCas9-ROS1 proteins was examined using a dual-luciferase 
reporter system. The firefly luciferase reporter gene was cloned under the control of the 
TK promoter (Figure 67B). The reporter vector (TK–Luc) was methylated in vitro with 
M.SssI as described in Material and Methods (Section 10). A second reporter plasmid 
with the Renilla luciferase gene (RLL) under the control of a CMV promoter (pRL-
CMV, Promega), was used for normalization of transfection yield and cell number in 
all co-transfection experiments.  
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Figure 67. Schematic diagram of CRIPSR constructs for combined expression of dCas9-
fusion proteins and sgRNAs. (A) Dual expression construct expressing both dCas9-ROS1_CD 
and sgRNA from separate promoters (CBh and hU6, respectively). A sequence coding for 2A-
eGFP (2A peptide followed by enhanced Green Fluorescent Protein) was cloned in frame 
downstream ROS1_CD. The construct also contains a HA-Tag at the N-terminus and two 
nuclear localization signals (NLS) flanking dCas9. A control construct encodes VP64 
transcription activator fused to dCas9. Appropriated sgRNA oligos (20 nt) containing 5´-
overhangs were annealed and inserted between the two BbsI sites located upstream the sgRNA 
scaffold. (B) The reporter construct contains a TK promoter fused to the firefly luciferase gene. 
Arrows indicate the target sites of the sgRNAs used. 
Transient expression of dCas9-ROS1_CD and dCas9-ROS1_CDmut in HEK293 cells 
was monitored by eGFP fluorescence, 48 h after co-transfection with the TK-Luc 
reporter vector (Figure 68). Numbers of eGFP+-cells levels were similar for dCas9-
ROS1_CD- and dCas9-ROS1_CDmut-expressing constructs, and the estimated co-
transfection efficiency was around 5% (Figure 68).  
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Figure 68. Transient expression of dCas9-ROS1_CD-2A-eGFP and dCas9-ROS1_CDmut-
2A-eGFP in HEK293 cells. Images were obtained by fluorescence microscopy 48 h after co-
transfection of the expression constructs (dCas9-ROS1_CD-2a-eGFP version guided by sgRNA 
TK 1) with the methylated reporter plasmid TK-Luc. Non-transfected cells were used as control. 
Upper panel: visible light; lower panel: ultraviolet light. Co-transfection efficiency, determined 
as the percentage of GFP+-cells detected by flow cytometry, was 5%. 
3.1.2. Effect of transient expression of dCas9 fusion proteins on luciferase 
activity in HEK293 cells 
The effect of transient expression of dCas9-ROS1_CD on luciferase activity in 
HEK293 cells was examined 48 h after co-transfection with TK-Luc (Figure 69). 
dCas9-ROS1_CD was co-expressed with either sgRNA TK 1, sgRNA TK 2, or no 
sgRNA. The catalytically defective mutant dCas9-ROS1_CD was used as a negative 
control.  
As expected, the luciferase activity was strongly reduced after in vitro methylation of 
the reporter TK-Luc plasmid, decreasing to about 0.10-0.20% of activity, compared to 
the un-methylated control in co-transfections with no sgRNAs (Figure 69B).  
However, no significant changes in activity were observed between cells expressing 
dCas9-ROS1_CD or the mutant version dCas9-ROS1_CDmut, both co-expressed with 
either sgRNA TK 1, sgRNA TK 2 or no sgRNA (Figure 69B). Similar results were 
obtained when using TK-Luc : dCas9-ROS1 ratios other than 1:1 (data not shown). 
These results indicate that the methylation-induced silencing of the TK promoter is not 
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reversed by expression of dCas9-ROS1_CD protein guided by either sgRNA TK 1 or 
sgRNA TK 2. 
Figure 69. Analysis of luciferase reporter activity in HEK293 cells after transient co-
transfection with different dual constructs expressing dCas9-ROS1_CD-2A-eGFP or its 
mutant version. (A) The reporter construct contains the TK promoter fused to the firefly 
luciferase gene. Arrows indicate target sites of the two sgRNAs used. (B) Cells were co-
transfected with 50 ng of in vitro-methylated reporter plasmid TK-Luc and 50 ng of different 
dual expression constructs. Luciferase activity, determined 48 h after co-transfection, is shown 
relative to that detected after co-transfection with unmethylated reporter and dual vector without 
sgRNA. 
The dCas9-ROS1_CD expressing constructs described above contain 2A-eGFP in 
frame downstream ROS1_CD. Since cleavage of the 2A peptide occurs at its C-
terminal proline residue (EGRGSLLTCGDVEENPG↓P) (Kim et al., 2011), a small 
peptide of 17 amino acids remains bound to the C-terminus of ROS1_CD that may 
negatively affect the catalytic activity of the enzyme. To test whether the presence of 
that extra sequence could explain the no re-activation of luciferase activity reported 
above, constructs expressing dCas9-ROS1_CD and its catalytically inactive mutant 
version but without 2A-eGFP were generated (Figure 67A). Furthermore, to check 
whether the CRISPR/dCas9 system with the two-selected sgRNA (TK 1 and TK 2) was 
correctly working, a construct expressing dCas9 fused to VP64 transcription activator 
(Addgene #48238) was used as positive control (Figure 67A). Activation of reporter 
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genes located in plasmids using targeted VP64 transcription activator has been 
previously shown (Farzadfard et al., 2013; Hu et al., 2014). In addition, two different 
TK-Luc : dCas9-ROS1 ratios were assayed (Figure 70). 
Figure 70. Analysis of luciferase reporter activity in HEK293 cells after transient 
expression of dCas9-VP64, dCas9-ROS1_CD or dCas9-ROS1_CDmut. (A) The reporter 
construct contains the TK promoter fused to the firefly luciferase gene. Arrows indicate the 
target sites of the two sgRNAs used. (B-C) Cells were co-transfected with in vitro-methylated 
reporter plasmid TK-Luc (50 ng) and different dual expression constructs at two different 
reporter : effector ratios, as indicated. Luciferase activity, determined 48 h after co-transfection, 
is shown relative to that detected after co-transfection with unmethylated reporter and non-
targeted dCas9-ROS1_CDmut. 
As expected, in the two tested ratios the luciferase activity was strongly reduced after in 
vitro methylation of the reporter TK-Luc plasmid, decreasing to <1% activity of the un-
methylated control in co-transfections with no sgRNAs (Figure 70B and C).  
Co-expression of dCas9-VP64 with either sgRNA TK 1 or sgRNA TK 2 at both 1:3 
and 1:5 TK-Luc : dCas9-VP64 ratios significantly increased luciferase activity to about 
2% or 3%, and 5% or 4%, respectively (Figure 70B and C). These results indicate that 
VP64 is being targeted to effectively up-regulate luciferase expression and that higher 
amounts of targeted dCas9-VP64 lead to higher increase in luciferase activity. 
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By contrast, in general and independently on the TK-Luc : dCas9-ROS1 ratio assayed, 
co-expression of dCas9-ROS1_CD with either sgRNA TK 1 or sgRNA TK 2 produced 
similar levels of luciferase activity to those detected when co-expressing either dCas9-
VP64 with no sgRNA or dCas9-ROS1_CDmut with sgRNAs TK1 or TK 2 (Figure 70B 
and C).  
Altogether, these results indicate that expression of dCas9-ROS1_CD guided by these 
two-selected sgRNAs is not efficiently re-activating luciferase expression, 
independently of both the TK-Luc : dCas9-ROS1_CD ratio and the presence or not of 
the remaining 2A peptide at the C-terminus of ROS1. 
3.2. Targeting dCas9 fusion proteins guided by different 
combinations of sgRNAs expressed from separate 
plasmids  
Several studies have shown that the level of gene activation by dCas9 fused to an 
activation domain can be synergistically enhanced by the simultaneous usage of 
multiple sgRNAs targeting different sites in the same promoter region (Cheng et al., 
2013; Maeder et al., 2013b; Perez-Pinera et al., 2013a). Therefore, six new sgRNAs 
were designed and tested to target the TK promoter fused to the firefly luciferase gene 
(Figure 71C). In this case, sgRNAs and dCas9 fusion proteins were expressed from 
separate plasmids (Figure 71A and B). 
The six new sgRNAs were designed to target different 20-nt DNA sequences on the 
sense (TK 3, TK 4 and TK 5) or the anti-sense (TK 6, TK 7 and TK 8) template in the 
TK promoter (Figure 71C and Table 7). They were generated by annealing 26 or 27-nt 
oligo pairs, which contained the 20-nt target sequence, an additional G/C nt for 
efficient U6-dependent transcription when the first base of the forward oligonucleotide 
differed from G, and 5’-overhangs for BsmBI restriction site. The sgRNAs were cloned 
into MLM3636 plasmid (Addgene #43860) by insertion between two BsmBI sites, 
located upstream the sgRNA scaffold (Figure 71B). The pMLM3636 empty vector (no 
sgRNA) and dCas9 fused to the catalytically inactive mutant version ROS1_CDmut 
(dCas9-ROS1_CDmut) were used as negative controls (Figure 71). 
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Figure 71. Schematic diagram of CRIPSR constructs for separate expression dCas9-
fusion proteins and sgRNAs. (A) dCas9-effector constructs. dCas9-VP64 and dCas9-
ROS1_CD fusion proteins were expressed from a pAC152-dual-derived plasmid with no 
sgRNA. dCas9-ROS1_CCD was expressed from a pAC93-pmax-derived plasmid. A non-
targeted full-length ROS1 protein expressed from a pCMVTag2-derived plasmid was used as a 
control. (B) sgRNA expression constructs. Appropriated sgRNA oligos (20 nt) containing 5´-
end overhangs were annealed and inserted into the pMLM3636 vector, between the two BsmBI 
sites located upstream the sgRNA scaffold. (C) The reporter construct contains a TK promoter 
fused to the firefly luciferase gene. Arrows indicate target sites of the six different sgRNAs 
used. 
3.2.1. Transient expression of dCas9-VP64 fusion protein guided by 
multiple sgRNAs synergistically increases luciferase activity in 
HEK293 cells 
Each sgRNA, either  alone or combined with other sgRNAs, was co-transfected into 
HEK293 cells with dCas9-VP64 and the TK-Luc reporter vector. The pMLM3636 
empty vector (no sgRNA) was used as negative control. The expression of dCas9-VP64 
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protein was confirmed by western-blot analysis using an anti-Cas9 antibody (Figure 
72). An intense band was detected at the expected size (168 kDa).  
Figure 72. Transient expression of dCas9-VP64 fusion protein in HEK293 cells. Western 
blot analysis with an anti-Cas9 antibody was performed in cell extracts (65 µg) prepared 48 h 
after co-transfection of dCas9-VP64 expression construct with the methylated reporter plasmid 
TK-Luc. Actin was used as an input control. 
The luciferase activity of the methylated reporter TK-Luc plasmid was about 1% when 
compared to the un-methylated control in co-transfections with pMLM3636 empty 
vector (no sgRNA) (Figure 73B). Co-transfection of dCas9-VP64 and sgRNA TK 3, 
which targeted -218 to -199 bp region upstream the start codon, increased the luciferase 
activity to 3.4%, whereas co-transfections of dCas9-VP64 with the remaining sgRNAs 
did not have any noticeable effect (Figure 73B). When dCas9-VP64 was co-transfected 
with different sgRNAs combinations, clear synergistic effects were observed with 
combinations 3+8 and 3+4+5, which further increased the luciferase activity to 5.4% 
and 15.6%, respectively (Figure 73B).  
These results indicate that expression of dCas9-VP64 guided by combined sgRNAs can 
activate silenced TK-Luc reporter gene in HEK293 cells to a greater extent than 
individual sgRNAs. 
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Figure 73. Analysis of luciferase reporter activity in HEK293 cells after transient 
expression of dCas9-VP64 and different sgRNAs combinations. (A) The reporter construct 
contains a TK promoter fused to the firefly luciferase gene. Arrows indicate target sites of the 
six sgRNAs used. (B) Cells were co-transfected with in vitro-methylated reporter plasmid TK-
Luc (250 ng), dCas9-VP64 (125 ng), and several combinations of sgRNAs (125 ng total). 
Luciferase activity, determined 48 h after co-transfection, is shown relative to that detected after 
co-transfection with unmethylated reporter, dCas9-VP64 and empty pMLM3636 (no sgRNA). 
Values are means ± SE (error bars) from two independent experiments. 
3.2.2. Effect of dCas9-ROS1_CD fusion proteins guided by individual or 
combined sgRNAs on luciferase activity in HEK293 cells 
Co-transfection experiments analogous to those described in the above section were 
performed with either dCas9-ROS1_CD or dCas9-ROS1_CDmut. In contrast to dCas9-
VP64, the expression of these fusion proteins could not be confirmed by western-blot 
(data not shown). Since expression of dCas9-ROS1_CD-2A-eGFP from the same 
promoter can be clearly detected by fluorescence (see Figure 68), it cannot be ruled out 
the possibility that the large size of dCas9-ROS1_CD (286 kDa) compared to dCas9-
VP64 (186 kDa) hampers its detection by immunoblotting. 
Figure 74B shows the levels of luciferase activity in co-transfections of the reporter 
TK-Luc plasmid, dCas9-ROS1_CD (or its mutant version) and different sgRNAs 
individually or in combination. The highly reduced luciferase activity of the reporter 
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TK-Luc plasmid, (<0.6% activity of the un-methylated control) were not significantly 
increased with any of the two fusion proteins, either with individual or with different 
combinations of sgRNAs (Figure 74B). 
Figure 74. Analysis of luciferase reporter activity in HEK293 cells after transient 
expression of WT or mutant dCas9-ROS1_CD and different sgRNAs combinations. (A) 
The reporter construct contains a TK promoter fused to the firefly luciferase gene. Arrows 
indicate target sites of the six sgRNAs used. (B) Cells were co-transfected with in vitro-
methylated reporter plasmid TK-Luc (250 ng), dCas9-ROS1_CD or its mutant version (125 ng), 
and several combinations of sgRNAs (125 ng total). Luciferase activity, determined 48 h after 
co-transfection, is shown relative to that detected after co-transfection with unmethylated 
reporter, dCas9-ROS1_CD or its mutant version, and empty pMLM3636 (no sgRNA). 
These results indicate that the methylation-induced silencing of the TK promoter is not 
reversed by dCas9-ROS1_CD protein guided by individual or combined sgRNAs 
targeting different regions of the TK promoter. 
3.2.3. Effect of different combinations of several dCas9-effector proteins, 
guided by combined sgRNAs, on luciferase activity in HEK293 cells 
The experiments described above indicate that VP64, but not ROS1_CD, can reactivate 
the expression of a methylated reporter gene when fused to an RNA-guided dCas9 
protein. Since reactivation induced by VP64 was not complete, the question arises of 
whether both types of effector proteins might act cooperatively for enhanced gene re-
expression.  
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To test this hypothesis, HEK293 cells were co-transfected with the TK-Luc reporter 
plasmid, a combination of three sgRNAs (3+4+5), and individual or combined effector 
constructs expressing dCas9-VP64 and/or different dCas9-ROS1 versions. The 
pCMVTag2 empty vector was used for mass compensation when testing individual 
effector-expressing plasmids (Figure 75B).  
Figure 75. Analysis of luciferase reporter activity in HEK293 cells after transient 
expression of different combinations of dCas9-effector proteins and sgRNAs. (A) The 
reporter construct contains a TK promoter fused to the firefly luciferase gene. Arrows indicate 
target sites of the 3 sgRNAs used. (B) Cells were co-transfected with 500 ng of in vitro-
methylated TK-Luc reporter plasmid, 250 ng of the sgRNA-expressing pMLM3636 plasmid, 
and 250 ng of individual or combined effector-expressing plasmids, as indicated. Luciferase 
activity, determined 48 h after co-transfection, is shown relative to that detected after co-
transfection with unmethylated reporter, empty pMLM3636 (no-sgRNA) and empty 
pCMVTag2 (no effector protein). Values are means ± SE (error bars) from at least two 
independent experiments. 
As expected, co-transfection of dCas9-VP64 alone with 3+4+5 sgRNAs significantly 
increased the luciferase activity (Figure 75B). Reactivation was lower compared to that 
shown in Figure 73B because half amount of dCas9-VP64 was used for appropriate 
comparison of effector combinations. Interestingly, the reactivation induced by dCas9-
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VP64 was significantly decreased when this effector was combined with targeted 
versions of ROS1 (dCas9-ROS1_CD, dCas9-ROS1_CDmut, or dCas9-ROS1_CCD, a 
shorter ROS1_CD version). However, such decrease was not observed when dCas9-
VP64 was combined with non-targeted ROS1 versions (ROS1_FL or ROS1mut_FL) 
(Figure 75B).  
These results suggest that dCas9-ROS1 variants, but not ROS1_FL, are being targeted 
to the TK promoter and compete with dCas9-VP64 for binding to the target sites, which 
results in lower reactivation levels than those observed with dCas9-VP64 alone. 
Therefore, VP64 and ROS1 do not act cooperatively to reactivate gene expression. 
3.2.4. Methylation analysis of the TK promoter after transient expression 
of different combinations of dCas9-effector proteins and sgRNAs 
It was next examined whether the changes in reporter gene activity described above are 
accompanied by changes in DNA methylation at the TK promoter. Methylation levels 
were analyzed by bisulfite pyrosequencing in HEK293 cells co-transfected with the 
TK-Luc reporter plasmid, a combination of three sgRNAs (3+4+5), and individual or 
combined effector constructs expressing dCas9-VP64 and/or different dCas9-ROS1 
versions (Figure 76).  
In the absence of any effector protein methylation levels ranged from 100% to about 
60%, depending on the specific CpG site (Figure 76). These levels were not 
significantly changed by expression of any of the different tested dCas9 fusion 
proteins/sgRNAs combinations (Figure 76). These results indicate that the reactivation 
of the methylated reporter plasmid by targeted dCas9-VP64 is not associated with 
changes in DNA methylation. Furthermore, they confirm that expression of dCas9-
ROS1_CD, either alone or in combination with other dCas9-VP64, does not alter the 
methylation status of the TK promoter. 
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Figure 76. DNA methylation analysis of the TK promoter upstream the luciferase 
reporter gene in HEK293 cells after transient expression of different combinations of 
dCas9-effector proteins and sgRNAs. (A) Schematic diagram of the targeted reporter 
construct the TK promoter fused to the firefly luciferase gene. CpG sites analyzed by bisulfite 
pyrosequencing, numbered relative to the start codon (ATG), are shown in red. (B) Quantitative 
methylation analysis of the TK region. Cells were co-transfected with 500 ng of either 
methylated or non-methylated TK-Luc reporter plasmid, 250 ng of the sgRNA-expressing 
pMLM3636 plasmid, and 250 ng of individual or combined effector-expressing plasmids, as 
indicated. Plasmid DNA was isolated 48 h after co-transfection, bisulfite-treated, PCR-
amplified, and pyrosequenced. The graph shows the percentage of methylation at each CpG site. 
C+ = methylated TK-Luc. !
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1. ROS1 actively interrogates DNA in search of 5-meC 
by using three predicted helix-invading residues 
Arabidopsis thaliana ROS1 protein has been chosen as a prototype enzyme to study the 
initial step of active DNA demethylation in plants. A recent study has defined the 
catalytic domain of ROS1 and has identified residues important for ROS1 catalysis, 
base specificity and stable binding (Ponferrada-Marín et al., 2011). However, a central 
question that remains to be answered is how ROS1 recognizes and excises its target 
base, which has been one of the objectives of this thesis.  
1.1. ROS1 catalytic domain contains three putative helix-
invading residues that are critical for 5-meC extrusion 
from DNA 
The conserved base-flipping mechanism used by DNA glycosylases entails the need to 
stabilize the resulting distortion of DNA. Central to this process is the intercalation of 
two residues into the base stack: a plug residue that fills the gap left by the flipped-out 
nucleotide and a wedge residue that intrudes between bases on the opposite strand and 
interacts with the orphan base. The homology modeling and functional analysis of 
ROS1 suggest that Q607 and M905 serve the roles of plug and wedge residues, 
respectively, with R903 additionally performing a critical function in the stabilization 
of the orphan G. In this first objective of the thesis, the function of these three putative 
DNA intercalating residues in initiation of DNA demethylation by ROS1 glycosylase 
has been analyzed by site-directed mutagenesis.  
An important result obtained in this thesis is that Q607A, M905G and R903A variants 
fail to process 5-meC:G pairs, but remain competent in cleaving an abasic site opposite 
G. This observation demonstrates that mutations in any of these three residues 
specifically impair early 5-meC recognition events, leaving intact the capacity to 
perform downstream steps in the base excision cascade. Similar separation of function 
mutations have been reported in other bifunctional DNA glycosylases. For example, 
blocking the 8-oxoG recognition pocket of hOGG1 with a bulky amino acid side chain 
generates a mutant variant unable to flip 8-oxoG nucleotides in DNA, but still able to 
recognize and cleave abasic sites (Dalhus et al., 2011). Also, mutation of two DNA 
intercalating residues in Fpg (also called MutM) (F114A and M77A) significantly 
decreases 8-oxoG excision but preserves AP lyase activity (Sung et al., 2013). 
Although the results obtained in this thesis do not exclude the possibility that Q607A, 
M905G and/or R903A may facilitate AP site hydrolysis following 5-meC excision, 
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they suggest that the major catalytic defect in the three mutant proteins relates to 
upstream steps of the base extrusion pathway. 
The ROS1 model structure predicts that Q607, M905 and R903 are candidates to 
intercalate in DNA, and therefore they might play a role in destabilization and extrusion 
of 5-meC opposite G. This hypothesis is supported by the remarkable observation that 
all three mutant ROS1 proteins retain a significant 5-meC excision activity when the 
target base is mispaired. Increased base excision activity by disruption of proper base 
pairing has been previously reported for several glycosylases (Francis et al., 2003; 
Krosky et al., 2005; Vallur et al., 2002). UDG has been proposed to capture 
spontaneously extruded uracils (Cao et al., 2004), and displays higher activity when its 
target base is mispaired with an unnatural adenine analog that lacks Watson–Crick 
hydrogen-bonding groups (Krosky et al., 2005). DNA glycosylases that use an active 
base-flipping mechanism, such as Fpg and human AAG, also excise their target bases 
with higher efficiency when mispaired with nonpolar analogs (Francis et al., 2003; 
Vallur et al., 2002), an effect that has been attributed to facilitated base extrusion from 
the helix. Interestingly, the catalytic activity of human AAG mutated in the plug 
residue Y162 was partially restored when the base opposite the target was changed to a 
nonhydrogen bonding partner (Vallur et al., 2002). This result mirrors the observation 
that variant Q607A retains a significant activity on mismatched 5-meC, thus suggesting 
that facilitated extrusion of the target base partially bypasses requirement for helix-
invading residues. 
1.2. Role of the plug residue (Q607) on DNA binding and 
motion of the DNA glycosylase along DNA 
Insertion of the plug residue into the gap left in the double helix by the extruded base is 
likely to play a crucial role in stabilizing the lesion-recognition complex. In fact, it has 
been consistently observed in different DNA glycosylases that mutation of the plug 
residue not only curtails catalytic activity, but also abrogates stable binding to DNA 
substrates (Maiti et al., 2009; Slupphaug et al., 1996; Vallur et al., 2002). However, 
there is growing evidence that, in addition to stabilizing the extrahelical state after base 
flipping, side chains that intercalate into DNA play a critical role during target location 
and substrate specificity (Banerjee et al., 2006; Dunn et al., 2011; Qi et al., 2009; Sung 
et al., 2013). There are several observations that, taken together with the stable binding 
of Q607A to a DNA substrate with blocked termini, support the idea that Q607A is not 
just a DNA binding-deficient mutant, but a faster slider with decreased extrusion rates 
on both methylated and unmethylated bases. WT ROS1 binds with similar affinity to 
methylated and nonmethylated DNA, whereas Q607A does not show detectable 
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binding activity on either substrate. However, despite such undetectable binding 
capacity, Q607A exhibits a significant activity on targets that do not require full 
extrusion competence, such as mismatched 5-meC and AP sites, and displays excision 
rates similar to those of the binding-proficient versions M905G and R903A. In contrast, 
the increased binding of Q607A to a DNA substrate with blocked ends does not result 
in an increased activity on 5-meC:G pairs, which suggests that unstable DNA binding is 
a derived consequence of a deficiency in a putative plug residue. Therefore the unstable 
DNA binding exhibited by the Q607A mutant is most likely due to increased sliding 
along DNA, thus implying that the side chain of Q607 inhibits the scanning rate of 
ROS1. The role of helix-invading residues in controlling motion of a DNA glycosylase 
along DNA is not without precedent. In Fpg, which performs intrahelical interrogation 
(Qi et al., 2009), mutations of the wedge (F114) and plug (R112) residues increase the 
diffusion rate (Dunn et al., 2011) and induce strandwise translocation (Qi et al., 2012), 
respectively. The results described here strengthen the hypothesis that ROS1 uses Q607 
as a plug residue for efficient 5-meC extrusion. In addition, they suggest that ROS1 
requires such residue for extrusion of both methylated and unmethylated bases in a 
DNA scanning process. 
1.3. Searching for the target base: DNA interrogation 
All these results shed some light on the possible mechanism used by ROS1 to locate its 
target base. Three possible strategies have been proposed to explain how DNA 
glycosylases find their target bases on DNA: (i) passive capture of extrahelical target 
bases that have spontaneously emerged from the DNA base stack (Cao et al., 2004), (ii) 
intrahelical inspection of the relative strength and flexibility of base pairs by inserting 
one or more residues into the DNA duplex (Banerjee et al., 2006; Qi et al., 2010) and 
(iii) sequential extrusion of every base out of the DNA helix for extrahelical 
interrogation (Verdine, 1997).  
Because methylation has been shown to decrease base opening rates (Mirau and 
Kearns, 1984), it is unlikely that ROS1 passively captures 5-meC residues 
spontaneously emerged from the DNA base stack at 5-meC:G pairs. By other hand, the 
inhibitory role of Q607 on ROS1 sliding along DNA suggests that base flipping 
precedes substrate discrimination, and that the enzyme actively interrogates bases on an 
extrahelical rather that intrahelical conformation. Intrahelical inspection may be rather 
inefficient to distinguish between C and 5-meC. Methylation does not induce gross 
conformational changes in DNA (Derreumaux et al., 2001) and the 5-methyl group is 
located on the major groove, whereas the catalytic domain of ROS1, as in all other 
DNA glycosylases (Huffman et al., 2005), is expected to bind DNA through the minor 
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groove. Intriguingly, both the DNA-binding domain of the methyl-specific 
endonuclease McrBC from E. Coli (Sukackaite et al., 2012) and the SET- and Ring-
associated (SRA) domains of mammalian UHRF1 (Hashimoto et al., 2008) and 
Arabidopsis SUVH5 (Rajakumara et al., 2011) flip out 5-meC from the base stack to 
achieve discrimination of 5-meC from C. In any case, a full understanding of the search 
mechanism used by ROS1 must await structural information for this enzyme. 
 
2. ROS1 is able to interact with histones through its C-
terminal domain 
ROS1 contains an N-terminal domain that mediates methylation-independent DNA 
binding (Ponferrada-Marín et al., 2010) and in Chapter 1 of this thesis it has been 
shown that several residues located in its discontinuous catalytic domain are implied in 
target searching and enzymatic removal of 5-meC. However, additional factors are 
required to precisely target active DNA demethylation to specific loci.  
There are several evidences for the existence of a targeting mechanism that regulates 
DNA demethylation in plants. For example, when analyzing DNA methylation levels 
in the genome of Arabidopsis ros1 dml2 dml3 triple mutant no global changes were 
found comparing with DNA methylation levels of WT plants, whereas significant 
differences were only observed in a small set of genes (Penterman et al., 2007; Zhu et 
al., 2007). However, the molecular mechanisms underlying the recruitment to specific 
loci remain poorly understood.  
In Arabidopsis, there is evidence indicating that demethylation by ROS1 may be guided 
by small RNAs bound to ROS3 (Zheng et al., 2008), an RNA-binding protein required 
for demethylation at a number of loci, some of which overlap with ROS1 targets. 
Alternatively, since DNA demethylation is occurring in a chromatin environment, 
nucleosome positioning and histone modifications may contribute to removal of 5-
meC. Nucleosome-bound DNA is more densely methylated than linker DNA sequences 
(Chodavarapu et al., 2010). Furthermore, a recent study discovered a histone 
acetyltransferase (IDM1) that controls the DNA methylation levels of a subset of loci 
targeted by ROS1 and its homologs in Arabidopsis. IDM1 binds methylated DNA at 
chromatin sites with unmethylated H3K4 and acetylates H3K18 and H3K23 to create a 
chromatin environment that allows 5-meC DNA glycosylases to function (Qian et al., 
2012). 
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The results obtained in Chapter 2 of this thesis show that ROS1 is able to interact with 
histones and their specific post-translational modifications, but such interactions may 
be abolished or modulated by specific modifications. Furthermore, the results obtained 
in this thesis identified ROS1 C-terminal domain, which is highly conserved between 
DML family proteins although its function remained unclear, as a strong candidate for 
mediating this interaction. Altogether, these results shed some light about a possible 
mechanism for targeting ROS1 activity to specific loci. 
2.1. Phospho-sensitive interaction with histone H3. Possible 
biological roles 
In this thesis, it has been shown that ROS1 is able to interact with the N-tails of H2A, 
H3 and H4 core histones, except for H2B, but such interaction may be abolished or 
modulated by specific modifications. Thus, the most relevant observation was that 
ROS1 binding to histone H3 peptides is disrupted when Ser28 is phosphorylated, 
independently of whether other modification marks are present or not in the same 
peptide. Pull-down assays confirm that ROS1 interacts with both regions (amino acids 
1-21 and 21-44) of unmodified histone H3 and when Ser10 is phosphorylated, but the 
binding is inhibited when Ser28 is phosphorylated, even though both serine residues are 
part of the same ARKS sequence motif. Therefore, the absence of ROS1 interaction 
with phosphorylated histone H3 at Ser28 is sequence-specific and most likely involves 
residues preceding and/or following the ARKS motif. In agreement to that hypothesis, a 
study showed that the chromodomain of Polycomb (Pc) proteins, which specifically 
binds to H3K27me3, specifically discriminates between the H3K27 and H3K9 
methylation sites, both part of the ARKS motif, due to recognition of five additional 
residues preceding the ARKS sequence (Fischle et al., 2003b). 
Histone H3 phosphorylation has been related with chromosome 
condensation/segregation during mitosis and meiosis, but it has also been involved in 
chromatin relaxation and transcription activation of specific genes during interphase in 
both animals and plants (Cerutti and Casas-Mollano, 2009; Houben et al., 2007; 
Rossetto et al., 2012; Sawicka and Seiser, 2012). Nevertheless, the role of both 
modifications (phosphorylation of histone H3S10 or H3S28), that have both a positive 
and a negative role in chromatin condensation, is better understood in combination with 
other histone marks within a particular chromatin context (Cerutti and Casas-Mollano, 
2009). For example, since many methylated lysine residues of histone H3 are adjacent 
to residues suitable to be phosphorylated, a “phospho-methyl switch” has been 
suggested as a mechanism to control the association of proteins with chromatin in 
various biological processes: during mitosis and during gene transcription regulation 
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(Arita et al., 2012; Fischle et al., 2003a; Gehani et al., 2010; Kim et al., 2012b; Varier 
et al., 2010). In mammals, for example, the amino-terminal chromodomain of 
heterochromatin protein 1 (HP1) interacts with tri-methylated Lys9 of histone H3 
during interphase, mediating heterochromatin formation. Phosphorylation of the 
adjacent Ser10 during mitosis abrogates the binding of HP1 to methylated Lys9 
(Fischle et al., 2005), and dephosphorylation of H3S10 at the end of mitosis re-
establishes the association of HP1 with chromatin, suggesting that this binary 
“phospho-methyl switching” permits dynamic control of the HP1–H3K9me interaction 
(Fischle et al., 2003a). By other hand, in mammals, Polycomb Repressive Complex 2 
(PRC2) di- and tri-methylates H3K27, and binds this mark in order to repress 
Polycomb group (PcG) target genes (Cao et al., 2002). Phosphorylation of the adjacent 
Ser28 residue by MSK1/2 kinases in response to mitogen, stress or differentiation 
signals displaces PcG proteins, leading to gene activation (Gehani et al., 2010). 
Since ROS1 does not bind H3 when Ser28 is phosphorylated even when other histone 
modifications are present in the same peptide, it may suggest that this modification 
could be excluding ROS1 from DNA during mitosis. Furthermore, in this thesis it has 
been proved that ROS1 C-terminal domain interacts with peptides containing any 
methylated state of H3K27, which is adjacent to Ser28. Then, it could be interesting to 
perform pull-down experiments using H3 peptides harboring both phosphorylation of 
H3S28 and methylation of H3K27 in order to investigate whether a similar “phospho-
methyl switch” mechanism described above for PRC2 or HP1 is probably happening 
with ROS1 enzyme. By other hand, phosphorylation at H3S10 might recruit ROS1 to 
specific regions in order to regulate gene expression through regulation of the 
methylation levels in response to certain stimuli, or to maintain unmethylated levels at 
the target genes, since hypermethylation of target genes in Arabidopsis ros1 dml2 dml3 
triple mutant did not usually affect gene expression (Penterman et al., 2007). In that 
way, it could be interesting to determine if ROS1 acts at regions that contain 
phosphorylated H3S10. For example, 14-3-3 proteins, which recognize phosphorylated 
H3, function as reader of histone code since they constituted a docking site for factors 
involved in transcriptional regulation during interphase, being excluded from mitotic 
chromosomes (Winter et al., 2008). 14–3–3 also binds to H3S28P-associated 
nucleosomes at immediate early genes (Drobic et al., 2010). 
Nevertheless, further analysis must be carried out in a chromatin context and in the 
presence of other histone marks to gain insight into the biological role of ROS1 
interaction with phosphorylated H3S10 or with methylated H3K27, and ROS1 
disruption by phosphorylated H3S28.  
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2.2. The C-terminal domain of DML family proteins: a new 
histone reader motif? 
In Chapter 2 of this thesis, several evidences show that ROS1 C-terminal domain is the 
main responsible for mediating ROS1 interaction with histones and their specific post-
translational modifications.  
Firstly, the N-terminal domain of ROS1 does not clearly interact with histone H3 
peptides, either unmodified or phosphorylated at Ser10 or Ser28, and up to date its 
function has been mainly related with DNA binding (Ponferrada-Marín et al., 2010; 
Ponferrada-Marín et al., 2012). Although the DNA glycosylase domain of ROS1 may 
modulate the interaction with the 1-21 region of unmodified H3, the C-terminal domain 
of ROS1 is the main responsible for ROS1 interaction with histone H3 and for specific 
discrimination between the region surrounding phosphorylated Ser10 or phosphorylated 
Ser28. In addition, the C-terminal domain of ROS1 is able to interact by itself with 
other H3 histone marks, such as methylation at Lys27, and with other core histones 
(H2A and H4). 
Secondly, analysis of several ROS1 mutant versions at different highly conserved 
residues of the C-terminal domain in DML family proteins (CR1286AA, YF1300AA 
and E1305Q) identified C1286, R1287, Y1300, F1301 and E1305 ROS1 residues as 
strong candidates for mediating phosphorylation-sensitive recognition of the region 
surrounding S28, reinforcing the finding that the C-terminal domain is the main 
responsible for ROS1 interaction with histone H3. Furthermore, residues Y1300, F1301 
and E1305 may take part in discrimination between H2B and the others core histones, 
since YF1300 and E1305 mutants are able to interact with H2B too. 
Thirdly, a region containing 4 Cys residues at ROS1 C-terminus may be a permuted 
version of a single unit of a ZF-CXXC domain (Long et al., 2013), which is found in a 
variety of chromatin-associated proteins (e.g. KMD2, DNMT1, MBD1, TET1/3) and 
binds non-methylated CpG. This putative ZF-CXXC separates the two C-terminal 
highly conserved regions among the members of DML family proteins, but they are not 
related to any known protein. The highest conserved region contains amino acids 
(C1286, R1287, Y1300, F1301 and E1305) important for ROS1 function in histone 
interaction and in DNA demethylation (see Section 2.3. Discussion).  
All these evidences suggest that ROS1 C-terminus may harbor more than one new 
histone reader motifs, or changed versions of already known motifs, since ROS1 is able 
to bind unmodified histones and, at least, phosphorylated and methylated marks, and 
each mark is usually recognized by defined motifs. Up to date, there are several histone 
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readers that interact with unmodified histone tails (PHD fingers, ADD and WD40 
modules), phosphorylated marks (14-3-3 proteins, tandem BRCT and BIR domains) or 
methylated marks (the Royal superfamily, ADD, ankyrin, BAH, DCD PHD, WD40, 
Zf-CW and Tudor domains) (Table 1). Furthermore, several proteins that interact with 
both DNA and histones or its epigenetics marks contain more than one histone reader 
domain. For example, UHRF1 contains a SRA (SET and RING-associated) domain, a 
PHD finger and a TTD histone binding domains, whereas DNMT3A and DNMT3B 
contain a cysteine-rich ADD motif and PWWP domains (Rothbart and Strahl, 2014). In 
addition, whether ROS1 contains a putative histone writer or eraser domain, or whether 
ROS1 is able to interact with histone modifiers could not be rule out. For example, 
TET2 protein is able to recruit O-linked B-N-acetylglucosamine (O-GlcNAc) 
transferase (OGT), which promotes O-GlcNAcylation of histone H2B, to regulate gene 
transcription (Chen et al., 2013b). 
Importantly, experiments in this thesis have been carried out using a plant DNA 
glycosylase expressed in bacteria, so possible post-translational modifications in ROS1 
that could be performed into the plant cell environment are not being considered. If 
ROS1 suffers these post-translational changes, such as phosphorylation, especially on 
critical residues of its putative histone reader motif(s), it could cause conformational 
changes that could be important for mediating histone interaction. For example, a study 
showed that phosphorylation of the chromodomain of mammalian Cbx2 Polycomb 
protein at a specific Ser residue changes its binding specificity for methylated H3, 
becoming more specific for H3K27me3 than H3K9me3 (Hatano et al., 2010). 
Nevertheless, further molecular and structural studies, such as site-directed mutagenesis 
of other conserved residues and crystallization of ROS1 C-terminal domain bound to 
different histone peptides, would help to obtained more information about the putative 
histone reader motif(s) of ROS1. 
2.3. Deciphering ROS1 C-terminal domain functions 
Results obtain in this thesis provide new insights about the putative functions of the 
highly conserved ROS1 C-terminal domain. Apart from its critical role in histone 
interaction, ROS1 C-terminus mutated residues (C1286, R1287, Y1300, F1301 and 
E1305) are required for efficient ROS1 catalytic activity, corroborating the recent 
observation that the C-terminal domain of DML family proteins is necessary for 5-meC 
excision (Hong et al., 2014; Mok et al., 2010). On one hand, the isolated DNA 
glycosylase domain of ROS1 was not able to excise 5-meC but cleaved partially the 
sugar phosphate backbone (Hong et al., 2014) and, as expected, the isolated C-terminal 
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domain was not able to process 5-meC (Ponferrada-Marín et al., 2010). The addition of 
the C-terminal domain restored the 5-meC excision activity of the enzyme (Hong et al., 
2014). On the other hand, a small deletion at DME C-terminus (51 amino acids) was 
enough to completely abolish the glycosylase activity when combined with an active 
truncated version lacking 677 amino acids of the N-terminus (Mok et al., 2010).  
In addition, ROS1 C-terminus may play a role in ROS1 DNA binding, since E1305 
residue is essential to form a DNA-protein complex and at least two of the other 
mutated residues (C1286, R1287, Y1300 or F1301) contribute to stabilize it. A 
previous study showed that the truncated ROS1 version containing only the C-terminal 
domain (NΔ1080) was able by itself to bind a methylated DNA, but with very low 
affinity, and a truncated version containing only the discontinuous catalytic domain of 
ROS1 (therefore lacking both the C-terminal domain and the major responsible domain 
for ROS1 DNA binding, the N-terminal domain), did not exhibit any detectable DNA 
binding capacity (Ponferrada-Marín et al., 2010), demonstrating that the C-terminal 
domain of ROS1 is somehow involved in DNA binding. 
Since ROS1 C-terminal domain is the main responsible for interaction with histones 
and it is also required for the catalytic activity and DNA binding capacity of the 
enzyme, it was studied whether ROS1 DNA demethylase activity is somehow regulated 
by its interaction with histones and its specific marks to act at specific loci. For 
example, a study showed that an unmodified version of a histone H3 peptide 
significantly stimulated the enzymatic activity of DNMT3A in vitro, but it was not 
observed with a version containing tri-methylated Lys4 (Guo et al., 2015). DNMT3A 
recognized unmethylated histone H3 through its ATRX–DNMT3–DNMT3L (ADD) 
domain, which interacted with the catalytic domain (CD) and blocked its DNA-binding 
affinity, inhibiting the enzymatic activity. Unmodified histone H3, but not 
trimethylation at Lys4, disrupted ADD–CD interaction by inducing a large movement 
of the ADD domain, allowing DNMT3A to methylate DNA. This is a way to ensure 
that the enzyme acts at proper targeting loci when unmethylated H3K4 is present, and 
not H3K4me3, which correlates with low DNA methylation levels and activation of 
transcription. By contrast, ROS1 interaction with different histone peptides (such as 
unmodified H3 or H3S10P) does not alter its capacity to process 5-meC, indicating that 
the putative histone reader motif(s) present in its C-terminal domain does not inhibit or 
enhance the enzymatic activity on methylated DNA. Further studies into a chromatin 
environment would provide new data of how ROS1 activity is directed to specific loci. 
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3. Targeted DNA demethylation by fusing ROS1 
catalytic domain to different DNA binding domains 
Epigenetic Editing is being increasingly used as an useful approach to determine 
functional domains within epigenetic enzymes, and to investigate the effect of edited 
epigenetic marks, gaining insight into chromatin functioning and gene regulation. 
Furthermore, Epigenetic Editing could become a promising therapeutic tool to deal 
with diseases related with an epigenetic deregulation, such as cancer (de Groote et al., 
2012). 
Up to date, a number of reported studies have used different natural or engineered 
DBDs and mammalian enzymes as EDs (de Groote et al., 2012). However, no efforts 
have been reported on expressing and targeting plant demethylases enzymes in 
mammalian cells. In Chapter 3 of this thesis, the catalytic domain of Arabidopsis 
thaliana ROS1 has been fused to different DBDs (GBD, engineered ZFPs and the 
CRISPR/dCas9 system) to test whether it is possible to direct its activity to specific 
sequences located into methylated oligonucleotides in vitro, and/or into a methylated 
endogenous target or luciferase reporter plasmid in human cells.  
3.1. Functional properties of GBD-ROS1_CD and 6F6-
ROS1_CD in vitro 
The DNA binding and enzymatic activity assays performed in vitro with purified GBD-
ROS1_CD and 6F6-ROS1_CD recombinant proteins demonstrate that replacing the N-
terminal domain of Arabidopsis thaliana ROS1 protein by a specific DBD does not 
abolish ROS1 activity on methylated substrates, and suggest that it may be possible to 
direct ROS1_CD activity to a specific sequence when fused to either a natural (GBD) 
or an artificial DBD (6F6 ZFP) at determined conditions.  
The in vitro binding properties of 6F6-ROS1_CD and GBD-ROS1_CD are clearly 
different. 6F6-ROS1_CD binds specifically and with strong affinity to a DNA 
containing the ZF binding site, whereas no binding is detected to a non-targeted 
substrate. In contrast, low concentrations of GBD-ROS1_CD fusion protein binds with 
higher affinity to a targeted substrate than to a non-targeted DNA, whereas at high 
concentrations the protein binds both types of DNA. These differences could be 
explained by the fact that GBD is a natural DBD from yeast Gal4 that belongs to a class 
of ZFP that contains a Cys6-zinc cluster motif (also known as Zn2Cys6-binuclear 
cluster) (Pan and Coleman, 1990), whereas 6F6 is an artificial engineered ZFP that 
contains 6 Cys2His2 ZFs modules joined by linkers (Papworth et al., 2003). Natural 
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transcription factors (such as Gal4) are expected to bind non-specifically to DNA while 
searching for its target site among an enormous amount of non-specific sites, whereas 
artificial transcription factors containing multiple ZFPs show a high stability of the 
specific complex with the target site (Iwahara and Levy, 2013). Furthermore, a study 
showed that GBD was able to recognizes a variety of UAS sequences that adjust to the 
general formula (A/C)GGN10-12CCG and that DNA-binding specificity is more 
stringent in vivo than in vitro (Vashee et al., 1993). 
Contrary to expectations, GBD-ROS1_CD and 6F6-ROS1_CD display detectable 
enzymatic activity on a substrate lacking the UAS site and on a DNA containing a 
mutated 6F6 target site, respectively, even though no protein–DNA complexes are 
observed in EMSAs in these conditions. However, it should be noted that salt 
concentration used in EMSAs was higher than in activity assays (250 mM NaCl 
opposite 50 or 100 mM NaCl, respectively). Both enzymes did not show activity in the 
presence of more than 150 mM NaCl (data not shown), and no binding reactions could 
be carried out at salt concentrations lower than 250 mM NaCl. Therefore, less 
restrictive conditions in activity assays might favor some non-specific binding, leading 
to 5-meC processing in non-targeted substrates.  
By other hand, results obtained in vitro with both recombinant proteins indicate that 
they are more efficiently targeted to methylated sites that are closer to the DNA 
sequence recognized by the DBD, although this behavior is modulated by salt 
concentration. These observations suggest that a way to modulate that the ED reach its 
target site is by separating the DBD and the ED by a linker sequence that provides 
flexibility between the two domains of the fusion protein and confers mobility to the 
ED in the fusion protein once the DBD specifically and strongly binds its recognition 
site. Several studies with nucleases fused to ZFPs demonstrate that the presence of a 
flexible linker (usually rich in Gly-Ser residues) and its length are critical in 
determination of the efficiency and the range of cleavage (Alwin et al., 2005; Bibikova 
et al., 2001; Kim et al., 1997). The importance of the linker sequence between the two 
components of a fusion enzyme has been demonstrated in other study using M.HhaI 
and M.HpaII DNA methyltransferases fused to a 3 ZFP (de Groote et al., 2012; 
McNamara et al., 2002). The region that separates the DBD and the catalytic domain of 
ROS1 in both GBD-ROS1_CD and 6F6-ROS1_CD is large (225 amino acids), and 
corresponds to a non-conserved region among DML proteins that is predicted to have a 
non-structured, and therefore flexible, conformation. However, it could be interesting to 
replace this fragment by alternative linker regions with augmented flexibility, and to 
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study their effects on DNA binding and catalytic activity of the resultant fusion 
proteins.  
3.2. Targeting ROS1 demethylase activity in human cells 
through DNA-protein interactions 
The results obtained in this thesis show that transient expression of GBD-ROS1_CD in 
HEK293 cells significantly increased the luciferase activity of a methylated 5xUAS-
TK-Luc reporter gene by 2.6-fold. Furthermore, both ROS1_CD catalytic activity and 
specific binding by GBD are necessary to achieve such targeted gene activation.  
Expression of GBD-ROS1_CD increased levels of luciferase transcripts compared to 
control transfections, but in quantities that could not be statistically considered as 
significant. Thus, luciferase activity increased by GBD-ROS1_CD only partially 
correlated with mRNA levels of the reporter gene. This partial correlation could be due 
to differences in stability between luciferase mRNA and protein. It remains to be tested 
whether a higher induction of luciferase mRNA levels may be detectable at earlier time 
points. 
An important result obtained in this thesis is that HEK293 cells that transiently express 
GBD-ROS1_CD, but not cells expressing a catalytically inactive mutant version, show 
a reduction in methylation levels at several CpG sites in the 5xUAS-TK region. This 
strongly suggests that the significant increase in luciferase activity induced by GBD-
ROS1_CD was directly caused by its targeted DNA demethylase activity. Several 
studies have previously suggested that partial changes in methylation might be 
sufficient to induce gene expression reactivation, emphasizing the potential of DNA 
demethylation for modulation of gene expression. For example, TDG fused to the 
Nuclear Factor kB (NF-kB) DNA binding domain caused a 5-10% reduction in 
methylation levels at the target CpG sites, leading to a 3-fold increase induction of gene 
expression in 3T3 cells (Gregory et al., 2013). Furthermore, TET2 fused to a ZFP 
(CD54) that binds ICAM-1 promoter, partially demethylates the CpG sites in the 
surrounding region of the ZF binding site in A2780 cells, leading to a 2-fold increase in 
gene expression (Chen et al., 2013a). Conversely, there are also evidences showing that 
increasing methylation of a single CpG site can be sufficient to repress gene expression 
(Pogribny et al., 2000).  
In contrast to the results obtained with GBD-ROS1_CD, no reactivation of the 
methylation-silenced reporter gene was detected in HEK293 cells that transiently 
expressed ZFP-ROS1_CD proteins. Lack of reactivation by ZFP-proteins in 
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comparison to GBD-proteins could be related to their higher DNA binding specificity, 
as shown the in vitro results obtained in this thesis with purified 6F6-ROS1_CD and 
GBD-ROS1_CD proteins (see Section 3.1. Discussion). Furthermore, although multiple 
ZFs allow higher DNA specificity, they require extensive contacts with DNA that may 
slow the target search process (Iwahara and Levy, 2013) and perhaps may also limit the 
capacity of the fused ROS1_CD to excise 5-meC. However, decreasing the number of 
ZF (as in B1-ROS1) did not resulted in detectable reactivation, even though B1 (a 
three-ZFP) has a higher koff than 6F6 (Papworth et al., 2003). By contrast, a study that 
fused these 6F6 or B1 ZFPs to the catalytic domain of DNMT3A showed a decrease in 
luciferase activity that were similar in HEK293T cells that transiently expressed either 
6F6-DNMT3A or B1-DNMT3A (Li et al., 2007d), but B1-DNMT3A protein increased 
the methylation levels of IE175k promoter to a greater extent than 6F6-DNMT3A 
protein (Li et al., 2007d). Nevertheless, it has to be considered that in Li et al.’s study, 
effects in DNA methylation levels and luciferase activity were analyzed 4 days after 
cell co-transfection, whereas in this thesis the luciferase reporter assay was performed 2 
days after cell co-transfection. Therefore, longer time incubations might be needed to 
observe an increment on luciferase activity mediated by 6F6- or B1-ROS1 proteins in 
HEK293 cells.  
By other hand, other types of ZFPs previously used with other EDs, at least with partial 
success (Chen et al., 2013a), such as those used in the experiments with the endogenous 
targets (CD54 targeting ICAM-1 promoter and ZF2 targeting RASSF1A promoter) in 
different human cancer cells (A2780 and MCF7, respectively), were also unable to 
target ROS1 activity. Nevertheless, it should be remarked that in these experiments the 
low transfection efficiencies (<1%-10%) could also explain why targeted DNA 
demethylation is not detected, since large transgene sizes (ROS1_CCD is ∼2100 bp) 
might difficult efficient production of viral particles and integration into the host 
genome (Chen et al., 2013a). Then, cells expressing ZFP-ROS1_CCD might be poorly 
represented in comparison with non-transduced cells. 
In addition, it should be also remembered that GBD is a natural domain whereas the 
ZFPs used are engineered domains that might fold improperly in vivo in human cells.  
In conclusion, further studies are required to decide whether engineered ZFPs are 
appropriate DBDs to be used in combination with ROS1 for targeted demethylation 
(see Section 3.4. Discussion). In that way, it could be interesting to test whether 
inhibition of HDACs could promote up-regulation of genes targeted by ZFP-ROS1, 
since there are several evidences that show that effects of targeting DNA demethylases 
are further improved in the presence of HDACs inhibitors, such as TSA. On one hand, 
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in this thesis it has been shown that TSA treatment enhanced by 2.4-fold the increase in 
luciferase activity after transitory expression of GBD-ROS1_CD protein in HEK293 
cells without altering DNA methylation levels. By other hand, a recent study that fused 
the catalytic domain of TET2 or TDG to ZFPs targeting EPB41L3 gene showed a 
significant reactivation of up to 2.7-fold of the target gene after expression of the fusion 
protein in CaSki cervical cancer cells, but only in the presence of TSA, whereas no-
reactivation was observed in the absence of TSA relative to the empty vector (Huisman 
et al., 2015).  
3.3. Targeting ROS1 demethylase activity in human cells 
through DNA-RNA interactions 
Apart from ZFPs, the CRISPR/Cas9 system may be used as a potent tool for Epigenetic 
Editing when fusing the chosen ED to a dead (inactive) Cas9 nuclease (dCas9). Unlike 
ZFPs, this system involves DNA-RNA interactions, instead of DNA-protein 
interactions. Furthermore, it uses a single protein whose specificity is changed by 
simply altering the sgRNA. 
In this thesis, a first strategy used a single plasmid to express both dCas9-ED and 
sgRNA. This approach partially reactivates the silenced reporter gene when using the 
transcriptional activator VP64 as ED, but not when using ROS1_CD. Expression of 
dCas9-ROS1_CD was indirectly detected by fluorescence when fused to a self-cleaved-
2A-eGFP polypepttide. However, it cannot be ruled out that dCas9-ROS1_CD is 
expressed at insufficient levels since, unlike dCas9-VP64, it was undetectable by 
western-blot. By other hand, only 2 different sgRNAs were tested using this approach, 
and it is possible that they are competent in guiding dCas9-VP64 but not dCas9-
ROS1_CD. It has been previously described that different sgRNAs are required for 
efficient targeting of different dCas9-EDs to the same sequence (Perez-Pinera et al., 
2013a). Thus, although this first strategy offers the advantage of employing the 
minimal number of plasmids for co-transfections and ensures that both dCas9-ED 
fusion protein and the sgRNA enter and express into the same cell, its main 
disadvantage is that only one sgRNA is expressed and it is not possible to study the 
effect of combined sgRNAs.  
A second strategy used separate plasmids to express dCas9-ED and sgRNA, in order to 
perform co-transfections with different combinations of effectors and/or guide RNAs. 
Additionally, this approach allowed testing a higher number of different sgRNAs. 
Again, reactivation of the silenced reporter gene is achieved by dCas9-VP64 guided by 
a specific sgRNA (sgRNA TK 3, which binds -218 to -199 bp from the start codon in 
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the TK-Luc reporter plasmid). VP64 is composed by four tandem copies of VP16, and 
VP16 complex could bring strong activity from a proximal position (Hagmann et al., 
1997). Several studies report that engineered transcription activators (such as TALE-
VP64 or dCas9-VP64) show high activity when targeted to the proximal promoter (Hu 
et al., 2014; Maeder et al., 2013b; Perez-Pinera et al., 2013a). For example, individual 
sgRNAs targeting mouse and human OCT4 promoters around the -147 to -89 bp region, 
but no sgRNAs targeting regions from -87 to -14 bp (closer to the TSS), could 
effectively up-regulate the corresponding luciferase reporter genes in the presence of 
dCas9-VP64 (Hu et al., 2014), so the target position greatly influence the activity of 
dCas9-VP64. Apart from the TSS proximity and/or the “chromatin context”, the use of 
highly optimal sgRNAs (Doench et al., 2014) is a relevant factor to the function of 
dCas9-ED fusion proteins (Hilton et al., 2015).  
In addition, such reactivation achieved by dCas9-VP64 is higher when combining 
specific sgRNAs. Several studies have also reported a synergistic effect on the 
expression of the target gene of dCas9-VP64 by using certain combinations of sgRNAs 
(Hu et al., 2014; Maeder et al., 2013b; Perez-Pinera et al., 2013a). By contrast, the 
p300_core effector domain fused to dCas9 did not display similar synergy with 
additional gRNAs, which was able to robustly activate gene expression through an 
individual sgRNA at promoters and characterized enhancers (Hilton et al., 2015). In 
addition, a recent study testing dCas9 fused to TET1_CD did not show additive or 
synergistic effects when using combined sgRNAs targeting RANKL or MAGEB2 genes 
in HEK293FT cells (Xu et al., 2016). Those reported results could be explained by the 
difference between the transcriptional activator (VP64), which recruits multiple 
transcriptional components, such as TATA-binding protein (TBP), TFIIB, and the 
SAGA histone acetylase complex (Hall and Struhl, 2002), and both epigenetic 
enzymes: p300, which is an histone acetyltransferase (Ogryzko et al., 1996), and TET1, 
which mediates indirect active DNA demethylation through oxidation of 5-meC (Ito et 
al., 2010). However, in this thesis, no reactivation of the silenced reporter gene is 
observed with dCas9-ROS1_CD, regardless of the sgRNA combination used. 
Interestingly, co-expression of dCas9-ROS1_CD decreases the reactivation induced by 
dCas9-VP64, and a similar effect is observed with a catalytically inactive mutant 
version (dCas9-ROS1_CDmut). However, untargeted ROS1 versions do not inhibit 
dCas9-VP64 activity. One possibility is that dCas9-ROS1_CD is indeed being targeted 
to the TK promoter, competing with dCas9-VP64, but either its levels are too low or it 
is unable to initiate demethylation, as shown bisulfite pyrosequencing results. By 
contrast, there are evidences indicating that the simultaneously use of engineered 
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transcription activators and epigenetic modifiers produce a more efficient gene 
modulation. For example, non-targeted p300 histone acetyltransferase significantly 
enhanced the activation of OCT4 genes induced by dCas9-VP64 (an also TALE-VP64) 
(Hu et al., 2014). However, no synergistic effect was reported for targeted dCas9-
p300_core in combination with dCas9-VP64 (Hilton et al., 2015). 
An important observation of this thesis is that reactivation induced by targeting dCas9-
VP64 took place without changes in DNA methylation. Similarly, it has been reported 
that transient transfection of combined TALE-VP64 targeting the endogenous OCT4 
promoter in HEK293 cells caused up-regulation of transcription but it did not alter the 
hypermethylated status of promoter (Hu et al., 2014). By contrast, other reports 
observed demethylation at the targeted regions together with transcriptional up-
regulation of target genes in different human cancer cells expressing VP64 fused to 
ZFPs (Beltran and Blancafort, 2011; Chen et al., 2013a; Huisman et al., 2013). They 
suggested that this demethylation is a result of a passive mechanism consequential to 
the recruitment of the RNA Pol II transcriptional complex to the target promoter 
(Beltran and Blancafort, 2011), or it might be reflect inaccessibility of the DNA or 
competition with DNMT1, due to steric hindrance by ZF binding when the fusion 
protein is expressed at high levels (Chen et al., 2013a).  In addition, the absence of 
changes in DNA methylation levels when targeting dCas-VP64 suggests that such 
reactivation is very likely to be temporary, and would require constant expression of the 
VP64 effector for persistent expression of the targeted gene. Nevertheless, for the long 
term, whether artificial transcription factors induced heritability effects might not be 
expected as no enzymatic activity is targeted (Huisman et al., 2013). For this reason, 
targeting epigenetic modifiers would lead to heritable effects during mitotic divisions. 
A recent study showed that transfection of dCas9-DNMT3A fusion protein targeted to 
endogenous BACH2 gene into HEK293 cells rapidly increase its methylation levels at 
the first 7 days, then slowly decrease in the following 10 to 15 days, but a low basically 
unchanging level of increased methylation was detected in the days 20 to 42 after 
transfection, even though the expression of dCas9-DNMT3A was no detectable by day 
10 (Vojta et al., 2016). 
3.4. Possible future improvements for targeting ROS1 
demethylase activity 
Further studies are needed to try to direct ROS1 demethylase activity to specific 
sequences into human cells by fusing its catalytic domain to a more universal DBD 
(such as ZFP or the CRISPR/dCas9 system) in order to efficiently demethylate DNA to 
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regulate transcription of desired genes, such as tumor suppressor genes, which are 
usually hypermethylated in human cancer cells (Esteller, 2007).  
For example, fusing to ROS1 a protein (dCas9) that is larger in size than 
ROS1_CD/CCD itself might interfere with ROS1 5-meC glycosylase activity, perhaps 
by improper protein folding. Using other SpdCas9 orthologs from other species, such as 
Cas9 from Staphylococcus aureus, which is 25% shorter (> 1 kb), but has similar 
editing capabilities to the SpCas9 (Ran et al., 2015), would overcome this putative 
problem. In addition, an atypical plant demethylase such as ROS1_CD might need 
codon optimization for efficiently working into human cells. In that way, using a 
flexible linker between a smaller dCas9 and a codon-optimized ROS1_CD could 
positively contribute to develop a functional targeted DNA demethylase from plants. 
Another possibility that could help to effectively achieve targeted DNA demethylation 
by ROS1_CD using the CRISPR/dCas9 system would be by engineering the sgRNA. 
The plasticity in sgRNA has allowed the insertion of additional RNA elements to form 
the sgRNA2.0 system (Konermann et al., 2015), in which such RNA elements are 
recognized by some RNA-specific binding protein effectors, potentially increasing the 
efficacy of the CRISPR/dCas9 system. For example, a recent study achieved targeted 
DNA demethylation and up-regulation of specific genomic loci by fusing TET1_CD 
both to MS2 RNA element-containing sgRNA2.0 system-guided dCas9 and MS2 
bacteriophage coat protein (Xu et al., 2016). 
Not only the size of the DBD, but also the location of its binding site would be 
important for achieving a change in methylation levels and gene expression mediated 
by a targeted ROS1 protein. Unlike VP64, which is a transcriptional activator that 
recruits multiple transcriptional components (Hall and Struhl, 2002), thus acting in the 
proximal promoter, it is probably that targeted DNA demethylation of regions upstream 
the desired promoter, and not only into the promoter itself, could be necessary to occur 
in order to produce an up-regulation of the target gene mediated by ROS1 demethylase 
activity, as shown with GBD-ROS1_CD, which binds five UASs located upstream the 
TK promoter. !
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1. Three predicted helix-invading residues of ROS1 (Q607, M905 and R903) are 
required for destabilization of 5-meC:G base pairs and 5-meC excision, but are 
dispensable for the AP lyase activity of the enzyme. 
2. ROS1 uses these three residues to actively interrogate DNA in search of 5-
meC. 
3. During such interrogation, Q607 restrains ROS1 sliding on DNA. 
4. ROS1 interacts with N-tails of H2A, H3 and H4 core histones through its C-
terminal domain. 
5. Phosphorylation of Ser28, but not Ser10, specifically inhibits ROS1 interaction 
with histone H3. 
6. Conserved residues at ROS1 C-terminus are involved in histone recognition 
and play an essential role in ROS1 DNA glycosylase activity and DNA binding 
capacity. 
7. Recombinant ROS1 fused to either the natural GAL4 DNA Binding Domain 
(GBD-ROS1) or an engineered zinc finger protein (ZFP-ROS1) displays 
preferential DNA binding and enzymatic activity on specific sequences in 
vitro. 
8. Transient expression of GBD-ROS1 in human cells elicits targeted 
demethylation and reactivation of a methylation-silenced reporter gene. 
9. Reactivation of a silenced reporter gene is achieved after transient expression 
of an RNA-guided CRISPR system based on dCas9 protein fused to the 
transcriptional activator VP64. 
10. Such up-regulation occurs without altering DNA methylation levels of the 
targeted promoter and is higher when using specific combinations of sgRNAs 
than when using individual sgRNAs. 
 !
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1. Homology-based modeling and sequence alignments 
A multiple sequence alignment of DML proteins and several members of the HhH-
GPD superfamily was generated using the program T-Coffee (Poirot et al., 2003), and 
was viewed, adjusted and refined manually with Jalview (Clamp et al., 2004). A 3D 
model structure of the two aligned regions from Arabidopsis ROS1 (amino acids 567–
625 and 883–1062) was built by using Swiss-Model (Schwede et al., 2003) and the 3D 
structure of Bacillus stearothermophilus Endonuclease III as a template [Protein Data 
Bank accession code: 1P59, (Fromme and Verdine, 2003)]. Nucleic acid coordinates 
extracted from 1P59 were used to superimpose a DNA structure with a flipped-out 
abasic (AP) site analog onto the ROS1 model. The structural figures were prepared 
with PyMOL (http://www.pymol.org). Protein structural disorder predictions were 
performed with VL3H [http://www.ist.temple.edu/disprot/Predictors.html (Peng et al., 
2005)]. 
A multiple sequence alignment of the C-terminal domain of several DML family 
proteins was performed with the Clustal W algorithm of Align X (Vector NTI Suite, 
version 11.0, Invitrogen). 
 
2. Protein expression and purification in E. coli 
2.1. WT ROS1 and mutant versions (Q607A, R903A, M905G, 
CR1286AA, YF1300AA and E1305Q) 
Site-directed mutagenesis was performed using the Quick-Change II XL kit 
(Stratagene). The mutations were introduced into the expression vector pET28a 
(Novagen) containing the full-length wild-type (WT) ROS1 cDNA using specific 
oligonucleotides (Table 2). Mutational changes were confirmed by DNA sequencing 
and the constructs were used to transform Escherichia coli BL21 (DE3) dcm− Codon 
Plus cells (Stratagene). WT and mutant versions were expressed and purified as N-
terminal His-tagged proteins, as follows: a fresh single transformant colony was 
inoculated into 10 ml of LB (Luria-Bertani) medium containing kanamycin (30 µg/ml) 
and chloramphenicol (34 µg/ml), and the culture was incubated at 37°C overnight with 
shaking. A 2.5 ml aliquot of the overnight culture was inoculated into 250 ml of LB 
medium containing kanamycin (30 µg/ml) and chloramphenicol (34 µg/ml) and 
incubated at 37°C, 250 rpm, until the A600 was 0.1. The culture was then placed at 
23°C, and incubation continued at 250 rpm for 90 min before adding 5 mM betaine, 5 
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mM Na-glutamate and 0.5 M NaCl. When the A600 reached 0.7, expression was 
induced by adding isopropyl-1-thio-β-D-galactopyranoside (IPTG) to 1 mM and 
incubating for 2 h. After induction, cells were collected by centrifugation at 13000 g 
for 30 min, and the pellet was kept frozen at –80°C. The stored pellet was thawed and 
resuspended in 3.5 ml of Sonication Buffer (SB: 20 mM Tris–HCl pH 8.0, 500 mM 
NaCl, 20% glycerol, 15 mM β-mercaptoethanol, 1% Tween-20) supplemented with 5 
mM imidazole. Cells were disrupted by sonication and the lysate was clarified by 
centrifugation. The supernatant was loaded onto a Ni2+-sepharose column (GE 
Healthcare) pre-equilibrated with SB buffer supplemented with 5 mM imidazole. The 
column was washed with 10 ml of SB supplemented with 5 mM imidazole, followed by 
10 ml of SB supplemented with 100 mM imidazole. Proteins were eluted with a 30 ml 
gradient of imidazole (100 mM to 1 M) in SB and collected in 0.5 ml fractions. An 
aliquot of each fraction was analysed by SDS–PAGE and those containing a single 
band of the overexpressed protein were pooled and dialysed against Dialysis Buffer 
(DB: 50 mM Tris–HCl pH 8.0, 1 mM DTT, 50% glycerol) containing either 500 mM 
NaCl (for standard enzymatic assays) or 200 mM NaCl (for pull-down assays). The 
protein preparation was divided into aliquots, and stored at –80°C. All steps were 
carried out at 4°C or on ice. Protein concentrations were determined by the Bradford 
assay (Bradford, 1976). Denatured proteins were analysed by SDS–PAGE (10%) using 
broad-range molecular weight standards (Bio-Rad). 
Table 2.  Oligonucleotides used as primers for generation of ROS1 mutant variants. 
Name Sequence (5’-3’)a 
ROS1Q607A-F GGAGTATTTCTCACTGCAAATGTTTCAGACCATCTCTCAAG 
ROS1Q607A-R CTTGAGAGATGGTCTGAAACATTTGCAGTGAGAAATACTCC 
ROS1R903A-F ACAATCAAGAGTGCCGGGATGAACCATAAACTTGCAGAACG 
ROS1R903A-R CGTTCTGCAAGTTTATGGTTCATCCCGGCACTCTTGATTGT 
ROS1M905G-F ACAATCAAGAGTCGCGGGGGGAACCATAAACTTGCAGAACG 
ROS1M905G-R CGTTCTGCAAGTTTATGGTTCCCCCCGCGACTCTTGATTGT 
ROS1CR1286AA-F GAGGGACAATTTTGATTCCTGCTGCAACAGCGATGAGGGGTAG 
ROS1CR1286AA-R CTACCCCTCATCGCTGTTGCAGCAGGAATCAAAATTGTCCCTC 
ROS1YF1300AA-F CCTCTAAATGGAACGGCCGCTCAAGTAAATGAGGTGTTTGCG 
ROS1YF1300AA-R CGCAAACACCTCATTTACTTGAGCGGCCGTTCCATTTAGAGG 
ROS1E1305Q-F CTTTCAAGTAAATCAGGTGTTTGCGGATCATGCATCCAG 
ROS1E1305Q-R CTGGATGCATGATCCGCAAACACCTGATTTACTTGAAAG 
aUnderlining indicates the mutagenized codon. 
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2.2. ROS1 truncated versions (NΔ294, NΔ88CΔ1075, NΔ1080 
and NΔ519CΔ313) 
ROS1 deletion constructs (Ponferrada-Marín et al., 2010) were expressed and purified 
as N-terminal His-tagged proteins, as described above (Section 2.1), except that 
expression was induced by adding IPTG to 1 mM and performed at 15°C overnight. 
Pooled pure fractions were dialysed against DB containing 200 mM NaCl. 
2.3. GBD-ROS1_CD and 6F6-ROS1_CD recombinant fusion 
proteins 
The pET28c-ROS1NΔ294 plasmid (encoding His6-ROS1_CD) was used as a 
backbone. To obtain the construct expressing His6-GBD-ROS1_CD, a fragment 
containing Gal4 DNA Binding Domain (GBD, 1-147 amino acids), a c-myc tag and a 
nuclear localization signal (NLS, PKKKKRK), was amplified by PCR from 
pcDNA3.1-GBD [kindly provided by Albert Jeltsch (Li et al., 2007d)], using primers 
with NheI and EcoRI restriction sites (Table 3). To obtain the construct expressing 
His6-6F6-ROS1_CD, a fragment containing the 6F6 zinc finger protein and a nuclear 
localization signal (NLS, PKKKRKV), was amplified by PCR from p6F6-KOX1-TR 
[kindly provided by Peter O´Hare, (Papworth et al., 2003)] using primers with NheI 
restriction sites (Table 3). The PCR products, generated by Velocity DNA polymerase 
(Bioline), were digested, subcloned into pET28c-ROS1NΔ294 (between the His6-tag 
and ROS1_CD) and verified by DNA sequencing. 
Table 3.  Oligonucleotides used as primers for generation of His6-GBD-ROS1_CD and 
His6-6F6-ROS1_CD recombinant fusion proteins. 
Name Sequence (5’-3’)a 
Fwd-NheI-GBD ATTCGCTAGCATGAAGCTACTGTCTTCTATC 
Rev-GBD-EcoRI TTTTGAATTCCCTTTCTCTTCTTCTTTTTTGGC 
NheI-6F6-F TAGCTAGCATGGCAGAGGAACGCCCATATG 
6F6-NheI-R TTTTGAATTCCCTTTCTCTTCTTCTTTTTTGGC 
aUnderlining indicates the restriction enzyme site. 
The two recombinant fusion proteins were overexpressed and purified as N-terminal 
His-tagged proteins, essentially as described above (Section 2.1) but with some 
variations to optimize expression and purification:  
a) GBD-ROS1_CD protein expression was induced by adding 1 mM IPTG in the 
presence of 100 µM ZnSO4 and incubating at 15°C overnight. 
b) 6F6-ROS1_CD protein expression was induced by adding 1 mM IPTG in the 
presence of 100 µM ZnSO4 and incubating for 2 h at 23°C. However, 5 mM 
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betaine, 5 mM Na-glutamate and 0.5 M NaCl were not added 90 min before 
induction. 
c) When purifying both fusion proteins, the column was washed with 10 ml of SB 
supplemented with 5 mM imidazole, followed by 10 ml of SB supplemented 
with 60 mM imidazole, instead of 100 mM imidazole. 
d) For GBD-ROS1_CD purification, proteins were eluted with a 30 ml gradient of 
imidazole (60 mM to 200 mM) in SB. 
e) For 6F6-ROS1_CD purification, proteins were eluted with a 30 ml gradient of 
imidazole (60 mM to 1 M) in SB. 
 
3. DNA substrates 
Oligonucleotides used as DNA substrates in enzymatic assays (Table 4) were 
synthesized by Operon or Integrated DNA Technologies (IDT) and purified by 
polyacrylamide gel electrophoresis (PAGE) or dual HPLC before use.  
Double-stranded DNA substrates were prepared by mixing a 5-µM solution of a 5′-
fluorescein-labeled oligonucleotide (upper-strand) with a 10-µM solution of an 
unlabeled oligomer (lower-strand), heating to 95°C for 5 min and slowly cooling to 
room temperature.  
Annealing reactions for the preparation of the 1-nt gapped duplex were carried out at 
95°C for 5 min in the presence of a 2-fold molar excess of both unlabeled 5′-
phosphorylated oligonucleotide (P30_51) and unlabeled oligonucleotide (CGR) with 
respect to the 5′-alexa-labeled 3′-phosphorylated oligonucleotide (Al-28P), followed by 
cooling to room temperature.  
DNA containing a natural AP site opposite guanine was prepared by incubating a DNA 
duplex containing a U:G mispair (200 nM) with 2.5 U of Escherichia coli Uracil DNA 
glycosylase (NEB) at 30°C for 5 min.  
Substrates SL1, SL2 and SL1-2 contain the same tetraloop obstacle at either one or 
both molecule ends. All three substrates were obtained by annealing two 
oligonucleotides of different lengths. The strands were complementary at their ends, 
but the longer strand contained an additional interior stretch of 20 nucleotides that was 
designed to fold into the obstacle described in Figure 77 (Ponferrada-Marín et al., 
2012).  
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Table 4. Oligonucleotides used as substrates. 
Name DNA Sequencea Strand X= 
Length 
(bp) 
FL-CGF 
5´TCACGGGATCAATGTGTTCTTTCAGCTCXGGTC
ACGCTGACCAGGAATACC 3´ 
Upper C 51 
FL-
meCGF 
5’TCACGGGATCAATGTGTTCTTTCAGCTCXGGTC
ACGCTGACCAGGAATACC 3´ 
Upper 5-meC 51 
CGR 
3´AGTGCCCTAGTTACACAAGAAAGTCGAGXCCA
GTGCGACTGGTCCTTATGG 5´ 
Lower G 51 
CGR-A 
3´AGTGCCCTAGTTACACAAGAAAGTCGAGXCCA
GTGCGACTGGTCCTTATGG 5´ 
Lower A 51 
CGR-T 
3´AGTGCCCTAGTTACACAAGAAAGTCGAGXCCA
GTGCGACTGGTCCTTATGG 5´  
Lower T 51 
CGR-C 
3´AGTGCCCTAGTTACACAAGAAAGTCGAGXCCA
GTGCGACTGGTCCTTATGG 5´ 
Lower C 51 
Al-28P  5´TCACGGGATCAATGTGTTCTTTCAGCTC 3´ Upper - 28 
P30_51  5´GGTCACGCTGACCAGGAATACC 3´ Upper - 22 
FL-
meCGF61 
5´TCACGCGGGATCAATGTGTTCTTTCAGCTCXGG
TCACGCTGACCAGGAATACCTCACTACC 3´ 
Upper 5-meC 61 
CGR61 
3´AGTGCGCCCTAGTTACACAAGAAAGTCGAGXCC
AGTGCGACTGGTCCTTATGGAGTGATGG 5´ 
Lower G 61 
CGR61 
LOOP1 
3´AGTGCGCCCTAGTTACACAAGAAAGTCGAGXCC
AGTGCGACTGGTaggaatgcctgggaatgcccCCTTATGGA
GTGATGG 5´ 
Lower G 81 
CGR61 
LOOP2 
3´AGTGCGCCCTAGTTACaggaatgcctgggaatgcccACAA
GAAAGTCGAGGXCAGTGCGACTGGTCCTTATGGA
GTGATGG 5´ 
Lower C 81 
CGR61 
LOOP1-2 
3´AGTGCGCCCTAGTTACaggaatgcctgggaatgcccACAA
GAAAGTCGAGXCCAGTGCGACTGGTaggaatgcctggga
atgcccCCTTATGGAGTGATGG 5´ 
Lower G 101 
FL-6F6F 
5’TCAGGCTGGAAGTAAGATCGGGCGGTAATGAG
ATCATCXGGGACAGTCXGGTATCATCTA 3’ 
Upper 5-meC 60 
6F6R 
5’TAGATGATACCGGACTGTCCCGGATGATCTCAT
TACCGCCCGATCTTACTTCCAGCCTGA 3’ 
Lower 5-meC 60 
Fl-6F6F2 
5’TCAGGGATCGGGCGGTAATGAGATCTGGAAGTA
ACATCXGGGACAGTCXGGTATCATCTA 3’ 
Upper 5-meC 60 
6F6R2 
5’TAGATGATACCGGACTGTCCCGGATGTTACTTC
CAGATCTCATTACCGCCCGATCCCTGA 3’ 
Lower 5-meC 60 
FL-UASF 
5’CGCTCGGAGGACAGTACTCCGTCGGTCAGGCGG
TCATCXGGGACAGTCXGGTATCATCTA 3’ 
Upper 5-meC 60 
UASR 
5’TAGATGATACCGGACTGTCCCGGATGACCGCCT
GACCGACGGAGTACTGTCCTCCGAGCG 3’ 
Lower 5-meC 60 
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a Relevant regions are boxed. Lower case indicates the presence of an obstacle created in the 
DNA substrate. Underlining indicate target sites for GBD and 6F6 proteins. FL = Fluorescein; 
Al = Alexa 
 
Figure 77. Design of DNA substrates SL1, SL2 and SL1-2. Tertiary structure is shown 
schematically, indicating obstacle positions relative to the target residue location (marked by a 
lollipop). Secondary structure diagrams show the intended base pairing of the DNA substrates. 
Obstacles are created by a 6-bp DNA helix capped at both ends with tetraloops, which is 
connected to the DNA substrate via a four-way junction (see text for details and Table 4 for 
oligonucleotide sequences). Schematic diagrams are adapted from (Kampmann, 2004). 
 
4. Enzyme activity assays 
For DNA glycosylase/lyase activity assays, fluorescein- or alexa-labeled duplex 
oligonucleotides (20 nM, unless otherwise stated) were incubated at 30°C for the 
indicated times in a reaction mixture containing 50 mM Tris–HCl pH 8.0, 1 mM 
EDTA, 1 mM DTT, 0.1 mg/ml bovine serum albumin (BSA) and the indicated amounts 
of WT ROS1 or mutant variant in a total volume of 50 µl.  
In several instances this standard protocol was appropriately modified as follows. When 
reactions included AP endonuclease 1 (APE 1, 5 U; NEB), EDTA was omitted and 5 
mM MgCl2 was added. When measuring AP lyase activity, after reaction the mixture 
was incubated with 300 mM NaBH4 at 0°C for 30 min and neutralized with 100 mM 
Tris–HCl pH 7.4. When studying DNA glycosylase activity of GBD-ROS1_CD and 
6F6-ROS1_CD fusion proteins, EDTA was omitted, and 20 µM ZnSO4 and up to 100 
Fl-
Mu6F6F 
5’TCAGGCTGGAAGTAAGGTAGTGAGGTCAGGCG
GTCATCXGGGACAGTCXGGTATCATCTA 3’ 
Upper 5-meC 60 
Mu6F6R 
5’TAGATGATACCGGACTGTCCCGGATGACCGCCT
GACCTCACTACCTTACTTCCAGCCTGA 3’ 
Lower 5-meC 60 
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mM NaCl were added. When analyzing the effect of histone peptides on ROS1 
enzymatic activity, WT ROS1 (20 nM) was pre-incubated at 4°C for 2 h with the 
biotinylated peptides (200 nM) in a reaction mixture containing 50 mM Tris–HCl pH 
8.0, 1 mM EDTA, 1 mM DTT, 0.1% Tween-20, and 0.09 mg/ml BSA in a total volume 
of 50 µl. After pre-incubation, a double-stranded oligonucleotide substrate (20 nM) 
containing a 5-meC:G pair was added and samples were incubated at 30°C for 8 h. 
All reactions were stopped by adding 20 mM EDTA, 0.6% sodium dodecyl sulphate 
(SDS) and 0.5 mg/ml proteinase K, and the mixtures were incubated at 37°C for 30 
min. DNA was extracted with 1 volume of phenol:chloroform:isoamyl alcohol 
(25:24:1, Sigma) and precipitated with 3 volumes of ethanol absolute at −20°C in the 
presence of 0.3 mM NaCl and 16 µg/ml glycogen. Samples were resuspended in 10 µl 
of 90% formamide and heated at 95°C for 5 min. Reaction products were separated in a 
12% denaturing polyacrylamide gel containing 7 M urea. Fluorescein- or alexa-labeled 
DNA was visualized in a FLA-5100 imager and analyzed using Multigauge software 
(Fujifilm). 
 
5. Analysis of enzyme kinetic data 
ROS1 does not exhibit significant turnover in vitro owing to strong product binding 
(Ponferrada-Marín et al., 2010), and therefore a simple Michaelis–Menten model is 
inadequate for a correct kinetic analysis of this enzyme. The standard reaction 
conditions were equimolar (20 nM) enzyme/substrate ratios and incubation at 30°C. 
Data were fitted to the equation [Product] = Pmax[1 – exp(−kt)] using nonlinear regression 
analysis and the software Sigmaplot. For each mutant enzyme and substrate, the 
parameters Pmax (maximum substrate processing within an unlimited period of time), 
T50 (the time required to reach 50% of the product plateau level, Pmax) and the relative 
processing efficiency (Erel = Pmax/T50) were determined (Hardeland et al., 2000). A 
representative example of 5-meC DNA glycosylase assay and kinetic analysis is shown 
in Figure 31. 
 
6. Electrophoretic mobility shift assay (EMSA) 
In standard electrophoretic mobility shift assay reactions, increasing amounts of WT 
ROS1 or ROS1 variants were incubated with the indicated concentrations of 
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fluorescein- or alexa-labeled duplex oligonucleotides. Competition band-shift reactions 
were performed by pre-incubating 130 nM protein with 100 nM labeled probe at 25°C 
for 5 min and then adding increasing amounts of unlabeled duplex as competitor.  
DNA binding reactions were carried out at 25°C for 60 min, unless otherwise stated, in 
10 mM Tris–HCl, pH 8.0, 1 mM DTT, 10 µg/ml BSA, 1 mM EDTA, in a final volume 
of 10 µl. When studying DNA binding capacity of GBD-ROS1_CD and 6F6-
ROS1_CD fusion proteins, EDTA was omitted and 20 µM ZnSO4 was added.  
Complexes were electrophoresed through 0.2% agarose gels in 1X TAE (40 mM Tris–
HCl, pH 8.0, 20 mM acetic acid, 1 mM EDTA). Electrophoresis was carried out in 1X 
TAE for 40 min at 80 V at room temperature. When analyzing 6F6-ROS1_CD DNA 
binding capacity, complexes were electrophoresed through 8% non-denaturing 
polyacrylamide gels (acrylamide/bisacrylamide, 37.5:1) in 0.5X TBE (45 mM Tris, 45 
mM boric acid, 1 mM EDTA) for 55 min at 70 V at room temperature. Fluorescein- or 
alexa-labeled DNA was visualized in a FLA-5100 imager and analyzed using 
Multigauge software (Fujifilm). 
 
7. Binding of ROS1 to a histone peptide array 
The MODifiedTM Histone Peptide Array (Active Motif) was used to study the 
interaction of ROS1 with different histones tails and their post-translational 
modifications. The array consists of a glass slide (26x76 mm) with a cellulose 
membrane containing 19-mer peptides from eight different regions of the N-terminal 
tails of H3, H4, H2A and H2B histones (H3 1–19, 7–26, 16–35 and 26–45, H4 1–19 
and 11–30, H2A 1–19 and H2B 1–19). The peptides are covalently bound to cellulose 
via their C-terminus. The array contains 59 different post-translational modifications 
for histone acetylation, methylation, phosphorylation and/or citrullination. Each peptide 
may contain up to four modifications. In total, 384 different modification combinations 
are spotted in duplicate onto the array. Five control spots are included (locations P20-
P24): biotin peptide, c-Myc tag, no histone peptide and two background spots 
containing a mixture of modifications that are present on the array. More information 
about the MODified Histone Peptide Array, including a complete list of the 
modifications available and their corresponding peptide location, can be found in 
Appendix 1. 
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The array was pre-incubated in blocking solution [5% non-fat dried milk in TBS-T 
buffer (10mM Tris–HCl pH 7.4, 150 mM NaCl and 0.05% Tween-20)] at 4°C 
overnight, washed three times with TBS-T buffer, and incubated with purified His6-
tagged ROS1 (10 nM) for 1 h at 25°C in binding buffer (50 mM Tris-HCl pH 8, 1 mM 
DTT, 100 µg/ml BSA, 1 mM EDTA, 100 mM NaCl and 0.1% glycerol) with gentle 
agitation. After washing three times with TBS-T buffer, the array was incubated with 
His-tag monoclonal antibody (Novagen) at a 1:4000 dilution in blocking solution for 1 
h at room temperature. Then it was washed three times with TBS-T buffer and 
incubated with horseradish peroxidase-conjugated anti-mouse IgG (GE healthcare) at a 
1:5000 dilution in blocking solution for 1 h at room temperature. Finally, the array was 
incubated with ECL Western blotting Detection Reagent (GE Healthcare) and an image 
was captured using the LAS-3000 analyzer (Fujifilm). 
 
8. Pull-down assays 
Histone peptides used for pull-down assays were obtained from Biomatik, Millipore or 
Anaspec. All peptides were biotinylated at the C-terminus, purified by HPLC before 
use (purity > 90-95%) and dissolved in sterile distilled water before dilution in the 
desired buffer. Their sequence, modifications, and molecular weight are shown in Table 
5.  
Table 5.  Biotinylated histone peptides used in pull-down assays. 
Name Sequence (N-terminal to C-terminal)a MW (Da) 
H3 1-21 ARTKQTARKSTGGKAPRKQLA-GGK-biotin 2724 
H3S10P ARTKQTARK[pS]TGGKAPRKQLA-GGK-biotin 2801.7 
H3 21-44 Ac-ATKAARKSAPATGGVKKPHRYRP-GGK-biotin 2959.51 
H3S28P Ac-ATKAARK[pS]APATGGVKKPHRYRP-GGK-biotin 3039.49 
H3K27me1 ATKAAR[me1K]SAPATGGVKKPHRYRP-GGK-biotin 2932.9 
H3K27me2 ATKAAR[me2K]SAPATGGVKKPHRYRP-GGK-biotin 2947.6 
H3K27me3 ATKAAR[me3K]SAPATGGVKKPHRYRP-GGK-biotin 2961 
H4 (8-30) Ac-KGLGKGGAKRHRKVLRDNIQGIT-WGK-biotin 3144 
H2A (1-20) SGRGKQGGKARAKAKTRSSR-GGK-biotin 2557.4 
H2B (1-21) PEPSKSAPAPKKGSKKAITKA-GGK-biotin 2590.8 
aAc = Acetylation; Post-translational histone modifications are coloured. 
Pull-down assays were performed by (1) loading magnetic Streptavidin beads with 
biotinylated peptides, (2) incubating the peptide-loaded beads with proteins, and (3) 
detecting proteins bound to beads by immunoblotting. 
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For peptide loading, 30 µl of Dynabeads M-280 Streptavidin (Invitrogen) were washed 
once with PBS-T (Phosphate Buffer Saline pH 7.4 + 0.01% Tween-20) and then 
incubated with the appropriated biotinylated histone peptide (400 pmol) in PBS at 4°C 
overnight, according to the manufacturer’s instructions. After incubation, beads were 
washed three times with PBS-T and twice with Binding Buffer (50 mM Tris-HCl pH 8, 
1 mM DTT, 1 mM EDTA, 100 mM NaCl, 0.1 % Tween-20, 0.01% protease inhibitor 
cocktail p8849 (Sigma), 50 nM tautomycin and 50 nM okadaic acid). Loading 
efficiency was verified by detection of bound peptides with avidin-peroxidase 
conjugate (Sigma-Aldrich).  
Once loaded with the appropriate peptide, the beads were incubated with 50 pmol of 
purified His6-tagged ROS1 (WT, truncated or mutant versions) in 400 µl of Binding 
Buffer containing 0.09 ug/ul BSA for 2 h at 4°C. After incubation, beads were washed 
three times with Binding Buffer. 
Proteins bound to beads were separated by SDS-PAGE (7% acrylamide/bisacrylamide, 
37.5:1) and transferred to nitrocellulose membranes at 30 V at 4°C overnight. After 
blotting, the membranes were blocked with Blocking Solution [1% BSA (bovine serum 
albumin) in TBS (10 mM Tris-HCl pH 7.4 and 150 mM NaCl)] for 1 h at room 
temperature and washed three times with TBS supplemented with 0.5% Tween-20 
(TBS-T). Then, membranes were incubated with His-tag monoclonal antibody 
(Novagen) at a 1:1000 dilution in Blocking Solution for 1 h at room temperature, 
washed three times with TBS-T, and incubated with horseradish peroxidase-conjugated 
anti-mouse (Cell Signalling) at a 1:3000 dilution in Blocking Solution for 1 h at room 
temperature. After three washes with TBS-T, membranes were incubated with ECL 
Prime Western Blotting Detection Reagent (GE Healthcare) and images were captured 
using the LAS-3000 analyzer (Fujifilm). 
 
9. Plasmid construction for cell co-transfection and 
retroviral transduction experiments 
9.1. Construction of GBD-ROS1_CD expression plasmid  
Firstly, pET28c-ROS1NΔ294 (encoding the His6-ROS1_CD) was digested with EcoRI 
and HindIII to release the ROS1_CD coding sequence. This DNA fragment was 
subcloned into pCMVTag2B vector (Stratagene) downstream the Flag-tag in order to 
obtain pCMVTag2B-ROS1_CD. Secondly, a fragment containing Gal4 DNA Binding 
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Domain (GBD, 1-147 amino acids), a c-myc tag and a nuclear localization signal (NLS, 
PKKKKRK), was amplified from pcDNA3.1-GBD plasmid with Velocity DNA 
polymerase (Bioline) using primers introducing PstI restriction sites at both ends (Table 
6). The amplification product was digested with PstI and inserted into pCMVTag2B-
ROS1_CD, downstream the Flag-tag and upstream ROS1_CD, to finally obtain 
pCMVTag2B-GBD-ROS1_CD.  
Table 6.  Oligonucleotides used as primers for generation of constructs used in cell co-
transfection and retroviral transduction experiments. 
Name Sequence (5’-3’)a 
PstI-GBD-F ATTCCTGCAGATGAAGCTACTGTCTTCTATC 
GBD-PstI-R TTTTCTGCAGTCTTTCTCTTCTTCTTTTTTGGC 
PstI-6F6-F TACTGCAGATGGCAGAGGAACGCCCATATG 
6F6-PstI-R TTCTGCAGTGACCTTTCTCTTCTTTTTTGGGCC 
pTR-CMV-
Forward (“a”) 
CGCAAATGGGCGGTAGGCGTG 
B1-NLS-R (“b”) GACCTTTCTCTTCTTTTTTGGTGGGCGTTCGCCATCTTTTT 
NLS-B1-F (“c”) AAAAAGATGGCGAACGCCCACCAAAAAAGAAGAGAAAGGTC 
EN7F12 (“d”) ACATAATTGTGCTGTTGTCC 
MluI-Flag-Fwd TATATAAACGCGTATGGATTACAAGGATGACGA 
PacI-ROS1-Rev TGTAATGTTAATTAATTAGGCGAGGTTAGCTTGTT 
FseI-EN7-F AATAAGGCCGGCCGAGCAATGTGACTACCAGAAAA 
EN7-EcoRI-R ATATTGAATTCGGCGAGGTTAGCTTGTTGTC 
EN7-stop-EcoRI-R ATATTGAATTCTTAGGCGAGGTTAGCTTGTTG 
XhoI-TK-F ATTCTCGAGCCCCGCCCAGCGTCTTGT 
aprt-TK-R GAGAAAGCTTGGCACGCTGTTGACGCTG 
XhoI-IE175k-F ATTCTCGAGGGGCGCGCGGGGCTCGTAT 
IE175k-HindIII-R AATAAGCTTCCGTGTCGGCAGCCGCGCT 
ROSD971A-F* CACCATCTTGCCTTTCCAGTTGCTACAAATGTTGGGCGC 
ROSD971A-R* GCGCCCAACATTTGTAGCAACTGGAAAGGCAAGATGGTG 
GBDL32PC38G-F* CGCCAAGTGTCCGAAGAACAACTGGGAGGGTCGCTACTCTC 
GBDL32PC38G-R* GAGAGTAGCGACCCTCCCAGTTGTTCTTCGGACACTTGGCG 
EN7S102S-F* GCTCGATTCCGGAATTTGTCATCAATGAATAAACTTGTGG 
EN7S102S-R* CCACAAGTTTATTCATTGATGACAAATTCCGGAATCGAGC 
aUnderlining indicates the restriction enzyme site. Bold case indicates mutagenized codons. 
Italics case indicates sequence complementary to template sequence on one side of the deletion 
via their 5’ ends. Asterisks indicate primers used in site-directed mutagenesis. 
Constructs expressing the catalytically inactive and the binding-deficient GBD-
ROS1_CD mutant versions (GBD-ROS1_CDmut and GBDmut-ROS1_CD, 
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respectively) were obtained by site-directed mutagenesis of pCMVTag2B-GBD-
ROS1_CD using the Quick-Change II XL kit (Stratagene) and specific oligonucleotides 
(Table 6). Mutational changes were confirmed by DNA sequencing. 
9.2. Construction of ZFP-ROS1_CD and ZFP-ROS1_CCD 
expression plasmids  
a) 6F6-ROS1_CD 
A fragment containing the 6F6 zinc finger protein and a nuclear localization signal 
(NLS, PKKKRKV), was amplified from p6F6-KOX1-TR with Velocity DNA 
polymerase (Bioline) using primers introducing PstI restriction sites at both ends (Table 
6). The amplification product was digested with PstI and inserted into pCMVTag2B-
ROS1_CD (see Section 9.1. above) downstream the Flag-tag and upstream ROS1_CD, 
to obtain pCMVTag2B-6F6-ROS1_CD.  
A construct expressing the catalytically inactive 6F6-ROS1_CD mutant version (6F6-
ROS1_CDmut) was obtained by site-directed mutagenesis of pCMVTag2B-6F6-
ROS1_CD using the Quick-Change II XL kit (Stratagene) and specific oligonucleotides 
(Table 6). Mutational changes were confirmed by DNA sequencing.  
b) B1-ROS1_CD and B1-ROS1_CCD 
The six zinc finger protein 6F6 comprises two three-zinc finger modules (B1 and A1) 
joined through a linker sequence (LRQKDGERP). To obtain constructs with just one 
zinc finger module (B1), the A1 coding sequence was deleted using an overlap 
extension method previously described (Ho et al., 1989) (Figure 78). In separate PCRs, 
“AB” and “CD” fragments were generated from pCMVTag2B-6F6-ROS1_CD using 
primers “a” + “b” and “c” + “d”, respectively (Table 6). Primers “b” and “c” hybridize 
to the template sequence on one side of the deletion (A1) via their 3’ ends, and are 
complementary to template sequence on the other side of the deletion via their 5’ ends. 
Therefore, the “AB” and “CD” products are overlapping at the deletion point. The 
“AD” fragment, containing the B1-linker-NLS sequence, flanked by PstI restriction 
sites, was finally obtained in a fusion PCR using “AB” + “CD” products as template 
and “a” + “d” primers. All amplification steps were carried out using Velocity DNA 
polymerase (Bioline). The “AD” product was cloned into pSpark I cloning vector 
(Canvax) and verified by DNA sequencing. Finally, the B1-linker-NLS sequence was 
released with PstI and subcloned into pCMVTag2B-ROS1_CD and pCMVTag2B-
ROS1_CCD constructs to obtain pCMVTag2B-B1-ROS1_CD and pCMVTag2B-B1-
ROS1_CCD expression vectors, respectively.  
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A construct expressing the catalytically inactive mutant version B1-ROS1_CDmut was 
generated by replacing 6F6 with B1 in pCMTag2B-6F6-ROS1_CDmut construct by 
PstI digestion. A construct expressing the catalytically inactive mutant version B1-
ROS1_CCDmut was generated by site-directed mutagenesis of pCMVTag2B-B1-
ROS1_CCD using the Quick-Change II XL kit (Stratagene) and specific 
oligonucleotides (Table 6). Mutational changes were confirmed by DNA sequencing.  
Figure 78. Generation of B1 constructs by deletion of A1 from 6F6 using the overlap 
extension method described in (Ho et al., 1989). 
c) ZF2-ROS1_CCD and CD54-ROS1_CCD 
Firstly, pCMVTag2B-B1-ROS1_CCD was digested with EcoRI and HindIII to release 
ROS1_CCD. This DNA fragment was subcloned into pCMVTag2C (Stratagene) 
downstream the Flag-tag, in order to obtain pCMVTag2C-ROS1_CCD. Secondly, this 
construct was used as a template to amplify Flag-ROS1_CCD with Velocity DNA 
polymerase (Bioline) using primers with MluI and PacI restriction sites (Table 6). The 
amplification product was digested and inserted into pMX-3ZF-MOF-IRES-GFP 
(provided by Marianne G. Rots), replacing the MOF effector domain, to obtain pMX-
3ZF-Flag-ROS1_CCD-IRES-GFP. Finally, pMX-ZF2-MOF-IRES-GFP (provided by 
Marianne G. Rots), was digested with SfiI to release the ZF2 sequence, which was 
inserted into pMX-3ZF-Flag-ROS1_CCD-IRES-GFP replacing 3ZF, thus generating 
pMX-ZF2-Flag-ROS1_CCD-IRES-GFP. 
The catalytically inactive mutant ZF2-ROS1_CCD version (ZF2-ROS1_CCDmut) was 
obtained following the same strategy described above for the WT construct, but using 
the pCMVTag2B-B1-ROS1_CCDmut plasmid instead. 
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To create pMX-CD54-Flag-ROS1_CCD-IRES-GFP, the Flag-ROS1_CCD sequence 
was released by MluI – PacI digestion and subcloned into pMX-CD54Opt31-hAID-
IRES-GFP (provided by Marianne G. Rots) replacing hAID. 
All ZFP-ROS1_CCD constructs contain a nuclear localization signal downstream the 
zinc finger. All PCR-cloned fragments were verified by DNA sequencing. 
9.3. Construction of dCas9-ROS1_CD-2A-eGFP and dCas9-
ROS1_CD expression plasmids  
The construct expressing dCas9-VP64 was purchased from Addgene (plasmid #48238: 
pAC152-pdual-dCas9VP64-sgExpression), a dual construct that expresses both the 
fusion protein and the sgRNA from two separate promoters. The dCas9-VP64 fusion 
protein is expressed under the control of a CBh promoter, and contained a HA-tag at 
the N-terminus and two NLS flanking dCas9. The sgRNAs is expressed under the 
control of an U6 promoter (see below, Section 10.5). 
To obtain the dCas9-ROS1_CD-2A-eGFP construct, the BbsI restriction site was firstly 
removed from pCMVTag2C-ROS1_CD by site-directed mutagenesis using the Quick-
Change II XL kit (Stratagene) and specific oligonucleotides (Table 6), introducing a 
silent mutation at codon 102 (S102S). Then, the ROS1_CD coding sequence (without 
its stop codon) was amplified using Velocity DNA polymerase and primers with FseI 
and EcoRI restriction sites (Table 6). The amplification product was digested and 
subcloned into pAC152-pdual-dCas9VP64-sgExpression plasmid (Addgene, plasmid 
#48238), replacing VP64. Finally, a fragment containing 2A-eGFP (“self-cleaving” 
small peptide 2A and enhanced Green Fluorescent Protein) was obtained after digestion 
of pSpark-2A-eGFP (kindly provided by Canvax) with EcoRI and cloned into pAC152-
pdual-dCas9-ROS1_CD-sgExpression to obtain the dCas9-ROS1_CD-2A-eGFP 
expressing construct. The fusion protein is expressed under the control of CBh 
promoter, and contains a HA-tag at the N-terminus and two NLS flanking dCas9. 
The construct expressing dCas9-ROS1_CD was obtained similarly to dCas9-
ROS1_CD-2A-eGFP, but amplifying ROS1_CD with its stop codon and not cloning 
2A-eGFP downstream ROS1_CD. 
The catalytically inactive mutant versions dCas9-ROS_CDmut-2A-eGFP and dCas9-
ROS1_CDmut were obtained following the same strategy for the wild-type constructs 
described above, but using pCMVTag2C-ROS1_CDmut instead. 
All PCR-cloned fragments and mutational changes were verified by DNA sequencing. 
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9.4. sgRNA design and cloning 
Each sgRNA comprises a 20-nt guide sequence and a scaffold sequence. Pairs of DNA 
oligonucleotides encoding the variable 20-nt sgRNA guide sequences were annealed 
together to generate short double strand DNA fragments with 4-bp overhangs and 
inserted upstream the sgRNA scaffold in the appropriate expression plasmid (Figures 
67A and 71B). The process of sgRNA design and cloning was as follows. 
For each sgRNA the 20-nt guide sequence that precedes NGG, the protospacer adjacent 
motif (PAM) required for sgRNA targeting, was selected using the “Feng Zhang lab's 
Target Finder” software (http://crispr.mit.edu/). This software provided a list of all 
possible sequence guides for the submitted target sequence, scored by inversed 
likelihood of off-target binding. Those guides with a high score (low off-target binding) 
and complementary to a sequence located at a desired position in the TK promoter were 
chosen.  
Overhangs for BbsI or BsmBI restriction sites were added to forward and reverse 
oligonucleotides guides, depending on the plasmid chosen for sgRNA expression 
[pAC152-pdual-dCas9-ED-sgExpression plasmid (Addgene, plasmid #48238) or 
pMLM3636 (Addgene #43860), respectively]. When the first base at the 5’ end of the 
guide sequence was not a G, an additional G:C base pair was added at this position for 
efficient U6-dependent transcription. This addition does not affect targeting efficiency. 
Oligonucleotides were ordered from Isogen Life Science and were purified by HPSF 
(High Purify Salt Free) before use (Table 7).  
sgRNAs TK 1 and 2 were prepared by mixing equimolar solutions of the corresponding 
forward and reverse oligonucleotides (1-µM each and ordered with their 5’ end 
phosphorylated), heating to 95°C for 5 min and slowly cooling to room temperature. 
These sgRNAs contain overhangs for BbsI. 
sgRNAs TK 3 to 8 were prepared by incubating 1-µM of both the corresponding 
forward and reverse oligonucleotides with 1X Reaction Buffer A for T4 PNK, 1 mM 
dATP and 10 units of T4 PNK (Thermo Scientific) at 37°C for 30 min, followed by 
inactivating at 75°C for 10 min. After this phosphorylation step, they were annealed by 
heating to 95°C for 5 min and slowly cooling to room temperature. These sgRNAs 
contain overhangs for BsmBI. 
Finally, expression plasmids were digested with BbsI (pduadCas9-sgExpression) or 
BsmBI (pMLM3636) and ligated to the annealed oligos. Insertion was verified by DNA 
sequencing. 
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Table 7.  Oligonucleotides used for sgRNA design and cloning. 
Name* Sequence (5’-3’) Target 
Position 
from ATG 
(bp) 
TK-5’P-sgRNA-F1 CACCGCCCGCCCAGCGTCTTGTCAT 
Sense -188 to -169 
TK-5’P-sgRNA-R1 AAACATGACAAGACGCTGGGCGGGC 
TK-5’P-sgRNA-F2 CACCGGCATATTAAGGTGACGCGTG 
Sense -113 to -94 
TK-5’P-sgRNA-R2 AAACCACGCGTCACCTTAATATGCC 
TK-sg-s-F3 ACACCGCTCTTACGCGTGCTAGCCCG 
Sense -218 to -199 
TK-sg-s-R3 AAAACGGGCTAGCACGCGTAAGAGCG 
TK-sg-s-F4 ACACCGCGAACACGCAGATGCAGTCGG 
Sense -159 to -140 
TK-sg-s-R4 AAAACCGACTGCATCTGCGTGTTCGCG 
TK-sg-s-F5 ACACCGCTTGGCATTCCGGTACTGTG 
Sense -33 to -14 
TK-sg-s-R5 AAAACACAGTACCGGAATGCCAAGCG 
TK-sg-as-F6 ACACCGCTGTTAAGCGGGTCGCTGCG Anti-
sense 
-69 to -50 
TK-sg-as-R6 AAAACGCAGCGACCCGCTTAACAGCG 
TK-sg-as-F7 ACACCGCGTCACCTTAATATGCGAAGG Anti-
sense 
-117 to -98 
TK-sg-as-R7 AAAACCTTCGCATATTAAGGTGACGCG 
TK-sg-as-F8 ACACCGTTCGCCAATGACAAGACGCTG Anti-
sense 
-181 to -162 
TK-sg-as-R8 AAAACAGCGTCTTGTCATTGGCGAACG 
Overhangs for ligation into the pair of BsbI sites in pdualdCas9-sgExpression plasmid are 
indicated by italics case. Overhangs for ligation into the pair of BsmBI sites in pMLM3636 are 
underlined. The additional G/C for efficient U6-dependent transcription is shown in red. * s = 
sense; as = anti-sense. 
9.5. Construction of luciferase reporter plasmids 
The reporter plasmid 5xUAS-TK-Luc was kindly provided by Albert Jeltsch (Li et al., 
2007d). It is derived from the pGL3-basic vector (Promega) and contains five repeats of 
the Upstream Activating Sequence (5xUAS) and the minimal TK (Human herpesvirus 
1 thymidylate kinase) promoter (156 bp) upstream the firefly luciferase reporter gene. 
The TK-Luc and IE175k-Luc reporter plasmids were obtained by replacing the 5xUAS-
TK sequence in 5xUAS-TK-Luc with either TK or IE175k respectively, using XhoI and 
HindIII sites. The TK promoter was amplified from the 5xUAS-TK-Luc plasmid and 
the entire HSV-1 IE175k promoter region (positions from -380 to +30) was amplified 
from the pPO13 plasmid [kindly provided by Peter O´Hare, (Papworth et al., 2003)]. 
PCRs were carried out using Velocity DNA polymerase (Bioline) and specific primers 
with XhoI and HindIII sites at their ends (Table 6).  
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A reporter plasmid containing the Renilla luciferase reporter gene under the control of 
the cytomegalovirus (CMV) promoter (pRL-CMV, Promega) was kindly provided by 
Mariano Rodríguez-Portillo group (IMIBIC). This plasmid was used for normalization 
of transfection yield and cell number in all co-transfection experiments involving 
luciferase expression analysis. 
 
10. In vitro methylation of reporter plasmids 
Plasmid DNA (50 µg) was in vitro methylated by incubating with M.SssI CpG 
methyltransferase (160 units, NEB) in a reaction mixture containing 50 mM NaCl, 10 
mM Tris–HCl pH 7.9, 1 mM DTT and 0.8 mM S-adenosylmethionine (SAM), at 37°C 
overnight. After incubation, plasmid DNA was purified by ethanol precipitation. 
Methylation was verified by confirming full resistance to HpaII digestion. 
 
11. Cell culture 
Human embryonic kidney HEK293 cells were cultured in Dulbecco’s modified Eagle’s 
medium (DMEM) High Glucose (4.5 g/L, Biowest) supplemented with 10% fetal 
bovine serum (FBS, Biowest, previously inactivated at 56°C for 1h), and 1% penicillin-
streptomycin solution stabilized (Sigma). HEK293T packaging cells, human ovarian 
cancer A2780 cells and human breast cancer MCF7 cells were grown in DMEM 
(BioWhittaker) supplemented with 10% FBS, 2mM L-glutamine and 50 mg/ml 
gentamicin sulfate. All cell lines were cultured at 37°C in a humidified 5% CO2-
containing atmosphere. 
 
12. Co-transfection of HEK293 cells with lipofectamine 
HEK293 cells were seeded in 6-well plates at a density of 6 x 105 cells/well one day 
before transfection. The co-transfection mix included constructs expressing GBD, 6F6 
or B1 fusion proteins (250 ng/well), the firefly luciferase reporter plasmid (250 
ng/well) (either methylated or not, as indicated) and Renilla luciferase reporter plasmid 
(25 ng/well), all three diluted in 500 µl Opti-MEM® I Reduced Serum Media 
(Invitrogen) and 5 µl Lipofectamine LTXTM Reagent (Invitrogen). After incubating for 
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30 min at room temperature, the co-transfection mix was added drop by drop to cells, 
previously changed to a fresh culture medium (1.5 ml/well). Forty-eight hours after co-
transfection, cells were trypsinazed, harvested by centrifugation at 1800 rpm for 5 min 
and resuspended in 500 µl PBS. For each sample, 100 µl were used for the luciferase 
activity assay (see below, Section 16) and the remaining 400 µl were pelleted and 
stored at -80°C for further analysis (Pyrosequencing, qRT-PCR or Western-Blot; see 
below, Sections 18, 17 and 14.1, respectively). When studying the effect of Trichostatin 
A (TSA), 24 h after co-transfection cells were treated with a final concentration of 0.3 
µM TSA (Sigma) in ethanol. Control cells were treated with an identical volume of 
ethanol. Twenty-four hours after TSA treatment, the culture medium was removed and 
fresh cell culture medium was added to cells. Finally, cells were grown for an 
additional period of 24 h before harvesting for further analysis, as described above. 
When using the CRISPR system, HEK293 cells were seeded in 24-well plates at a 
density of 1 x 105 cells/well one day before transfection. Plasmids for co-transfection 
included Renilla luciferase reporter gene (25 ng/well), the firefly luciferase reporter 
plasmid TK-Luc (250 ng/well) (methylated or not, as indicated), and either dual 
constructs expressing dCas9 fusion proteins and sgRNA (250 ng/well), or constructs 
separately expressing dCas9 fusion proteins (125 ng/well) and sgRNAs (125 ng/well). 
When more than one dCas9 fusion protein and/or sgRNA expressing plasmid was 
included, the 125 ng mass was divided equally among the plasmids to be used in each 
case. Empty pCMVTag (no effector protein) was used for mass compensation when 
using different combinations of dCas9-effector proteins and/or sgRNAs. The co-
transfection mix included the appropriate plasmids diluted in 100 µl Opti-MEM® I 
Reduced Serum Media (Invitrogen) and 1.5 µl Lipofectamine LTXTM Reagent 
(Invitrogen). After incubating for 30 min at room temperature, the co-transfection mix 
was added drop by drop to cells, previously changed to fresh culture medium (400 
µl/well). Forty-eight hours after co-transfection, cells were washed with PBS and 
assayed for luciferase activity (see below, Section 16). When expressing eGFP, cells 
were examined by fluorescence microscopy (see below, Section 15.2) before the 
luciferase activity assay. When using 12 well-plates instead of 24 well-plates, all 
amounts described for 24-well plates were scaled-up two fold, according to the 
manufacturer’s instructions. Cells in 12-well plates were trypsinized, harvested by 
centrifugation at 1800 rpm for 5 min and resuspended in 500 µl PBS. For each sample 
50 µl were used for the luciferase activity assay and the remaining 450 µl were pelleted 
and stored at -80°C for further analysis (Pyrosequencing or Western-Blot; see below, 
Sections 18 and 14.1, respectively). 
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13. Retroviral transductions 
HEK293T cells were transfected with retroviral vector pMX-IRES-GFP encoding ZFP-
ROS1_CCD or control constructs together with the accessory plasmid pMDLg/pRRE 
and packaging plasmid pMD2.G in a 3:2:1 ratio, using a standard calcium-phosphate 
protocol to produce retroviral particles. Host cells (A2780 and MCF7) were seeded 
with a density of 2.5 x 105 cells in T25 flasks or 7-7.5 x 105 cells in T75 flasks. Forty-
eight and 72 h after transfection, viral supernatants were supplemented with fetal 
bovine serum (10%) and polybrene (6 µg/ml) (Sigma) and used to transduce the host 
cells up to 4 times. Seventy-two hours after the last infection, cells were harvested to 
evaluate transduction efficiency by flow cytometry. When transduction efficiency was 
low, GFP-positive cells were isolated by fluorescence-activated cell sorting (FACS, see 
below, Section 16). If the number of sorted cells was low for further analysis, GFP-
positive cells were seeded and subcultured for a new infection (superinfection), and 
sorted again, if required. Finally, sorted or harvested cells were used for genomic DNA 
extraction and subsequent pyrosequencing (see below, Section 19). 
 
14. Detection of protein expression 
14.1. Western-Blot analysis 
Transient expression of GBD, 6F6 and B1 fusion proteins in HEK293 cells after co-
transfection was monitored by western blot using an anti-Flag antibody. Briefly, cells 
were lysed in 1X RIPA buffer (Sigma), containing 1% protease inhibitor cocktail set 
III, animal-free (Calbiochem), and protein concentration was determined by the 
Bradford assay (Bradford, 1976). Total cell lysates (80 µg) were subjected to SDS-
PAGE (7% acrylamide/bisacrylamide, 37.5:1), and transferred to nitrocellulose 
membranes at 30 V at 4°C overnight. After blotting, the membranes were blocked with 
blocking solution [3% skim milk in TBS (10 mM Tris-HCl pH 8 and 150 mM NaCl)] 
for 1 h at room temperature and washed three times with TBS. Then, membranes were 
incubated with Monoclonal Anti-Flag® M2, Clone M2 (F1804) antibody (Sigma) at a 
1:1000 dilution in blocking solution at 4°C overnight, washed three times with TBS 
supplemented with 0.5% Tween-20 (TBS-T), and incubated with horseradish 
peroxidase-conjugated anti-mouse (Cell Signalling) at a 1:3000 dilution in blocking 
solution for 1 h at room temperature. Finally, after three washes with TBS-T, 
membranes were incubated with ECL Prime Western Blotting Detection Reagent (GE 
Healthcare) and images were captured using the LAS-3000 analyzer (Fujifilm).  
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Transient expression of dCas9 fusion proteins in HEK293 cells after co-transfection 
was monitored by western blot using an anti-Cas9 antibody. Briefly, cells were lysed in 
1X RIPA buffer (Sigma), containing 1% protease inhibitor cocktail set III, animal-free 
(Calbiochem), and protein concentration was determined by the Bradford assay 
(Bradford, 1976). Total cell lysates (65 µg) were subjected to SDS-PAGE using 4-20% 
Mini-Protean® TGX Stain-FreeTM Precast Gels (Bio-Rad), and transferred to 
nitrocellulose membranes at 30 V at 4°C overnight. After blotting, the membranes were 
blocked with blocking solution [3% skim milk in TBS (10 mM Tris-HCl pH 7.4 and 
150 mM NaCl)] for 1 h at room temperature and washed three times with TBS. Then, 
membranes were incubated with CRISPR/Cas9-4G10 monoclonal antibody 
(Diagenode) at a 1:2000 dilution in blocking solution at 4°C overnight, washed three 
times with TBS supplemented with 0.5% Tween-20 (TBS-T), and incubated with 
horseradish peroxidase-conjugated anti-mouse (Cell Signalling) at a 1:5000 dilution in 
blocking solution for 1 h at room temperature. Finally, after three washes with TBS-T, 
membranes were incubated with ECL Ultra Chemiluminescent Reagent TMA-6 
(Lumigen) and images were captured using the Molecular Imager Chemi-DocTM XRS+ 
with Image LabTM Software (Bio-Rad). 
To verify equal loading of total cell lysates, the Monoclonal Anti-Actin antibody clone 
AC-40 (Sigma) was used at 1:2000 dilution in blocking solution at 4°C overnight, 
following the protocol described above. 
14.2. Fluorescence microscopy  
Transient expression of eGFP was monitored by fluorescence microscopy using a 
Nikon Eclipse Ti microscope 48 h after co-transfection. 
 
15. Flow cytometry and cell sorting 
Co-transfection efficiency of HEK293 cells was monitored by green fluorescent protein 
(GFP) signal count by flow cytometry. Cells were co-transfected with Renilla 
luciferase reporter plasmid (25 ng/well), GBD-ROS1_CD or GBD-ROS1_CDmut (250 
ng/well) expressing constructs, the methylated reporter plasmid 5xUAS-TK-Luc (250 
ng/well) and pACGFP-C1 plasmid (250 ng, Clontech), as described above (Section 13). 
Cells were harvested 48 h after co-transfection, washed once with phosphate buffered 
saline (PBS) and resuspended in PBS. Transduction efficiency of A2780 ovarian cancer 
and MCF7 breast cancer cells by pMX-IRES-GFP constructs, expressing CD54 and 
Materials and Methods 
 187 
ZF2 fusion proteins, was determined by fluorescence-activated cell sorting (FACS) 
analysis. Cells were harvested 72 h after transduction, washed three times with cold 
PBS and resuspended in PBS. In all cases, GFP expression was analyzed using a BD 
FACSCalibur flow cytometer (Becton Dickinson Biosciences) and CellQuest software. 
Data were analyzed with FlowJo software. 
 
16. Luciferase activity assay 
Luciferase activity assay was performed using the Dual-Luciferase® Reporter Assay 
System (Promega). Cells were washed once with PBS and lysed with 1X Passive Lysis 
Buffer (1X PLB). After incubating for 15 min at 25°C and gently shaking, lysate 
samples were clarified by centrifuging for 30 sec at 17000 g and clear lysates were 
transferred to new tubes. Luciferase Assay Reagent II (LAR II)  (50 µl/well) was added 
to Greiner Bio-One µClear White Plates, and mixed with 20 µl of clear lysate to 
determine firefly luciferase activity. The firefly luciferase reaction was stopped and the 
Renilla luciferase reaction was simultaneously initiated by adding 50 µl of Stop & Glo® 
Reagent. Measurements were carried out in a TECAN infinite F200 PRO microplate 
reader and using the i-Control 1.7 software. Renilla luciferase activity was used to 
normalize transfection yield and cell number in all co-transfection experiments. 
Expression data [Luciferase Activity (%)] were calculated as the ratio of firefly/Renilla 
luciferase activity relative to that detected after co-transfection with unmethylated 
reporter and/or control vector, as indicated. 
 
17. Analysis of firefly luciferase reporter gene 
expression by quantitative Real-Time PCR (qRT-
PCR) 
Total RNA was extracted from HEK293 cells 48 h after co-transfection using the 
RNeasy Mini Kit 74016 (Qiagen). 1 µg RNA was treated with 1 U DNase I, RNase-
free (Thermo Scientific), and subsequently used for cDNA synthesis using the 
qSCRIPTTM cDNA synthesis Kit (Quanta Biosciences), following the manufacturer's 
instructions. Then, 1 µl cDNA synthesis reaction was used as template in a 20 µl PCR 
reaction with specific primers (Table 8) and iQ SYBR® Green Supermix (Bio-Rad). All 
reactions were carried out on the CFX Connect Real-Time System (Bio-Rad) and data 
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were analysed using the CFX Manager Software (Bio-Rad). The comparative threshold 
cycle (Ct) method was used for determining relative transcript levels (Bulletin 5279, 
Real-Time PCR Applications Guide, Bio-Rad), with GAPDH as an internal control. 
Expression levels relative to GAPDH were determined with the formula 2-ΔCt. Fold 
increase in gene expression compared with unmethylated firefly reporter gene, co-
transfected with empty vector, was calculated with the formula 2-ΔΔCt (Livak and 
Schmittgen, 2001). 
Table 8.  Oligonucleotides used as primers for qRT-PCR analysis of firefly luciferase 
reporter gene expression. 
Name Sequence (5’-3’) 
FLuc-F AGGTGGCTCCCGCTGAAT 
FLuc-R CATCGTCTTTCCGTGCTCCA 
GAPDH-Fw2 TGTCCCCACTGCCAACGTGTCA 
GAPDH-Rv2 AGCGTCAAAGGTGGAGGAGTGGGT 
 
18. Analysis of DNA methylation by bisulfite 
sequencing  
Bisulfite sequencing is the gold standard to assess DNA methylation status, 
differenciating and detecting unmethylated versus methylated cytosines at single 
nuleotide resolution (Frommer et al., 1992). After treatment of single-stranded 
(denatured) DNA with sodium bisulfite, unmethylated cytosines are deaminated to 
uracil, while methylated cytosines (5-meC) are protected from this conversion. In 
subsequent PCR process, uracil residues are amplified as thymines, whereas 5-meC 
residues are amplified as cytosines, and the PCR products are then analyzed either by 
Sanger sequencing or by pyrosequencing. Comparison of sequence information 
between the reference (non-treated) and the bisulfite-treated DNA provides information 
about the methylation status. 
18.1. DNA isolation and bisulfite conversion 
To analyze DNA methylation levels of targeted and non-targeted firefly luciferase 
reporter vectors in HEK293 cells, 48 h after co-transfection with constructs expressing 
GBD or dCas9 fusion proteins, cells were harvested and washed once with PBS. 
Plasmids were isolated with modified Hirt method as described in (Arad, 1998) using 
Spin Columns CB3 from PerfectPrep Spin Mini Kit (5-prime) and eluting DNA in 50 
µl sterile distilled water. Isolated plasmids (9 µl) were bisulfite converted using EZ 
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DNA Methylation-Direct Kit (Zymo Research) following the manufacturer’s 
instructions with little variations: the reaction mix (including isolated DNA, after 
digestion or not with proteinase K, and CT conversion reagent) was repeatedly heated 
between 64°C for 15.min and 95°C for 30.sec for 20 cycles (Ehrich et al., 2007), and 
bisulfite-treated DNA were eluted in 12 µl Elution Buffer.  
To analyze methylation of ICAM-1 and RASFF1A endogenous genes in A2780 and 
MCF7 cells, respectively, genomic DNA was isolated 48 h after the last infection as 
follows: cells were resuspended in 1X SE buffer (75 mM NaCl and 25 mM EDTA pH 
8), and incubated at 55°C overnight in the presence of 1 mg/ml proteinase K and 1% 
SDS. After chloroform and isopropanol precipitation, genomic DNA (100-500 ng) was 
bisulfite converted using EZ DNA Methylation-Gold Kit (Zymo Research) following 
the manufacturer’s instructions (alternative 2). 
18.2. Sanger sequencing 
A 2 µl aliquot of bisulfite-treated plasmid DNA was used for PCR amplification with 
Platinum Taq DNA Polymerase High Fidelity (Invitrogen) using specific primers 
(Table 9) in 25 µl total volume. PCR products were subcloned into pGEMT-easy vector 
(Promega), after adding dATP at 3’ ends using BioTaq DNA Polymerase (Bioline). 
Between 3 and 17 independent top-strand clones were sequenced from each sample. 
Data were analysed using BIQ-Analyzer software (http://biq-analyzer.bioinf.mpi-
inf.mpg.de/), following manufacturer’s instructions. 
18.3. Pyrosequencing 
A 2 µl aliquot of bisulfite-treated plasmid DNA was used for PCR amplification with 
Platinum Taq DNA Polymerase High Fidelity (Invitrogen) using specific primers 
(Table 9) in 25 µl total volume. Bisulfite-treated genomic DNA (10–20ng) was 
amplified by PCR in a 25 µl reaction using the PyroMark PCR kit (Qiagen). In 
RASFF1A PCR, the amplification product was biotinylated during the PCR reaction by 
using an universal biotinylated primer and a reverse primer containing the universal 
primer sequence at 5’ end (Table 9), instead of using a biotinylated-forward or –reverse 
primer (Royo et al., 2007). Pyrosequencing was performed with 15 µl of PCR products 
and a specific sequencing primer (Table 9) on the PyroMark Q24 instrument (Qiagen), 
according to the manufacturer’s guidelines. Analysis of the percentage of methylation 
at each CpG was determined using PyroMark Q24 Software (Qiagen). 
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Table 9.  Oligonucleotides used as primers for bisulfite sequencing.  
Name Sequence (5’-3’) 
5UAS-TK piro F1 AGGTGGCTCCCGCTGAAT 
5UAS-TK piro R1 CATCGTCTTTCCGTGCTCCA 
5UAS-TK piro R1-biotin Biotin-CATCGTCTTTCCGTGCTCCA 
5UAS-TK piro S1 AGAGGTGGTTTAGGAT 
TK piro F1 GGTTGTTTTTAGTGTAAGTGTAGG 
TK piro R1-biotin Biotin-TCCATAATAACTTTACCAACAATA 
TK piro S1 GTGTAGGTGTTAGAATATTTTT 
ICAM-1 Pyro-F GGGGAAGTTGGTAGTATTTAAAAGT 
ICAM-1 Pyro-R CCTTCCCCTCCCAAACAAATACTACAATTA 
ICAM-1 Pyro-Seq ATTTCCCAACTAACAAAATACCC 
RassF1a Pyro FW AAGGAGGGAAGGAAGGGTAAG 
RassF1a Pyro RV 
gggacaccgctgatcgtttaCCCCCAACTCAATAAACTCAAACT
CCCC 
Universal Pyroseq Biotin Biotin-gggacaccgctgatcgttta 
RassF1a Pyro SEQ GAAGGAAGGGTAAGG 
Lower case indicates the sequence of the universal primer. The oligonucleotides were designed 
using the PyroMark Assay Design Software (Qiagen). !!
  
!
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Appendix 1: Additional information about the MODified 
Histone Peptide Array (ActiveMotif) 
Figure 79. Reference grid for histone peptides locations. 
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Table 10. Histone peptides content. 
Spot Name Mod 1 Mod 2 Mod 3 Mod 4  Spot Name Mod 1 Mod 2 Mod 3 Mod 4  
A 1 H3 1-19 unmod    A22 H3 1-19 R2me2s K4me2   
A 2 H3 1-19 R2me2s 
   
A23 H3 1-19 R2me2s K4me3   
A 3 H3 1-19 R2me2a 
   
A24 H3 1-19 R2me2s K4ac   
A 4 H3 1-19 R2Citr 
   
B 1 H3 1-19 R2me2a T3P   
A 5 H3 1-19 T3P 
   
B 2 H3 1-19 R2me2a K4me1   
A 6 H3 1-19 K4me1    B 3 H3 1-19 R2me2a K4me2   
A 7 H3 1-19 K4me2 
   
B 4 H3 1-19 R2me2a K4me3   
A 8 H3 1-19 K4me3 
   
B 5 H3 1-19 R2me2a K4ac   
A 9 H3 1-19 K4ac 
   
B 6 H3 1-19 R2Citr T3P   
A10 H3 1-19 R8me2s 
   
B 7 H3 1-19 R2Citr K4me1   
A11 H3 1-19 R8me2a    B 8 H3 1-19 R2Citr K4me2   
A12 H3 1-19 R8Citr 
   
B 9 H3 1-19 R2Citr K4me3   
A13 H3 1-19 K9me1    B10 H3 1-19 R2Citr K4ac   
A14 H3 1-19 K9me2 
   
B11 H3 1-19 T3P K4me1   
A15 H3 1-19 K9me3 
   
B12 H3 1-19 T3P K4me2   
A16 H3 1-19 K9ac    B13 H3 1-19 T3P K4me3   
A17 H3 1-19 S10P 
   
B14 H3 1-19 T3P K4ac   
A18 H3 1-19 T11P    B15 H3 1-19 R2me2s T3P K4me1  
A19 H3 1-19 K14ac 
   
B16 H3 1-19 R2me2s T3P K4me2  
A20 H3 1-19 R2me2s T3P 
  
B17 H3 1-19 R2me2s T3P K4me3  
A21 H3 1-19 R2me2s K4me1   B18 H3 1-19 R2me2s T3P K4ac  
H3 1-19 
H3 7-26 
H3 16-35 
H3 26-45 H4 1-19 
H4 11-30 
H2A 1-19 
H2B 1-19 Controls 
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Spot Name Mod 1 Mod 2 Mod 3 Mod 4  Spot Name Mod 1 Mod 2 Mod 3 Mod 4  
B19 H3 1-19 R2me2a T3P K4me1  E 3 H3 1-19 R8me2a K9ac S10P T11P 
B20 H3 1-19 R2me2a T3P K4me2  E 4 H3 1-19 R2me2s K4me1 R8me2s  
B21 H3 1-19 R2me2a T3P K4ac 
 
E 5 H3 1-19 R2me2s K4me2 R8me2s  
B22 H3 1-19 R2me2a T3P 
  
E 6 H3 1-19 R2me2s K4me3 R8me2s  
B23 H3 1-19 R8me2s K9me1 
  
E 7 H3 1-19 R2me2s K4ac R8me2s  
B24 H3 1-19 R8me2s K9me2 
  
E 8 H3 1-19 R2me2a K4me1 R8me2a  
C 1 H3 1-19 R8me2s K9me3   E 9 H3 1-19 R2me2a K4me2 R8me2a  
C 2 H3 1-19 R8me2s K9ac 
  
E10 H3 1-19 R2me2a K4me3 R8me2a  
C 3 H3 1-19 R8me2s S10P 
  
E11 H3 1-19 R2me2a K4ac R8me2a  
C 4 H3 1-19 R8me2s T11P 
  
E12 H3 1-19 R2me2s K4me1 K9me1  
C 5 H3 1-19 R8me2a K9me1 
  
E13 H3 1-19 R2me2s K4me2 K9me1  
C 6 H3 1-19 R8me2a K9me2   E14 H3 1-19 R2me2s K4me3 K9me1  
C 7 H3 1-19 R8me2a K9me3 
  
E15 H3 1-19 R2me2s K4ac K9me1  
C 8 H3 1-19 R8me2a K9ac   E16 H3 1-19 R2me2a K4me1 K9me2  
C 9 H3 1-19 R8me2a S10P 
  
E17 H3 1-19 R2me2a K4me2 K9me2  
C10 H3 1-19 R8me2a T11P 
  
E18 H3 1-19 R2me2a K4me3 K9me2  
C11 H3 1-19 R8Citr K9me1   E19 H3 1-19 R2me2a K4ac K9me2  
C12 H3 1-19 R8Citr K9me2 
  
E20 H3 1-19 R2me2s K4me1 K9me3  
C13 H3 1-19 R8Citr K9me3   E21 H3 1-19 R2me2s K4me2 K9me3  
C14 H3 1-19 R8Citr K9ac 
  
E22 H3 1-19 R2me2s K4me3 K9me3  
C15 H3 1-19 R8Citr S10P 
  
E23 H3 1-19 R2me2s K4ac K9me3  
C16 H3 1-19 R8Citr T11P   E24 H3 1-19 R2me2a K4me1 K9ac  
C17 H3 1-19 K9me1 S10P 
  
F 1 H3 1-19 R2me2a K4me2 K9ac  
C18 H3 1-19 K9me1 T11P   F 2 H3 1-19 R2me2a K4me3 K9ac  
C19 H3 1-19 K9me1 K14ac 
  
F 3 H3 1-19 R2me2a K4ac K9ac  
C20 H3 1-19 K9me2 S10P 
  
F 4 H3 1-19 K4me1 R8me2s K9me1  
C21 H3 1-19 K9me2 T11P   F 5 H3 1-19 K4me2 R8me2s K9me1  
C22 H3 1-19 K9me2 K14ac 
  
F 6 H3 1-19 K4me3 R8me2s K9me1  
C23 H3 1-19 K9me3 S10P   F 7 H3 1-19 K4ac R8me2s K9me1  
C24 H3 1-19 K9me3 T11P 
  
F 8 H3 1-19 K4me1 R8me2a K9me1  
D 1 H3 1-19 K9me3 K14ac 
  
F 9 H3 1-19 K4me2 R8me2a K9me1  
D 2 H3 1-19 K9ac S10P 
  
F10 H3 1-19 K4me3 R8me2a K9me1  
D 3 H3 1-19 K9ac T11P 
  
F11 H3 1-19 K4ac R8me2a K9me1  
D 4 H3 1-19 K9ac K14ac   F12 H3 1-19 K4me1 R8me2s K9me2  
D 5 H3 1-19 S10P T11P 
  
F13 H3 1-19 K4me2 R8me2s K9me2  
D 6 H3 1-19 S10P K14ac 
  
F14 H3 1-19 K4me3 R8me2s K9me2  
D 7 H3 1-19 T11P K14ac S10P 
 
F15 H3 1-19 K4ac R8me2s K9me2  
D 8 H3 1-19 R8me2s K9me1 S10P 
 
F16 H3 1-19 K4me1 R8me2a K9me2  
D 9 H3 1-19 R8me2s K9me2 S10P  F17 H3 1-19 K4me2 R8me2a K9me2  
D10 H3 1-19 R8me2s K9me3 S10P 
 
F18 H3 1-19 K4me3 R8me2a K9me2  
D11 H3 1-19 R8me2s K9ac T11P  F19 H3 1-19 K4ac R8me2a K9me2  
D12 H3 1-19 R8me2s K9me1 T11P 
 
F20 H3 1-19 K4me1 R8me2s K9me3  
D13 H3 1-19 R8me2s K9me2 T11P 
 
F21 H3 1-19 K4me2 R8me2s K9me3  
D14 H3 1-19 R8me2s K9me3 T11P  F22 H3 1-19 K4me3 R8me2s K9me3  
D15 H3 1-19 R8me2s K9ac S10P 
 
F23 H3 1-19 K4ac R8me2s K9me3  
D16 H3 1-19 R8me2a K9me1 S10P  F24 H3 1-19 K4me1 R8me2a K9me3  
D17 H3 1-19 R8me2a K9me2 S10P 
 
G 1 H3 1-19 K4me2 R8me2a K9me3  
D18 H3 1-19 R8me2a K9me3 S10P 
 
G 2 H3 1-19 K4me3 R8me2a K9me3  
D19 H3 1-19 R8me2a K9ac T11P  G 3 H3 1-19 K4ac R8me2a K9me3  
D20 H3 1-19 R8me2a K9me1 T11P 
 
G 4 H3 1-19 K4me1 R8me2s K9ac  
D21 H3 1-19 R8me2a K9me2 T11P  G 5 H3 1-19 K4me2 R8me2s K9ac  
D22 H3 1-19 R8me2a K9me3 T11P 
 
G 6 H3 1-19 K4me3 R8me2s K9ac  
D23 H3 1-19 R8me2a K9ac S10P T11P G 7 H3 1-19 K4ac R8me2s K9ac  
D24 H3 1-19 R8me2a K9me1 S10P T11P G 8 H3 1-19 K4me1 R8me2a K9ac  
E 1 H3 1-19 R8me2a K9me2 S10P T11P G 9 H3 1-19 K4me2 R8me2a K9ac  
E 2 H3 1-19 R8me2a K9me3 S10P T11P G10 H3 1-19 K4me3 R8me2a K9ac  
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Spot Name Mod 1 Mod 2 Mod 3 Mod 4  Spot Name Mod 1 Mod 2 Mod 3 Mod 4  
G11 H3 1-19 K4ac R8me2a K9ac 
 
I19 H3 1-19 R2me2a K4ac R8me2a K9me3 
G12 H3 1-19 R2me2s K4me1 R8me2s K9me1 I20 H3 1-19 R2me2s K4me1 R8me2a K9me3 
G13 H3 1-19 R2me2s K4me2 R8me2s K9me1 I21 H3 1-19 R2me2s K4me2 R8me2a K9ac 
G14 H3 1-19 R2me2s K4me3 R8me2s K9me1 I22 H3 1-19 R2me2s K4me3 R8me2a K9ac 
G15 H3 1-19 R2me2s K4ac R8me2s K9me1 I23 H3 1-19 R2me2s K4ac R8me2a K9ac 
G16 H3 1-19 R2me2a K4me1 R8me2s K9me1 I24 H3 1-19 R2me2a K4me1 R8me2a K9ac 
G17 H3 1-19 R2me2a K4me2 R8me2s K9me1 J 1 H3 1-19 R2me2a K4me2 R8me2a K9ac 
G18 H3 1-19 R2me2a K4me3 R8me2s K9me1 J 2 H3 1-19 R2me2a K4me3 R8me2a K9ac 
G19 H3 1-19 R2me2a K4ac R8me2s K9me1 J 3 H3 1-19 R2me2a K4ac R8me2a K9ac 
G20 H3 1-19 R2me2s K4me1 R8me2s K9me2 J 4 H3 7-26 unmod   K9ac 
G21 H3 1-19 R2me2s K4me2 R8me2s K9me2 J 5 H3 7-26 K14ac    
G22 H3 1-19 R2me2s K4me3 R8me2s K9me2 J 6 H3 7-26 K14ac S10P   
G23 H3 1-19 R2me2s K4ac R8me2s K9me2 J 7 H3 7-26 K14ac T11P   
G24 H3 1-19 R2me2a K4me1 R8me2s K9me2 J 8 H3 7-26 R17me2s    
H 1 H3 1-19 R2me2a K4me2 R8me2s K9me2 J 9 H3 7-26 R17me2a    
H 2 H3 1-19 R2me2a K4me3 R8me2s K9me2 J10 H3 7-26 R17Citr    
H 3 H3 1-19 R2me2a K4ac R8me2s K9me2 J11 H3 7-26 K18ac    
H 4 H3 1-19 R2me2s K4me1 R8me2s K9me3 J12 H3 7-26 K14ac R17me2s   
H 5 H3 1-19 R2me2s K4me2 R8me2s K9me3 J13 H3 7-26 K14ac R17me2a   
H 6 H3 1-19 R2me2s K4me3 R8me2s K9me3 J14 H3 7-26 K14ac K18ac   
H 7 H3 1-19 R2me2s K4ac R8me2s K9me3 J15 H3 7-26 R17me2s K18ac   
H 8 H3 1-19 R2me2a K4me1 R8me2s K9me3 J16 H3 7-26 R17me2a K18ac   
H 9 H3 1-19 R2me2a K4me2 R8me2s K9me3 J17 H3 7-26 R17Citr K18ac   
H10 H3 1-19 R2me2a K4me3 R8me2s K9me3 J18 H3 7-26 K14ac R17me2s K18ac  
H11 H3 1-19 R2me2a K4ac R8me2s K9me3 J19 H3 7-26 K14ac R17me2a K18ac  
H12 H3 1-19 R2me2s K4me1 R8me2s K9ac J20 H3 16-35 unmod      
H13 H3 1-19 R2me2s K4me2 R8me2s K9ac J21 H3 16-35 R26me2s     
H14 H3 1-19 R2me2s K4me3 R8me2s K9ac J22 H3 16-35 R26me2a    
H15 H3 1-19 R2me2s K4ac R8me2s K9ac J23 H3 16-35 R26Citr    
H16 H3 1-19 R2me2a K4me1 R8me2s K9ac J24 H3 16-35 K27me1    
H17 H3 1-19 R2me2a K4me2 R8me2s K9ac K 1 H3 16-35 K27me2    
H18 H3 1-19 R2me2a K4me3 R8me2s K9ac K 2 H3 16-35 K27me3    
H19 H3 1-19 R2me2a K4ac R8me2s K9ac K 3 H3 16-35 K27ac    
H20 H3 1-19 R2me2s K4me1 R8me2a K9me1 K 4 H3 16-35 S28P      
H21 H3 1-19 R2me2s K4me2 R8me2a K9me1 K 5 H3 16-35 R26me2s K27me1    
H22 H3 1-19 R2me2s K4me3 R8me2a K9me1 K 6 H3 16-35 R26me2s K27me2   
H23 H3 1-19 R2me2s K4ac R8me2a K9me1 K 7 H3 16-35 R26me2s K27me3   
H24 H3 1-19 R2me2a K4me1 R8me2a K9me1 K 8 H3 16-35 R26me2s K27ac   
I 1 H3 1-19 R2me2a K4me2 R8me2a K9me1 K 9 H3 16-35 R26me2s S28P    
I 2 H3 1-19 R2me2a K4me3 R8me2a K9me1 K10 H3 16-35 R26me2a K27me1    
I 3 H3 1-19 R2me2a K4ac R8me2a K9me1 K11 H3 16-35 R26me2a K27me2   
I 4 H3 1-19 R2me2s K4me1 R8me2a K9me2 K12 H3 16-35 R26me2a K27me3   
I 5 H3 1-19 R2me2s K4me2 R8me2a K9me2 K13 H3 16-35 R26me2a K27ac   
I 6 H3 1-19 R2me2s K4me3 R8me2a K9me2 K14 H3 16-35 R26me2a S28P    
I 7 H3 1-19 R2me2s K4ac R8me2a K9me2 K15 H3 16-35 R26Citr K27me1    
I 8 H3 1-19 R2me2a K4me1 R8me2a K9me2 K16 H3 16-35 R26Citr K27me2   
I 9 H3 1-19 R2me2a K4me2 R8me2a K9me2 K17 H3 16-35 R26Citr K27me3   
I10 H3 1-19 R2me2a K4me3 R8me2a K9me2 K18 H3 16-35 R26Citr S28P    
I11 H3 1-19 R2me2a K4ac R8me2a K9me2 K19 H3 16-35 K27me1 S28P     
I12 H3 1-19 R2me2s K4me1 R8me2a K9me3 K20 H3 16-35 K27me2 S28P     
I13 H3 1-19 R2me2s K4me2 R8me2a K9me3 K21 H3 16-35 K27me3 S28P     
I14 H3 1-19 R2me2s K4me3 R8me2a K9me3 K22 H3 16-35 K27ac S28P     
I15 H3 1-19 R2me2s K4ac R8me2a K9me3 K23 H3 16-35 R26me2s K27me1 S28P   
I16 H3 1-19 R2me2a K4me1 R8me2a K9me3 K24 H3 16-35 R26me2s K27me2 S28P   
I17 H3 1-19 R2me2a K4me2 R8me2a K9me3 K24 H3 16-35 R26me2s K27me2 S28P   
I18 H3 1-19 R2me2a K4me3 R8me2a K9me3 L 1 H3 16-35 R26me2s K27me3 S28P   
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Spot Name Mod 1 Mod 2 Mod 3 Mod 4  Spot Name Mod 1 Mod 2 Mod 3 Mod 4  
L 2 H3 16-35 R26me2s K27ac S28P   N 8 H4 11-30 K16ac R17me2s   
L 3 H3 16-35 R26me2a K27me1 S28P   N 9 H4 11-30 K16ac R17me2a   
L 4 H3 16-35 R26me2a K27me2 S28P   N10 H4 11-30 K16ac R19me2s   
L 5 H3 16-35 R26me2a K27me3 S28P   N11 H4 11-30 K16ac R19me2a   
L 6 H3 16-35 R26me2a K27ac S28P   N12 H4 11-30 K16ac K20me1   
L 7 H3 26-45 unmod 
   
N13 H4 11-30 K16ac K20me2   
L 8 H3 26-45 K36me1    N14 H4 11-30 K16ac K20me3   
L 9 H3 26-45 K36me2 
   
N15 H4 11-30 K16ac K20ac   
L10 H3 26-45 K36me3 
   
N16 H4 11-30 K12ac K16ac K20me1  
L11 H3 26-45 K36ac 
   
N17 H4 11-30 K12ac K16ac K20me2  
L12 H4 1-19 unmod 
   
N18 H4 11-30 K12ac K16ac K20me3  
L13 H4 1-19 S1P    N19 H4 11-30 K12ac K16ac K20ac  
L14 H4 1-19 R3me2s 
   
N20 H4 11-30 R19me2a K20me1   
L15 H4 1-19 R3me2a    N21 H4 11-30 R19me2a K20me2   
L16 H4 1-19 K5ac 
   
N22 H4 11-30 R19me2a K20me3   
L17 H4 1-19 K8ac 
   
N23 H4 11-30 R19me2a K20ac   
L18 H4 1-19 K12ac    N24 H4 11-30 R19me2s K20me1   
L19 H4 1-19 K16ac 
   
O 1 H4 11-30 R19me2s K20me2   
L20 H4 1-19 S1P R3me2s   O 2 H4 11-30 R19me2s K20me3   
L21 H4 1-19 S1P R3me2a 
  
O 3 H4 11-30 R19me2s K20ac   
L22 H4 1-19 S1P K5ac 
  
O 4 H4 11-30 R24me2a K20me1   
L23 H4 1-19 R3me2s K5ac   O 5 H4 11-30 R24me2a K20me2   
L24 H4 1-19 R3me2s K8ac 
  
O 6 H4 11-30 R24me2a K20me3   
M 1 H4 1-19 R3me2a K5ac   O 7 H4 11-30 R24me2a K20ac   
M 2 H4 1-19 R3me2a K8ac 
  
O 8 H4 11-30 R24me2s K20me1   
M 3 H4 1-19 K5ac K8ac 
  
O 9 H4 11-30 R24me2s K20me2   
M 4 H4 1-19 K8ac K12ac   O10 H4 11-30 R24me2s K20me3   
M 5 H4 1-19 K8ac K16ac 
  
O11 H4 11-30 R24me2s K20ac   
M 6 H4 1-19 K12ac K16ac   O12 H2a 1-19 unmod    
M 7 H4 1-19 S1P R3me2s K5ac 
 
O13 H2a 1-19 S1P    
M 8 H4 1-19 S1P R3me2a K5ac 
 
O14 H2a 1-19 K5ac    
M 9 H4 1-19 R3me2s K5ac K8ac 
 
O15 H2a 1-19 K9ac    
M10 H4 1-19 R3me2a K5ac K8ac 
 
O16 H2a 1-19 K13ac    
M11 H4 1-19 K5ac K8ac K12ac  O17 H2a 1-19 S1P K5ac   
M12 H4 1-19 K8ac K12ac K16ac 
 
O18 H2a 1-19 S1P K9ac   
M13 H4 1-19 S1P R3me2s K5ac K8ac O19 H2a 1-19 S1P K13ac   
M14 H4 1-19 S1P R3me2a K5ac K8ac O20 H2a 1-19 K5ac K9ac   
M15 H4 1-19 R3me2s K5ac K8ac K12ac O21 H2a 1-19 K5ac K13ac   
M16 H4 1-19 R3me2a K5ac K8ac K12ac O22 H2a 1-19 K9ac K13ac   
M17 H4 1-19 K5ac K8ac K12ac K16ac O23 H2a 1-19 S1P K5ac K9ac  
M18 H4 11-30 unmod    O24 H2a 1-19 S1P K5ac K13ac  
M19 H4 11-30 K12ac 
   
P 1 H2a 1-19 S1P K9ac K13ac  
M20 H4 11-30 K16ac 
   
P 2 H2a 1-19 K5ac K9ac K13ac  
M21 H4 11-30 R17me2s    P 3 H2a 1-19 S1P K5ac K9ac K13ac 
M22 H4 11-30 R17me2a 
   
P 4 H2B 1-19 unmod    
M23 H4 11-30 R19me2s    P 5 H2B 1-19 K5ac    
M24 H4 11-30 R19me2a 
   
P 6 H2B 1-19 K12ac    
N 1 H4 11-30 K20me1 
   
P 7 H2B 1-19 S14P    
N 2 H4 11-30 K20me2    P 8 H2B 1-19 K15ac    
N 3 H4 11-30 K20me3 
   
P 9 H2B 1-19 K5ac K12ac   
N 4 H4 11-30 K20ac    P10 H2B 1-19 K5ac S14P   
N 5 H4 11-30 R24me2a 
   
P11 H2B 1-19 K5ac K15ac   
N 6 H4 11-30 R24me2s 
   
P12 H2B 1-19 K12ac S14P   
N 7 H4 11-30 K12ac K16ac 
  
P13 H2B 1-19 K12ac K15ac   
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Spot Name Mod 1 Mod 2 Mod 3 Mod 4  
P14 H2B 1-19 S14P K15ac   
P15 H2B 1-19 K5ac K12ac S14P 
 
P16 H2B 1-19 K5ac K12ac K15ac  
P17 H2B 1-19 K5ac S14P K15ac 
 
P18 H2B 1-19 K12ac S14P K15ac  
P19 H2B 1-19 K5ac K12ac S14P K15ac 
P20 Biotin peptide 
    
P21 c-myc tag     
P22 neg. contol 
    
P23 background 01     
P24 background 02 
    
 
*CelluSpots™ arrays are manufactured under license by INTAVIS Bioanalytical Instruments 
AG !
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ABSTRACT
Active DNA demethylation is crucial for epigenetic
control, but the underlying enzymatic mechanisms
are incompletely understood. REPRESSOR OF
SILENCING 1 (ROS1) is a 5-methylcytosine (5-meC)
DNA glycosylase/lyase that initiates DNA
demethylation in plants through a base excision repair
process. The enzyme binds DNA nonspecifically and
slides along the substrate in search of 5-meC. In this
work, we have used homology modelling and bio-
chemical analysis to gain insight into the mechanism
of target location and recognition by ROS1. We have
found that three putative helix-intercalating residues
(Q607, R903 and M905) are required for processing of
5-meC:G pairs, but dispensable for excision of mis-
matched 5-meC. Mutant proteins Q607A, R903A and
M905G retain the capacity to process an abasic site
opposite G, thus suggesting that all three residues
play a critical role in early steps of the base extrusion
process and likely contribute to destabilization of 5-
meC:G pairs. While R903 and M905 are not essential
for DNA binding, mutation of Q607 abrogates stable
binding to both methylated and nonmethylated DNA.
However, the mutant protein Q607A can form stable
complexes with DNA substrates containing blocked
ends, which suggests that Q607 intercalates into the
helix and inhibits sliding. Altogether, our results
suggest that ROS1 uses three predicted helix-
invading residues to actively interrogate DNA in
search for 5-meC.
INTRODUCTION
DNA methylation at carbon 5 of cytosine (5-meC) is a
reversible epigenetic mark essential for cell differentiation
and genome defense against transposable elements (1).
Active DNA demethylation processes play a pivotal role
in shaping methylation patterns, but the underlying mech-
anisms are still incompletely understood (2,3). In plants,
active DNA demethylation is initiated by a family of
DNA glycosylases that specifically excise 5-meC and
initiate its replacement with unmethylated C in a base
excision repair (BER) process (2,4). No 5-meC DNA
glycosylases have been unambiguously identified in
animals, which may resort to BER of deaminated and/or
oxidized derivatives of 5-meC to perform demethylation
(5,6).
Plant 5-meC DNA glycosylases are typified by
Arabidopsis REPRESSOR OF SILENCING 1 (ROS1)
(7–9), and its paralogs DME (DEMETER), DML2 and
DML3 (DEMETER-like proteins 2 and 3) (8,10–12).
ROS1, DML2 and DML3 counteract excessive methyla-
tion at several hundred loci across the genome in vegeta-
tive tissues (11–13). DME demethylates the maternal allele
of imprinted genes in the endosperm (14), but its basal
function appears to be the reactivation of transposons in
companion cells to generate short interfering RNAs
(siRNAs) that would reinforce transposon silencing in
male and female gametes (15,16). ROS1, DML2 and
DML3 may also contribute to such reactivation in male
gametes (15). All four proteins are bifunctional enzymes
with an associate lyase activity that cleaves the phospho-
diester backbone at the 5-meC removal site by b,d-elimin-
ation, generating as a major product a single-nucleotide
gap flanked by 30-phosphate and 50-phosphate termini
(8,9,11,12,14). The DNA 30-phosphatase zinc finger
DNA 30-phosphoesterase (ZDP) functions downstream
of ROS1 by removing the blocking 30-phosphate (17),
and the repair protein XRCC1 stimulates 5-meC
excision and facilitates 30-end cleaning and DNA
ligation (18).
Plant 5-meC DNA glycosylases belong to the HhH-
GPD superfamily (19), but they are distinctively
characterized by a bipartite catalytic domain divided by
a large insert predicted to have an unstructured
*To whom correspondence should be addressed. Tel: +34 957 218 979; Fax: +34 957 212 072; Email: ge1roarr@uco.es
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conformation (20). They also contain a carboxy-terminal
domain of unknown function (8), and a short amino-
terminal domain significantly rich in lysine (21). In
ROS1, this basic domain mediates strong methylation-in-
dependent binding (21) and endows the protein with the
capacity to perform facilitated diffusion through random
1D sliding along DNA (22).
ROS1 and its homologs face the challenge to locate and
excise a modified, but otherwise nondamaged, correctly
paired base. Although no crystal structure is available
for any 5-meC DNA glycosylase, the combination of
sequence alignment and available structural data of
HhH-GPD enzymes allows predicting functional residues
that can be tested by site-directed mutagenesis. Most
DNA glycosylases use a common base-flipping mechanism
to extrude the target lesion from the base stack into a
substrate-recognition pocket (23–25). The resulting distor-
tion of the DNA is stabilized by insertion of a bulky
intercalating side chain that plugs the vacant space left
by the flipped-out nucleotide and a second side chain
that wedges between the bases on the opposite strand
(25). In a previous study (20), we used homology modeling
and biochemical analysis to identify residues important
for ROS1 function. Two amino acids predicted to be pos-
itioned between the base stack and the recognition pocket
(T606 and D611) were found to be essential for catalysis,
whereas mutational changes in two aromatic residues pre-
sumably located in the substrate-binding pocket (F589
and Y1028) altered the base specificity of the enzyme.
Our study also proposed Q607, which is essential for
both catalytic activity and stable DNA binding, as a
strong candidate for the plug residue that replaces the
flipped 5-meC in the base stack (20).
A central question that remains to be answered is how
ROS1 locates its target base. In this work, we have built
on our previous analysis (20) by investigating in detail the
functional role of the putative plug residue Q607 and two
other putative helix-intercalating amino acids (R903 and
M905) that are predicted to contact the orphan G on the
complementary strand. We have found that all three
residues are specifically required for excision of 5-meC:G
pairs, but dispensable for excision of mismatched 5-meC.
We also found evidence that Q607, which is essential for
stable methylation-independent DNA binding, slows
down ROS1 sliding along DNA. Altogether, our results
suggest that ROS1 performs sequential extrusion of every
base for extrahelical interrogation while sliding along the
DNA in search of 5-meC.
MATERIALS AND METHODS
DNA substrates
Oligonucleotides used as DNA substrates (Supplementary
Table S1) were synthesized by Operon or Integrated DNA
Technologies (IDT) and purified by polyacrylamide gel
electrophoresis (PAGE) before use. Double-stranded
DNA substrates were prepared by mixing a 5-mM
solution of a 50-fluorescein-labeled oligonucleotide
(upper-strand) with a 10-mM solution of an unlabeled
oligomer (lower-strand), heating to 95!C for 5min and
slowly cooling to room temperature. Annealing reactions
for the preparation of the 1-nt gapped duplex were carried
out at 95!C for 5min in the presence of a 2-fold molar
excess of both unlabeled 50-phosphorylated oligonucleo-
tide (P30_51) and unlabeled oligonucleotide (CGR) with
respect to the 50-alexa-labeled 30-phosphorylated oligo-
nucleotide (Al-28P), followed by cooling to room tem-
perature. DNA containing a natural AP site opposite
guanine was prepared by incubating a DNA duplex con-
taining a U:G mispair (200 nM) with 2.5U of Escherichia
coli Uracil DNA glycosylase (New England BioLabs) at
30!C for 5min. Substrates SL1 and SL1-2 contain the
same tetraloop obstacle at either one or both molecule
ends, respectively. The obstacle is created by a 6-bp
DNA helix capped at both termini with tetraloops,
which is connected to the DNA substrate via a four-way
junction (22). Both substrates were obtained by annealing
two oligonucleotides of different lengths, as previously
described (22).
Production of ROS1 mutant versions
Site-directed mutagenesis was performed using the Quick-
Change II XL kit (Stratagene). The mutations were
introduced into the expression vector pET28a (Novagen)
containing the full-length wild-type (WT) ROS1 cDNA
using specific oligonucleotides (Supplementary Table S2).
Mutational changes were confirmed by DNA sequencing,
and the constructs were used to transform E. coli BL21
(DE3) dcm" Codon Plus cells (Stratagene). WT and
mutant versions were expressed and purified as N-
terminal His-tagged proteins, as previously described
(21,26).
Enzyme activity assays
Fluorescein-labeled duplex oligonucleotides (20 nM,
unless otherwise stated) were incubated at 30!C for the
indicated times in a reaction mixture containing 50mM
Tris–HCl pH 8.0, 1mM EDTA, 1mM dithiothreitol
(DTT), 0.1mg/ml bovine serum albumin (BSA) and the
indicated amounts of WT ROS1 or mutant variant in a
total volume of 50 ml. When reactions included AP endo-
nuclease 1 (APE 1, 5U; New England BioLabs), EDTA
was omitted and 5mM MgCl2 was added. When
measuring AP lyase activity, the reaction mixture was
then incubated with 300mM NaBH4 at 0
!C for 30min
and neutralized with 100mM Tris–HCl pH 7.4.
Reactions were stopped by adding 20mM EDTA, 0.6%
sodium dodecyl sulphate and 0.5mg/ml proteinase K, and
the mixtures were incubated at 37!C for 30min. DNA was
extracted with phenol:chloroform:isoamyl alcohol
(25:24:1) and ethanol precipitated at "20!C in the
presence of 0.3mM NaCl and 16 mg/ml glycogen.
Samples were resuspended in 10 ml of 90% formamide
and heated at 95!C for 5min. Reaction products were
separated in a 12% denaturing polyacrylamide gel con-
taining 7M urea. Fluorescein-labeled DNA was visualized
in a FLA-5100 imager and analyzed using Multigauge
software (Fujifilm).
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Kinetic analysis
ROS1 does not exhibit significant turnover in vitro owing
to strong product binding (26), and therefore a simple
Michaelis–Menten model is inadequate for a correct
kinetic analysis of this enzyme. The standard reaction con-
ditions were equimolar (20 nM) enzyme/substrate ratios
and incubation at 30!C. Data were fitted to the equation
[Product]=Pmax[1 – exp
("kt)] using nonlinear regression
analysis and the software Sigmaplot. For each mutant
enzyme and substrate, the parameters Pmax (maximum
substrate processing within an unlimited period of time),
T50 (the time required to reach 50% of the product plateau
level, Pmax) and the relative processing efficiency
(Erel=Pmax/T50) were determined (27). A representative
example of 5-meC DNA glycosylase assay and kinetic
analysis is shown in Supplementary Figure S1.
Electrophoretic mobility shift assay
In standard electrophoretic mobility shift assay reactions,
increasing amounts of WT ROS1 or mutant variants were
incubated with 10 nM fluorescein- or alexa-labeled duplex
oligonucleotides, unless otherwise stated. Competition
band-shift reactions were performed by preincubating
WT ROS1 or mutant variants (130 nM) with 100 nM
fluorescein-labeled substrates at 25!C for 5min and then
adding increasing amounts of unlabeled duplex as com-
petitor. DNA binding reactions were carried out at 25!C
for 60min, unless otherwise stated, in 10mM Tris–HCl,
pH 8.0, 1mM DTT, 10 mg/ml BSA, 1mM EDTA, in a
final volume of 10 ml. Complexes were electrophoresed
through 0.2% agarose gels in 1# TAE (40mM Tris–
HCl, pH 8.0, 20mM acetic acid, 1mM EDTA).
Electrophoresis was carried out in 1# TAE for 40min at
80V at room temperature. Fluorescein- or alexa-labeled
DNA was visualized in a FLA-5100 imager and analyzed
using Multigauge software (Fujifilm).
RESULTS
Identification of putative helix-intercalating residues
in ROS1
In E. coli Endonuclease III, the side chain of L82 serves as
the wedge that intercalates into the DNA duplex and
stacks with the G opposite the lesion (estranged G),
which donates a hydrogen bond to the backbone
carbonyl of I80 (28). The homologous residues of L82
and I80 in ROS1 are M905 and R903, respectively
(Figure 1B). The residue R903 is conserved within the
ROS1/DME family of DNA demethylases, whereas Q
instead of M is observed at the homologous position of
M905 in some members of the family (Supplementary
Figure S2). The modeled structure of ROS1 (20) predicts
that M905 and R903 are positioned close to the G
opposite 5-meC (Figure 1C). To test the prediction that
M905 and R903 have a role in ROS1 enzymatic activity,
we mutated them to Gly (M905G) and Ala (R903A), re-
spectively. In our experiments, we also used the mutant
version Q607A, which lacks the putative plug residue (20).
Q607, R903 and M905 are specifically required for
processing of 5-meC:G base pairs
We first examined the ability of WT and mutant proteins
M905G, R903A and Q607A to process a 51-mer duplex
oligo substrate containing a single 5-meC opposite G, A, T
or C (Figure 2). Consistent with our previously reported
observations (26), we found that WT ROS1 processed
5-meC with higher efficiency when mispaired with either
C, T or A than when paired with G. Mutants M905G and
R903A had no detectable base excision activity on a
5-meC:G pair, whereas the Q607A mutant displayed a
strongly reduced activity on the same substrate
(Figure 2). Interestingly, however, all three mutant
proteins retained a significant activity on DNA substrates
containing a mismatched 5-meC. In contrast, two catalyt-
ically disabled mutants (D611V and T606L) did not show
detectable base excision activity on either paired or
mispaired 5-meC (data not shown). Therefore, Q607,
R903 and M905 are specifically required for efficient
excision of 5-meC opposite G.
These results strongly suggest significant differences in
recognition and processing of 5-meC:G pairs and 5-meC
mismatches. To explore further such possibility, we
examined the temperature dependence of WT ROS1
activity on both types of substrates (Supplementary
Figure S3). The catalytic activity on all four DNA sub-
strates increases with temperature from 5 to 30!C, but the
temperature dependence is significantly lower for the
DNA substrate containing a 5-meC:G pair.
ROS1 is a bifunctional DNA glycosylase/lyase that
catalyzes both the release of 5-meC and the cleavage of
DNA at the resulting abasic site (8). We therefore asked
whether the incapacity of the three mutant proteins to
process 5-meC:G pairs is due to a deficiency in DNA
glycosylase activity, lyase activity or both (Figure 3). To
detect DNA glycosylase activity, we analyzed the reaction
products generated by different ROS1 variants after an
additional alkaline treatment with NaOH, which cleaves
all abasic sites generated by the enzyme and reflects 5-meC
excision. We found that R903A and M905G mutant
enzymes did not generate detectable incision products,
whereas the Q607A variant showed a significantly
decreased activity (Figure 3B). Analogous results were
obtained when performing reactions in the presence of
human APE1 (data not shown). We next tested whether
the three variants retained AP lyase activity by incubating
the proteins with a 51-mer duplex oligo substrate contain-
ing an AP site opposite G. We found that all three mutant
variants cleaved the abasic site as efficiently as WT ROS1
(Figure 3C). These results indicate that R903A, M905G
and Q607A exhibit a specific defect in catalysis of
glycosylic bond cleavage. Because such defect is greatly
alleviated when the target base is mispaired, we conclude
that Q607, R903 and M905 are critical for destabilization
of 5-meC:G base pairs and are likely to perform a key role
in extrusion of the target base from DNA.
R903 and M905 are dispensable for DNA binding
We have previously reported that the Q607A mutant
exhibits a drastically reduced DNA binding capacity
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(20). We therefore decided to examine whether R903 and/
or M905 also play a role in substrate binding. We
incubated increasing concentrations of WT ROS1,
R903A, M905G or Q607A proteins with a labeled DNA
substrate containing a 5-meC:G pair (Figure 4). No
protein–DNA complexes were detected in binding reac-
tions containing the mutant protein Q607A. In the case
of WT ROS1, R903A and M905G proteins, we observed a
major band with retarded mobility at high protein concen-
trations and a minor diffuse band, exhibiting higher
mobility that was detectable at low protein concentra-
tions. Analogous results were obtained with
nonmethylated DNA (data not shown). These results
suggest the formation of protein–DNA complexes con-
taining more than one ROS1 molecule. A similar
observation has been previously reported for a mamma-
lian homolog of the DNA glycosylase MutY (29).
Quantitation of the total amount of protein–DNA
complexes (Figure 4, left) indicates that there are not sig-
nificant differences in DNA binding capacity between WT
ROS1 and either R903A or M905G proteins.
We next examined in detail the binding affinity of
WT ROS1, R903A and M905G through competition
experiments with unlabeled oligonucleotides (Figure 5).
In agreement with its methylation-independent DNA
binding capacity (21), WT ROS1 binding to a methylated
DNA probe was reduced with equivalent intensity
when incubated with increasing amounts of either
nonmethylated or methylated unlabeled competitor
DNA (Figure 5, upper panel). We found that the two
Figure 1. Identification of putative helix-invading residues in ROS1. (A) Schematic diagram showing conserved regions among members of the
ROS1/DME family: a N-terminal lysine-rich region (green), a noncontiguous DNA glycosylase domain distributed over two segments (blue and red)
separated by a nonstructured linker region and a highly conserved C-terminal domain (yellow) that is not found in any other protein family.
(B) Multiple sequence alignment of part of the DNA glycosylase domain of ROS1/DME proteins and several HhH-GPD superfamily members.
ROS1 amino acids analyzed in this work are indicated by inverted triangles and highlighted in orange (Q607), green (R903) or pink (M905). Names
of organisms are abbreviated as follows: Ath, Arabidopsis thaliana; Nta, Nicotiana tabacum; Bst, Bacillus stearothermophilus; Eco, Escherichia coli;
Mth, Methanobacterium thermoautotrophicum; Mmu, Mus musculus; Hsa, Homo sapiens. Genbank accession numbers are as follows: Ath ROS1:
AAP37178; Ath DME: ABC61677; Nta ROS1: BAF52855; Bst EndoIII: 1P59; Eco EndoIII: P20625; Mth Mig: NP_039762; Eco MutY: NP_417436;
Mmu MBD4: 1NGN; Hsa OGG1: O15527; Eco AlkA: P04395. (C) Structural model for the DNA glycosylase domain of ROS1 bound to a DNA
containing an abasic site. The position of Q607, R903 and M905 residues (colored as in panel B) in relation to the estranged guanine (blue) are
shown. The model was generated as described in (20) and the figure was prepared with PyMOL (http://www.pymol.org). (D) Schematic sequence
diagram indicating the predicted interactions between mutated amino acids and the orphan guanine (blue) opposite 5-meC (M, in red).
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mutant proteins exhibited dissociation rates not signifi-
cantly different from those of the WT protein, and both
bound methylated and nonmethylated DNA with similar
affinity (Figure 5, middle and lower panels). We also
found that the two mutant versions do not show any
enhanced affinity for DNA substrates containing mis-
matched 5-meC, or for a single nucleotide gap opposite
A, T or C (Supplementary Figure S4). Altogether, these
results indicate that R903 and M905 are dispensable for
DNA binding.
Q607 inhibits ROS1 sliding along DNA
The results discussed above indicate that residues Q607,
R903 and M905 are required for excision of 5-meC
opposite G, but only the former is critical for stable
DNA binding (20). We have suggested that Q607 is the
plug residue used by ROS1 to flip out 5-meC and com-
pensate its extrusion by filling in the vacant space in the
DNA base stack (20). Because Q607 is required for stable
binding to both methylated and unmethylated DNA (20),
we hypothesized that ROS1 performs extrahelical interro-
gation of unmethylated base pairs by insertion of this
residue into the DNA helix.
We have recently reported that ROS1 performs sliding
on DNA while searching for its target base (22).
Therefore, we reasoned that if Q607 plays any role in
DNA interrogation, the absence of this residue in the
mutant protein should have an effect on DNA sliding.
To examine this possibility, we compared the diffusive
Figure 3. Q607A, M905G and R903A mutant proteins lack DNA glycosylase activity on 5-meC:G pairs but retain AP liase activity. (A) Schematic
diagram of ROS1 DNA glycosylase/AP lyase activity on 5-meC. ROS1 excises 5-meC as a free base and then cleaves the phosphodiester backbone at
the 5-meC removal site by successive b,d-elimination. (B) DNA glycosylase assay. The generation of incision products was measured by incubating
purified WT ROS1 or mutant variants (20 nM) at 30!C for 4 h with a double-stranded oligonucleotide substrate (20 nM) containing a single 5-meC:G
pair. After incubation, NaOH (100 nM) was added and samples were immediately transferred to 90!C for 10min. Products were separated in a 12%
denaturing polyacrylamide gel and the amounts of incised oligonucleotide were quantified by fluorescent scanning. (C) AP liase assay. A double-
stranded oligonucleotide substrate containing an AP site opposite G (20 nM) was incubated at 30!C for 2 h in the presence of purified WT ROS1 or
mutant variants (20 nM). Samples were treated with NaBH4 (300mM) at 0
!C for 30min to stabilize nonprocessed AP sites and neutralized with
100mM Tris–HCl, pH 7.4. Products were separated in a 12% denaturing polyacrylamide gel and the amount of incised oligonucleotide was
quantified by fluorescent scanning. Values are mean±SE (error bars) from three independent experiments.
Figure 2. Enzymatic activity of WT ROS1 and mutant variants on
DNA substrates containing 5-meC opposite different bases. Purified
proteins (20 nM) were incubated at 30!C with 51-mer double-stranded
oligonucleotide substrates (20 nM) containing 5-meC opposite G, A, T
or C, as indicated. Relative processing efficiencies were determined in
kinetic assays as described in ‘Materials and Methods’ section. Values
are mean±SE (error bars) from three independent experiments.
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behavior of WT ROS1 and Q607A on a substrate con-
taining tetraloop obstacles along the DNA surface
(Figure 6). We preincubated WT ROS1 or Q607A with
labeled substrates S or SL1-2 and then added increasing
concentrations of unlabeled S competitor to promote dis-
sociation. Consistent with our previously reported obser-
vations (22), we found that WT ROS1 dissociates from
substrate S when chased by the competitor, but remains
bound to substrate SL1-2 even at high competitor con-
centrations. As expected, Q607A was unable to bind sub-
strate S. However, the mutant protein was able to form a
stable complex with substrate SL1-2, resisting competi-
tion with increasing concentrations of unlabeled S
(Figure 6). By performing DNA binding measurements
at different time points in the absence of competitor, we
detected stable complexes of WT ROS1 with both S and
SL1-2, whereas Q607A only bound stably to SL1-2
(Figure 7). Furthermore, we found that unblocking one
of the substrate ends greatly reduced the capacity of
Q607A to form a stable complex with DNA
(Supplementary Figure S5). We therefore conclude that
the Q607A variant is unable to form a stable complex
with a DNA substrate containing free ends, but remains
bound to a molecule whose ends are obstructed with
tetraloop blocks. Importantly, we found that the stable
binding of Q607A to substrate SL1-2 did not have any
positive effect on the reduced catalytic activity of
the mutant protein (Supplementary Figure S6), thus
Figure 4. DNA binding capacity of R903A, M905G and Q607A mutant proteins. Increasing concentrations of purified WT ROS1 or mutant
variants were incubated at 25!C for 1 h with 10 nM of fluorescein-labeled 5-meC:G duplex. After nondenaturing gel electrophoresis, gels were
scanned to detect fluorescein-labeled DNA. Protein–DNA complexes were identified by their retarded mobility compared with that of free DNA.
A representative gel is shown for each protein. Graphs on the left show the percentage of protein–DNA complex versus protein concentration. All
bands with slower mobility were used in quantitation of bound protein. Values are mean±SE (error bars) from three independent experiments.
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corroborating the essential role of Q607 for base
excision. Altogether, these results indicate that Q607
has an inhibitory effect on ROS1 sliding along DNA,
and suggest that the enzyme extrudes unmethylated
bases for interrogation by inserting this residue into the
base stack.
DISCUSSION
The conserved base-flipping mechanism used by DNA
glycosylases entails the need to stabilize the resulting dis-
tortion of DNA. Central to this process is the intercalation
of two residues into the base stack: a plug residue that fills
the gap left by the flipped-out nucleotide and a wedge
residue that intrudes between bases on the opposite
strand and interacts with the orphan base. Our
homology modeling and functional analysis of ROS1
suggest that Q607 and M905 serve the roles of plug and
wedge residues, respectively, with R903 additionally per-
forming a critical function in the stabilization of the
orphan G. In this work, we have analyzed the function
of these three putative DNA intercalating residues in ini-
tiation of DNA demethylation by ROS1 glycosylase.
We have found that Q607A, M905G and R903A
variants fail to process 5-meC:G pairs, but remain com-
petent in cleaving an abasic site opposite G. These results
demonstrate that mutations in any of these three residues
specifically impair early 5-meC recognition events, leaving
intact the capacity to perform downstream steps in the
base excision cascade. Similar separation of function mu-
tations have been reported in other bifunctional DNA
glycosylases. For example, blocking the 8-oxoG recogni-
tion pocket of hOGG1 with a bulky amino acid side
chain generates a mutant variant unable to flip 8-oxoG
nucleotides in DNA, but still able to recognize and
cleave abasic sites (30). Interestingly, mutation of two
DNA intercalating residues in Fpg (also called MutM)
(F114A and M77A) significantly decreases 8-oxoG
excision but preserves AP lyase activity (31). Although
our results do not exclude the possibility that Q607A,
M905G and/or R903A may facilitate AP site hydrolysis
following 5-meC excision, they suggest that the major
catalytic defect in the three mutant proteins relates to
upstream steps of the base extrusion pathway.
WT ROS1 excises 5-meC more efficiently from
mismatches (26), which suggests that facile extrusion
from the helix plays a critical role in 5-meC excision.
The ROS1 model structure predicts that Q607, M905
and R903 are candidates to intercalate in DNA, and there-
fore they might play a role in destabilization and extrusion
of 5-meC opposite G. This hypothesis is supported by the
remarkable observation that all three mutant ROS1
proteins retain a significant 5-meC excision activity when
the target base is mispaired. Increased base excision
activity by disruption of proper base pairing has been pre-
viously reported for several glycosylases (32–34). UDG
has been proposed to capture spontaneously extruded
Figure 5. Binding of R903A and M905G mutant proteins to methylated and nonmethylated DNA. WT ROS1 (upper panel), R903A (center panel)
or M905G (lower panel) proteins (130 nM) were incubated at 25!C for 1 h with 100 nM labeled methylated DNA containing a single 5-meC:G pair,
in the presence of increasing amounts (0, 0.1, 0.25, 0.5 and 1.0 mM) of either methylated (lanes 2–6) or nonmethylated (lanes 2 and 7–10) unlabeled
competitor DNA. After nondenaturing gel electrophoresis, the gel was scanned to detect fluorescein-labeled DNA. Protein–DNA complexes were
identified by their retarded mobility compared with that of free DNA, as indicated. Graphs on the left show the percentage of remaining complex
versus competitor molar excess ratios. Values are mean±SE (error bars) from three independent experiments. M indicates 5-meC.
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uracils (35), and displays higher activity when its target
base is mispaired with an unnatural adenine analog that
lacks Watson–Crick hydrogen-bonding groups (33). DNA
glycosylases that use an active base-flipping mechanism,
such as Fpg and human AAG, also excise their target
bases with higher efficiency when mispaired with
nonpolar analogs (32,34), an effect that has been
attributed to facilitated base extrusion from the helix.
Interestingly, the catalytic activity of human AAG
mutated in the plug residue Y162 was partially restored
when the base opposite the target was changed to a
nonhydrogen bonding partner (34). This result mirrors
our observation that variant Q607A retains a significant
activity on mismatched 5-meC, thus suggesting that
facilitated extrusion of the target base partially bypasses
requirement for helix-invading residues.
Insertion of the plug residue into the gap left by the
extruded base is likely to play a crucial role in stabilizing
the lesion-recognition complex. In fact, it has been con-
sistently observed in different DNA glycosylases that
mutation of the plug residue not only curtails catalytic
activity, but also abrogates stable binding to DNA sub-
strates (34,36,37). However, there is growing evidence
that, in addition to stabilizing the extrahelical state after
base flipping, side chains that intercalate into DNA play a
critical role during target location and substrate specificity
(31,38–40). The results described here strengthen the
hypothesis that ROS1 uses Q607 as a plug residue for
efficient 5-meC extrusion. In addition, they suggest that
ROS1 requires such residue for extrusion of both
methylated and unmethylated bases in a DNA scanning
process. There are several observations that, taken
together with the stable binding of Q607A to a DNA sub-
strate with blocked termini, support the idea that Q607A
is not just a DNA binding-deficient mutant, but a faster
slider with decreased extrusion rates on both methylated
Figure 6. The Q607A variant remains bound to a DNA substrate with blocked ends. (A) Schematic diagram showing the experimental setup used to
assay for linear diffusion. Proteins were preincubated for 5min with fluorescein-labeled substrates S or SL1-2, both containing a single 5-meC:G pair,
and then chased by addition of unlabeled S competitor. If linear diffusion occurs, dissociation will be faster from labeled substrate S. (B) Gel shift
assay showing dissociation of WT ROS1 (upper panel, 130 nM) and the Q607A mutant (lower panel, 130 nM) from fluorescein-labeled substrates S
(lanes 2–6, 100 nM) and SL1-2 (lanes 7–11, 100 nM) on addition of increasing amounts (0, 0.1, 0.25, 0.5 and 1.0 mM) of methylated unlabeled
competitor S. After nondenaturing gel electrophoresis, the gel was scanned to detect fluorescein-labeled DNA. Protein–DNA complexes were
identified by their retarded mobility compared with that of free DNA, as indicated. Graphs on the left show the percentage of remaining
complex versus competitor molar excess ratios. Values are mean±SE (error bars) from three independent experiments.
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and unmethylated bases. WT ROS1 binds with similar
affinity to methylated and nonmethylated DNA, whereas
Q607A does not show detectable binding activity on either
substrate. However, despite such undetectable binding
capacity, Q607A exhibits a significant activity on targets
that do not require full extrusion competence, such as
mismatched 5-meC and AP sites, and displays excision
rates similar to those of the binding-proficient versions
M905G and R903A. In contrast, the increased binding
of Q607A to a DNA substrate with blocked ends does
not result in an increased activity on 5-meC:G pairs
(Supplementary Figure S6), which suggests that unstable
DNA binding is a derived consequence of a deficiency in a
putative plug residue. We therefore propose that the
unstable DNA binding exhibited by the Q607A mutant
is most likely due to increased sliding along DNA, thus
implying that the side chain of Q607 inhibits the scanning
rate of ROS1. The role of helix-invading residues in
controlling motion of a DNA glycosylase along DNA
is not without precedent. In Fpg, which performs
intrahelical interrogation (39), mutations of the wedge
(F114) and plug (R112) residues increase the diffusion
rate (40) and induce strandwise translocation (41),
respectively.
Our results shed some light on the possible mechanism
used by ROS1 to locate its target base. Three possible
strategies have been proposed to explain how DNA
glycosylases find their target bases on DNA: (i) passive
capture of extrahelical target bases that have spontan-
eously emerged from the DNA base stack (35), (ii)
intrahelical inspection of the relative strength and flexibil-
ity of base pairs by inserting one or more residues into the
DNA duplex (38,42) and (iii) sequential extrusion of every
base out of the DNA helix for extrahelical interrogation
(43). Because methylation has been shown to decrease
base opening rates (44), it is unlikely that ROS1 passively
captures 5-meC residues spontaneously emerged from the
DNA base stack at 5-meC:G pairs. By other hand, the
inhibitory role of Q607 on ROS1 sliding along DNA
suggests that base flipping precedes substrate discrimin-
ation, and that the enzyme actively interrogates bases on
an extrahelical rather that intrahelical conformation.
Intrahelical inspection may be rather inefficient to distin-
guish between C and 5-meC. Methylation does not induce
gross conformational changes in DNA (45) and the
5-methyl group is located on the major groove, whereas
the catalytic domain of ROS1, as in all other DNA
glycosylases (23), is expected to bind DNA through the
minor groove. Intriguingly, both the DNA-binding
domain of the methyl-specific endonuclease McrBC from
E. coli (46) and the SET- and Ring-associated (SRA)
domains of mammalian UHRF1 (47) and Arabidopsis
SUVH5 (48) flip out 5-meC from the base stack to
achieve discrimination of 5-meC from C. In any case, a
full understanding of the search mechanism used by ROS1
must await structural information for this enzyme.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
The authors thank members of their laboratory for helpful
discussions and advice.
Figure 7. Stable binding of Q607A variant to a DNA substrate with blocked ends. Purified WT ROS1 (upper panel, 130 nM) or Q607A mutant
variant (lower panel, 130 nM) were incubated at 25!C with 100 nM of fluorescein-labeled substrates S (lanes 2–6) or SL1-2 (lanes 7–11), both
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Name 
DNA Sequence
a 
Strand
X=  Length 
FL-CGF 
5´-TCACGGGATCAATGTGTTCTTTCAGCTCXGGTCACGCTGACCAGGAATACC-3´ 
  Upper 
C 
51 
FL-meCGF 
5´-TCACGGGATCAATGTGTTCTTTCAGCTCXGGTCACGCTGACCAGGAATACC-3´ 
Upper 
5-me
51 
CGR 
3´-AGTGCCCTAGTTACACAAGAAAGTCGAGXCCAGTGCGACTGGTCCTTATGG-5´ 
Lower 
G 
 51 
CGR-A 
    3´-AGTGCCCTAGTTACACAAGAAAGTCGAGXCCAGTGCGACTGGTCCTTATGG-5´  
Lower 
A 
 51 
CGR-T 
    3´-AGTGCCCTAGTTACACAAGAAAGTCGAGXCCAGTGCGACTGGTCCTTATGG-5´  
Lower 
T 
 51 
CGR-C 
3´-AGTGCCCTAGTTACACAAGAAAGTCGAGXCCAGTGCGACTGGTCCTTATGG-5´ 
Lower 
C 
 51 
Al-28P  
5´-TCACGGGATCAATGTGTTCTTTCAGCTC-3´ 
Upper 
- 
   28 
P30_51  
5´-GGTCACGCTGACCAGGAATACC-3´ 
Upper 
- 
   22 
FL-meCGF61 
5´-TCACGCGGGATCAATGTGTTCTTTCAGCTCXGGTCACGCTGACCAGGAATACCTCACTACC-3´ 
Upper 
5-me
   61 
CGR61 
3´-AGTGCGCCCTAGTTACACAAGAAAGTCGAGXCCAGTGCGACTGGTCCTTATGGAGTGATGG-5´ 
Lower 
G 
   61 
CGR61 LOOP1 
3´-AGTGCGCCCTAGTTACACAAGAAAGTCGAGXCCAGTGCGACTGGTaggaatgcctgggaatgcccCCTTATGGAGTGATGG-5´ 
Lower 
G 
81 
CGR61 LOOP1-2 
3´-AGTGCGCCCTAGTTACaggaatgcctgggaatgcccACAAGAAAGTCGAGXCCAGTGCGACTGGTaggaatgcctgggaatgcccCCTTATGGAGTGATGG-5´
Lower 
G 
101 
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Table S2. Oligonucleotides used as primers for generation of ROS1 mutant variants 
Name Sequence (5’-3’)a 
ROS1Q607A-F GGAGTATTTCTCACTGCAAATGTTTCAGACCATCTCTCAAG 
ROS1Q607A-R CTTGAGAGATGGTCTGAAACATTTGCAGTGAGAAATACTCC 
ROS1R903A-F ACAATCAAGAGTGCCGGGATGAACCATAAACTTGCAGAACG 
ROS1R903A-R CGTTCTGCAAGTTTATGGTTCATCCCGGCACTCTTGATTGT 
ROS1M905G-F ACAATCAAGAGTCGCGGGGGGAACCATAAACTTGCAGAACG 
ROS1M905G-R CGTTCTGCAAGTTTATGGTTCCCCCCGCGACTCTTGATTGT 
aUnderlining indicates the mutagenized codon. 
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Figure S1
Figure S1. Representative example of 5-meC DNA glycosylase assay and kinetic 
analysis. The time-dependent generation of incision products was measured by 
incubating purified  WT ROS1 (20 nM) at 30 °C with a fluorescein-labeled duplex 
substrate containing a single 5-meC:G pair (20 nM). Reactions were stopped at the 
indicated times, products were separated in a 12% denaturing polyacrylamide gel and 
quantified by fluorescence scanning. The graph shows the generation of incision 
products versus time. Values are means ± S.E. (error bars) from three independent 
experiments. Data were fitted to the equation [Product] = Pmax[1-exp(-kt)] using non-
linear regression analysis. Blue and red curves indicate 95% confidence and prediction 
intervals, respectively.
Ath ROS1
C-terminal domainlysine-rich domain
Modeled region
6a 6b
258 aa
6c
A
B 6d 6d´
FLTQN LAEMN
E
Ath ROS1  597  VDSVVGV VSDHLSSSAFMSLASQF-(258)-VDWKAIRAADVKEVAETIK RGS HK RIQGFLDRLVND-H 
Ath DME  1025  VDSVIGVFLTQNVSDHLSSSAFMSLAARF-(421)-IDYEAIRRASISEISEAIK RGMNNMLAVRIKDFLERIVKD-H 
Ath DML2  566 VDSVVGVFLTQNVADHSSSSAYMDLAAEF-(221)-VDWDALRCTDVHKIANIIIKRGMNNMLAERIKAFLNRLVKK-H 
Ath DML3  477 VDSVVGVFLTQNTTDYLSSNAFMSVAAKF--(79)-VNWSDVRLSGQNVLETTIKKRGQFRILSERILKFLNDEVNQ-N 
Nta ROS1  833 VDSVVGVFLTQNVSDHLSSSAFMSLAAQF-(410)-LDWEAVRCADVNEIAHTIRERGMNNMLAERIKDFLNRIFRE-H 
Nta ROS2  903 VDSVVGVFLTQNVSDHLSSSAFMSLAAHF-(340)-LDWEAVRCANVNEIAHTIRERGMNNKLAERIKNFLNRIVSE-H 
Osa DMLA  524 TDSVVGTFLTQNVADNLSSNAFLNLVAKF-(148)-ADWEAVLHAPAVEIANSIAVRGQHYVIALRIQAFLKRVKKD-H 
Osa DMLB  935 VDSVVGVFLTQNVSDHLSSSAFMALAAKF-(464)-IDWETIRQAEVKEISDTIRERGMNNMLAERIKDFLNRLVRD-H 
Osa DMLC  916 VDSVVGVFLTQNVADHLSSSAYMALAASF-(392)-VDWEAVRCADVQRISHAIRERGMNNVLAERIQKFLNRLVTD-H 
Sbi DML   802 VDSVVGVFLTQNVADHLSSSAYMALAASF-(389)-VDWEAVRCADAQRISHAIRERGMNNILAERIQNFLNRLVRD-H 
Ppa DML   837 MDSVGGAFLTQNVSDFLSSNAFMALRARF-(376)-VDWNAVQQASVHEVADVIKNRGQHNALAGRLKAFLDRVHRDQN 
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Figure S2. Conservation of Q607, R903 and M905 residues among members of the 
ROS1/DME family. (A) The upper schematic diagram shows the conserved regions 
among members of the ROS1/DME family: a N-terminal lysine-rich region (green), a 
non-contiguous DNA glycosylase domain distributed over two segments (blue and red) 
separated by a non-structured linker region, and a highly conserved C-terminal domain 
(yellow) that is not found in any other protein family. (B) Multiple sequence alignment 
of part of the DNA glycosylase domain of member of the ROS1/DME family. ROS1 
amino acids analyzed in this work are indicated by inverted triangles and highlighted in 
orange (Q607), green (R903) or pink (M905). Names of organisms are abbreviated as 
follows: Ath, Arabidopsis thaliana; Nta, Nicotiana tabacum; Osa, Oryza sativa; Sbi, 
Sorghum bicolor; Ppa, Physcomitrella patens. Genbank accession numbers are: Ath 
ROS1 AAP37178; Ath DME ABC61677; Ath DML2 Q9SR66; Ath DML3 O49498; 
Nta ROS1 BAF52855; Nta ROS2 BAF52856; Osa DMLA BAD23025; Osa DMLB 
BAF04322; Osa DMLC EEE63898; Sbi DML  XP_002441186; Ppa DML  DS545358.
Figure S2
02
4
6
8
10
12
0 10 20 30
Co
nc
en
tr
ati
on
 (n
M
) 
Temperature (ºC)
5-meC:G
5-meC:A
5-meC:T
5-meC:C
Pr
od
uc
t
Parrilla-Doblas et al.
Figure S3. Temperature dependence of ROS1 activity on 5-meC opposite G, A, 
T or C. Generation of incision products was measured by incubating for 4 h at 
the indicated temperatures purified WT ROS1 or mutant proteins (20 nM) with 
double-stranded oligonucleotide substrates (20 nM) containing 5-meC opposite 
G (filled circles), A (open circles), T (filled triangles) or C (open triangles) on 
the complementary strand. Products were separated in a 12% denaturing 
polyacrylamide gel, and the amount of incised oligonucleotide was quantified by 
fluorescence scanning. Values are mean ± SE (error bars) from three 
independent experiments.
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Figure S4. R903A and M905G mutant proteins bind with similar affinity 
to both substrate and product, independently of whether the opposite base 
is G, A, T or C. DNA-binding reactions were performed incubating at 25 º 
C for 60 min purified WT ROS1 or mutant variants (130 nM) with 100 nM 
of fluorescein-labelled substrates containing either 5-meC (upper panel) or 
a 1-nt gap flanked with 3´-P and 5´-P termini (lower panel) opposite G, A, 
T or C. After non-denaturing gel electrophoresis, the gel was scanned to 
detect fluorescein-labelled DNA. Protein -DNA complexes were identified 
by their retarded mobility compared with that of free DNA, as indicated. 
The asterisk depicts 5'-end labeling of the upper strand.
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Figure S5. Binding of WT-ROS1 and Q607A mutant protein to 
S, SL1 and SL1-2 substrates. Purified WT ROS1 (upper panel, 
130 nM) or Q607A mutant variant (lower panel, 130 nM) were 
incubated at 25ºC with 100 nM of fluorescein-labelled 
substrates S, SL1 or SL1-2, containing a single 5-meC:G pair. 
Samples were analyzed by non-denaturing gel electrophoresis 
either inmediately (0 min) or after 60 min incubation. Protein-
DNA complexes were identified by their retarded mobility 
compared with that of free DNA, as indicated. The asterisk 
depicts 5'-end labeling of the upper strand.
Figure S5
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Figure S6. The Q607 residue is required for ROS1 5-meC 
excision activity. Purified WT ROS1 and Q607A mutant 
proteins (20 nM) were incubated at 30ºC for 7 h with 
fluorescein-labelled substrates S and SL1-2 (20 nM) 
containing a single 5-meC:G pair. Reaction products were 
separated in a 12% denaturing polyacrylamide gel and 
quantified by fluorescence scanning. Values are mean ± SE 
from three independent experiments.
Figure S6
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